Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL5,Fc receptor-like protein 5,33121,-0.100839351961713,0.0229048879264244,-0.145732932297505,-0.0559457716259211,1.08280435972975e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZB1,Marginal zone B- and B1-cell-specific protein,33153,-0.0900288042450672,0.0207653403826058,-0.130728871394975,-0.0493287370951597,1.47044964818334e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL17,C-X-C motif chemokine 17,33208,-0.067644968854359,0.0169752750995946,-0.100916508049564,-0.0343734296591536,6.8052805902513e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMG,Oligodendrocyte-myelin glycoprotein,33062,0.101860100253264,0.0260647835768639,0.0507731244426111,0.152947076063917,9.37922359894092e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR1,Hepatitis A virus cellular receptor 1,33174,-0.0956203312747967,0.0248897254568764,-0.144404193170274,-0.046836469379319,0.000123021588092403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHI3L1,Chitinase-3-like protein 1,32914,-0.111078125579914,0.0309306750413267,-0.171702248660915,-0.0504540024989142,0.000331029449033129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL20,C-C motif chemokine 20,33208,-0.128903862501814,0.0368749934409394,-0.201178849646055,-0.0566288753575726,0.000475163995883383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,31809,-0.0563051675045461,0.0162747961963222,-0.0882037680493375,-0.0244065669597546,0.000543937169577673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE2,Angiotensin-converting enzyme 2,32973,-0.0673248523625322,0.0200099687592223,-0.106544391130608,-0.0281053135944566,0.000770025990203649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MST1,Hepatocyte growth factor-like protein,31928,-0.0835639375126301,0.0253364386424793,-0.133223357251889,-0.0339045177733707,0.000977711256115221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY96,Lymphocyte antigen 96,33042,-0.047440327042334,0.0144651666412407,-0.0757920536591658,-0.0190886004255021,0.00104358891388792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WARS,"Tryptophan--tRNA ligase, cytoplasmic",33121,-0.0501151949744908,0.0156490641219122,-0.0807873606534387,-0.0194430292955429,0.00136760805766983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11D,Transmembrane protease serine 11D,31988,-0.0499831883869558,0.0157782052855293,-0.0809084707465932,-0.0190579060273183,0.00154177261213762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF15,Growth/differentiation factor 15,33208,-0.0533097973092182,0.016835672817474,-0.0863077160314672,-0.0203118785869693,0.00154826095064686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCA2A,Guanylin,33078,0.0418125646605312,0.013325001117226,0.0156955624707682,0.0679295668502941,0.00170734187507243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APLP1,Amyloid-like protein 1,33117,0.0664848096961342,0.0212894135188511,0.0247575591991861,0.108212060193082,0.00179665709390714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLC2,Immunoglobulin lambda constant 2,32055,-0.0309548340058003,0.0100827341309726,-0.0507169929025066,-0.0111926751090941,0.0021475389448168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGCR6,Protein DGCR6,31804,-0.0551287762404589,0.0180512495833376,-0.0905092254238007,-0.0197483270571171,0.0022660923604898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELE,E-selectin,33208,-0.0618027658118605,0.0205225840537077,-0.102027030557128,-0.0215785010665934,0.00260743935470741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTXR,Neuronal pentraxin receptor,33117,0.0423068655306794,0.0140487584451041,0.0147712989782755,0.0698424320830833,0.00260769362834978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LF,CMRF35-like molecule 1,33189,-0.0750568710874692,0.025119806618806,-0.124291692060329,-0.0258220501146095,0.00281630750671083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC2,WAP four-disulfide core domain protein 2,32655,-0.04609928554274,0.015475385817747,-0.0764310417455241,-0.0157675293399559,0.00290152971117829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",33208,-0.0346258026157685,0.0116631100918913,-0.0574854983958754,-0.0117661068356616,0.00299744784052914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMH,Granzyme H,32973,-0.093918957149102,0.0318407048985198,-0.156326738750201,-0.0315111755480032,0.00318998321420222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN2,Calsyntenin-2,33208,-0.0471712380684004,0.0160355424127768,-0.0786009011974428,-0.0157415749393579,0.00327305191120519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEG1,Protein HEG homolog 1,31907,-0.0319459655603168,0.0108627829524472,-0.0532370201471133,-0.0106549109735203,0.00328304568549017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRCP,Lysosomal Pro-X carboxypeptidase,33164,-0.0369865283420522,0.0126518075824418,-0.061784071203638,-0.0121889854804663,0.00347102006096401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB4A_DEFB4B,Beta-defensin 4A,32985,-0.177403789680528,0.0611269422073832,-0.297212596406999,-0.0575949829540569,0.00371477439772829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIA,Melanoma-derived growth regulatory protein,33126,-0.0434505386445904,0.0150567572507856,-0.0729617828561301,-0.0139392944330507,0.00391403878495869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP7,Matrilysin,32956,-0.0569187706464961,0.0198008175376529,-0.0957283730202958,-0.0181091682726963,0.00405585860157469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGFR,Tumor necrosis factor receptor superfamily member 16,32042,-0.0345252357842784,0.0120407898513051,-0.0581251838928365,-0.0109252876757204,0.00415056598546016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1R,Huntingtin-interacting protein 1-related protein,32000,-0.0522602716840183,0.0182547584960539,-0.0880395983362839,-0.0164809450317526,0.00421031876295075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK1,SLIT and NTRK-like protein 1,31816,0.0373094184314643,0.0130699878910453,0.0116922421650154,0.0629265946979131,0.00432131842627262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BATF,Basic leucine zipper transcriptional factor ATF-like,31826,-0.101981711654492,0.0359280125464877,-0.172400616245608,-0.0315628070633758,0.00454498005871084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL28,"39S ribosomal protein L28, mitochondrial",32020,0.0438656710700011,0.0154589481389149,0.0135661327177278,0.0741652094222744,0.00455809079428127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5L,CD5 antigen-like,32025,-0.0545808358971071,0.019245906628474,-0.0923028128889162,-0.016858858905298,0.00458077550884502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR4,Proline-rich protein 4,31845,-0.0811242546310704,0.0287154548332907,-0.13740654610432,-0.0248419631578207,0.00473913669048857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH3,Neurexophilin-3,31816,0.0346980492119092,0.0122897400422492,0.0106101587291008,0.0587859396947176,0.00476544964351139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,31816,-0.039856801658521,0.0141575411430202,-0.0676055822988404,-0.0121080210182015,0.00488710909187558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFL4,Insulin growth factor-like family member 4,31816,0.0882892358921098,0.0313657498335905,0.0268123662182724,0.149766105565947,0.00489326987286071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10,V-set and immunoglobulin domain-containing protein 10,31990,-0.0421272131310898,0.0150131890492753,-0.0715530636676693,-0.0127013625945102,0.00502871970497329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPL,N-acetylneuraminate lyase,32042,-0.0505886453793906,0.0180292628092964,-0.0859260004856117,-0.0152512902731696,0.00503011191075736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REN,Renin,33117,-0.0813623263421051,0.029019820262013,-0.138241174055651,-0.0244834786285596,0.00506351865715309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB2,BPI fold-containing family B member 2,32028,-0.079221937711993,0.0282560946504103,-0.134603883226797,-0.0238399921971889,0.00506466023060544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GASK1A,Golgi-associated kinase 1A,31791,-0.0501803546795087,0.0179123210115467,-0.0852885038621403,-0.0150722054968771,0.00510077699443736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UHRF2,E3 ubiquitin-protein ligase UHRF2,31791,-0.0417894328227248,0.0149666683709719,-0.0711241028298298,-0.0124547628156198,0.00524918418244608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP7,Insulin-like growth factor-binding protein 7,33208,-0.0332200085563035,0.0119058592863286,-0.0565554927575076,-0.00988452435509934,0.0052785592951628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR15L,Protein GPR15L,31998,-0.0706257112197298,0.0254031345206431,-0.12041585488019,-0.0208355675592694,0.00544605776858921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JUN,Transcription factor AP-1,32981,0.0603996940487807,0.0217660371803563,0.0177382611752824,0.103061126922279,0.00553301625138079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RA,Interleukin-2 receptor subunit alpha,33043,-0.0458442262774377,0.0165989566721843,-0.078378181354919,-0.0133102711999565,0.00575927755695444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAC3,Ras-related C3 botulinum toxin substrate 3,31826,-0.0796584929290265,0.0288804355175352,-0.136264146543395,-0.0230528393146576,0.00582608968079857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRHR,Growth hormone-releasing hormone receptor,32911,-0.0676849846149793,0.0246654567032723,-0.116029279753393,-0.0193406894765655,0.00608011978821289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA,Lymphotoxin-alpha,33109,0.045313409125187,0.0166597329048895,0.0126603326316035,0.0779664856187704,0.00654248413460792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPE,Carboxypeptidase E,33125,0.0425449745431683,0.0156642107291746,0.0118431215139861,0.0732468275723505,0.00661943857548888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK6,Kallikrein-6,33117,0.0335573743085972,0.012366872586428,0.00931830403919828,0.0577964445779961,0.00667103774924941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP5,Tartrate-resistant acid phosphatase type 5,33151,-0.0345753374278581,0.0128974482516291,-0.0598543360010511,-0.00929633885466504,0.00735872964521349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT16,U8 snoRNA-decapping enzyme,31986,-0.0975619838658705,0.0365178357826312,-0.169136941999828,-0.0259870257319133,0.00756471635184075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPX,Sushi repeat-containing protein SRPX,32042,-0.0363335397545197,0.0136153314475778,-0.0630195893917721,-0.00964749011726718,0.00763356072214281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH1,Protocadherin-1,33186,0.0245704958290606,0.0092490716200926,0.0064423154536791,0.0426986762044421,0.00790914296129464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSA,Arylsulfatase A,33121,-0.0487958902412248,0.0184388631352795,-0.0849360619863727,-0.012655718496077,0.00815098918791063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFP,Alpha-fetoprotein,33011,0.0759005068544939,0.0287291625673023,0.0195913482225814,0.132209665486406,0.00825844272877692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17C,Interleukin-17C,32981,-0.0754116751460401,0.0288864234284719,-0.132029065065845,-0.0187942852262352,0.00905345112430789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRL,Prolactin,33191,0.0807916487402381,0.0311709454063465,0.0196965957437989,0.141886701736677,0.00956092230388219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL10,C-X-C motif chemokine 10,33167,-0.0736777546288005,0.0285149466699598,-0.129567050101922,-0.0177884591556794,0.00978713751743554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBI,Transforming growth factor-beta-induced protein ig-h3,33065,-0.0286765923429265,0.0111128581575018,-0.05045779433163,-0.00689539035422307,0.00988248828761504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC6A,C-type lectin domain family 6 member A,32951,-0.0500256918199437,0.0194579506679571,-0.0881632751291397,-0.0118881085107478,0.0101584436672069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAN,Brevican core protein,33042,0.0351935220541381,0.0137561697116956,0.00823142941921466,0.0621556146890616,0.0105330801671418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL1,Interleukin-1 receptor-like 1,33180,-0.0472627893809893,0.0185845607000756,-0.0836885283531374,-0.0108370504088412,0.0110038226959763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT1,Glutathione hydrolase 1 proenzyme,33109,-0.0503479233147723,0.019901500156659,-0.0893548636218239,-0.0113409830077207,0.0114285324575052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN4,Cerebellin-4,33189,-0.0330778789348703,0.0131146887874606,-0.0587826689582931,-0.00737308891144741,0.0116799306552207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL28,C-C motif chemokine 28,33079,-0.0604787783620973,0.0240795307330628,-0.1076746585989,-0.0132828981252942,0.0120357507907602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA2A,Chymotrypsin-like elastase family member 2A,32044,0.0606718561533636,0.0242085274481863,0.0132231423549185,0.108120569951809,0.0122237698052463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP3,Lysosome-associated membrane glycoprotein 3,33197,-0.0524562309094739,0.0209335748375556,-0.0934860375910829,-0.0114264242278649,0.0122340399776039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESR1,Estrogen receptor,31816,0.060798594199241,0.0243299380507812,0.0131119156197098,0.108485272778772,0.0124788173877143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM3,Intercellular adhesion molecule 3,33208,-0.0261411102756262,0.0104864874189422,-0.0466946256167529,-0.00558759493449961,0.0126910093007569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,31907,-0.0413453021160205,0.0166637337309682,-0.0740062202287181,-0.00868438400332283,0.0131176338307447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK1,Kallikrein-1,33003,0.130336684092023,0.0525863099226677,0.0272675166435942,0.233405851540451,0.0132116928143256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI3,Elafin,32998,-0.0542684590500207,0.021903609668931,-0.0971995340011254,-0.011337384098916,0.0132459884211405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY1,Aminoacylase-1,33117,-0.0606955522956692,0.0245585216196393,-0.108830254670162,-0.0125608499211761,0.0134751125488766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP8,GTPase IMAP family member 8,31793,-0.0542914140241734,0.0220322378117248,-0.097474600135154,-0.0111082279131928,0.0137554349608821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT8,"Keratin, type II cytoskeletal 8",31804,-0.0634825016987051,0.025780379824836,-0.114012046155384,-0.0129529572420266,0.0138224971355507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEG1,Protein LEG1 homolog,31649,-0.0696103249067804,0.0283415463956011,-0.125159755842159,-0.0140608939714022,0.014067963546578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG1,Adhesion G-protein coupled receptor G1,33062,-0.0553587008004467,0.0225852178220884,-0.0996257277317399,-0.0110916738691534,0.0142616489521664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPI,Intestinal-type alkaline phosphatase,31816,-0.12233344713628,0.0499526019522988,-0.220240546962785,-0.024426347309774,0.014348868969115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENG,Endoglin,33208,-0.0169389153424741,0.00691879395279899,-0.0304997514899601,-0.00337807919498805,0.0143748124094228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD27,CD27 antigen,33126,-0.0402785612736884,0.0165125885434768,-0.0726432348189029,-0.00791388772847391,0.0147371217719238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",31816,0.0494066244976976,0.0202750458044518,0.00966753472097201,0.0891457142744232,0.0148406025399038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,31791,-0.0698187137867486,0.0286613717111478,-0.125995002340598,-0.0136424252328989,0.0148748701803148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPA33,Cell surface A33 antigen,33062,0.137524674225961,0.0564840894936122,0.026815858818481,0.248233489633441,0.0149222285112234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC7,Sialic acid-binding Ig-like lectin 7,33117,-0.0283182210301079,0.01168541798417,-0.0512216402790811,-0.00541480178113468,0.0153971336256579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB118,Beta-defensin 118,31804,-0.057496200550617,0.0237388166716637,-0.104024281227078,-0.010968119874156,0.0154579676984854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON2,Serum paraoxonase/arylesterase 2,32973,-0.0343912379251438,0.01421157260269,-0.0622459202264163,-0.00653655562387137,0.0155435972642942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,32858,0.0852931965974269,0.0353525655277094,0.0160021681631164,0.154584225031737,0.0158584977583262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WDR46,WD repeat-containing protein 46,31990,-0.0382989424346837,0.0159075335813725,-0.0694777082541738,-0.00712017661519358,0.0160817347639914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7,Complement component C7,31896,-0.0316449478311393,0.0131562575558582,-0.0574312126406213,-0.00585868302165727,0.0161827622506445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPO,Lactoperoxidase,32836,-0.0589772837395224,0.0245287077797836,-0.107053550987898,-0.0109010164911465,0.0162197597349414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFB,Vascular endothelial growth factor B,31816,-0.0279833218966748,0.0116644745820924,-0.050845692077576,-0.00512095171577368,0.0164636689536804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLMH,Bleomycin hydrolase,33208,-0.0314527359217978,0.0131140246366314,-0.0571562242095952,-0.00574924763400031,0.0164874630867427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5A,Eukaryotic translation initiation factor 5A-1,32981,0.0299669829435091,0.0125088148111618,0.00544970591363202,0.0544842599733863,0.0166114750476678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM1,Intercellular adhesion molecule 1,33071,-0.0285810633593101,0.0119346737244183,-0.0519730238591701,-0.00518910285945014,0.0166510093923251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM2,Inactive carboxypeptidase-like protein X2,32042,-0.0252033299376482,0.0105455770062419,-0.0458726608698822,-0.0045339990054141,0.0168752265720549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFM,Afamin,32071,-0.0184963834998022,0.00774465467625838,-0.0336759066652686,-0.0033168603343358,0.0169517665565512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSG,Alpha-2-HS-glycoprotein,32048,-0.0265002982901329,0.0111417703582828,-0.0483381681923672,-0.00466242838789858,0.0174095189551061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARCO,Macrophage receptor MARCO,33117,-0.0260163155112961,0.0109391464316189,-0.0474570425172691,-0.00457558850532311,0.0174153257976841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAR,Immunoglobulin alpha Fc receptor,33109,-0.0465033130169399,0.0195842556519627,-0.0848884540947868,-0.00811817193909298,0.017593197145824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPCAM,Epithelial cell adhesion molecule,33119,0.0979663225486379,0.0413187010887964,0.0169816684145969,0.178950976682679,0.0177621410639695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAT,Tissue-type plasminogen activator,33180,-0.0482564380912488,0.0204016764648855,-0.0882437239624244,-0.00826915222007315,0.0180363697129016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5RA,Interleukin-5 receptor subunit alpha,33109,-0.0527925613603955,0.0223963327330301,-0.0966893735171344,-0.00889574920365649,0.0184356272732152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRK1,Protein BRICK1,32911,-0.0433660882273542,0.018442221721614,-0.0795128428017177,-0.00721933365299076,0.0187228718118088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF7,SLAM family member 7,33109,-0.0553787018468934,0.0235567466889067,-0.10154992535715,-0.00920747833663638,0.0187521972876128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SART1,U4/U6.U5 tri-snRNP-associated protein 1,31791,-0.0363104300758255,0.0154631716616925,-0.0666182465327429,-0.00600261361890813,0.0188914082055638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,31791,-0.0543535010376762,0.0232164089046353,-0.0998576624907613,-0.00884933958459098,0.0192501633355333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPESP1,Sperm equatorial segment protein 1,32042,-0.0262910817633344,0.0112400338802437,-0.048321548168612,-0.00426061535805676,0.0193582801611828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,32020,-0.0779466313574503,0.033343296998953,-0.143299493475398,-0.0125937692395024,0.0194287285557812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCLY,Selenocysteine lyase,33161,-0.0458928454654596,0.0196334801532813,-0.0843744665658909,-0.0074112243650282,0.0194368279934847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACSL1,Long-chain-fatty-acid--CoA ligase 1,31791,-0.0359280211641266,0.0154263147498491,-0.0661635980738308,-0.00569244425442241,0.019885611392473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST2,Bone marrow stromal antigen 2,33191,-0.051652141412123,0.0222192630948602,-0.095201897078049,-0.00810238574619705,0.0201131611982565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2,Ribonucleoside-diphosphate reductase subunit M2,32951,-0.0514691120567556,0.0221597032839494,-0.0949021304932965,-0.00803609362021476,0.0202217540335614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TUBB3,Tubulin beta-3 chain,31804,-0.0270120118763241,0.0116358845000512,-0.0498183454964244,-0.00420567825622376,0.0202902875144749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR4,Fibroblast growth factor receptor 4,31907,0.0511669569372443,0.0221429265930845,0.00776682081479869,0.0945670930596898,0.0208733505890681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,31990,-0.0720032258485375,0.0311940938745196,-0.133143649842596,-0.010862801854479,0.0210131345311826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF1,Pigment epithelium-derived factor,31961,-0.0249930292448249,0.0108675140498302,-0.046293356782492,-0.00369270170715778,0.0214872678702141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRSF1,G-rich sequence factor 1,31756,-0.0760418281466687,0.0330742366844037,-0.1408673320481,-0.0112163242452375,0.0215258885228119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMA,Granzyme A,33208,-0.033587762781527,0.014632243385328,-0.0622669598167698,-0.00490856574628415,0.0217301713632426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD6,MICOS complex subunit MIC25,31990,-0.0274402676193138,0.0119582067575547,-0.050878352864121,-0.00400218237450663,0.0217787749342341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC28A,Coiled-coil domain-containing protein 28A,31826,-0.0278522529643004,0.0121693114166029,-0.051704103340842,-0.00400040258775872,0.022123264783523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G1B,Phospholipase A2,33193,0.0402527149540971,0.017619745938204,0.00571801291521714,0.074787416992977,0.0223646685477571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGEA3,Melanoma-associated antigen 3,31908,0.0812552163651119,0.0357074230766575,0.0112686671348632,0.151241765595361,0.022899207032279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT2,Angiopoietin-2,33189,-0.0362780440093239,0.0159442912448041,-0.0675288548491398,-0.00502723316950789,0.0229120583286945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN2,Vascular non-inflammatory molecule 2,33062,-0.0430991230132428,0.018974941575608,-0.0802900085014345,-0.00590823752505119,0.0231491303345675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LZTFL1,Leucine zipper transcription factor-like protein 1,31907,-0.0672462002768941,0.0296276759291339,-0.125316445097996,-0.00917595545579164,0.0232536824760672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMCH,Pro-MCH,31791,-0.0806330696927639,0.0355264991642173,-0.15026500805463,-0.0110011313308979,0.0232571112013868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPLX2,Complexin-2,31793,-0.02981606922825,0.0131570550560071,-0.055603897138024,-0.00402824131847595,0.0234702146040307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,31908,0.0490052381271568,0.0216325955440747,0.00660535086077039,0.0914051253935432,0.0235202337700775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST7,Cystatin-F,33139,-0.0872591927467537,0.0386344600879158,-0.162982734519069,-0.0115356509744386,0.0239339381055261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAP1,Proline-rich acidic protein 1,32044,-0.0387308789865943,0.0171720798639181,-0.0723881555198737,-0.0050736024533148,0.0241330430160328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM1,Neural cell adhesion molecule 1,33138,-0.0258314782334348,0.0114887597378765,-0.0483494473196728,-0.00331350914719687,0.0245748265868702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",31804,0.0514287103408697,0.0228857917914006,0.00657255842972462,0.0962848622520148,0.0246574580213402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL27,C-C motif chemokine 27,33117,-0.0547513937312072,0.0243890268567563,-0.10255388637045,-0.0069489010919648,0.0247984436143382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AREG,Amphiregulin,33062,-0.0445109104748542,0.0199151444869394,-0.0835445936692553,-0.005477227280453,0.0254410394650067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACVRL1,Serine/threonine-protein kinase receptor R3,33024,-0.0219448653794723,0.00981882183052233,-0.0411897561672961,-0.00269997459164857,0.0254443551366032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPS,Calcyphosin,32006,0.0886663296305014,0.0398430163545497,0.0105740175755839,0.166758641685419,0.0260843429682143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL17,C-C motif chemokine 17,33108,-0.0833274211566558,0.0375407336433733,-0.156907259097668,-0.00974758321564408,0.026468112193912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGF,Hepatocyte growth factor,33208,-0.0307790906342927,0.0138747344248674,-0.0579735701070327,-0.00358461116155263,0.0265561705365388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON2,Spondin-2,33082,-0.0311381788041351,0.0140534724930847,-0.058682984890581,-0.00359337271768915,0.0267385409960503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL11,C-X-C motif chemokine 11,33191,-0.0741670221272251,0.0335118791859468,-0.139850305331681,-0.00848373892276931,0.0269126199797147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,31990,-0.0353922883792612,0.016046203069116,-0.0668428463947285,-0.00394173036379385,0.0274386668053528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VGF,Neurosecretory protein VGF,32020,0.0271546330845527,0.0123237601626158,0.00300006316582574,0.0513092030032796,0.027593953778626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL13,C-X-C motif chemokine 13,33191,-0.0551796332502546,0.0250644795212332,-0.104306013111872,-0.00605325338863748,0.0277261757801734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID1,Nidogen-1,33111,-0.0359558615113808,0.0163358505130666,-0.0679741285169913,-0.0039375945057702,0.0277594816943624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NHLRC3,NHL repeat-containing protein 3,31728,-0.0289644352090814,0.0132021852104565,-0.0548407182215763,-0.00308815219658661,0.0282732361191386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAM,Basal cell adhesion molecule,33121,0.0216184124128776,0.00987283275815331,0.00226766020689712,0.0409691646188581,0.0285735120767374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD5,Sushi domain-containing protein 5,31856,0.0306637865859835,0.0140261468049817,0.00317253884821951,0.0581550343237476,0.0288330954197888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN2,Prorelaxin H2,31895,-0.127392536843186,0.0584490509177555,-0.241952676641987,-0.0128323970443855,0.0293221916330506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL7,C-C motif chemokine 7,33109,-0.0550774091684882,0.0252978953094598,-0.104661283975029,-0.00549353436194696,0.0294960139126866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MME,Neprilysin,33062,-0.0732993691432496,0.0336875232900308,-0.13932691479171,-0.00727182349478915,0.0295927546316815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22,Interleukin-22,31990,-0.0591926092316529,0.0273426583137388,-0.112784219526581,-0.00560099893672479,0.0304308605993792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT8,"Alpha-(1,6)-fucosyltransferase",33042,-0.0525662924309356,0.0243148951417969,-0.100223486908857,-0.00490909795301381,0.0306536625343236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD1,Protein disulfide isomerase CRELD1,31907,-0.0333904244358691,0.015483722198522,-0.0637385199449722,-0.0030423289267659,0.031077642186445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTNL10,Butyrophilin-like protein 10,31793,0.03554832912174,0.0165510396897995,0.003108291329733,0.0679883669137469,0.0317622510462346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,33109,-0.0328987890814285,0.0153537726712197,-0.062992183517019,-0.0028053946458379,0.0321636334349224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN4B,Sodium channel subunit beta-4,31854,0.037012931232888,0.0172750373044992,0.00315385811606945,0.0708720043497065,0.032180372843812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEFL,Neurofilament light polypeptide,32890,-0.0370914940051703,0.0173402412144789,-0.0710783667855489,-0.00310462122479171,0.0324609322978398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40LG,CD40 ligand,33208,-0.0679485738217368,0.0318289107524203,-0.130333238896481,-0.00556390874699295,0.0328044813432845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG2,Secretogranin-2,33146,0.0275293680166343,0.0129436695029206,0.00215977579090994,0.0528989602423587,0.0334598279091065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WIF1,Wnt inhibitory factor 1,33189,-0.0298750564329899,0.0140685197005993,-0.0574493550461646,-0.0023007578198153,0.0337366973600436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDCP1,CUB domain-containing protein 1,33042,-0.0420265511185214,0.0198687850645507,-0.0809693698450408,-0.00308373239200192,0.0344412006576082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A14,Protein S100-A14,32020,0.0465879755224663,0.0220320842526038,0.00340509038736281,0.0897708606575699,0.0345008035555358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,33191,-0.0400756058219826,0.0189734225719892,-0.0772635140630814,-0.00288769758088372,0.0346978531449039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALY,Neuron-specific vesicular protein calcyon,31791,-0.0339385876005939,0.0161295683144629,-0.0655525414969411,-0.00232463370424666,0.0354016909685989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAP,Gamma-aminobutyric acid receptor-associated protein,31990,-0.0427535646225442,0.020401296210282,-0.0827401051946968,-0.0027670240503915,0.0361483131341413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPC2,NPC intracellular cholesterol transporter 2,31920,-0.0266736463419283,0.0127521561225515,-0.0516678723421293,-0.00167942034172736,0.0364993253005271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX5,Syntaxin-5,31816,-0.0352254306351453,0.0168560792040199,-0.0682633458750242,-0.00218751539526636,0.0366721459923388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC4,Apical endosomal glycoprotein,31990,-0.0466530435210397,0.0223452455441885,-0.0904497247876491,-0.00285636225443028,0.0368467838710165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,32020,-0.0272589276356473,0.0130666438032005,-0.0528695494899202,-0.0016483057813744,0.0369987956539349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCAR2,Cell cycle and apoptosis regulator protein 2,32006,-0.0501848034117537,0.0240902980264156,-0.0974017875435283,-0.0029678192799791,0.0372669414831879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,32042,-0.0632019840686445,0.0303430989973054,-0.122674458103363,-0.00372951003392599,0.0372927028088364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSN,Gelsolin,32025,0.0154989267488155,0.00745026290649795,0.000896411452079558,0.0301014420455515,0.0375297834472067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHC1,SHC-transforming protein 1,31793,-0.0994767177070647,0.0478600931288524,-0.193282500239615,-0.00567093517451402,0.0376989172619629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSD,Cathepsin D,32541,-0.0337537653787816,0.0162468540289551,-0.0655975992755336,-0.00190993148202968,0.0377816514041611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,31990,-0.0742222559703157,0.0358830440372907,-0.144553022283405,-0.0038914896572259,0.0386318185690607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL9,C-X-C motif chemokine 9,33167,-0.0585494000756538,0.0284477991195199,-0.114307086349913,-0.00279171380139479,0.0396068813308204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP3,Latent-transforming growth factor beta-binding protein 3,32951,-0.0455034386845521,0.022136942082002,-0.0888918451652761,-0.00211503220382817,0.0398570608284114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,33074,-0.0515012665976137,0.025071006543643,-0.100640439423154,-0.00236209377207345,0.0399848562131791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH2,Growth hormone variant,32951,-0.146263783217997,0.0714363334333919,-0.286278996747445,-0.00624856968854914,0.0406425891496279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN1,CCN family member 1,33044,-0.0666329656565765,0.0326429392856362,-0.130613126656423,-0.00265280465672965,0.0412547502375488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN1,Ficolin-1,32034,-0.0471404255521424,0.0231129949422521,-0.0924418956389564,-0.00183895546532835,0.0414283948667636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPO,Erythropoietin,33109,0.064436635234808,0.0317264516817406,0.0022527899385965,0.12662048053102,0.0422848112032231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCND2,G1/S-specific cyclin-D2,31908,0.0318371912402465,0.0156853654161274,0.00109387502463672,0.0625805074558563,0.0424185594330901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR158,Probable G-protein coupled receptor 158,32020,0.0306226437512892,0.0150873857163367,0.00105136774726927,0.0601939197553091,0.0424234631499445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL2,ADAMTS-like protein 2,32044,-0.0259905127041561,0.0128085243345198,-0.0510952203998149,-0.000885805008497349,0.0424770748106263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDHB15,Protocadherin beta-15,31990,-0.0333504417169975,0.0164535726378597,-0.0655994440872024,-0.00110143934679254,0.0427034449362802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD1,Sphingomyelin phosphodiesterase,33140,-0.0397320306304224,0.0196097949927838,-0.0781672288162786,-0.00129683244456627,0.0427817681487986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53I3,Quinone oxidoreductase PIG3,31754,-0.0449367095411079,0.0222605523880121,-0.0885673922216117,-0.00130602686060413,0.0435580120194183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYAL1,Hyaluronidase-1,33059,-0.0189537997768298,0.00941085614079175,-0.0373990778127817,-0.000508521740878013,0.0440368457940232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCLN,Nicalin,32981,0.0457190823745752,0.0227044730650003,0.00121831516717469,0.0902198495819757,0.0440766217913169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPL,Lipoprotein lipase,33117,0.0380806249541667,0.0189154428364746,0.00100635699467639,0.075154892913657,0.0441241508785661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",32042,-0.0611317459901657,0.0304012438014433,-0.120718183840995,-0.0015453081393367,0.0443786690861975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS2,"Nitric oxide synthase, inducible",31791,-0.0326977280519442,0.0162755105864514,-0.0645977288013889,-0.000797727302499537,0.0445722052684667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFIC,Nuclear factor 1 C-type,32020,-0.0371579863503425,0.0185241492505663,-0.0734653188814524,-0.00085065381923257,0.0449001650714853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN1,Prorelaxin H1,32020,-0.0670958875213202,0.033533830713292,-0.132822195719373,-0.0013695793232678,0.0454451016005256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FASLG,Tumor necrosis factor ligand superfamily member 6,33208,0.0304935723921693,0.0152745472653684,0.000555459752047269,0.0604316850322913,0.0459251123491072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELB,Transcription factor RelB,31816,0.0443432847144858,0.0222195237617609,0.000793018141434357,0.0878935512875373,0.0460044311680717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF7,Fibroblast growth factor 7,31793,-0.0667109952117644,0.0334576581352095,-0.132288005156775,-0.00113398526675375,0.0462006656320015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1,Allograft inflammatory factor 1,32951,-0.0427534524374615,0.0214590227057728,-0.0848131369407763,-0.000693767934146813,0.046366808213748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD80,T-lymphocyte activation antigen CD80,32042,-0.0277401095855111,0.0139299871268016,-0.0550428843540423,-0.000437334816979846,0.0464732380905908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL18A1,Collagen alpha-1(XVIII) chain,33138,-0.018714631938746,0.00940268284018477,-0.0371438903055081,-0.00028537357198382,0.0465836579545596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST1,Cystatin-SN,31054,0.0854695640357035,0.0429930609267654,0.00120316461924337,0.169735963452164,0.0468545727098849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC2,Mucin-2,32044,0.074222904759183,0.0374296932382773,0.00086070601215936,0.147585103506207,0.0474039354428005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",32044,-0.0516942751201027,0.0260858924532553,-0.102822624328483,-0.000565925911722387,0.0475494288822428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAP18,Chromatin complexes subunit BAP18,32006,-0.0563002421892144,0.0284253818067676,-0.112013990530479,-0.000586493847949933,0.0476686896197397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIM,Vimentin,32973,-0.0971980474753316,0.0490919949438385,-0.193418357565255,-0.000977737385408156,0.0477450412723893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALMS1,Alstrom syndrome protein 1,31908,0.0366557855908647,0.018524194992951,0.000348363404680779,0.0729632077770485,0.0478746058868122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2,Ataxin-2,31804,-0.0914405279778036,0.0462677152669373,-0.182125249901001,-0.000755806054606456,0.0481541103643565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB2,Plexin-B2,33166,-0.0190633973198178,0.00965723476282884,-0.0379915774549624,-0.000135217184673311,0.0484130897364165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECAP2,Adaptin ear-binding coat-associated protein 2,31791,-0.05580760967815,0.0283370616024461,-0.111348250418944,-0.000266968937355741,0.0489422993018666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRF5,Adhesion G protein-coupled receptor F5,32042,-0.0243128722123519,0.0123742367846489,-0.0485663763102638,-5.9368114440031e-05,0.049474076946756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMB,Granzyme B,33109,-0.0524432372886058,0.0267369232238921,-0.104847606807434,-3.8867769777351e-05,0.049858121821242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",31854,-0.0557204704233432,0.0284191580152333,-0.1114220201332,-1.89207134859912e-05,0.0499554715206292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",32042,-0.0254029309073615,0.0129786921758698,-0.0508411675720663,3.53057573433402e-05,0.0503511899424924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL6,Fc receptor-like protein 6,33109,-0.0544169280357827,0.0278663747861828,-0.109035022616701,0.000201166545135585,0.0508777264349507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA1,Glutathione S-transferase A1,33105,-0.0671531728279664,0.0344766927284741,-0.134727490575776,0.000421144919842895,0.051473031081041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",33097,-0.0520556007566012,0.0267846228853968,-0.104553461611979,0.00044226009877664,0.0519896001870601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL32,Interleukin-32,33109,-0.0344303784081885,0.0177309867755763,-0.0691831124883181,0.000322355671941124,0.0521913368214896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT18,"Keratin, type I cytoskeletal 18",33062,-0.062005947907514,0.0319813571160657,-0.124689407855003,0.000677512039974744,0.0525564548118027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,33122,-0.0393601165075108,0.0203059314462506,-0.0791597421421619,0.000439509127140338,0.0526122685299048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK5,Serine protease inhibitor Kazal-type 5,33121,0.0257196301638226,0.0132701137529677,-0.000289792791994006,0.0517290531196392,0.0526358878254672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGFAC,Hepatocyte growth factor activator,31965,-0.0229567530944704,0.0118517500046405,-0.0461861831035657,0.000272676914624858,0.0527836794385202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX6B1,Cytochrome c oxidase subunit 6B1,32042,-0.0257099864319653,0.0132971335096305,-0.0517723681108412,0.000352395246910581,0.0532119698375185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMNDC1,Survival of motor neuron-related-splicing factor 30,31998,-0.0506658580436387,0.0262325415421972,-0.102081639466345,0.000749923379067707,0.0534694670566733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6,Interleukin-6,33062,-0.0576109842873359,0.0298943799474085,-0.116203968984256,0.000982000409584724,0.0539936784585264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO6,Unconventional myosin-VI,32020,-0.0297424411109888,0.0154555894539909,-0.0600353964408109,0.000550514218833301,0.0543443074084763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROK1,Prokineticin-1,33109,-0.0545852123708109,0.0283661980563587,-0.110182960561274,0.00101253581965217,0.0543491242072725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDO1,"Indoleamine 2,3-dioxygenase 1",31854,-0.0519144633440388,0.0270003651548357,-0.104835179047517,0.00100625235943922,0.0545520559138716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF5,Rho guanine nucleotide exchange factor 5,31804,-0.0594186090807917,0.0309115595559839,-0.12000526581052,0.00116804764893673,0.0546175309756926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOBR,Apolipoprotein B receptor,31854,-0.0336281376233834,0.0175137692224435,-0.0679551252993725,0.000698850052605823,0.0548840206378961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A2,Secretoglobin family 3A member 2,33150,-0.066322975451939,0.0345664693405259,-0.13407325535937,0.00142730445549182,0.05505393907205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LATS1,Serine/threonine-protein kinase LATS1,31816,-0.0667696186394673,0.034857375571878,-0.135090074760348,0.00155083748141346,0.0554663013624601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX1B,Syntaxin-1B,31826,0.0350257529573407,0.0182906635702032,-0.00082394764025745,0.0708754535549389,0.0555372004848881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCY2C,Heat-stable enterotoxin receptor,31908,-0.0683687915931781,0.0357110878035999,-0.138362523688234,0.00162494050187775,0.0555948375556826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE2,Glia-derived nexin,32042,-0.0503048370476904,0.026291852888375,-0.101836868708905,0.00122719461352468,0.0557441492206314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFASC,Neurofascin,33208,-0.0214940983188932,0.0112566881994454,-0.0435572071898061,0.000569010552019786,0.0562365417851229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT1,Dynein light chain Tctex-type 1,31826,-0.0651245066386552,0.0341765480381816,-0.132110540793491,0.00186152751618071,0.0567498014330851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,32981,-0.0334832778821781,0.0175946277356502,-0.0679687482440524,0.00100219247969618,0.0570689816700554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC1,Amiloride-sensitive amine oxidase [copper-containing],32981,0.0452715401596453,0.0238345146295819,-0.00144410851433527,0.0919871888336259,0.0575441579571999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGR1,Prostaglandin reductase 1,32042,-0.0621421077937412,0.0327178601397324,-0.126269113667617,0.00198489808013427,0.0575585973960312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL19,Interleukin-19,32904,-0.0542488502008477,0.0286236059531955,-0.110351117869111,0.00185341746741539,0.0580935580789054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP12,Macrophage metalloelastase,33129,-0.0402688122455976,0.0212713374905684,-0.0819606337271116,0.0014230092359164,0.0583775453311353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG2,Adhesion G-protein coupled receptor G2,33117,0.0210073903274008,0.0110974711511474,-0.000743653128848103,0.0427584337836497,0.0583926296941645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSB,Arylsulfatase B,33062,-0.0433228152604887,0.0228942447838559,-0.0881955350368463,0.00154990451586887,0.0584843289660732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM2,Junctional adhesion molecule B,33191,0.0198627079157217,0.0105363747152954,-0.000788586526257226,0.0405140023577007,0.0594419537350833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS8,Prostasin,33087,-0.0309477025858165,0.0164199197510546,-0.0631307452978836,0.00123534012625057,0.0594950228530955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG4,Desmoglein-4,33037,0.0394744690617455,0.0209557655660953,-0.00159883144780126,0.0805477695712923,0.0596387307480803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES3,Carboxylesterase 3,33062,0.0532062789264882,0.0282503936063462,-0.00216449254195036,0.108577050394927,0.0596823121293328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD7,FERM domain-containing protein 7,31826,-0.0248603013406705,0.0132134263851476,-0.0507586170555598,0.00103801437421878,0.0599511167957096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOG,Myelin-oligodendrocyte glycoprotein,33189,0.0247307451331875,0.0131789832226976,-0.00110006198329971,0.0505615522496747,0.0606159709937664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GART,Trifunctional purine biosynthetic protein adenosine-3,32020,0.0207838138854003,0.0110806974641228,-0.000934353144280441,0.042501980915081,0.0607380556332953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,31791,0.0408064720756105,0.0217765550369558,-0.00187557579682284,0.0834885199480439,0.060987801480506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,33107,-0.024459097010015,0.0130533106056685,-0.0500435857971252,0.00112539177709525,0.060993738003033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART3,Ecto-ADP-ribosyltransferase 3,33138,0.0252572492434237,0.0135180589960627,-0.00123814638885914,0.0517526448757065,0.0617388642387918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF174,Zinc finger protein 174,31816,0.0297808617546302,0.0159650026161211,-0.00151054337296714,0.0610722668822276,0.0621673237160315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF6,SLAM family member 6,32951,-0.0293709546550495,0.015746308745979,-0.0602337197971684,0.00149181048706943,0.0621794473956415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL33,Interleukin-33,32981,0.029673949038757,0.0159136421690818,-0.00151678961264326,0.0608646876901573,0.0622597221861609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE,Angiotensin-converting enzyme,32048,-0.0196822634210303,0.0105640227016182,-0.0403877479162019,0.00102322107414138,0.0624810023273649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGLN1,Egl nine homolog 1,33109,-0.0432924774513017,0.0232551292655382,-0.0888725308117566,0.00228757590915327,0.0626889369058583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDA2R,Tumor necrosis factor receptor superfamily member 27,33189,-0.0267916718329119,0.0143948085111413,-0.0550054965147488,0.00142215284892496,0.0627489677735197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VMO1,Vitelline membrane outer layer protein 1 homolog,33062,0.0519368628471482,0.0279108369729022,-0.00276837761974014,0.106642103314037,0.0628045780644083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2,Low-density lipoprotein receptor-related protein 2,31826,-0.0291479662980525,0.0156654038553606,-0.0598521578545592,0.00155622525845424,0.0628321981868197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRB1,Killer cell lectin-like receptor subfamily B member 1,33208,-0.0284780256751179,0.0153132548114981,-0.0584920051056541,0.0015359537554184,0.0629618121478229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIAE,Sialate O-acetylesterase,33113,-0.036410762370216,0.0196242158949366,-0.0748742255242916,0.0020527007838597,0.0635731353687611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,33189,0.0195207255872601,0.010535473322678,-0.00112880212518878,0.040170253299709,0.0639365534143924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1GALT1C1,C1GALT1-specific chaperone 1,31791,-0.0245869468476812,0.0132800745596778,-0.0506158929846497,0.0014419992892872,0.0641498256656824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",33136,0.0265843765310558,0.0143624822462446,-0.00156608867158367,0.0547348417336952,0.0642092771717442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM3,Junctional adhesion molecule C,31907,-0.038932203903759,0.0210347269922155,-0.0801602688085014,0.00229586100098351,0.0642301214415714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,32951,-0.0596821849887919,0.0322903741364457,-0.122971318296225,0.00360694831864162,0.0645941795290812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECR,Peroxisomal trans-2-enoyl-CoA reductase,31854,-0.0215244771762386,0.0116577762162809,-0.0443737185601491,0.00132476420767191,0.0648795306022213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHPK,Sedoheptulokinase,31908,-0.031632857780549,0.0171382505332289,-0.0652238288256777,0.0019581132645796,0.0649687102360272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,32973,-0.0237479303978358,0.0128864084833772,-0.0490052910252551,0.0015094302295835,0.0653832191847087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHISA5,Protein shisa-5,32044,-0.0189953673681119,0.010313087310633,-0.0392090184969526,0.00121828376072883,0.0655331293785361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4E,Eukaryotic translation initiation factor 4E,31816,-0.0692500467682602,0.0376224269408283,-0.142990003572284,0.00448991003576323,0.065711800956939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYNU,Kynureninase,33208,-0.0344402209008298,0.0187479593167442,-0.0711862211616485,0.00230577935998881,0.066242038306847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRC,Chymotrypsin-C,33124,0.048088352744113,0.0262536379493737,-0.0033687776366594,0.0995454831248855,0.0670328859751327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBN,Ameloblastin,32981,0.0208688057757003,0.0114110441882645,-0.00149684083329806,0.0432344523846987,0.0674606917966486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASS1,Argininosuccinate synthase,31791,-0.060140461720131,0.0329798855121854,-0.124781037324014,0.00450011388375226,0.0682608242905572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBH,Dopamine beta-hydroxylase,32034,0.0787023644887425,0.0431638743475011,-0.00589882923235951,0.163303558209845,0.0682914559318208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNC4,Potassium voltage-gated channel subfamily C member 4,31804,-0.0425553325165363,0.02335045575965,-0.0883222258054503,0.00321156077237764,0.0684254231742698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN2,Alpha-actinin-2,31791,-0.0405458267556707,0.0222743894446598,-0.0842036300672038,0.00311197655586247,0.0687557118093958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPA,Inosine triphosphate pyrophosphatase,31791,-0.0516976088819845,0.0284410935590801,-0.107442152257782,0.00404693449381252,0.069149499672931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G2A,"Phospholipase A2, membrane associated",33094,-0.0443883731024982,0.0244269356339488,-0.0922651669450379,0.00348842074004144,0.0692227066552726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRL,Chymotrypsin-like protease CTRL-1,32006,0.0495198241013554,0.0272574572592736,-0.00390479212682085,0.102944440329532,0.0692959203801622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY9,T-lymphocyte surface antigen Ly-9,33029,-0.0217100326464625,0.0119607022147894,-0.0451530089874498,0.00173294369452471,0.0695413721965844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL28A1,Collagen alpha-1(XXVIII) chain,31826,-0.0547740018125592,0.0301917857700578,-0.113949901921872,0.004401898296754,0.0696872352904146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",33011,0.0308880626484811,0.0170261632614099,-0.0024832173438822,0.0642593426408444,0.0696891947194528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,33042,-0.0247056080639015,0.0136406980088467,-0.0514413761612409,0.00203016003343801,0.0701496252410091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMA,Repulsive guidance molecule A,33191,0.0227176359286823,0.0125645697537768,-0.00190892078872022,0.0473441926460849,0.0706297930388511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHDC3L,KH domain-containing protein 3,31793,0.0509827934643188,0.0282060600776217,-0.00430108428781972,0.106266671216457,0.0707233945810404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHIT1,Chitotriosidase-1,33131,-0.109952064286724,0.0608387830653116,-0.229196079094734,0.00929195052128703,0.070754914160909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,32042,-0.0193312771484284,0.0106977641665454,-0.0402988949148573,0.00163634061800047,0.0707957795002467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QPCT,Glutaminyl-peptide cyclotransferase,33127,-0.0196711579127905,0.0108887073699176,-0.041013024357829,0.00167070853224795,0.0708647649421434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,33138,-0.0313048082420316,0.0173296742902855,-0.0652709698509912,0.00266135336692794,0.0708861131028137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM1,Probable carboxypeptidase X1,33126,-0.0508901067374667,0.0281790231260696,-0.106120992064563,0.0043407785896296,0.0709596923912015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN3,Neuronal-specific septin-3,32020,-0.0526858802341566,0.0291860099943187,-0.109890459823021,0.00451869935470803,0.0710868968557843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR3,Transforming growth factor beta receptor type 3,33208,0.0241880561961379,0.0134068211855443,-0.00208931332752888,0.0504654257198047,0.0712405125680576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2D1A,SH2 domain-containing protein 1A,33109,-0.0424348560330517,0.0235747219717237,-0.0886413110976302,0.00377159903152677,0.071893051916646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL16,C-C motif chemokine 16,33208,-0.0389188721788773,0.0216778361750483,-0.081407431081972,0.00356968672421746,0.0726355902200463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF21,Fibroblast growth factor 21,33176,-0.0867406184247966,0.0483213089863959,-0.181450384038132,0.00796914718853929,0.0726755454322543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB6,Integrin beta-6,32981,0.0220580433046345,0.0122933116197854,-0.0020368474701449,0.0461529340794139,0.0727986987270437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH7,Protocadherin-7,31998,-0.0265253540731394,0.0147943408010269,-0.0555222620431522,0.00247155389687342,0.0730226763495405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2L,Ataxin-2-like protein,32020,-0.035320809643189,0.0197420014600001,-0.0740151325047892,0.00337351321841117,0.0736354691611385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,31826,-0.0303241155297454,0.0169871718787368,-0.0636189724120694,0.0029707413525787,0.0742831813038329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,31791,-0.0236412845803094,0.0132527483110046,-0.0496166712698785,0.00233410210925968,0.0744848163485259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO1,R-spondin-1,33042,-0.0257829873155525,0.0144715749994887,-0.0541472743145504,0.00258129968344546,0.0748449628387732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD109,CD109 antigen,33121,0.0238503032387513,0.0133905783199632,-0.00239523026837655,0.0500958367458791,0.0749269213142608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLH1,Glutamate carboxypeptidase 2,31816,0.0807372739627618,0.0453557501250021,-0.0081599962822423,0.169634544207766,0.0751026116664067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTIF3,"Translation initiation factor IF-3, mitochondrial",31998,-0.0645510536919712,0.0362758799016285,-0.135651778299163,0.00654967091522062,0.0752065276638989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",31791,-0.0324750751950866,0.0183317026202816,-0.0684052123308385,0.00345506194066537,0.0765148772840517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN15,Tetraspanin-15,31791,-0.0365065271338622,0.0206219357057006,-0.0769255211170354,0.00391246684931106,0.0767226071846924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELP,P-selectin,33138,-0.0420881278482873,0.0238155797145078,-0.0887666640887226,0.00459040839214803,0.0772211637215867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,32973,-0.0254011701038882,0.0143923136463894,-0.0536101048508115,0.00280776464303513,0.0776143373426127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF3,Immunoglobulin superfamily member 3,33062,-0.0244566305224424,0.013860554644961,-0.051623317626566,0.00271005658168116,0.0776871478141563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF14,Tumor necrosis factor ligand superfamily member 14,33042,-0.041637111209201,0.0236350680562438,-0.0879618445994388,0.00468762218103679,0.0781612029431085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA2,Heat shock-related 70 kDa protein 2,31990,-0.0242830645576508,0.0137851208424659,-0.0513019014088839,0.00273577229358237,0.0781873025507478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC1,Syndecan-1,33117,-0.0285633930539899,0.016219671197699,-0.06035394860148,0.00322716249350011,0.0782679093553581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,31752,-0.0245192373019064,0.0139382034542138,-0.0518381160721654,0.0027996414683527,0.0785957899985975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN3A2,Butyrophilin subfamily 3 member A2,33109,-0.0265983821279205,0.0151575951269805,-0.0563072685768022,0.00311050432096119,0.079330767727725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRP,Agouti-related protein,33208,-0.0383353054546694,0.0218612539846958,-0.0811833632646732,0.00451275235533449,0.0795386814200788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGER,Advanced glycosylation end product-specific receptor,33105,0.0293445577856929,0.0167377239774354,-0.00346138121008047,0.0621504967814663,0.0796032939261279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH2,"Aldehyde dehydrogenase, mitochondrial",31990,0.0372407358260457,0.0212474231889013,-0.00440421362420081,0.0788856852762923,0.0796911174557627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBX2,Chromobox protein homolog 2,31791,-0.0301543448043761,0.0172167756137758,-0.0638992250073767,0.00359053539862456,0.0799099650497824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL22,C-C motif chemokine 22,33023,-0.0373660068102403,0.0213394168398532,-0.0791912638163525,0.00445925019587199,0.0799761277415585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN2,Dynactin subunit 2,33062,0.0684927270060561,0.0391383831768613,-0.00821850402059206,0.145203958032704,0.0801514804924352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",31804,-0.0328616658808096,0.0188259764325549,-0.0697605796886172,0.00403724792699806,0.0809311099887965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200,OX-2 membrane glycoprotein,33109,0.018161800486061,0.0104301367803059,-0.00228126760333851,0.0386048685754605,0.0816698327422949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE6,Ribonuclease K6,31991,-0.0208232343726167,0.0119843936673038,-0.0443126459605322,0.00266617721529881,0.0823346346716519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",31791,-0.0348461005813657,0.0200605605597774,-0.0741647992785294,0.00447259811579803,0.0824211469670193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,32951,-0.0315606075956359,0.0181738270829434,-0.067181308678205,0.00406009348693318,0.0824946215465224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,32071,-0.0195934368065732,0.0112866834696976,-0.0417153364071805,0.00252846279403412,0.0826081099819347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,32951,-0.0444509821809298,0.0256496784259526,-0.0947243518957968,0.00582238753393725,0.0831313208156399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLM2,Protein GOLM2,33191,-0.0156192827328494,0.00902001307922515,-0.0332985083681307,0.00205994290243194,0.0833755908974237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPEP,Aspartyl aminopeptidase,32006,0.0408517660891072,0.0236056113416894,-0.00541523214060412,0.0871187643188185,0.083564762754143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPSE,Heparanase,31939,-0.0661573678016982,0.0382833704463542,-0.141192773876552,0.0088780382731561,0.08401211388208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML1,Trem-like transcript 1 protein,32048,-0.0375189521491811,0.0217143389951937,-0.0800790565797607,0.0050411522813986,0.0840571558254498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFAP,Glial fibrillary acidic protein,32939,-0.0325847412814314,0.0189102082684557,-0.0696487494876047,0.00447926692474181,0.0849014997549063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRPEL1,"GrpE protein homolog 1, mitochondrial",33062,-0.0429282449239795,0.0249146738911114,-0.0917610057505578,0.00590451590259876,0.0849225302298447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK4,Kallikrein-4,33189,-0.043715755563061,0.0254255394788557,-0.0935498129416182,0.00611830181549616,0.0855835437873355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH4,Cadherin-4,31804,-0.0329189708712371,0.0191691895734569,-0.0704905824352126,0.00465264069273831,0.0859691383564303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,31998,-0.0636777581439189,0.0371435867122884,-0.136479188100004,0.00912367181216633,0.0865023151595168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAP,Prosaposin,31974,-0.0198879647016194,0.0116060791912231,-0.0426358799164166,0.0028599505131779,0.086646782530496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP9,Matrix metalloproteinase-9,33107,-0.043036653695816,0.0251400084003869,-0.0923110701605743,0.00623776276894233,0.0869547846860543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP20,Centrosomal protein 20,32951,-0.0531862230595623,0.0310892876177699,-0.114121226790391,0.00774878067126672,0.0871624335080114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL7,Angiopoietin-related protein 7,33189,0.0259984682934977,0.0152049736175873,-0.00380327999697349,0.0558002165839688,0.0873261507420552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,31791,-0.0281349325050755,0.0164546859763268,-0.0603861170186759,0.00411625200852495,0.0873371470872696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,31791,-0.0490151319752443,0.0286820479448409,-0.105231945947132,0.00720168199664381,0.0875092986286586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA1,BolA-like protein 1,31804,-0.0388885773559232,0.0227985200495765,-0.0835736766530931,0.00579652194124675,0.088096860160703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSM,Oncostatin-M,33067,-0.0510301545834618,0.0299252793785038,-0.109683702165329,0.00762339299840568,0.088183411114285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,33167,0.0278275244076269,0.0163270138766155,-0.00417342279053955,0.0598284716057934,0.0883447505966726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL5,C-C motif chemokine 5,33138,-0.0710865309854877,0.0417364622335307,-0.152889996963208,0.0107169349922324,0.0885619897513107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTKN2,Rhotekin-2,31791,-0.0374757869714568,0.0220050009926376,-0.0806055889170266,0.00565401497411291,0.0885996072934091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B1,Aldo-keto reductase family 1 member B1,32951,-0.0535428578854885,0.0314463110082277,-0.115177627461615,0.00809191169063785,0.0886654103912784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECE1,Endothelin-converting enzyme 1,32911,-0.0251762807629503,0.0147983581060071,-0.0541810626507243,0.00382850112482361,0.0889255227946938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRB3,Adhesion G protein-coupled receptor B3,33024,0.0235797840185472,0.0138748040815476,-0.0036148319812861,0.0507744000183806,0.089267341895133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDM3A,Lysine-specific demethylase 3A,31816,0.0655638772764759,0.0385873892642996,-0.0100674056815514,0.141195160234503,0.0893423653571182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO1,Roundabout homolog 1,33136,-0.0167164245171597,0.00984281535023058,-0.0360083426036116,0.00257549356929228,0.0894798644097839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMTOR5,Ragulator complex protein LAMTOR5,31990,0.0284345902218781,0.0167732972814504,-0.00444107244976479,0.061310252893521,0.090073171672817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHPS,Deoxyhypusine synthase,31990,-0.0305005197721877,0.0179972620698692,-0.0657751534291314,0.00477411388475597,0.0901677474682703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP1,Guanylate-binding protein 1,31994,-0.0467085598259781,0.027567710146109,-0.100741271712352,0.00732415206039565,0.090245522635032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCNE1,G1/S-specific cyclin-E1,31816,0.0669650115945047,0.0395321955959319,-0.0105180917735219,0.144448114962531,0.0903197223323839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL23,C-C motif chemokine 23,33167,-0.0285855256095191,0.0168974474207684,-0.0617045225542253,0.00453347133518704,0.0907376544090848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA14,Carbonic anhydrase 14,33189,0.0238648642535769,0.0141344621543401,-0.0038386815689297,0.0515684100760835,0.0913669224376637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFC,Vascular endothelial growth factor C,33126,-0.0390612911730101,0.023139919333151,-0.084415533065986,0.00629295071996577,0.0914379921008051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD8,Frizzled-8,31804,-0.0301413679448113,0.0178935699041173,-0.0652127649568813,0.00493002906725866,0.0921313081924882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB1,BPI fold-containing family B member 1,33088,-0.0428701946203712,0.0254509903833868,-0.0927541357718093,0.00701374653106684,0.0921363798132358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",32020,-0.0306086420577303,0.0181857488288791,-0.0662527097623333,0.00503542564687275,0.092394764733097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDNRB,Endothelin receptor type B,31816,0.0325498438494707,0.0193890334914778,-0.00545266179382579,0.0705523494927672,0.0932381369220605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN15,Lipocalin-15,32020,-0.0434088727164619,0.0258754358310119,-0.0941247269452452,0.00730698151232133,0.0934646820593376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,31854,-0.037323157408652,0.022277211087106,-0.0809864911393799,0.00634017632207583,0.0938987364533439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FTCD,Formimidoyltransferase-cyclodeaminase,31994,-0.0575528785859328,0.0343535337269892,-0.124885804690832,0.00978004751896595,0.0939145362889998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGA,Alpha-N-acetylgalactosaminidase,31798,0.0419122169377512,0.0250338596895747,-0.00715414805381515,0.0909785819293175,0.0941297171652142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM17,Splicing factor 45,32020,-0.0531468297408437,0.0317768430457139,-0.115429442110443,0.00913578262875558,0.0944667320893916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTA2,"Actin, aortic smooth muscle",32973,0.030198733635017,0.018071559738662,-0.00522152345276046,0.0656189907227945,0.094745751105519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LONP1,"Lon protease homolog, mitochondrial",31854,-0.0598319895416776,0.0358254406436018,-0.130049853203137,0.0103858741197819,0.0949422968267959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK2A1,Casein kinase II subunit alpha,32020,-0.0312693776987051,0.0187265920396187,-0.0679734980963578,0.00543474269894761,0.0950033159952368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC5,Sialic acid-binding Ig-like lectin 5,33121,-0.0806947856545462,0.0483389911036474,-0.175439208217695,0.0140496369086027,0.0950837710147617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPP1,Tripeptidyl-peptidase 1,33067,-0.0311491763270074,0.0186684675947679,-0.0677393728127524,0.00544102015873757,0.0952439458033347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOA,Elongin-A,33062,-0.0373202821253682,0.0224009463683176,-0.0812261370072708,0.00658557275653437,0.0957470750981402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G10,Group 10 secretory phospholipase A2,33042,0.0405849512037893,0.0244197800768404,-0.00727781774681788,0.0884477201543965,0.0965552013160501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL24A1,Collagen alpha-1(XXIV) chain,31998,-0.0375612565995123,0.0226441617686454,-0.0819438136660572,0.00682130046703262,0.0972054840531462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI2B,Protein EVI2B,31793,-0.0262147240950349,0.0158090488289782,-0.0572004597998323,0.00477101160976242,0.0973177951349863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPI,Glucose-6-phosphate isomerase,32048,-0.0328270956577183,0.0198304022220377,-0.0716946840129122,0.00604049269747568,0.0978862508482129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDO2,"Tryptophan 2,3-dioxygenase",31826,-0.0269485335263795,0.0162920179406864,-0.0588808886901247,0.0049838216373658,0.0981509220465597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP10,Caspase-10,32911,-0.0498434929515674,0.0301827614528828,-0.109001705399218,0.00931471949608288,0.0986962026333397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,33042,-0.0372659382983111,0.02259307488623,-0.0815483650753218,0.00701648847869965,0.0990939371327233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCHE,Cholinesterase,31914,-0.0191734680555462,0.011628320121259,-0.0419649754932137,0.00361803938212142,0.0992184826673835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EREG,Proepiregulin,33030,-0.0541635844648734,0.0328549018206433,-0.118559192033334,0.0102320231035873,0.099272510492024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRB,Paired immunoglobulin-like type 2 receptor beta,33117,-0.0390213056787768,0.0236715847607573,-0.085417611809861,0.00737500045230745,0.0992976403349001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD7B,OTU domain-containing protein 7B,32020,-0.0431827716753717,0.026208346065561,-0.0945511299638712,0.00818558661312779,0.0994614026825402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,33042,0.0235097992793295,0.0142730166521074,-0.00446531335880104,0.05148491191746,0.0995637966167871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3S2,AP-3 complex subunit sigma-2,32006,-0.0316721380406807,0.0192547933066509,-0.0694115329217165,0.00606725684035505,0.100032808125349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP6,Dipeptidyl aminopeptidase-like protein 6,33062,0.0219843228821217,0.0133853144986786,-0.00425089353528845,0.0482195392995318,0.100539284216646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,31793,0.0295930401424779,0.0180248812210963,-0.00573572705087091,0.0649218073358266,0.100676706944143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL6A3,Collagen alpha-3(VI) chain,33208,-0.0224063242877287,0.0136824259443111,-0.0492238791385785,0.00441123056312116,0.101541347281856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSMB,Beta-microseminoprotein,33075,-0.046137591854421,0.0281785708858737,-0.101367590790734,0.0090924070818915,0.101598229404714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",31896,-0.045073490226046,0.0275434788841395,-0.0990587088389595,0.00891172838686743,0.101787987000787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMMT,MICOS complex subunit MIC60,31990,-0.0299713857301536,0.0183162038720848,-0.0658711453194399,0.00592837385913261,0.10181192367691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSNA1,Sjoegren syndrome nuclear autoantigen 1,31998,-0.0353557047837096,0.0216353720441472,-0.0777610339902382,0.00704962442281896,0.102266535007317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT1,Diamine acetyltransferase 1,31791,-0.0340481769937386,0.0208366349685237,-0.0748879815320451,0.00679162754456795,0.102290502153087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTDH,Protein LYRIC,31816,-0.0616784347042095,0.0377647247014526,-0.135697295119057,0.0123404257106377,0.102463642915405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAPL1,Proactivator polypeptide-like 1,31998,0.0338910306851648,0.0207838115698808,-0.00684523999180145,0.0746273013621311,0.103006856904839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM1,Dynamin-1,31998,-0.0762088371560447,0.0467381161440948,-0.16781554479847,0.0153978704863811,0.103027032213994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRAID,All-trans retinoic acid-induced differentiation factor,31998,-0.0195281788892584,0.0119778076537904,-0.0430046818906876,0.00394832411217075,0.103066455843314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG3,Secretogranin-3,33136,0.0224471576783804,0.0138068646107014,-0.00461429695859432,0.0495086123153552,0.104029154102516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MASP1,Mannan-binding lectin serine protease 1,33030,-0.0157577399917213,0.00971572616766814,-0.0348005632803509,0.00328508329690821,0.104865838882533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD3,Sphingomyelin phosphodiesterase 3,31816,0.0402499115213387,0.0248366318526402,-0.00842988690983614,0.0889297099525135,0.105149154299621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRELP,Prolargin,33121,0.0152948780003036,0.00944566828991641,-0.00321863184793253,0.0338083878485398,0.105430323545379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF168,E3 ubiquitin-protein ligase RNF168,31816,0.0285623311721176,0.0176512887547235,-0.00603419478714043,0.0631588571313756,0.105674343776012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN7,Tetraspanin-7,31804,-0.0613515104099907,0.0379290454588027,-0.135692439509244,0.0129894186892625,0.105806020153489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB14,EF-hand calcium-binding domain-containing protein 14,31998,-0.0183529699354434,0.0113547190695711,-0.0406082193118027,0.00390227944091587,0.106064845453166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GAT1,"Beta-1,4-glucuronyltransferase 1",33121,0.0159819160672907,0.00990093378989824,-0.0034239141609098,0.0353877462954913,0.106524197344755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C19orf12,Protein C19orf12,32911,-0.0408215406409179,0.0252939559920847,-0.0903976943854039,0.00875461310356813,0.106589633731926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF21,Immunoglobulin superfamily member 21,31854,-0.0264537311190865,0.0163963930493483,-0.0585906614958093,0.0056831992576362,0.106703033934743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB10,Ras-related protein Rab-10,32042,-0.0361572857588345,0.0224495172893761,-0.0801583396460118,0.00784376812834271,0.107307611066767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFI,Complement factor I,32071,-0.0133800496594724,0.00831085920393398,-0.029669333699183,0.00290923438023824,0.107450675169995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM5,Intercellular adhesion molecule 5,33117,-0.0292519074828849,0.0181790493937401,-0.0648828442946154,0.00637902932884566,0.107630917111829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB2,Integrin beta-2,33049,-0.0188953837284801,0.0117479535397801,-0.0419213726664492,0.0041306052094889,0.10778478222388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RB,Interleukin-17 receptor B,33012,0.0353758027991582,0.0220106889354571,-0.00776514751433777,0.0785167531126543,0.108045157030896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC9,DnaJ homolog subfamily C member 9,31998,-0.0518025102897515,0.0322579417487909,-0.115028076117382,0.0114230555378787,0.108341257820967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOT,Angiomotin,31907,0.0275994932457698,0.0171909112704076,-0.00609469284422914,0.0612936793357686,0.108432753485278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTR1,Endosome-associated-trafficking regulator 1,31854,-0.0374234502052242,0.0233332464181351,-0.083156613184769,0.00830971277432067,0.108785788128533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNA4,Plexin-A4,33109,-0.0545019486745469,0.033989703093825,-0.121121766738444,0.0121178693893501,0.108864295848808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NACC1,Nucleus accumbens-associated protein 1,31990,-0.0371077388103653,0.0231779134846986,-0.0825364492403745,0.00832097161964394,0.109419785288716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",31998,-0.0678528914933749,0.0423849133225771,-0.150927321605626,0.0152215386188761,0.109446763753065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF3,Neurotrophin-3,33109,-0.023390746957886,0.0146306154079137,-0.0520667531573969,0.00528525924162495,0.109911888361893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,32042,-0.0429987350340054,0.0269013059645318,-0.0957252947244878,0.00972782465647704,0.109998192802494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN1,Neuroligin-1,31826,-0.045533657802067,0.0284953314392013,-0.101384507422902,0.0103171918187676,0.110100521124862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACRT,Extracellular glycoprotein lacritin,31978,0.035569775960907,0.0222958971471233,-0.00813018244745455,0.0792697343692686,0.110675813685879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROD,Uroporphyrinogen decarboxylase,31907,-0.0471493082222575,0.0295841428582778,-0.105134228224482,0.0108356117799669,0.111037610070635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOP56,Nucleolar protein 56,31791,-0.0737900914328103,0.0463633785236652,-0.164662313339194,0.0170821304735735,0.111526707843444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,33191,-0.0295094940568651,0.0185792689669204,-0.0659248612320291,0.00690587311829892,0.112254192988411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP1,Neuropilin-1,33148,-0.0183303358473158,0.0115780201610945,-0.041023255363061,0.00436258366842936,0.113411969301361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2AP,CD2-associated protein,33117,-0.0423364361409363,0.0267927170949979,-0.0948501616471322,0.0101772893652596,0.114109666674575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDSN,Corneodesmosin,33175,0.028159037101165,0.0178210108623085,-0.00677014418895967,0.0630882183912897,0.114119481602981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARP1,Poly [ADP-ribose] polymerase 1,33109,-0.0371783551384428,0.0235503599888804,-0.0833370607166484,0.00898035043976277,0.114447249742324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SWAP70,Switch-associated protein 70,31998,-0.0241783000191984,0.0153699742462046,-0.0543034495417595,0.00594684950336268,0.115740698617327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG2,Desmoglein-2,33121,0.0174443839143969,0.0110966290630844,-0.00430500904924859,0.0391937768780424,0.115976950539722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,31908,-0.0457560194950339,0.0291149297411414,-0.102821281787671,0.0113092427976033,0.116093781458742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMN,Protein amnionless,32981,0.0305072334857779,0.0194352421313572,-0.00758584109168225,0.0686003080632381,0.116525203455023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP47,Ubiquitin carboxyl-terminal hydrolase 47,31791,0.0548985537533221,0.0350198769323667,-0.0137404050341166,0.123537512540761,0.117008324854245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLGA3,Golgin subfamily A member 3,32020,-0.0501368450582361,0.0319828858343546,-0.112823301293571,0.0125496111770989,0.117012864961821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCPEP1,Retinoid-inducible serine carboxypeptidase,31830,-0.0321758385426454,0.020539504226939,-0.0724332668274458,0.00808158974215498,0.117266463244783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,31990,-0.0346465822470371,0.0221530130211849,-0.0780664877685595,0.00877332327448532,0.117867286009287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F13B,Coagulation factor XIII B chain,32025,0.0165808556793964,0.0106049648569301,-0.00420487544018659,0.0373665867989793,0.117976971810476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAEP,Glycodelin,33042,-0.0859230213030573,0.0550614007195041,-0.193843366713285,0.0219973241071706,0.118679871454898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIP,Pancreatic triacylglycerol lipase,32048,0.0386815820550133,0.024791825681012,-0.00991039627977015,0.0872735603897968,0.118741176939026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD177,CD177 antigen,33104,0.0823809674804044,0.0528751209108332,-0.0212542695048288,0.186016204465638,0.119262968198179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAPPA,Pappalysin-1,32981,-0.0297633114424928,0.019112697126107,-0.0672241978096625,0.00769757492467697,0.119447451595296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,32951,-0.032130515933132,0.0206390697991081,-0.0725830927393839,0.00832206087311984,0.119559675203159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT2,Omega-amidase NIT2,32018,-0.0482350046333749,0.0309992626966053,-0.108993559518721,0.0125235502519716,0.119748752839844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP2,Lysosome-associated membrane glycoprotein 2,32815,-0.0120226636444625,0.00772714138152051,-0.0271678607522427,0.00312253346331773,0.119769578533152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSHB,Thyrotropin subunit beta,33117,-0.054036206802518,0.0347336602285784,-0.122114180850532,0.0140417672454956,0.11980876491088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL8,C-C motif chemokine 8,33174,-0.0394737023985276,0.0254095167761244,-0.0892763552797313,0.0103289504826762,0.120339841603563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDRG1,p53 and DNA damage-regulated protein 1,31826,-0.0339424341094504,0.0218695065767754,-0.0768066669999301,0.00892179878102935,0.120694636221712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNF,Tumor necrosis factor,32961,-0.0257525395214895,0.0165975565999518,-0.0582837504573951,0.00677867141441607,0.120798461211898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI2,Serpin I2,31998,0.0367358275039995,0.0237368469815556,-0.00978839257984937,0.0832600475878484,0.121753633635159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP3,Fibroblast growth factor-binding protein 3,32006,-0.0235833774163147,0.0152555242927301,-0.0534842050300656,0.00631745019743623,0.122172788981926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPT1,Translationally-controlled tumor protein,32981,-0.0418269363062547,0.0270649196829226,-0.094874178884783,0.0112203062722736,0.122279412108443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CERT,Ceramide transfer protein,32911,-0.0386610213540247,0.0250341125486076,-0.0877278819492956,0.0104058392412462,0.122544942341536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPBP,Platelet basic protein,32017,-0.0532824775547232,0.0345817845269226,-0.121062775227491,0.0144978201180451,0.123415292663667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP2,Metalloproteinase inhibitor 2,32042,-0.0157846423138529,0.0102500049875919,-0.0358746520895329,0.00430536746182713,0.123610729216118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POMC,Pro-opiomelanocortin,31854,-0.0431305716104216,0.0280121405608423,-0.0980343671096724,0.0117732238888292,0.123673815058187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTF1,Cardiotrophin-1,32973,-0.0537997229234039,0.0350066955371857,-0.122412846176288,0.01481340032948,0.12436939406785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPD,Pulmonary surfactant-associated protein D,33117,-0.0417567292716294,0.0271808465206157,-0.0950311884520361,0.0115177299087773,0.124512201610584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPKOW,G-patch domain and KOW motifs-containing protein,32911,-0.0186337664560225,0.0121347817293502,-0.0424179386455488,0.00515040573350387,0.124682092168766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABRAXAS2,BRISC complex subunit Abraxas 2,31791,-0.0429898850969751,0.0280037313905336,-0.0978771986224209,0.0118974284284708,0.124790472087872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YJU2,Splicing factor YJU2,31990,-0.0204286654635959,0.0133403833235071,-0.0465758167776698,0.005718485850478,0.125727294890245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,32006,-0.0390268700452099,0.0254870128980499,-0.0889814153253877,0.0109276752349678,0.12575064031874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA6,Carbonic anhydrase 6,33095,0.0398263684060443,0.0260389394952459,-0.0112099530046377,0.0908626898167263,0.126178938237605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XRCC4,DNA repair protein XRCC4,32911,-0.0235791765066187,0.0154350316703194,-0.0538318385804448,0.00667348556720728,0.126639257622685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRL,Appetite-regulating hormone,33117,0.050292123657386,0.0329372795733553,-0.0142649443063903,0.114849191621162,0.126820932778097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN1,Perilipin-1,32911,0.0221926851758174,0.0145352449250805,-0.00629639487734036,0.0506817652289753,0.126843463696514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNG,Uracil-DNA glycosylase,31990,-0.0218888533169144,0.0143389570508914,-0.0499932091366617,0.00621550250283279,0.126919789672465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,32951,-0.0426941551731376,0.0279761936018356,-0.0975274946327353,0.0121391842864601,0.127024966320628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BEX3,Protein BEX3,31793,-0.0293960692461158,0.0192950469305929,-0.0672143612300779,0.00842222273784636,0.12767589000715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,33121,-0.0185413267748439,0.0121767816382555,-0.0424078187858247,0.00532516523613688,0.127875568922299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",31793,-0.0336359776535198,0.0221033001518304,-0.0769584459511074,0.00968649064406776,0.128111622231386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,31998,-0.0298845536142434,0.0196415647025656,-0.068382020431272,0.00861291320278518,0.128177423168104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRN,Agrin,33167,-0.0206164688401566,0.0135639798038026,-0.0472018692556098,0.00596893157529649,0.128561714376996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAP1A,Ras-related protein Rap-1A,31816,-0.043089075733074,0.0283564439451532,-0.0986677058655743,0.0124895543994262,0.128666676897884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",31907,-0.0562027967572479,0.0370604545899072,-0.128841287753466,0.0164356942389702,0.129431160629587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",32006,-0.024386774048151,0.0160815458455934,-0.0559066039055142,0.00713305580921207,0.129448801367378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN1,Contactin-1,33208,-0.0171025794673063,0.011282982773126,-0.0392172257026333,0.00501206676802076,0.129609747348569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,33161,-0.0211279578319274,0.0139475436883552,-0.0484651434611036,0.00620922779724873,0.129855379790194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,31854,-0.029570224627786,0.0195268223900741,-0.0678427965123312,0.00870234725675916,0.129982631611102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,33020,0.0196189828396012,0.0129896710591034,-0.00584077243624152,0.045078738115444,0.130990365159503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR2,Asialoglycoprotein receptor 2,32048,-0.0161608047654247,0.0107065831244511,-0.0371457076893488,0.00482409815849944,0.1312313107467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APP,Amyloid-beta precursor protein,33112,-0.0414161492386456,0.0274655673830649,-0.0952486613094529,0.0124163628321616,0.13160895691163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2L,von Willebrand factor C domain-containing protein 2-like,32020,0.0289219657787773,0.0191877180567014,-0.00868596161235734,0.066529893169912,0.131771266255028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEPE,Matrix extracellular phosphoglycoprotein,33121,0.0163106754869644,0.010829956048854,-0.00491603836878934,0.0375373893427182,0.132085554986949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA2,Adenosine deaminase 2,33056,-0.0260994833792305,0.0173355085341483,-0.0600770801061612,0.0078781133477002,0.132219314779377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS8,Regulator of G-protein signaling 8,32981,0.0407214313924724,0.0270538654468627,-0.0123041448833784,0.0937470076683232,0.132310140904366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOB,Apolipoprotein B-100,32048,-0.0140199387528664,0.00932236255457171,-0.032291769359827,0.00425189185409413,0.132647649598716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,33042,-0.0250620938912398,0.0166651906496034,-0.0577258675644625,0.00760167978198294,0.132654486329043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR2,Complement factor H-related protein 2,32016,0.0359317760863163,0.0239119937868005,-0.0109357317358127,0.0827992839084454,0.132966551484462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACYP1,Acylphosphatase-1,31878,-0.041813267340018,0.0278369462869688,-0.0963736820624767,0.0127471473824408,0.133119459773757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",31816,0.0280313354350581,0.0186698033251558,-0.00856147908224716,0.0646241499523635,0.13328818694584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,33138,-0.026198233940184,0.0175122485464408,-0.0605222410912079,0.00812577321083992,0.134691324076434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,33208,-0.017039109046011,0.0114023144736968,-0.0393876454144567,0.00530942732243473,0.135118813914463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANPEP,Aminopeptidase N,33123,-0.0176250736196149,0.0117984806542636,-0.0407500957019715,0.00549994846274168,0.135253137254227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",31854,-0.0422046099436571,0.0282739379952038,-0.0976215284142565,0.0132123085269423,0.135557401692617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPY30,Protein dpy-30 homolog,33162,-0.0374134976834005,0.0251007772333545,-0.0866110210607752,0.0117840256939743,0.136120766806281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYY,Peptide YY,31791,0.0587593802001466,0.0394823414777476,-0.0186260090962386,0.136144769496532,0.136729372965684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FN1,Fibronectin,32071,-0.0162332630994987,0.0109242824110249,-0.0376448566251075,0.00517833042611012,0.137325837217219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LECT2,Leukocyte cell-derived chemotaxin-2,32042,-0.0398129361199227,0.0268029140291627,-0.0923466476170816,0.0127207753772363,0.137480536713547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECAM1,Platelet endothelial cell adhesion molecule,33121,-0.0185637377035073,0.0125058216529446,-0.0430751481432787,0.0059476727362641,0.137737156386861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HHEX,Hematopoietically-expressed homeobox protein HHEX,32006,-0.0462312780548525,0.0311703141953506,-0.10732509387774,0.0148625377680347,0.138067532420683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP6,Bone morphogenetic protein 6,32960,-0.0256427719078624,0.0173115085369694,-0.0595733286403224,0.00828778482459758,0.138575461802212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,32859,-0.0541431501971385,0.0365564702769521,-0.125793831939965,0.0175075315456876,0.138622053415134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTM4,Glutathione S-transferase Mu 4,31791,-0.0437370152105937,0.0295357167305426,-0.101627020002457,0.0141529895812697,0.138698058795711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEK7,Serine/threonine-protein kinase Nek7,31908,-0.046945986706848,0.0317033823414106,-0.109084616096013,0.0151926426823167,0.13870534156292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPA2,Replication protein A 32 kDa subunit,31816,-0.0196502119850864,0.0132736457565168,-0.0456665576678594,0.00636613369768655,0.138811182759821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,31907,-0.0376630347673808,0.0254474599804745,-0.0875400563291108,0.0122139867943492,0.138907176227079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGCT,Gamma-glutamylcyclotransferase,32030,-0.0296558631268028,0.0200452310334585,-0.0689445159523814,0.00963278969877577,0.139062371016375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAN,Neurocan core protein,33191,0.0228218925465235,0.0154316393974468,-0.00742412067247212,0.0530679057655192,0.139202375048873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF1,Scavenger receptor class F member 1,33208,-0.025955773659644,0.0175732751177254,-0.0603993928903858,0.00848784557109788,0.139710894820566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL11,Eotaxin,33208,-0.023015467756472,0.0155987779742157,-0.0535890725859348,0.00755813707299065,0.140123238512585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPM3,Tropomyosin alpha-3 chain,31791,-0.0262912214440692,0.0178217273075906,-0.0612218069669468,0.00863936407880837,0.140192490258848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGL1,Fibrinogen-like protein 1,32048,-0.0388014857714519,0.0263047337847158,-0.0903587639894947,0.012755792446591,0.140233513806503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,32951,0.0738012661895695,0.0500424091712363,-0.0242818557860537,0.171884388165193,0.14031023462369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDRG1,Protein NDRG1,32911,-0.0426304501310336,0.0289222343381074,-0.0993180294337242,0.0140571291716569,0.140527398322342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN2,CCN family member 2,33120,-0.0351772146972943,0.0238857589349615,-0.0819933022098188,0.0116388728152302,0.140860829416144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR2,GMP reductase 2,31907,-0.0417976445295433,0.0283942168422621,-0.0974503095403771,0.0138550204812904,0.141050181395066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NINJ1,Ninjurin-1,32951,0.0346484386165105,0.0235441444451442,-0.0114980844959721,0.080794961728993,0.141155901600774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB1,Nuclear factor NF-kappa-B p105 subunit,31791,-0.0453240579385595,0.030834045422037,-0.105758786965752,0.0151106710886331,0.141622090871329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MVK,Mevalonate kinase,32981,-0.0474838768218239,0.0323184161131462,-0.11082797240359,0.0158602187599426,0.141801506829214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRN1,Leucine-rich repeat neuronal protein 1,32981,0.0233479925883851,0.0158987061143521,-0.00781347139574511,0.0545094565725153,0.141992656237219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNRPB2,U2 small nuclear ribonucleoprotein B'',32006,-0.0274691536794236,0.0187068618890485,-0.0641346029819586,0.00919629562311143,0.142037272958917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD5,Mothers against decapentaplegic homolog 5,33062,-0.012495978793602,0.00851805888401149,-0.0291913742062645,0.00419941661906051,0.142413012998518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC1A4,Neutral amino acid transporter A,31826,-0.0325547869274691,0.0222035547560675,-0.0760737542493615,0.0109641803944232,0.142637247039743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUP50,Nuclear pore complex protein Nup50,31791,-0.02064129707019,0.0140946764684473,-0.0482668629483467,0.0069842688079667,0.143107124148167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP1,"Fatty acid-binding protein, liver",33121,-0.0560667784796152,0.0384128109276751,-0.131355887897858,0.0192223309386281,0.144440285098388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRR,Receptor-type tyrosine-protein phosphatase R,32006,0.0209961293547048,0.0144102575797783,-0.00724797550166062,0.0492402342110702,0.145150588824747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH9,Myosin-9,32044,-0.0672614681914473,0.0461832977891481,-0.157780731858178,0.0232577954752829,0.145322750999382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB2,Carboxypeptidase B2,32051,-0.0135801125005268,0.00932717234254948,-0.0318613702919238,0.00470114529087022,0.145441354219471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL8,Interleukin-8,33035,-0.041514495954334,0.0285343537404906,-0.0974418292856957,0.0144128373770276,0.145734830283799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSAP,Gamma-secretase-activating protein,32951,0.0515781814962172,0.0355082453058951,-0.0180179793033372,0.121174342295772,0.146380334859318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA5,Integrin alpha-5,33121,-0.0149938845930038,0.0103255145025604,-0.0352318930180222,0.00524412383201468,0.146504472711131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HJV,Hemojuvelin,32020,-0.0278612204747343,0.0191947692942901,-0.0654829682915428,0.00976052734207418,0.146681946257518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSHB,Follitropin subunit beta,31854,0.0418112815937457,0.0288246648622082,-0.0146850615361823,0.0983076247236737,0.146950827709115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASP,Vasodilator-stimulated phosphoprotein,32048,-0.0435826009151021,0.0300467531688002,-0.102474237125951,0.0153090352957463,0.146962419268428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP2B,DNA topoisomerase 2-beta,31816,-0.0479695471631174,0.0331070149154158,-0.112859296397332,0.0169202020710975,0.147401398378897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD5,26S proteasome non-ATPase regulatory subunit 5,31826,0.0344088978682511,0.0237555282042843,-0.0121519374121462,0.0809697331486484,0.147531369195684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLNK,B-cell linker protein,31816,-0.0235267316206225,0.0162530990780068,-0.0553828058135159,0.00832934257227093,0.147793121880024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFA2,BPI fold-containing family A member 2,31599,0.0655799043141623,0.0453614571296142,-0.0233285516598816,0.154488360288206,0.14829997968041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORT1,Sortilin,33107,-0.0217377116530605,0.0150701738211628,-0.0512752523425397,0.00779982903641866,0.149216527486888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA7A,Semaphorin-7A,33180,-0.0157341769202563,0.0109110775030204,-0.0371198888261763,0.00565153498566369,0.149327830403336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP5,Retinol-binding protein 5,33062,-0.0329180420720056,0.0228314900657645,-0.0776677626009039,0.0118316784568928,0.149400120761954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2,Complement C2,33127,-0.0143255429824872,0.00994773574461947,-0.0338231050419413,0.00517201907696699,0.149880634099714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB1,Carboxypeptidase B,33208,0.0335295191436282,0.0233046839717516,-0.0121476614410051,0.0792066997282614,0.150258264828197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTF2,Transcription termination factor 2,31826,-0.0292778127313804,0.0203497931989562,-0.0691634074013346,0.0106077819385738,0.150270107598051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUMB,Protein numb homolog,31816,-0.049231557730704,0.0342377841245231,-0.116337614614769,0.0178744991533613,0.150496236714102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPB1,Beta-ureidopropionase,32042,-0.0539251266400619,0.0375125753417543,-0.1274497743099,0.0195995210297766,0.150611144713615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSPN,Persephin,33109,0.0592608493235803,0.0412398180153185,-0.0215691939864439,0.140090892633604,0.150759432517944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES2,Retinoic acid receptor responder protein 2,33148,-0.0271745825540805,0.0189183696647097,-0.0642545870969115,0.00990542198875055,0.15092097324428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLTA,Clathrin light chain A,32973,0.0289409597896245,0.0201777888487953,-0.0106075063540142,0.0684894259332632,0.151523971278777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFC1,Cryptic protein,32951,0.0278603121883715,0.0194371361374453,-0.0102364746410212,0.0659570990177642,0.15179325597519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD63,CD63 antigen,33024,-0.0310046735268607,0.0216321923468238,-0.0734037705266353,0.0113944234729139,0.151818467163868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MXRA8,Matrix remodeling-associated protein 8,31907,0.0177133697988238,0.0123620198935856,-0.00651618919260398,0.0419429287902516,0.151932245004945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP3,"Fatty acid-binding protein, heart",32042,-0.0277849909264709,0.0193914896169988,-0.0657923105757884,0.0102223287228467,0.151943441659853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS2,Thrombospondin-2,33121,-0.0210696254301522,0.0147057094673738,-0.0498928159862048,0.00775356512590031,0.151964961154881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL2,Angiopoietin-related protein 2,33140,-0.0239729485125775,0.0167335390107761,-0.0567706849736986,0.0088247879485437,0.151999949691165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OBP2B,Odorant-binding protein 2b,33004,-0.038999360062713,0.0272255660465068,-0.0923614695138664,0.0143627493884404,0.15205059838612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTS,6-pyruvoyl tetrahydrobiopterin synthase,32870,-0.0325297144535686,0.0227703581587034,-0.0771596164446272,0.01210018753749,0.153156578720504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHACTR2,Phosphatase and actin regulator 2,32020,-0.0674393893630365,0.0472243393446778,-0.159999094478605,0.0251203157525319,0.153314638914868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP29,Endoplasmic reticulum resident protein 29,31907,-0.0701172513856397,0.0491026840296216,-0.166358512083698,0.0261240093124185,0.153341845082071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3D,T-cell surface glycoprotein CD3 delta chain,31804,-0.0210656253531252,0.014753058275834,-0.0499816195737599,0.00785036886750947,0.153368319846163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAB2,Stabilin-2,32044,-0.0171269328165839,0.01200623039742,-0.040659144395527,0.0064052787623593,0.153764102167493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B2M,Beta-2-microglobulin,32071,-0.0197783569270473,0.0138906657265899,-0.0470040617511635,0.00744734789706891,0.154528086639571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,32973,-0.0499362352214233,0.0351083654793631,-0.118748631560975,0.0188761611181284,0.154962501012211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB104A_DEFB104B,Beta-defensin 104,31804,-0.0326770192248561,0.0229810206132914,-0.0777198196269073,0.0123657811771951,0.155093836837903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,31998,0.045959175470875,0.0323743430737232,-0.0174945369536225,0.109412887895372,0.155760452367199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALLD,Palladin,31816,0.025032079124582,0.0176350164170195,-0.00953255305277628,0.0595967113019403,0.155809281550834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM19,Probable RNA-binding protein 19,31791,-0.0280187717719593,0.0197696691446257,-0.0667673232954256,0.0107297797515071,0.156449220571581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP25,Synaptosomal-associated protein 25,31804,-0.0272134550768424,0.0192218163144404,-0.0648882150531455,0.0104613048994608,0.156888504404108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAXX,Protein PAXX,31907,-0.0276011127975692,0.019497998396201,-0.065817189654123,0.0106149640589847,0.156938237039429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,31998,0.0426151813983405,0.0301092763313971,-0.0163990002111978,0.101629363007879,0.157007002382599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGBL2,Cytosolic carboxypeptidase 2,31804,-0.0516461844301706,0.0365232939961303,-0.123231840662586,0.0199394718022448,0.157386185196651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,32951,-0.0337286789068626,0.0238554248424969,-0.0804853115981565,0.0130279537844314,0.157434125759858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOT1,"Aspartate aminotransferase, cytoplasmic",32044,-0.0239282088057621,0.0169307142497209,-0.0571124087352152,0.0092559911236909,0.157608004640513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",32020,-0.0530391943092058,0.0375397943706973,-0.126617191275772,0.0205388026573609,0.157732371934695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGN,Cingulin,31826,-0.0242165405414194,0.0171400833385014,-0.0578111038848821,0.00937802280204339,0.157739056327508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIP2,Cysteine-rich protein 2,33042,-0.0213251308836666,0.0150960981687275,-0.0509134832943725,0.00826322152703944,0.157802141548108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KITLG,Kit ligand,33117,0.0211980069462225,0.0150078295543691,-0.00821733898034094,0.050613352872786,0.157849532892997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,31791,-0.0238937032641541,0.0169185403464289,-0.0570540423431548,0.00926663581484661,0.157910157812886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT3,Kunitz-type protease inhibitor 3,31998,-0.0744997702015926,0.0527798656917571,-0.177948306957437,0.0289487665542513,0.158132940031788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPGN,Epigen,31990,-0.0276164160325944,0.0195784770131055,-0.0659902309782812,0.0107573989130924,0.158418678680888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EEF1D,Elongation factor 1-delta,32042,-0.0539139198118109,0.0383137141124023,-0.129008799472119,0.0211809598484976,0.159417849627025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA7,Carbonic anhydrase 7,31908,-0.0203282966836193,0.0144567121164809,-0.0486634524319218,0.00800685906468331,0.159721446552391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOH,Beta-2-glycoprotein 1,33121,-0.0200924571896541,0.0142935902823404,-0.0481078941430413,0.00792297976373303,0.159849951655186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECI2,Enoyl-CoA delta isomerase 2,31791,-0.0366370430409051,0.0261051180050797,-0.0878030743308613,0.0145289882490511,0.160527110106831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO4,Roundabout homolog 4,31854,-0.0101785184709462,0.00725281202545184,-0.0243940300408318,0.00403699309893938,0.160542742702559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,32020,0.0136944199658289,0.00977224661283361,-0.00545918339532499,0.0328480233269828,0.161147929037493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F9,Coagulation factor IX,33127,-0.0102948774466038,0.0073597538150549,-0.0247199949241114,0.00413024003090376,0.161906523074657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB2,Receptor tyrosine-protein kinase erbB-2,33126,-0.0139995095956031,0.0100120146416359,-0.0336230582932095,0.00562403910200334,0.162067455754121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1MT,"DNA topoisomerase I, mitochondrial",31793,-0.0283946773401099,0.0203490280498617,-0.0682787723178389,0.011489417637619,0.162942737706978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPYL1,Testis-specific Y-encoded-like protein 1,31816,-0.0236994310682231,0.0169863414997809,-0.0569926604077936,0.00959379827134752,0.162996059630079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR2,Cadherin-related family member 2,33062,-0.0442369145052805,0.0317199778607613,-0.106408071112373,0.0179342421018117,0.163170254702905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK6,SLIT and NTRK-like protein 6,32973,0.0198169613523668,0.0142544437126076,-0.00812174832434402,0.0477556710290777,0.164495228925887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP2,Fibroblast growth factor-binding protein 2,32044,-0.0285197416453614,0.0205223960020636,-0.0687436378094062,0.0117041545186833,0.164664179152028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP1,Syntaxin-binding protein 1,32020,-0.0445608708863158,0.032087309680965,-0.107451997861007,0.0183302560883756,0.164953258032427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMM2,Phosphomannomutase 2,31791,-0.0353575622062585,0.0254607966902572,-0.0852607237191627,0.0145455993066457,0.164964298110512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",33062,-0.025898607557936,0.0186918862586925,-0.0625347046249733,0.0107374895091012,0.165919188919673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G2,V-type proton ATPase subunit G 2,31791,0.0564578090747008,0.0407706570771067,-0.0234526787964283,0.13636829694583,0.166166205323439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA3A,Chymotrypsin-like elastase family member 3A,33196,0.0321435778070613,0.0232138810516094,-0.0133556290540931,0.0776427846682157,0.166188553677568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPS10,40S ribosomal protein S10,31791,-0.0246629281788604,0.0178391335912726,-0.0596276300177546,0.0103017736600339,0.166854691228301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF11,Multiple epidermal growth factor-like domains protein 11,31791,0.0192208336122743,0.0139117353246889,-0.00804616762411591,0.0464878348486645,0.167128217369399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPHOSPH8,M-phase phosphoprotein 8,32973,-0.0434212035388143,0.0314435988310188,-0.105050657247611,0.0182082501699825,0.167338708948097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROS,Uroporphyrinogen-III synthase,31826,-0.0409330951166092,0.0296596650489516,-0.0990660386125542,0.0171998483793359,0.167599861021197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD274,Programmed cell death 1 ligand 1,33042,-0.0194764865060868,0.0141155648696362,-0.0471429936505737,0.00819002063840003,0.167687852332545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRA,Paired immunoglobulin-like type 2 receptor alpha,33121,-0.0238115469815963,0.0172701659188909,-0.0576610721826224,0.0100379782194298,0.168001962431525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3BP,Galectin-3-binding protein,32071,-0.0174435393064488,0.0126747873208544,-0.0422861224553235,0.00739904384242581,0.168788032537429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLA,Alpha-galactosidase A,31892,-0.0204476376128445,0.0148585188989492,-0.049570334654785,0.00867505942909597,0.168814808018963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL3,C-C motif chemokine 3,33109,-0.034523420037363,0.0251128606183301,-0.0837446268492901,0.014697786774564,0.169250535699595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC1,Glypican-1,33189,0.0163365661011595,0.0118866887776721,-0.00696134390307794,0.0396344761053968,0.169365811813364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",31854,-0.0439052252967311,0.0319928206602472,-0.106611153790816,0.0188007031973535,0.169997278077936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",31804,-0.018372374202318,0.0133960254929808,-0.0446285841685605,0.00788383576392437,0.17026738748013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTBDN,Retbindin,33062,0.0161395098019437,0.0117794976501941,-0.00694830559243676,0.0392273251963242,0.170680282008159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPK2,Death-associated protein kinase 2,31816,-0.0316691350523413,0.0231289876457696,-0.0770019508380497,0.0136636807333672,0.17096602326056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMA1,Proteasome subunit alpha type-1,32951,0.0265959244548379,0.0194244727331657,-0.0114760421021669,0.0646678910118428,0.170973969699192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,32981,-0.0234478743360682,0.0171331641615131,-0.057028876092634,0.0101331274204975,0.171170870736001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRIB,Protein scribble homolog,31854,-0.052613326677732,0.0385115618203202,-0.12809598784556,0.0228693344900955,0.171927225584555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSS,Cathepsin S,31224,-0.0138454578704157,0.0101412514295187,-0.0337223106722724,0.00603139493144103,0.172216295234672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,33117,0.0174065477664631,0.0127546392718094,-0.00759254520628331,0.0424056407392096,0.172375609143965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,33110,-0.027924692172705,0.0204963636921167,-0.0680975650092537,0.0122481806638437,0.173100255124259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",32951,-0.0444039250831286,0.0326044299664256,-0.108308607817323,0.0195007576510657,0.173266007576621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTAG1A_CTAG1B,Cancer/testis antigen 1,31893,-0.0282210014908895,0.0207536283924123,-0.0688981131400176,0.0124561101582386,0.173931103261369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNAR1,Interferon alpha/beta receptor 1,31998,-0.015091887416939,0.0111012622330253,-0.0368503613936687,0.00666658655979062,0.174036771348573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L1,Bcl-2-like protein 1,32006,-0.0560685411105407,0.0412475556713726,-0.136913750226431,0.0247766680053497,0.174086448377036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYAP1,Synapse-associated protein 1,31907,-0.0318785093807481,0.023465630379819,-0.0778711449251933,0.0141141261636972,0.174340099597243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,32006,-0.0268511300899653,0.0197832839303231,-0.0656263665933987,0.011924106413468,0.174738035107644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGF,Placenta growth factor,33208,-0.0137813211091562,0.0101659931954062,-0.0337066677721524,0.00614402555383997,0.175252018213393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON1,Spondin-1,33136,-0.0178431894462324,0.0131775191932546,-0.0436711270650114,0.00798474817254668,0.175751555768036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRG1,Scrapie-responsive protein 1,32042,-0.0153394470843395,0.0113292944957412,-0.0375448642959923,0.00686597012731335,0.175788451364865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS8,Galectin-8,33191,-0.0338957380838845,0.0250888357841804,-0.0830698562208782,0.0152783800531092,0.176721204514234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171A2,Protein FAM171A2,32020,-0.0898367299268011,0.0666613218867089,-0.22049292082475,0.0408194609711483,0.17780842793964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFHD1,EF-hand domain-containing protein D1,32020,0.0190877321714922,0.0141651435800478,-0.00867594924540148,0.0468514135883859,0.177855020899987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOMO1,Nodal modulator 1,33121,-0.0132193658350071,0.00981763575382332,-0.0324619319125008,0.00602320024248658,0.178179172920846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTUS1,Microtubule-associated tumor suppressor 1,31908,-0.0307091217081599,0.0228308434416662,-0.0754575748538257,0.014039331437506,0.178642986323556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIABLO,"Diablo homolog, mitochondrial",33089,-0.0614883721115545,0.0457408244213257,-0.151140387977353,0.028163643754244,0.178893896518134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK2B,Divergent protein kinase domain 2B,31907,0.0145982365883352,0.0108634204047031,-0.00669406740488289,0.0358905405815534,0.179054792120963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCC1,Regulator of chromosome condensation,31990,0.0303700274935493,0.0226296274893365,-0.0139840423855503,0.0747240973726488,0.179621122854596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THSD1,Thrombospondin type-1 domain-containing protein 1,31760,0.0185659051776211,0.0138445334874127,-0.00856938045770771,0.04570119081295,0.179953083123982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP2,Neuropilin-2,33121,-0.0161920230386215,0.0120866384077175,-0.0398818343177479,0.00749778824050486,0.180390027878721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UMOD,Uromodulin,33185,0.029248246348325,0.0218482598295604,-0.0135743429176135,0.0720708356142634,0.180703487936234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD70,CD70 antigen,33109,0.0230726989015504,0.0172832614182403,-0.0108024934782006,0.0569478912813013,0.181920069212547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,31998,-0.0116417676050657,0.00873147958884796,-0.0287554675992077,0.00547193238907627,0.182470395403846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCG,Gamma-synuclein,33042,-0.0362286651198729,0.0272578152633415,-0.0896539830360222,0.0171966527962764,0.183846615054367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRAL,GDNF family receptor alpha-like,31780,0.0335967431216323,0.0252996843377588,-0.015990638180375,0.0831841244236396,0.18423562908445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBP2,Poly(rC)-binding protein 2,32020,-0.0391762686781822,0.0295087087408166,-0.0970133378101828,0.0186608004538184,0.18434464975656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEAR1,Platelet endothelial aggregation receptor 1,33208,-0.0124986883095244,0.00941761818269142,-0.0309572199475996,0.00595984332855078,0.184490289716875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH1,Acid ceramidase,31981,-0.0251323486804607,0.0189763548941103,-0.0623260042729168,0.0120613069119955,0.185409311238269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,33042,-0.0220729476456631,0.0166698350587026,-0.0547458243607202,0.0105999290693941,0.185496719754236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH2,Neutral ceramidase,33042,-0.0283472320508693,0.0214148727106149,-0.0703203825636746,0.0136259184619359,0.185632260878359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549L,UPF0606 protein KIAA1549L,31908,-0.0154927518635338,0.0117092212104185,-0.0384428254359541,0.00745732170888646,0.185834711090675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLKB1,Plasma kallikrein,31928,0.0137357205425262,0.0103838132747396,-0.00661655347596336,0.0340879945610157,0.18594196195289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORCS2,VPS10 domain-containing receptor SorCS2,32951,0.0192260283307427,0.0145552873452273,-0.00930233486590277,0.0477543915273881,0.186571435191528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBKS,Ribokinase,32881,-0.0277921623781382,0.0210606347957794,-0.0690710065778658,0.0134866818215894,0.186995740282534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCXR,L-xylulose reductase,33126,-0.0284662611003845,0.0215719472729555,-0.0707472777553772,0.0138147555546082,0.187004677482864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG4,BAG family molecular chaperone regulator 4,31816,-0.027344900789199,0.0207858409270916,-0.0680851490062986,0.0133953474279006,0.188364663046343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THPO,Thrombopoietin,32973,-0.020722694721086,0.0157538914214512,-0.0516003219071303,0.0101549324649583,0.188410345231888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EZR,Ezrin,33191,-0.0130317958578697,0.00990791497523469,-0.0324513092093297,0.00638771749359028,0.18844647886806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP2,Pancreatic lipase-related protein 2,33121,0.157360939569789,0.119699879462367,-0.0772508241764511,0.391972703316029,0.188669377624856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,31791,-0.0142420736159911,0.0108429263690237,-0.0354942092992776,0.00701006206729544,0.18905900320909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR1,Natural cytotoxicity triggering receptor 1,33091,0.0191697687980049,0.0146223368294936,-0.00949001138780255,0.0478295489838124,0.189895261827444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIE1,Tyrosine-protein kinase receptor Tie-1,33208,0.0226727289327291,0.0173006289826188,-0.0112365038732037,0.0565819617386619,0.190056141754426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP1G2,AP-1 complex subunit gamma-like 2,31990,-0.0436934032236256,0.0333817192952549,-0.109121573042325,0.0217347665950741,0.190607408352187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",31854,-0.0313851161057407,0.0239847983990959,-0.0783953209679687,0.0156250887564873,0.190730165719418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN3,Calsyntenin-3,32006,-0.0165486305055239,0.0126476164713743,-0.0413379587894176,0.00824069777836977,0.190764371265675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL34,Interleukin-34,32899,-0.0193772116554815,0.0148320386503602,-0.0484480074101875,0.00969358409922461,0.191437553426483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,31791,0.0283529503439386,0.0217036543256839,-0.0141862121344019,0.0708921128222791,0.19146852456536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS4,Galectin-4,33121,-0.0282333718078651,0.0216140162809065,-0.0705968437184419,0.0141301001027117,0.191501219246848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASC3,Protein CASC3,31826,-0.0225192738518411,0.017241028771052,-0.0563116902431031,0.0112731425394208,0.191544183628271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCOF1,Treacle protein,32042,-0.01721536927773,0.0132022787390269,-0.0430918356062227,0.00866109705076273,0.192283514007984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTL1,Cytokine-like protein 1,32044,-0.01228220372862,0.00942280436307303,-0.0307509002802431,0.00618649282300313,0.192458913064411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAAM1,Disheveled-associated activator of morphogenesis 1,31907,-0.0449989222867304,0.0345250830647066,-0.112668085093555,0.0226702405200945,0.192489071724146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,31907,-0.0227280042891526,0.0174390687100282,-0.0569085789608078,0.0114525703825027,0.192519145115479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,33191,-0.0286361781586676,0.0219747215212029,-0.0717066323402253,0.01443427602289,0.192560688366241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX1,Heme oxygenase 1,33017,-0.0250657786716867,0.0192428816732172,-0.0627818267511925,0.0126502694078191,0.192746362340552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYDGF,Myeloid-derived growth factor,32042,-0.0543079085365061,0.0417111840894809,-0.136061829351889,0.0274460122788764,0.192956332070126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLGAP5,Disks large-associated protein 5,32020,-0.0294362575292895,0.0226406972806006,-0.0738120241992667,0.0149395091406877,0.193589839230536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZPR1,Zinc finger protein ZPR1,31804,-0.0522202800781221,0.0401798454017632,-0.130972777065578,0.0265322169093337,0.193757060576962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXYD5,FXYD domain-containing ion transport regulator 5,32981,0.0353726965580863,0.0272245511722647,-0.0179874237395526,0.0887328168557251,0.193878165292199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR1,Cadherin-related family member 1,32911,0.0231195487700824,0.017794873573101,-0.0117584034331955,0.0579975009733603,0.193902053574405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LXN,Latexin,32998,0.0367194678698067,0.028269426401,-0.0186886078761533,0.0921275436157666,0.194009530946204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB2,Interleukin-12 receptor subunit beta-2,31816,0.0219397911988596,0.0168939756124688,-0.0111724010015792,0.0550519833992985,0.194096000922223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,31907,-0.0263291965506223,0.0203021661791398,-0.0661214422617363,0.0134630491604917,0.194717305875703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA12,Carbonic anhydrase 12,33062,0.0167468491183657,0.0129177465804547,-0.00857193417932561,0.042065632416057,0.194864928487386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP1,Metalloproteinase inhibitor 1,33002,-0.0149505197498233,0.0115380591593725,-0.0375651157021934,0.00766407620254677,0.195094230766605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERC2,ERC protein 2,31826,-0.0421822018120626,0.0325774676294541,-0.106034038365793,0.0216696347416675,0.195420274630179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB3,Receptor tyrosine-protein kinase erbB-3,33093,0.00997825816642217,0.00771405292524279,-0.0051412855670537,0.025097801899898,0.195866903736424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGB,Secretogranin-1,33164,0.0206448675272552,0.0159726049789601,-0.0106614382315066,0.051951173286017,0.196212353615819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSRC1,Proline/serine-rich coiled-coil protein 1,32951,-0.0313886731447888,0.0242915868096149,-0.079000183291634,0.0162228370020563,0.19633607036872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEC31A,Protein transport protein Sec31A,31854,-0.0412493559474592,0.0319233038293488,-0.103819031452983,0.0213203195580645,0.196349241407903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDT,D-dopachrome decarboxylase,32044,-0.021799571340683,0.0168736929033021,-0.0548720094311551,0.0112728667497891,0.196421918162484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD244,Natural killer cell receptor 2B4,33208,-0.0145289220553,0.0112515183635277,-0.0365818980478143,0.00752405393721433,0.196638798731212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH17,Protocadherin-17,33117,0.0184022607250835,0.0142805555068521,-0.00958762806834657,0.0463921495185137,0.197563381935154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",32042,-0.028902007391841,0.0224397658814769,-0.0728839485195358,0.0150799337358538,0.197791605301349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GLB2,Endophilin-B2,32006,-0.0355336639142122,0.0276337880764743,-0.0896958885441018,0.0186285607156773,0.198525262143011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTD1,D-aminoacyl-tRNA deacylase 1,31907,-0.0466547404318075,0.0363029296849865,-0.117808482614381,0.0244990017507659,0.198779504365218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB1,Calbindin,33062,0.022823481651353,0.017763671965173,-0.011993315400386,0.0576402787030921,0.198882659596768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGP1,SURP and G-patch domain-containing protein 1,31998,-0.0218018955270946,0.0169705435177815,-0.0550641608219463,0.0114603697677571,0.198939904361317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHL1,Neural cell adhesion molecule L1-like protein,33120,-0.0166673096078228,0.0129740147524596,-0.0420963785226436,0.008761759306998,0.198942438780941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL15,C-C motif chemokine 15,33208,-0.0229306841912321,0.0178821274456513,-0.0579796539847087,0.0121182856022444,0.199762901296309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOR1AIP1,Torsin-1A-interacting protein 1,31854,-0.0284946780298627,0.0222513925468527,-0.072107407421694,0.0151180513619685,0.200381514879564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNAS,Neuroendocrine secretory protein 55,32020,-0.0466753736773596,0.0364510423936932,-0.118119416768998,0.0247686694142792,0.200410382188864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPO,Myeloperoxidase,33121,-0.0251898493023774,0.0196827942865687,-0.063768126104052,0.0133884274992973,0.20065314217478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCTS1,Malignant T-cell-amplified sequence 1,31998,0.0131334381184328,0.0102716655632446,-0.0069990263855267,0.0332659026223923,0.201074304277464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GJA8,Gap junction alpha-8 protein,31793,-0.0334839665869462,0.0261954194532705,-0.0848269887153564,0.017859055541464,0.20120612266853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOSB,Protein fosB,32911,0.0208407253798851,0.0163166032327635,-0.0111398169563315,0.0528212677161016,0.201541617154034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESPL1,Separin,31793,-0.0300709715861187,0.0235720148445452,-0.0762721206814273,0.0161301775091899,0.20209966900004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SGSH,N-sulphoglucosamine sulphohydrolase,31917,-0.0294052893156436,0.0230541848610629,-0.0745914916433269,0.0157809130120398,0.20217697710846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RB,Interleukin-2 receptor subunit beta,32981,0.0207842717503403,0.0163051569598302,-0.0111738358909269,0.0527423793916076,0.20244825767687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD101,Immunoglobulin superfamily member 2,31998,0.0219675669207524,0.0172688111924658,-0.0118793030164806,0.0558144368579853,0.203378596957253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT,Linker for activation of T-cells family member 1,33208,-0.039754982126726,0.0312547686405465,-0.101014328662197,0.0215043644087451,0.203419218278166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPGR,X-linked retinitis pigmentosa GTPase regulator,31826,-0.0222198243047517,0.0174992686404527,-0.0565183908400389,0.0120787422305355,0.204211159083306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",31998,-0.0533492234458975,0.0420361583261458,-0.135740093765143,0.0290416468733483,0.204434915181784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR1,Asialoglycoprotein receptor 1,33042,-0.0152604047411633,0.0120274344568589,-0.0388341762766068,0.00831336679428014,0.204546906809497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIT,Vitrin,32042,0.0188892543152554,0.0148898165146115,-0.0102947860533831,0.048073294683894,0.204621877289937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARD3,Partitioning defective 3 homolog,31908,0.0383533611532936,0.0302480129129051,-0.0209327441560005,0.0976394664625877,0.204850757140297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACYBP,Calcyclin-binding protein,31892,-0.0536626033103157,0.0423401146500433,-0.1366492280244,0.0293240214037692,0.205045703808789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R2,Interleukin-1 receptor type 2,33107,0.0102412929503572,0.00808631229933727,-0.00560787915634381,0.0260904650570583,0.205369167297102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD9,Enhancer of filamentation 1,31816,-0.0176473311329534,0.013938075357835,-0.0449659588343099,0.00967129656840317,0.205508757306746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM106A,Transmembrane protein 106A,31990,-0.0367239054120203,0.029023495706409,-0.093609956996582,0.0201621461725414,0.205797036668846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",33062,-0.0367075551055656,0.0290475804935159,-0.0936408128728567,0.0202257026617256,0.206370361053641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MET,Hepatocyte growth factor receptor,33110,0.0103300993838452,0.00817509393914243,-0.005693084736874,0.0263532835045643,0.206405429583897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP3,Insulin-like growth factor-binding protein 3,33138,-0.0141423466104952,0.0112125064377476,-0.0361188592284806,0.0078341660074902,0.207234261368542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYMP,Thymidine phosphorylase,33053,-0.0351637904558686,0.0278908601458988,-0.0898298763418302,0.019502295430093,0.207428111652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,31998,-0.0726995786388756,0.0576895369199136,-0.185771071001906,0.0403719137241551,0.207641041320677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN1,Calsyntenin-1,32911,-0.0269290066725952,0.0213710570542568,-0.0688162784989385,0.0149582651537481,0.207679229645152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,31804,-0.0260983851246837,0.0207117973547671,-0.0666935079400271,0.0144967376906598,0.207682875740754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN1,Pantetheinase,32048,-0.0377159197249147,0.0299662324324908,-0.0964497352925967,0.0210178958427673,0.20820846813661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSE,Cathepsin E,31907,0.0263464782640577,0.0209342473637301,-0.0146846465688534,0.0673776030969688,0.208237830523312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN1,Transcobalamin-1,31891,-0.0172926478075533,0.0137489345191752,-0.0442405594651368,0.00965526385003022,0.208523625752582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAUR,Urokinase plasminogen activator surface receptor,33064,-0.0136946706492764,0.0108898644169711,-0.0350388049065398,0.00764946360798695,0.208584602782665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP9,Caspase-9,31816,0.032188775751076,0.0255992116677916,-0.0179856791177956,0.0823632306199475,0.208644081265152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18R1,Interleukin-18 receptor 1,33208,-0.0171165938709326,0.0136185986531106,-0.0438090472310294,0.00957585948916431,0.208839936714765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRF1,Killer cell lectin-like receptor subfamily F member 1,31816,-0.022780925860099,0.0181321656098627,-0.05831997045543,0.0127581187352319,0.209017371286531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA,Adenosine deaminase,33208,-0.0184953349919148,0.0147362517107324,-0.0473783883449502,0.0103877183611207,0.209479270247538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPD52L2,Tumor protein D54,31907,-0.0559282512583831,0.0445664003539987,-0.143278395952221,0.0314218934354543,0.209539124297495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B4,Protein ATP1B4,31793,-0.0216123455832328,0.0172395290155615,-0.0554018224537333,0.0121771312872676,0.210008959959329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP28,Ubiquitin carboxyl-terminal hydrolase 28,32006,-0.0191343089168603,0.0152761248341122,-0.0490755135917203,0.0108068957579997,0.210403558324697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7R,Interleukin-7 receptor subunit alpha,33121,0.0268213609163482,0.0214145455489188,-0.0151511483595326,0.068793870192229,0.210427592255548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDNF,Glial cell line-derived neurotrophic factor,32911,-0.0197488785141984,0.015771535057609,-0.050661087227112,0.0111633301987151,0.210537106042379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1,Methionine aminopeptidase 1,32911,0.0154991113555796,0.0123923767321254,-0.00878994703938622,0.0397881697505455,0.211079551366236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMNL1,Formin-like protein 1,32911,-0.032745992564801,0.0261938810549531,-0.0840859994325091,0.0185940143029071,0.211283353978772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC1,Hamartin,31816,0.0391110565292043,0.0313055733921368,-0.0222478673193837,0.100469980377792,0.211583354176841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAD,Chondroadherin,31907,0.0276333728395975,0.0221200753570664,-0.0157219748602528,0.0709887205394477,0.211615041383184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK1,Cyclin-dependent kinase 1,31793,0.0195116390364122,0.0156311466846073,-0.0111254084654182,0.0501486865382426,0.211977918722676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAEA,E3 ubiquitin-protein transferase MAEA,32951,-0.020770821105889,0.0166527531212024,-0.0534102172234457,0.0118685750116676,0.212325360404688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYTL4,Synaptotagmin-like protein 4,32042,-0.0380200203936004,0.0304936758752831,-0.0977876251091553,0.0217475843219545,0.212503237521494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP4,Secreted frizzled-related protein 4,31907,0.021568104116437,0.0172994585234349,-0.0123388345894954,0.0554750428223694,0.212528259875306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE1,Plasminogen activator inhibitor 1,33208,-0.0344826528380064,0.0276737057949239,-0.0887231161960572,0.0197578105200444,0.212781609100576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,32020,-0.0252432050464859,0.0202689582693064,-0.0649703632543266,0.0144839531613547,0.213018880495851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB44,Ras-related protein Rab-44,31990,-0.0233472497079322,0.0187537787258724,-0.060104656010642,0.0134101565947776,0.213194067137499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPN,Asporin,32042,-0.014097465385162,0.0113287559620921,-0.0363018270708625,0.00810689630053861,0.21339205908066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBN,Nibrin,32981,-0.0274610641222162,0.0221294179179868,-0.0708347232414703,0.0159125949970379,0.214665647376755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,31826,-0.0264596514811356,0.0213400762113154,-0.0682862008553137,0.0153668978930426,0.215050261302301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",32911,0.0255599304697507,0.0206186220096897,-0.014852568669241,0.0659724296087424,0.215138268184222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY2,Protein canopy homolog 2,32973,0.0315012179682458,0.0254191600834119,-0.0183203357952415,0.081322771731733,0.215279431827472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMFG,Glia maturation factor gamma,32042,-0.0368398345430207,0.029748458109603,-0.0951468124378426,0.0214671433518011,0.215614252951817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN4,CCN family member 4,33189,-0.020873229008268,0.0168731290897535,-0.0539445620241849,0.0121981040076489,0.216094625851048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP1,Fibroblast growth factor-binding protein 1,33126,0.015944896850285,0.0128914719348608,-0.00932238814204219,0.0412121818426121,0.216173963102703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA5,Protein disulfide-isomerase A5,31793,0.0326147530302842,0.0263718996340799,-0.0190741702525124,0.0843036763130808,0.216229243692221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS22,Brain-specific serine protease 4,31816,0.0176637235677006,0.0142864365788954,-0.0103376921269344,0.0456651392623355,0.216350040831931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIGR,Polymeric immunoglobulin receptor,33011,-0.0181157422192831,0.0146576779706403,-0.0468447910417382,0.0106133066031719,0.21652158966877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUK1,Guanylate kinase,31791,-0.0209586155180358,0.0169677411913311,-0.0542153882530448,0.0122981572169732,0.216794269258389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3B1,AP-3 complex subunit beta-1,31998,-0.0390193700014151,0.0316552317538949,-0.101063624239049,0.0230248842362189,0.21775009797372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAC1,Cartilage acidic protein 1,33208,-0.014947502282126,0.0121301293400067,-0.0387225557885392,0.00882755122428723,0.217884168680242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPY,Pro-neuropeptide Y,33189,-0.0337640813008253,0.0274116365825668,-0.0874908890026562,0.0199627264010057,0.218078390667813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA1,DnaJ homolog subfamily A member 1,31793,-0.0241961692055978,0.019679524778987,-0.0627680377724124,0.0143756993612167,0.218920118446055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,33123,-0.0286785709282859,0.0233419142502261,-0.074428722858729,0.0170715810021573,0.219243989639731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3,Microfibril-associated glycoprotein 3,32973,-0.0251083395081454,0.0205150833014941,-0.0653179027790738,0.015101223762783,0.221025098290472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC12A,C-type lectin domain family 12 member A,31816,-0.0106480944985822,0.00870285244502129,-0.027705685290824,0.00640949629365949,0.221173349777317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,33136,-0.0168827142485748,0.0137997771794927,-0.0439302775203805,0.0101648490232309,0.221210020089674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES1,Retinoic acid receptor responder protein 1,32951,0.01748624277726,0.0142950606783584,-0.0105320761523225,0.0455045617068425,0.221274224354644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LETM1,Mitochondrial proton/calcium exchanger protein,32020,-0.026525018169504,0.0216874421193924,-0.069032404723513,0.015982368384505,0.221345549611737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH4,Myosin-4,31791,-0.0239331577621495,0.0195793501805444,-0.0623086841160166,0.0144423685917176,0.221608008096666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L1CAM,Neural cell adhesion molecule L1,33126,-0.0143678822899592,0.0117564829961223,-0.037410588962359,0.00867482438244054,0.221693874872059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT1,NAD-dependent protein deacetylase sirtuin-1,31816,0.0450861193571754,0.0369055886617531,-0.0272488344198607,0.117421073134211,0.221874946271125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFD,Complement factor D,32071,-0.00973442361401872,0.00796859052646394,-0.0253528610458881,0.00588401381785061,0.221897036817386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA1,Carboxypeptidase A1,33208,0.0289075554214732,0.0236639577940034,-0.0174738018547734,0.0752889126977198,0.22189717949799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFA,Platelet-derived growth factor subunit A,33208,-0.0360031821977453,0.0294915346846973,-0.093806590179752,0.0218002257842615,0.222195697131063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOL1,Apolipoprotein L1,32048,-0.0324983116116544,0.0266932358829276,-0.0848170539421924,0.0198204307188836,0.223461871606633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAG3,Lymphocyte activation gene 3 protein,33062,-0.0205333921603618,0.0168738215595531,-0.0536060824170858,0.0125392980963622,0.223683767536393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO6,Coronin-6,31804,-0.0180079788807214,0.0148108574180965,-0.0470372594201904,0.0110213016587478,0.224076015258968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR3,Toll-like receptor 3,33208,0.0307353089109412,0.0252873537567884,-0.018827904452364,0.0802985222742464,0.224230371745257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT6C,"Keratin, type II cytoskeletal 6C",31791,-0.0203219464800799,0.0167243047683792,-0.0531015838261031,0.0124576908659433,0.224361485335593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB1A1,Uteroglobin,33137,0.028108739361518,0.023144700632447,-0.0172548738780782,0.0734723526011142,0.22459810669166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE5,Adhesion G protein-coupled receptor E5,33162,-0.0148182095391405,0.0122075342517883,-0.0387449766726455,0.00910855759436449,0.22483497809115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXJ3,Forkhead box protein J3,31816,-0.0230066816063511,0.0189748408910056,-0.0601973697527221,0.0141840065400199,0.225366249290775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOF,Apolipoprotein F,32048,0.0119637924556097,0.00986770182573942,-0.00737690312283954,0.031304488034059,0.225389611711063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAMBI,BMP and activin membrane-bound inhibitor homolog,32951,0.0149022857062171,0.0123010314934535,-0.00920773602095172,0.039012307433386,0.225750406208188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL9,Interleukin-9,31908,-0.0288825488786311,0.0238429715615987,-0.0756147731393646,0.0178496753821023,0.225793815647927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIRBP,Cold-inducible RNA-binding protein,31998,-0.0478205148988259,0.0394825922884647,-0.125206395784217,0.029565365986565,0.225864464178441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,32951,-0.0388668469332003,0.0320951622759073,-0.101773364993979,0.0240396711275779,0.225933788883354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPACT,Protein IMPACT,32006,-0.0285709839917191,0.0236015460247018,-0.0748300142001345,0.0176880462166964,0.226103639746526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,32020,-0.0289380666805502,0.0239132351040191,-0.0758080074844277,0.0179318741233273,0.226267714969186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARF6,ADP-ribosylation factor 6,31998,-0.0527551176011492,0.0435987802602472,-0.138208726911234,0.0326984917089353,0.22631157222215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH12,Protocadherin-12,32020,-0.0127151424338195,0.010513267526152,-0.0333211467850774,0.0078908619174383,0.226532499349279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGHMBP2,DNA-binding protein SMUBP-2,31791,-0.0287677431467689,0.0238014263819646,-0.0754185388554196,0.0178830525618818,0.22683386996815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPIND1,Heparin cofactor 2,32051,-0.013730606983264,0.0113624655119639,-0.0360010393867133,0.00853982542018518,0.226924151138764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRB,Receptor-type tyrosine-protein phosphatase beta,32042,-0.0140755133172937,0.0116540717846697,-0.0369174940152463,0.00876646738065893,0.227170898971544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRC,Receptor-type tyrosine-protein phosphatase C,32044,-0.0112023511917006,0.00928487518287965,-0.0294007065501447,0.00699600416674349,0.227656157308125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC8,Histone deacetylase 8,31816,0.0314842474913801,0.0261058988878894,-0.0196833143288831,0.0826518093116434,0.227848357939357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP4,Zona pellucida sperm-binding protein 4,31793,-0.0169940910603296,0.014093131089029,-0.0446166279948265,0.0106284458741673,0.22791723498354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRRT3,Proline-rich transmembrane protein 3,31854,0.0186432282051628,0.0154620274159966,-0.0116623455301906,0.0489488019405162,0.227955218051948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",31969,-0.0545241180563591,0.0452406144260336,-0.143195722331385,0.0341474862186668,0.228162935874681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",32020,-0.0396259069076875,0.0329018443616112,-0.104113521856445,0.0248617080410705,0.228485291938257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD51,DNA repair protein RAD51 homolog 1,31908,-0.0273949432185535,0.0227597930666931,-0.072004137629272,0.017214251192165,0.228761088621748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF1,Rho guanine nucleotide exchange factor 1,32006,-0.0450591889820153,0.037455083825679,-0.118471153280346,0.0283527753163155,0.229006552034652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP1,Peptidoglycan recognition protein 1,33162,-0.0207276600200406,0.0172324553650845,-0.0545032725356062,0.0130479524955249,0.229076026890106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",31998,-0.0733586109749112,0.0610120854606001,-0.192942298477687,0.0462250765278649,0.22926104611988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA1,Alpha-1-antitrypsin,31937,-0.00406833936512785,0.00338598509065426,-0.0107048701428102,0.0025681914125545,0.229586359545816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAMT,Guanidinoacetate N-methyltransferase,31791,-0.0186729991288518,0.0155490809930296,-0.0491491978751898,0.0118031996174863,0.229826062436553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALB,Ras-related protein Ral-B,31816,0.0146749675093711,0.0122276842366607,-0.00929129359448391,0.0386412286132261,0.230122482896126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,33208,-0.0112464670689052,0.00938343185879776,-0.0296379935121489,0.00714505937433836,0.230737281117664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPB2,Coatomer subunit beta',31791,-0.0212113900832561,0.0177196280491767,-0.0559418610596425,0.0135190808931303,0.231323326766082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG3,Proteasome assembly chaperone 3,33109,-0.0258895087053847,0.0216294174839006,-0.0682831669738298,0.0165041495630605,0.231355622288544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEND1,Cell cycle exit and neuronal differentiation protein 1,31804,-0.0288050944208182,0.0240814574441986,-0.0760047510114475,0.018394562169811,0.23167564570726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JPT2,Jupiter microtubule associated homolog 2,31998,-0.0430501301148632,0.0360305137509005,-0.113669937066628,0.0275696768369017,0.232193271090784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XCL1,Lymphotactin,33189,-0.0277311917814344,0.0232254836996737,-0.0732531398327949,0.0177907562699262,0.232510986383664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA4,Ephrin-A4,33024,-0.0141663098793451,0.011872888213784,-0.0374371707783617,0.00910455101967149,0.232837939637304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH1,Neurexophilin-1,32911,0.0182830440277802,0.0153280983338197,-0.0117600287065063,0.0483261167620667,0.232989131012526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA2,DnaJ homolog subfamily A member 2,33181,-0.0405749761557799,0.0340302506746708,-0.107274267478135,0.0261243151665749,0.233167888173157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIT2,Slit homolog 2 protein,32911,-0.0255834976509449,0.0214571763701807,-0.067639563336499,0.0164725680346093,0.233175139105148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYN,Tyrosine-protein kinase Lyn,33062,-0.0414987160199,0.0348108072353388,-0.109727898201164,0.026730466161364,0.233246415018202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS4B,Vacuolar protein sorting-associated protein 4B,31990,-0.0468587172711037,0.0393184748469179,-0.123922927971063,0.0302054934288555,0.233387579813738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLRAP1,Low density lipoprotein receptor adapter protein 1,32020,-0.0471101278292521,0.0395737764157251,-0.124674729604073,0.030454473945569,0.233911618299156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD3,Ly6/PLAUR domain-containing protein 3,33058,0.017163603820422,0.0144551336128807,-0.0111684580608242,0.0454956657016682,0.235114156996796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY75,Lymphocyte antigen 75,33109,-0.018923613335383,0.0159455329200066,-0.0501768578585959,0.01232963118783,0.235352573143869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL13B,ADP-ribosylation factor-like protein 13B,31791,-0.0345723651311552,0.0291615661616854,-0.0917290348080585,0.0225843045457482,0.23584019828299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,31990,-0.0338659492324338,0.0285747059625071,-0.0898723729189477,0.0221404744540801,0.235986701745128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRC1,Protein regulator of cytokinesis 1,31990,-0.0237095593680225,0.0200910839055057,-0.0630880838228137,0.0156689650867687,0.237996273288719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX18,Sorting nexin-18,31998,-0.0217483191618462,0.0184408912970409,-0.0578924661040463,0.014395827780354,0.238294851580582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RB,Interleukin-20 receptor subunit beta,31816,-0.0208583216698992,0.0176941556372121,-0.0555388667188349,0.0138222233790365,0.238505759496571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD1,Ly6/PLAUR domain-containing protein 1,32911,0.0316077674839967,0.0268280895267523,-0.0209752879884379,0.0841908229564312,0.238766183176832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1B,Protein phosphatase 1B,31816,0.0313606437911461,0.0266326408808711,-0.0208393323353613,0.0835606199176535,0.239023430543047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL1,Protein kinase C-binding protein NELL1,33126,0.0205295444663599,0.0174548107327498,-0.0136818845698296,0.0547409735025494,0.239565643476821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL14,C-X-C motif chemokine 14,32981,-0.0298315752145697,0.0253733065550452,-0.0795632560624583,0.0199001056333189,0.239744780543529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR4,Toll-like receptor 4,31816,-0.0135107463623359,0.0114929955455005,-0.0360370176315169,0.00901552490684517,0.239807343255514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCA,Tubulin-specific chaperone A,31907,-0.0426876194303511,0.036335739842955,-0.113905669522543,0.0285304306618406,0.240107942691109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBC,Inhibin beta C chain,33121,-0.0208502937360348,0.0177831937760156,-0.0557053535370254,0.0140047660649558,0.241039893705693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN3,CCN family member 3,33195,-0.0159410502563126,0.0135985399684487,-0.042594188594472,0.0107120880818468,0.241123865199004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6A,Ras-related protein Rab-6A,33109,0.0233313470462888,0.019907820334324,-0.0156879808089863,0.062350674901564,0.241241779190034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN8,Tetraspanin-8,31998,0.0507199030532373,0.0432844477314052,-0.034117614500317,0.135557420606792,0.241321898975634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,31907,-0.0313002049953682,0.0267146451362678,-0.0836609094624531,0.0210604994717168,0.241375183528059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNR,Tenascin-R,33042,0.0206171301094353,0.0176231318115008,-0.0139242082411062,0.0551584684599768,0.242077595338761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YWHAQ,14-3-3 protein theta,31907,-0.0358013937859576,0.0306081655987562,-0.0957933983595198,0.0241906107876045,0.242171968776785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RYR1,Ryanodine receptor 1,31791,-0.0170290031061484,0.0145593412543516,-0.0455653119646774,0.0115073057523807,0.242188966988879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS3,"Nitric oxide synthase, endothelial",32911,-0.0251803299123669,0.0215422943225418,-0.0674032267845489,0.017042566959815,0.242485427110681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F12,Coagulation factor XII,32071,-0.0205123658845003,0.0175683473912796,-0.0549463267714084,0.0139215950024078,0.243014715005539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GC,Vitamin D-binding protein,32071,0.0124465913467064,0.010677532950541,-0.00848137323635387,0.0333745559297668,0.243780160197812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSB,Lupus La protein,32911,-0.0275133669980294,0.0236148832447964,-0.0737985381578303,0.0187718041617714,0.244017085814803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",31854,-0.0442901916257995,0.0380246049821958,-0.118818417390903,0.0302380341393043,0.244146740939738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300A,CMRF35-like molecule 8,31907,-0.0141046109937269,0.0121100888493473,-0.0378403851384477,0.00963116315099387,0.244178034361289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,32020,-0.0134549473011833,0.011563170668876,-0.0361187618121802,0.00920886720981359,0.244621366045667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUSB,Beta-glucuronidase,33151,-0.0278958662838906,0.0239866008118634,-0.0749096038751429,0.0191178713073618,0.24487071454984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD2,Polycystin-2,31791,-0.0289670376338627,0.0249207835318229,-0.0778117733562355,0.0198776980885101,0.245125175853189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX1,Peroxiredoxin-1,32862,0.0424499843787033,0.0365281662186608,-0.029145221409872,0.114045190167279,0.245221127181886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORBS1,Sorbin and SH3 domain-containing protein 1,32020,-0.0187848074761558,0.0161679809690613,-0.0504740501755159,0.0129044352232043,0.245332065483472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT2,NAD-dependent protein deacetylase sirtuin-2,33062,-0.0432635530744405,0.0372591424926724,-0.116291472360078,0.0297643662111974,0.245612005900007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFYA,Nuclear transcription factor Y subunit alpha,31791,-0.0192298307050457,0.0165610813626754,-0.0516895501758894,0.0132298887657981,0.2456203612353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHLHE40,Class E basic helix-loop-helix protein 40,31804,0.0331029942584509,0.0285495802710223,-0.0228541830727529,0.0890601715896547,0.246293574332873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RP2,Protein XRP2,33062,-0.0203039480835395,0.01751516775704,-0.0546336768873379,0.014025780720259,0.246398312350203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK7,Kallikrein-7,31701,0.0188102798616009,0.0162397917922123,-0.0130197120511351,0.050640271774337,0.246786596508357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON3,Serum paraoxonase/lactonase 3,33167,0.0130285444071266,0.0112584229966625,-0.00903796466633192,0.0350950534805851,0.247211587327108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF3,Fibroblast growth factor 3,31816,-0.0145329625069439,0.0125610083389724,-0.0391525388513298,0.010086613837442,0.247313926763862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX7,Syntaxin-7,31816,0.0242815684708921,0.0210276007974504,-0.0169325290921107,0.0654956660338949,0.248231330697509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHS1,"Enoyl-CoA hydratase, mitochondrial",31854,-0.0464884201859013,0.0402616753375199,-0.12540130384744,0.0324244634756376,0.248268241532933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPR,Nucleoprotein TPR,31791,-0.024474184780318,0.021204446617925,-0.066034900151451,0.017086530590815,0.248455524086894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPE4,NXPE family member 4,31791,-0.0163791023938698,0.0141948706264243,-0.0442010488216615,0.0114428440339218,0.248589108509572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,32042,-0.0165362053577724,0.0143368277886004,-0.0446363878234291,0.0115639771078843,0.248779465578147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA80,N-alpha-acetyltransferase 80,31826,-0.0568734676719223,0.0493093113166328,-0.153519717852523,0.0397727825086781,0.248782726562665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,33191,-0.0346092083239257,0.0300727772744145,-0.0935518517817781,0.0243334351339268,0.249826087116142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP3R1,Calcineurin subunit B type 1,33042,-0.0197783765355456,0.0172024194218492,-0.05349511860237,0.0139383655312788,0.250281382488861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSL,Cathepsin L1,33117,-0.0112685336992479,0.00980376915076915,-0.0304839212347554,0.00794685383625965,0.250419380683784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,32044,-0.0120262942526562,0.0104746839857584,-0.0325566748647427,0.00850408635943039,0.250951260178851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB1,DnaJ homolog subfamily B member 1,33062,-0.042048030734601,0.0366833712650692,-0.113947438414137,0.0298513769449345,0.251726777374148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPB1,Signal-regulatory protein beta-1,33106,-0.021034172708607,0.0183571863655005,-0.0570142579849881,0.014945912567774,0.251898133092591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1B,Meprin A subunit beta,33117,0.0558708046192003,0.0488174949863777,-0.0398114855540999,0.151553094792501,0.252454899106516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTOA,Otoancorin,31804,-0.0243040771852494,0.0212416873544335,-0.065937784399939,0.0173296300294402,0.252590864828146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUCL3,Mucin-like protein 3,31793,-0.0209875999312214,0.0183634284851145,-0.0569799197620459,0.0150047198996031,0.253116535726046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53INP1,Tumor protein p53-inducible nuclear protein 1,32973,0.0147567700814389,0.0129182881921881,-0.0105630747752498,0.0400766149381276,0.253354699920325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRA2,Ankyrin repeat family A protein 2,31793,0.02657880916445,0.0232675154624784,-0.0190255211420077,0.0721831394709077,0.253360770546083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPP,"Alkaline phosphatase, placental type",33062,-0.0489249628366542,0.042837348970947,-0.13288616681971,0.035036241146402,0.253440076835259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC3,Membrane primary amine oxidase,33138,-0.0143051716904213,0.0125273630359226,-0.0388588032408296,0.0102484598599871,0.253521231307712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSP90B1,Endoplasmin,32867,0.0325401480588913,0.0285358832145073,-0.0233901830415429,0.0884704791593255,0.254183861208225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBI3_IL27,Interleukin-27,33176,-0.0146233121008557,0.0128244233473949,-0.0397591818617497,0.0105125576600384,0.254204911693655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53BP1,TP53-binding protein 1,31816,0.0412610283339091,0.0362013442320693,-0.0296936063609467,0.112215663028765,0.254421252303183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5IF1,"ATPase inhibitor, mitochondrial",33167,-0.0525358331265938,0.0461748574357962,-0.143038553700754,0.0379668874475667,0.255252647247092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD58,Lymphocyte function-associated antigen 3,33106,0.00825976896748344,0.00726208798946094,-0.00597392349186,0.0224934614268269,0.255410072213829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA1,Ephrin type-A receptor 1,33152,0.0158704136760516,0.0139534967085678,-0.0114784398727412,0.0432192672248445,0.255411219278426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS,RNA-binding protein with multiple splicing,31816,0.0320676041635728,0.0282117652348719,-0.023227455696776,0.0873626640239217,0.255711221395905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA2,Integrin alpha-2,31907,0.0155117948957153,0.0136665032162604,-0.011274551408155,0.0422981411995857,0.256402190484028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,33126,-0.0452567182968715,0.0399051169504201,-0.123470747519695,0.032957310925952,0.256780527651346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGH,Gamma-glutamyl hydrolase,32937,-0.0161129467271343,0.0142186115089843,-0.0439814252847435,0.0117555318304749,0.257150004699724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1L,Allograft inflammatory factor 1-like,31854,-0.0276004674435826,0.024368219297658,-0.0753621772669923,0.0201612423798271,0.257401331550818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL16,C-X-C motif chemokine 16,33194,0.0107460247818422,0.00948987142064567,-0.00785412320262332,0.0293461727663077,0.257510896015968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST13,Hsc70-interacting protein,31907,-0.0268408296820079,0.0237030774536604,-0.0732988614911823,0.0196172021271665,0.257512213411883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3B,Protein FAM3B,33062,0.0165789111832534,0.0146664978008465,-0.0121674245064058,0.0453252468729126,0.258342013939906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5PO,"ATP synthase subunit O, mitochondrial",32911,0.0199049014666789,0.0176115400980725,-0.0146137171255431,0.054423520058901,0.258415899873355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP6,Lysophosphatidic acid phosphatase type 6,33176,-0.0316955466423841,0.0280757157560842,-0.0867239495243093,0.023332856239541,0.258957972657501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS27,Serine protease 27,33089,0.0187303109770643,0.0166137860800666,-0.0138327097398661,0.0512933316939948,0.259606535179791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP2,Latent-transforming growth factor beta-binding protein 2,33208,-0.0146386076095056,0.0129876518389812,-0.0400944052139088,0.0108171899948975,0.259723758904212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2BP,LRP2-binding protein,31826,0.0398435498046419,0.0353970038301323,-0.0295345777024174,0.109221677311701,0.260363339156427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3G,Regenerating islet-derived protein 3-gamma,31990,-0.0190597033152558,0.0169332345471481,-0.0522488430276661,0.0141294363971544,0.260379343690565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,33042,-0.0346642464072586,0.0308144202404448,-0.0950605100785305,0.0257320172640133,0.260647645338045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR37,Prosaposin receptor GPR37,32973,-0.0309671264665582,0.0275442205215246,-0.0849537986887463,0.02301954575563,0.260930392067205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD79B,B-cell antigen receptor complex-associated protein beta chain,33208,-0.0204974250669102,0.0182393962614636,-0.0562466417393788,0.0152517916055584,0.261128887250076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFL7,Epidermal growth factor-like protein 7,32951,-0.0191061779619985,0.0170123078808111,-0.0524503014083882,0.0142379454843913,0.261435361937777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP3,Tubulin polymerization-promoting protein family member 3,32911,0.0189551414537287,0.0168886853101172,-0.014146681754101,0.0520569646615584,0.261742352405865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACSTD2,Tumor-associated calcium signal transducer 2,32115,0.014326587407507,0.0127686575410454,-0.0106999813729421,0.0393531561879561,0.261892479198981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPTP,Ceramide-1-phosphate transfer protein,31791,-0.0186240425881881,0.0166465750528956,-0.0512513296918636,0.0140032445154873,0.26326582059096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,32020,-0.0390085885798015,0.0348896527768511,-0.10739230802243,0.0293751308628267,0.263578529803598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC13A1,Solute carrier family 13 member 1,31990,0.0282649946220138,0.0252998273739581,-0.021322667030944,0.0778526562749716,0.263943963134754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDAN1,Codanin-1,32006,0.0112335111176754,0.0100733285622738,-0.0085102128643812,0.0309772350997321,0.264811468257613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XPNPEP2,Xaa-Pro aminopeptidase 2,33126,0.0407787410068786,0.036576035766317,-0.0309102890951029,0.11246777110886,0.264922774204375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE1,Ribonuclease pancreatic,32048,-0.0113265861956582,0.0101700916956552,-0.0312599659191423,0.00860679352782593,0.265436605323789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL21R,Interleukin-21 receptor,31816,-0.0251949065669205,0.0226308654442658,-0.0695514028376815,0.0191615897038405,0.265616626121422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL1,Kin of IRRE-like protein 1,31804,-0.0278693166760466,0.0250401613441746,-0.0769480329106288,0.0212093995585356,0.265751385335592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSH3,Protein phosphatase Slingshot homolog 3,31793,0.0137088129383407,0.0123185392258072,-0.0104355239442414,0.0378531498209228,0.265804883308947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD83,CD83 antigen,33109,-0.0151091391811456,0.0136289243105798,-0.0418218308298821,0.0116035524675908,0.26762997527605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD1,Leiomodin-1,32020,-0.0158600810873199,0.0143109774022592,-0.043909596795748,0.0121894346211082,0.267790879952498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6R,Interleukin-6 receptor subunit alpha,33065,-0.0155866803172932,0.014066235193544,-0.0431565012966394,0.0119831406620531,0.267853100446534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANGAP1,Ran GTPase-activating protein 1,32951,0.0228795326158246,0.0206765077976922,-0.017646422667652,0.0634054878993013,0.268521048208904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,31998,-0.0134581644137287,0.012164152828468,-0.037299903957526,0.0103835751300686,0.268597738680068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA5A,"Carbonic anhydrase 5A, mitochondrial",32973,-0.041721819784237,0.0377290159953267,-0.115670691135077,0.0322270515666033,0.268831992837148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPF,Centromere protein F,31908,-0.0256196396294843,0.0231876314894445,-0.0710673973487956,0.0198281180898269,0.269245572456378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAAA,N-acylethanolamine-hydrolyzing acid amidase,32997,0.0269587823561984,0.0244031783454785,-0.0208714472009394,0.0747890119133361,0.269310207093666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP350,Centrosome-associated protein 350,31793,-0.0170163970724926,0.0154190947475714,-0.0472378227777325,0.0132050286327474,0.269806126984824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG4,Regenerating islet-derived protein 4,33136,-0.02142595096648,0.019415556645358,-0.0594804419913817,0.0166285400584217,0.26982090449861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL16,Pro-interleukin-16,33208,-0.0193161713130547,0.0175154022866002,-0.0536463597947911,0.0150140171686817,0.270139733065613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1,Programmed cell death protein 1,33180,-0.0198420250310557,0.0179975225053006,-0.0551171691414448,0.0154331190793334,0.27028063672745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASET2,Ribonuclease T2,33169,-0.0117185680902505,0.0106314726362657,-0.0325562544573312,0.00911911827683031,0.270382312269586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG4,Proteasome assembly chaperone 4,31816,-0.0265169163710071,0.0240835100874233,-0.0737205961423569,0.0206867634003427,0.270915083715941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX1,ATP-dependent RNA helicase DDX1,31998,-0.0233495112999149,0.0212133652833154,-0.064927707255213,0.0182286846553832,0.271063174296809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSH1,Chorionic somatomammotropin hormone 1,32048,-0.0146464380312179,0.013324729148603,-0.0407629071624799,0.011470031100044,0.271719087077406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL3,Myosin light chain 3,31854,-0.0312603498012813,0.028446343985399,-0.0870151840126634,0.0244944844101007,0.27183727052792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,33062,0.0175760151102505,0.0160164521079313,-0.0138162310212948,0.0489682612417957,0.272509250713963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,33136,-0.0122644352998109,0.011177231962413,-0.0341718099461405,0.00964293934651864,0.272554041008195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBPL,FK506-binding protein-like,31998,-0.0268915069959959,0.0245452811771471,-0.0750002581032042,0.0212172441112124,0.273294232586291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGR,Progesterone receptor,31816,0.0477683322449433,0.0436099311158921,-0.0377071327422053,0.133243797232092,0.273397202534773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA0319,Dyslexia-associated protein KIAA0319,32006,0.0136857652631488,0.0124946335181127,-0.0108037164323521,0.0381752469586497,0.273406367272653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,31854,-0.0126433455990695,0.0115525337153692,-0.0352863116811931,0.00999962048305404,0.273805606197619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMPER,BMP-binding endothelial regulator protein,31907,-0.0103657353336042,0.00947185702554997,-0.0289305751036821,0.00819910443647378,0.273827205912954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERVV_1,,31791,-0.0211512145917601,0.0193442243875727,-0.0590658943914027,0.0167634652078824,0.274248664252799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB6,DnaJ homolog subfamily B member 6,31838,-0.0382250899737472,0.0350202396387111,-0.106864759665621,0.0304145797181264,0.275082276821768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGA,Glycoprotein hormones alpha chain,33121,0.0394288466533468,0.0361577418708059,-0.0314403274134328,0.110298020720126,0.275537518691092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF4,E3 ubiquitin-protein ligase RNF4,31908,-0.0295731926592758,0.0271388632475468,-0.0827653646244675,0.0236189793059158,0.275880965364457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCP1,Plastin-2,32044,-0.0212927062351826,0.0195573882710299,-0.0596251872464012,0.017039774776036,0.276307731923698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STOML2,"Stomatin-like protein 2, mitochondrial",31793,0.0417862789805872,0.0383814937690853,-0.0334414488068199,0.117014006767994,0.27631795642549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC8,Sialic acid-binding Ig-like lectin 8,31854,-0.0204398002733923,0.0187775769630982,-0.0572438511210649,0.0163642505742802,0.276400295138958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,32048,-0.0197831271594536,0.0182020291693991,-0.0554591043314758,0.0158928500125687,0.27713147986256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",33047,-0.0473345773938354,0.0435833309223968,-0.132757906001733,0.0380887512140623,0.277478186243419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM24,Transcription intermediary factor 1-alpha,31893,-0.0297731237875323,0.0274291582987053,-0.0835342740529947,0.0239880264779302,0.277755238953276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB37,Ras-related protein Rab-37,32981,-0.037580449577905,0.0346276281223987,-0.105450600697807,0.0302897015419965,0.277831182325714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCTD5,BTB/POZ domain-containing protein KCTD5,31883,-0.0200916077002009,0.0185179044915047,-0.05638670050355,0.0162034851031482,0.277964474833253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL2,Fc receptor-like protein 2,33162,-0.0218785485748373,0.0201705510833129,-0.0614128286981306,0.0176557315484561,0.278094414031379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,31908,-0.016138234171788,0.0148889621576311,-0.045320600000745,0.013044131657169,0.278441564204752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,31826,0.0468063996695306,0.0431860413379517,-0.0378382413528547,0.131451040691916,0.278474872320302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,33208,-0.0449192688976407,0.041451953239328,-0.126165097246724,0.0363265594514422,0.278551351356615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAVL4,ELAV-like protein 4,31804,-0.0378271623081076,0.0349090213532764,-0.106248844160529,0.0305945195443141,0.278580943110905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TWF2,Twinfilin-2,32044,-0.0373161240319791,0.0344877781225213,-0.104912169152121,0.0302799210881627,0.279282408639907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH17,Cadherin-17,33117,0.0300992925306403,0.0278315645617241,-0.0244505740103389,0.0846491590716194,0.279513556259623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,31992,-0.037283402768307,0.0345643638715159,-0.105029555956478,0.0304627504198642,0.280771170448046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNW1,Interferon omega-1,31791,-0.0165817574799726,0.0153739389086419,-0.0467146777409107,0.0135511627809655,0.280818151757797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLN,Promotilin,33109,-0.0389380055818278,0.0361220787127458,-0.10973727985881,0.031861268695154,0.281083500571892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,31804,-0.0279045514795561,0.0258897169897288,-0.0786483967794245,0.0228392938203123,0.281147787390674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSCA,Prostate stem cell antigen,31998,-0.116193809951994,0.107887985446349,-0.327654261426838,0.0952666415228489,0.281521114505984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASSF2,Ras association domain-containing protein 2,32951,-0.0256111606447207,0.0237985007100389,-0.072256222036397,0.0210339007469556,0.281883131488925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK1C,Divergent protein kinase domain 1C,31826,-0.0193578665224658,0.0179945041564675,-0.054627094669142,0.0159113616242104,0.282067346687951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAO1,Hydroxyacid oxidase 1,33189,-0.058217473191589,0.0541974760722171,-0.164444526293134,0.0480095799099565,0.282774751974319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BECN1,Beclin-1,31854,-0.0273676226521436,0.025490975887057,-0.0773299353907753,0.0225946900864881,0.283028008404939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUS,RNA-binding protein FUS,32935,-0.0177954822604155,0.0165777838792901,-0.0502879386638241,0.0146969741429932,0.283098167754022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1S,Complement C1s subcomponent,32071,-0.00939939681529236,0.00876071309407654,-0.0265703944796824,0.00777160084909766,0.283348545905098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFAP2A,Transcription factor AP-2-alpha,31804,-0.0259437244621466,0.0242094309427558,-0.0733942091099481,0.0215067601856548,0.283918237378655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SF3B4,Splicing factor 3B subunit 4,33062,-0.0332520655405582,0.0310370100935446,-0.0940846053239057,0.0275804742427893,0.284033936805234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG4A,Cysteine protease ATG4A,32951,-0.0267225785152053,0.0249771277477771,-0.0756777489008484,0.0222325918704377,0.284702825171448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDNF,Cerebral dopamine neurotrophic factor,33062,0.0141164287333924,0.0131974032642074,-0.011750481664454,0.0399833391312388,0.284812790856757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP7,Retinoid-binding protein 7,31998,-0.0268282817479272,0.0251021777453373,-0.0760285501287884,0.022371986632934,0.285210609643662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAYN,Layilin,33030,0.0145917272966547,0.0136532803310931,-0.0121687021522877,0.0413521567455971,0.285219540959542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI5,Ecotropic viral integration site 5 protein homolog,31816,-0.0396989333161382,0.0371543505021513,-0.112521460300355,0.0331235936680783,0.285336002330052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A1,Collagen alpha-1(IV) chain,33117,-0.017497086520249,0.0164195876403386,-0.0496794782953127,0.0146853052548148,0.286623891646409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA11,Annexin A11,33099,-0.0294645695902593,0.0276568957399369,-0.0836720852405356,0.024742946060017,0.286742483858647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPLA2,Acyl-protein thioesterase 2,31804,-0.0481737840773469,0.0452668059345145,-0.136896723708995,0.0405491555543014,0.287264561432735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFLAM,Pikachurin,31998,-0.0140051678409372,0.0131635259669104,-0.0398056787360816,0.0117953430542072,0.287391094465164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,31816,-0.0214690527373805,0.0202240673711791,-0.0611082247848916,0.0181701193101306,0.288470478264859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA3,GDNF family receptor alpha-3,33012,0.0126173226737752,0.0119086893414827,-0.0107237084355309,0.0359583537830814,0.289399489266042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRP14,Signal recognition particle 14 kDa protein,33062,-0.0265903764262779,0.0251181239149033,-0.0758218992994885,0.0226411464469326,0.289805690744463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAG,Myelin-associated glycoprotein,31826,-0.0201283772846259,0.019018101493501,-0.0574038562118878,0.017147101642636,0.289916925378132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L1,Mortality factor 4-like protein 1,31908,-0.0177375554102926,0.01676796622674,-0.0506027692147029,0.0151276583941178,0.290170005191508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCF2,Neutrophil cytosol factor 2,33095,-0.0374785861556349,0.0354323801023616,-0.106926051156264,0.0319688788449939,0.290199174089412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XG,Glycoprotein Xg,33167,-0.0126608802025288,0.0119904191680864,-0.0361621017719781,0.0108403413669205,0.291035682173518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31,Interleukin-31,31816,-0.0255462400065673,0.0242712087150909,-0.0731178090881455,0.0220253290750109,0.292589766767515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2R,Proteinase-activated receptor 1,33150,-0.0249174720040268,0.02368912527853,-0.0713481575499456,0.0215132135418921,0.292896325366057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD207,C-type lectin domain family 4 member K,32926,-0.0167469068988825,0.0159378485390273,-0.047985090035376,0.014491276237611,0.293397262618893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP4,Contactin-associated protein-like 4,31826,0.0438541580780238,0.0417430802255894,-0.0379622791641314,0.125670595320179,0.293489118984111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC51B,Organic solute transporter subunit beta,31791,0.0346398514671969,0.0329959187242532,-0.0300321492323393,0.0993118521667332,0.293834386322986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CADPS,Calcium-dependent secretion activator 1,31826,0.0195118746933991,0.0186365436799574,-0.0170157509193173,0.0560395003061156,0.295148409593889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,31907,-0.0365718055443188,0.0349342489003682,-0.10504293338904,0.0318993223004029,0.295190992231254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN2,Transcobalamin-2,33190,-0.0128187725595202,0.0122570422368391,-0.0368425753437249,0.0112050302246845,0.29566883064475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD5,Programmed cell death protein 5,33191,-0.0255602827052204,0.0244454714118941,-0.0734734066725328,0.022352841262092,0.295772821387334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC2,SPARC-related modular calcium-binding protein 2,33167,-0.0162882815840652,0.0155849786505181,-0.0468348397390807,0.0142582765709503,0.29599327552044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAS,Tumor necrosis factor receptor superfamily member 6,33180,-0.0139465913129496,0.0133689050032105,-0.0401496451192422,0.0122564624933429,0.296879384727538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHD3,EH domain-containing protein 3,31854,-0.0504992020008808,0.04842188231617,-0.145406091340574,0.0444076873388124,0.297028468746049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRD54,Ankyrin repeat domain-containing protein 54,32951,-0.0248904028558046,0.0238789797758903,-0.0716932032165496,0.0219123975049403,0.297276209330531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPRC5C,G-protein coupled receptor family C group 5 member C,31990,-0.0242048328181959,0.0232398420170121,-0.0697549231715396,0.0213452575351478,0.297666230315384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLF4,Krueppel-like factor 4,31804,-0.0168439387681406,0.0161823013664866,-0.0485612494464543,0.014873371910173,0.297962463179493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,31791,-0.0288103064591615,0.0276892391279541,-0.0830812151499515,0.0254606022316285,0.298147756626399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTNB,Dystrobrevin beta,31978,-0.0182380971471979,0.0175491171337026,-0.052634366729255,0.0161581724348592,0.298717174516572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OCLN,Occludin,32020,-0.0186260274193605,0.0179271732485956,-0.0537632869866079,0.0165112321478868,0.298845856625499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLO1,Lactoylglutathione lyase,32973,-0.0258334493787987,0.0249232034891913,-0.0746829282176137,0.0230160294600163,0.299988082432721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,31793,0.0116817300895081,0.0112827176064135,-0.0104323964190624,0.0337958565980785,0.300532623217404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPART,Spartin,31907,-0.0331059488073852,0.0319823284959397,-0.095791312659427,0.0295794150446567,0.30064059540422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOE,Apolipoprotein E,32071,0.0326182471892721,0.0315139627186592,-0.0291491197392999,0.094385614117844,0.300682559521746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP9,Fatty acid-binding protein 9,33109,0.0240265606088956,0.0232206993608061,-0.0214860101382843,0.0695391313560755,0.300835866730249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRD1,Natural killer cells antigen CD94,33208,-0.0197426190426638,0.01909973045225,-0.0571780907290739,0.0176928526437462,0.301323891000424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTT2B,Glutathione S-transferase theta-2B,32006,-0.100739016680376,0.097516403467586,-0.291871167476845,0.0903931341160926,0.301615030159337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGCC,Regulator of cell cycle RGCC,32020,-0.0318056811178409,0.0307907999959119,-0.0921556491098283,0.0285442868741464,0.301655377039229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,32042,-0.0265366213664188,0.0256904146360068,-0.0768898340529922,0.0238165913201546,0.301665536503528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4B,Eukaryotic translation initiation factor 4B,33042,-0.0252468835382471,0.0244422728828442,-0.0731537383886217,0.0226599713121276,0.30167097242559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,32020,-0.0281422201241378,0.0272642322744016,-0.0815801153819649,0.0252956751336893,0.302010052240711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSV,Cathepsin L2,33162,-0.018183793889965,0.0176254802661054,-0.0527297352115317,0.0163621474316017,0.302252332613224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOS,Proto-oncogene c-Fos,31780,-0.0152372246867726,0.0147855328661626,-0.0442168691044514,0.0137424197309061,0.302786102121737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXK,Tyrosine-protein kinase TXK,31908,0.0329816923607552,0.0320209914189245,-0.0297794508203368,0.0957428355418472,0.303042372289462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A1,Secretoglobin family 3A member 1,31907,-0.0104763434083133,0.0101795397209652,-0.030428241261405,0.0094755544447785,0.303439346369663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRD1,Adhesion G-protein coupled receptor D1,31907,-0.0154566204833915,0.0150242281256845,-0.0449041076097331,0.01399086664295,0.303616597686552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTP4A3,Protein tyrosine phosphatase type IVA 3,31816,-0.0224240307401592,0.0218010887782936,-0.0651541647456146,0.0203061032652963,0.303713733905958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSG1,Pregnancy-specific beta-1-glycoprotein 1,33042,-0.0487167624375367,0.047373795371293,-0.141569401365271,0.0441358764901977,0.303814968411877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF43,E3 ubiquitin-protein ligase RNF43,31908,-0.0260090406472662,0.0253340804742519,-0.0756638383767999,0.0236457570822675,0.304622195667224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD74,HLA class II histocompatibility antigen gamma chain,33191,-0.014854771986228,0.0144948361932126,-0.0432646509249248,0.0135551069524688,0.305470830374864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C8B,Complement component C8 beta chain,32071,-0.0125425149418533,0.012249232567501,-0.0365510107741554,0.0114659808904487,0.30589474583206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKG1,cGMP-dependent protein kinase 1,31907,-0.0531194372117918,0.051910134699113,-0.154863301222053,0.0486244267984698,0.30620108130577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD2,Mothers against decapentaplegic homolog 2,31990,-0.0290496393439315,0.0284017440071929,-0.0847170575980295,0.0266177789101666,0.306429653208665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",33109,-0.0404293321728094,0.0395898622197803,-0.118025462123579,0.0371667977779599,0.307186255934031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,31736,-0.0217735437618688,0.021377642636388,-0.0636737233291894,0.0201266358054518,0.308465013569166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,33008,-0.0210023640181594,0.0206329640563976,-0.0614429735686987,0.01943824553238,0.30875265303376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,31804,0.02676481676909,0.0263013180507332,-0.0247857666103471,0.0783154001485272,0.308890808645044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB2A2,Mammaglobin-A,31791,-0.0128879577140915,0.0126730199474856,-0.0377270768111633,0.0119511613829803,0.309205856432044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,31854,0.0257740287415738,0.0253675375969876,-0.0239463449485218,0.0754944024316695,0.309651133901647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLA2,Src-like-adapter 2,32020,-0.0435178454113087,0.0428362463517262,-0.127476888260692,0.0404411974380747,0.309703895886657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2B,Sodium channel subunit beta-2,31826,-0.0121786526717783,0.0119904506645905,-0.0356799359743756,0.011322630630819,0.309807501463836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK2,"Adenylate kinase 2, mitochondrial",32006,-0.0444048740028521,0.0437311654600972,-0.130117958304643,0.0413082102989384,0.309945005057378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD33,Myeloid cell surface antigen CD33,33126,-0.0335681504635047,0.0330628382452671,-0.0983713134242283,0.0312350124972189,0.309999078545664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBQLN3,Ubiquilin-3,31791,-0.0183988475857743,0.0181502567143559,-0.053973350745912,0.0171756555743633,0.31076112081941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBR,Delta(14)-sterol reductase LBR,33191,-0.0285374795364209,0.0281703675277328,-0.0837513998907771,0.0266764408179354,0.311072994163895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA4,Protein disulfide-isomerase A4,32044,-0.02552862313372,0.0252137872798168,-0.0749476462021609,0.023890399934721,0.311337690561985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XIAP,E3 ubiquitin-protein ligase XIAP,31816,-0.0244456627282424,0.0241526139119078,-0.0717847859955816,0.0228934605390968,0.311507617536846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5A,Cytochrome b5,31793,-0.0311040527696189,0.0307404553739358,-0.0913553453025329,0.0291472397632952,0.311653658686553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,33109,0.0161049830186685,0.0159331581868435,-0.0151240070275448,0.0473339730648818,0.312148022770543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNG,Interferon gamma,32981,-0.0479936003280756,0.0474980837002233,-0.141089844380513,0.045102643724362,0.312316859400526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIA1,Nucleolysin TIA-1 isoform p40,32872,-0.0507465142896159,0.0502814141598511,-0.149298086042924,0.0478050574636923,0.312883782252503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCL2,Phosducin-like protein 2,31793,0.0231099286339879,0.0228993768957858,-0.0217728500817524,0.0679927073497281,0.312914554356148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA2,Apolipoprotein A-II,32048,-0.0197031775623338,0.0195323200531743,-0.0579865248665554,0.0185801697418878,0.313127912342076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAP1,Antigen peptide transporter 1,31908,-0.0235120097633768,0.02337545447813,-0.0693279005405115,0.0223038810137579,0.314524305958919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDAP1,28 kDa heat- and acid-stable phosphoprotein,32042,-0.0404489518127041,0.0402147790198116,-0.119269918691535,0.0383720150661266,0.314532760037084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA2,Ephrin type-A receptor 2,32799,-0.0127044361300819,0.0126479614209968,-0.0374944405152357,0.0120855682550719,0.315183591004738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FETUB,Fetuin-B,33127,-0.0142855575368885,0.0142225389031011,-0.0421617337869667,0.0135906187131896,0.315198978114808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP11,Low-density lipoprotein receptor-related protein 11,33117,0.0142849330344911,0.0142258193795962,-0.0135976729495175,0.0421675390184997,0.315331766471045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,33180,-0.0117010580617012,0.0116829035912511,-0.0345995491005534,0.0111974329771509,0.316586844446718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRGN,Neurogranin,32048,-0.0377113101590577,0.0376561580086064,-0.111517379855926,0.0360947595378109,0.316634134764815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBK,Lymphokine-activated killer T-cell-originated protein kinase,31793,0.0129120249044331,0.0129094802562644,-0.0123905563978452,0.0382146062067114,0.317248092218661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",31854,-0.0208051839536281,0.0208075331641038,-0.0615879489552716,0.0199775810480154,0.317397833983339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEPR,Leptin receptor,33117,0.0128440939783155,0.0128565067005774,-0.0123546591548161,0.0380428471114471,0.317805867332565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FEN1,Flap endonuclease 1,32951,-0.0271174836515665,0.0272041545511333,-0.0804376265717878,0.0262026592686548,0.318883152847496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEO1,RNA polymerase-associated protein LEO1,32020,-0.0139445404820994,0.0139921591778021,-0.0413691724705916,0.0134800915063928,0.318992142790363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCLRE1C,Protein artemis,31793,-0.0130981725816659,0.0131469454943379,-0.0388661857505682,0.0126698405872365,0.319142015746519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN2A1,Butyrophilin subfamily 2 member A1,33167,0.0101214728165397,0.0101619676458957,-0.0097959837694159,0.0300389294024953,0.319270481033901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,33121,-0.0115974106760877,0.0116535312371155,-0.0344383319008341,0.0112435105486586,0.319674440008058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1A,Interleukin-1 alpha,32981,-0.0229222552028823,0.0230570418323359,-0.0681140571942607,0.0222695467884961,0.320176000130359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOM,Apolipoprotein M,33127,0.0109135232230059,0.0109805186322868,-0.0106082932962761,0.032435339742288,0.320299907436133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CINP,Cyclin-dependent kinase 2-interacting protein,31908,-0.0187913571591213,0.0189084043892292,-0.0558518297620105,0.0182691154437679,0.320347735655778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,31791,-0.0156953465361012,0.015804308186704,-0.046671790582041,0.0152810975098386,0.320691249766847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549,UPF0606 protein KIAA1549,31908,-0.0294043572639636,0.0296394134163463,-0.0874976075600023,0.0286888930320751,0.321195830196526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKIV2L,Helicase SKI2W,31791,-0.0171011586541502,0.0172455137658169,-0.0509023656351514,0.016700048326851,0.321411029146238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX5,"Peroxiredoxin-5, mitochondrial",33208,-0.0282815484998615,0.0285218826044877,-0.0841844384046574,0.0276213414049345,0.321432927092423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK6,Serine protease inhibitor Kazal-type 6,33189,-0.0221794565794563,0.0223859218894351,-0.0660558634827491,0.0216969503238366,0.321821919018306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,32020,0.0109739533598711,0.0110814483579668,-0.0107456854217439,0.0326935921414861,0.32205938501397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR2,Anterior gradient protein 2 homolog,32831,0.0415017360469205,0.041937448397939,-0.0406956628130399,0.123699134906881,0.322393149299122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD163,Scavenger receptor cysteine-rich type 1 protein M130,33138,-0.0175491109257808,0.0177398401052987,-0.0523191975321662,0.0172209756806046,0.322569110414781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNC,Tenascin,33138,-0.0194949727369047,0.0197153186292438,-0.0581369972502224,0.0191470517764131,0.322776989379263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF9,Multiple epidermal growth factor-like domains protein 9,33180,-0.00846367433881953,0.00856272720959858,-0.0252466196696327,0.00831927099199369,0.322968478893154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMI,N-myc-interactor,31960,-0.0291124289616953,0.0294580396406676,-0.0868501866574037,0.0286253287340131,0.323053408911297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5R2,NADH-cytochrome b5 reductase 2,31905,-0.0233317969755766,0.0236188685781234,-0.0696247793886986,0.0229611854375454,0.323260306678916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP1,Low molecular weight phosphotyrosine protein phosphatase,31816,0.018209407599848,0.0184545668175585,-0.0179615433625666,0.0543803585622626,0.32381453480345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC5,Glypican-5,33042,-0.0229086331544808,0.0232174514058872,-0.0684148379100197,0.0225975716010581,0.323818073297608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TALDO1,Transaldolase,32018,-0.0186600036202886,0.0189258706688229,-0.0557547101311816,0.0184347028906043,0.324188102828075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGBP1,Immunoglobulin-binding protein 1,32020,-0.0252556750171299,0.0256201424245163,-0.0754711541691819,0.0249598041349221,0.324275450119133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX6,Peroxiredoxin-6,33189,0.0243682034853091,0.0247530960676239,-0.0241478648072338,0.072884271777852,0.324921205806887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,33121,-0.0150688660210747,0.0153080536770198,-0.0450726512280335,0.0149349191858841,0.324958615492786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP8,Neutrophil collagenase,33180,-0.0300414981597738,0.0305940570058159,-0.0900058498911731,0.0299228535716254,0.326157111731797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,31816,-0.023649291178989,0.0241071720918618,-0.0708993484790381,0.02360076612106,0.32662179122876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEL1L,Protein sel-1 homolog 1,31854,-0.0132409322458739,0.0135131975530262,-0.0397267994498053,0.0132449349580575,0.327191254562891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",31791,-0.0253048131111875,0.0258309217885225,-0.0759334198166915,0.0253237935943165,0.327299797439752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL18,C-C motif chemokine 18,32979,-0.0282822923462721,0.028876308881705,-0.0848798577544138,0.0283152730618696,0.327395874529758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBI,Acyl-CoA-binding protein,33080,-0.0321425585896723,0.0328209953091005,-0.0964717093955093,0.0321865922161647,0.327444812973827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL21,C-C motif chemokine 21,33167,-0.0174760086094524,0.0178627271455071,-0.0524869538146464,0.0175349365957416,0.327928142004108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM26,Tripartite motif-containing protein 26,31793,-0.0237760371017683,0.0243319549286763,-0.0714666687619739,0.0239145945584372,0.328525726341778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNLY,Granulysin,33121,-0.0206457480334123,0.021128930101014,-0.0620584510313998,0.0207669549645752,0.328531206755261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIAP1,TP53-regulated inhibitor of apoptosis 1,33189,-0.0255827411155406,0.0261862628585496,-0.0769078163182978,0.0257423340872165,0.328619601224782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA3,Protein disulfide-isomerase A3,31907,-0.0103041494563101,0.0105483041821425,-0.0309788256533094,0.0103705267406893,0.328673307135447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECSCR,Endothelial cell-specific chemotaxis regulator,31804,-0.0204640550936598,0.0209531330973972,-0.0615321959645582,0.0206040857772387,0.328770391846564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,32981,0.0220556607029838,0.0225985319177503,-0.0222374618558068,0.0663487832617744,0.329103250264702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,31644,-0.0434897331781602,0.0445611978209267,-0.130829680907177,0.0438502145508562,0.329119485581877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40,Tumor necrosis factor receptor superfamily member 5,33122,-0.0201850658656534,0.0207350646603474,-0.0608257925999344,0.0204556608686276,0.330344466733378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FARSA,Phenylalanine--tRNA ligase alpha subunit,31826,-0.0279199126814623,0.0286901529110145,-0.0841526123870507,0.028312787024126,0.330509112090234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNB2,Ephrin-B2,31826,-0.0238961161982026,0.0245596762801031,-0.0720330817072047,0.0242408493107996,0.330594299678058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTG,Protogenin,33189,0.0100509767903508,0.0103410601649456,-0.0102175011329426,0.0303194547136442,0.331103130800832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO9B,Unconventional myosin-IXb,32981,0.0267492063071388,0.0275310044891665,-0.0272115624916275,0.0807099751059051,0.331275646895128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THTPA,Thiamine-triphosphatase,31976,-0.035430594283146,0.0364789536390896,-0.106929343415762,0.0360681548494697,0.331449419419617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPP1,Osteopontin,33190,-0.0187880200854055,0.01935516058615,-0.0567241348342594,0.0191480946634485,0.331725442672506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC15,Sialic acid-binding Ig-like lectin 15,32911,0.0323743253654311,0.0333629701996124,-0.0330170962258093,0.0977657469566715,0.33189133527105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD1,Polycystin-1,32042,-0.0103127524424401,0.0106326906759214,-0.0311528261672459,0.0105273212823658,0.332122287911008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX53,Probable ATP-dependent RNA helicase DDX53,31826,0.0138684161588388,0.0143165864613384,-0.0141920933053845,0.0419289256230622,0.332728794528207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,31998,-0.0260300183613004,0.0268821165154174,-0.0787189667315186,0.0266589300089177,0.332924391915265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,33062,-0.0122123374538419,0.0126154377428132,-0.0369385954297558,0.0125139205220721,0.333048056946971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC5,Thioredoxin domain-containing protein 5,33191,-0.0269363683311727,0.0278570055647215,-0.0815360992380268,0.0276633625756814,0.333595127455505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZI2,5-azacytidine-induced protein 2,32020,-0.0222849599563092,0.0230518467023282,-0.0674665794928726,0.0228966595802541,0.333708871709398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",31854,-0.0102596479070567,0.010616216719984,-0.0310674326782253,0.010548136864112,0.333869226370503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD23B,UV excision repair protein RAD23 homolog B,32951,0.0189202755320839,0.0195981765259858,-0.0194921504588483,0.0573327015230161,0.334366965115019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F3,Tissue factor,33132,0.0110913545436538,0.0114900249649261,-0.0114290943876014,0.033611803474909,0.334420007107994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRLF1,Cytokine receptor-like factor 1,33167,-0.0104536567741257,0.0108296728699821,-0.0316798155992907,0.0107725020510393,0.334431826194599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,32020,0.0459076206548521,0.047582529544735,-0.0473541372528285,0.139169378562533,0.334675864027925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP2,Methionine aminopeptidase 2,33176,-0.0233663128911118,0.0242292130804225,-0.0708555705287398,0.0241229447465163,0.334879190049467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR2,Toll-like receptor 2,31908,0.00925387786884816,0.00959660582946542,-0.00955546955690405,0.0280632252946004,0.334933558673842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSF,Cathepsin F,33126,0.0158409698322133,0.0164669534084137,-0.0164342588482776,0.0481161985127042,0.336083720980888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA1,GDNF family receptor alpha-1,33176,-0.0108523040339016,0.0112854232187614,-0.0329717335426739,0.0112671254748708,0.336266489052582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",31826,-0.0170590737934491,0.0177443234347576,-0.0518379477255739,0.0177198001386758,0.336391635813894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDN1,Endothelin-1,31854,0.0115205124276208,0.0119880596056179,-0.0119760843993904,0.035017109254632,0.336584097310641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFB,Platelet-derived growth factor subunit B,33167,-0.0339479508952846,0.0353717021223238,-0.103276487055039,0.0353805852644701,0.337208249833237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHB,Lutropin subunit beta,32951,-0.0335691786857472,0.0349855934214319,-0.102140941791754,0.0350025844202593,0.337326992589819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC5A,C-type lectin domain family 5 member A,33089,-0.0112614105207672,0.0117370149932905,-0.0342659599076167,0.0117431388660822,0.337344733071127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL2,Podocalyxin-like protein 2,33126,-0.0108553792616089,0.0113155968689875,-0.0330339491248245,0.0113231906016066,0.337419812414889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHEK2,Serine/threonine-protein kinase Chk2,32973,0.0136954106531114,0.0142837013216831,-0.0143006439373875,0.0416914652436104,0.337679734694491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL2,Interferon lambda-2,31804,-0.0250390761954108,0.0261575148544105,-0.0763078053100553,0.0262296529192337,0.338476514002984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA1,Annexin A1,31863,-0.0179431796629426,0.0187486453732884,-0.0546905245945879,0.0188041652687026,0.338578927505998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,31908,-0.028529160854911,0.0298371201647668,-0.0870099163778539,0.0299515946680318,0.339020711824579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,33042,-0.0178845783753112,0.0187094949840581,-0.0545551885440651,0.0187860317934428,0.339145011116658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOC2B,Double C2-like domain-containing protein beta,31826,-0.013979669032204,0.0146255414648635,-0.0426457303033365,0.0146863922389286,0.339184704259155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REST,RE1-silencing transcription factor,31793,0.0141517677602084,0.0148091275280515,-0.0148741221947725,0.0431776577151893,0.33930018030871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC79,Protein unc-79 homolog,31793,-0.0226488894687782,0.0237029444546153,-0.0691066605998242,0.0238088816622677,0.339340886893243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,33197,-0.0149417969996763,0.015641386915814,-0.0455989153546718,0.0157153213553192,0.339465985603442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP1,Interstitial collagenase,32785,-0.0366660702304556,0.0383851661111241,-0.111900995808259,0.0385688553473476,0.339496904377434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK1,Dickkopf-related protein 1,33191,-0.0234792160772945,0.0246011571581549,-0.0716974841072781,0.024739051952689,0.339910243520224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREG1,Protein CREG1,33007,-0.0143845854224431,0.0150791643416846,-0.043939747532145,0.0151705766872588,0.340142061573175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO1,Amphoterin-induced protein 1,31826,-0.020269455537468,0.0212804988883378,-0.0619792333586101,0.0214403222836741,0.340879917547984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA4,Ephrin type-A receptor 4,31907,0.0110602789925212,0.0116142617029737,-0.0117036739453072,0.0338242319303496,0.34097496448168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THY1,Thy-1 membrane glycoprotein,33191,0.0107939507049712,0.0113447373885518,-0.0114417345765903,0.0330296359865326,0.341402287755734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA2,Interleukin-13 receptor subunit alpha-2,31804,-0.0113321182453247,0.0119127168988718,-0.0346810433671134,0.012016806876464,0.341502520165342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OFD1,Oral-facial-digital syndrome 1 protein,31908,-0.0262939631449653,0.0276562986295115,-0.0805003084588078,0.0279123821688773,0.341766941035061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCAM,Cell surface glycoprotein MUC18,33138,0.0132691083733903,0.0139633952474134,-0.01409914631154,0.0406373630583205,0.341997415258571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNMT,Histamine N-methyltransferase,33001,-0.0179041281417437,0.0188413902473761,-0.0548332530266008,0.0190249967431134,0.342009483851714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL2A1,Collagen alpha-1(II) chain,31854,-0.0316875675035292,0.0333557507916809,-0.0970648390552239,0.0336897040481654,0.342149297083198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL2,C-C motif chemokine 2,33024,0.0209158297735567,0.0220205334419308,-0.0222444157726277,0.064076075319741,0.342223883119221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CARHSP1,Calcium-regulated heat-stable protein 1,32911,-0.0211088347606695,0.0222430379726076,-0.0647051891869804,0.0224875196656415,0.342643339280955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKN3,Serine/threonine-protein kinase N3,31908,-0.0292977670524993,0.0309195933438597,-0.0899001700064644,0.0313046359014658,0.34339084110071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN2B2,Epididymis-specific alpha-mannosidase,32042,-0.0229887147456061,0.0243062285329131,-0.0706289226701158,0.0246514931789035,0.34428315220211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL25,C-C motif chemokine 25,33208,-0.0190690826366943,0.0201758631228399,-0.0586137743574606,0.0204756090840719,0.344611781690424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA4H,Leukotriene A-4 hydrolase,33189,-0.0222472740878884,0.0235535037863828,-0.0684121415091986,0.0239175933334218,0.344918857580491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD6,Programmed cell death protein 6,33117,-0.0264029304644842,0.0279618879191164,-0.0812082307859524,0.0284023698569841,0.345069739204577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,31826,-0.0213134797185066,0.0226022716949709,-0.0656139322406496,0.0229869728036365,0.345722261997828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300C,CMRF35-like molecule 6,33191,-0.013103039712863,0.0138958420599619,-0.0403388901503884,0.0141328107246623,0.345734185079418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,33042,-0.0307061778761389,0.032599817512225,-0.0946018202001,0.0331894644478221,0.346263892357797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,32042,-0.0304433944715602,0.0323297136986356,-0.093809633320886,0.0329228443777656,0.346399936837701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1A,5-hydroxytryptamine receptor 1A,31804,-0.0316082982148194,0.0335823778978445,-0.0974297588945947,0.0342131624649558,0.346624693968932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT2,Kunitz-type protease inhibitor 2,33167,-0.0161428257100014,0.0171829088181666,-0.0498213269936079,0.0175356755736051,0.347515573670657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IST1,IST1 homolog,31944,-0.0388638967412265,0.041405598603499,-0.120018870004084,0.0422910765216315,0.347958944481364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED4,Transmembrane emp24 domain-containing protein 4,31791,-0.0225006398592024,0.0239946314349573,-0.0695301174717187,0.0245288377533139,0.348410738823557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGMN,Legumain,33167,-0.013651896533967,0.0145749990732403,-0.0422188947175181,0.014915101649584,0.348956682457634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L2,Seizure 6-like protein 2,33062,-0.00911520865007672,0.0097477425488245,-0.0282207840457727,0.0099903667456193,0.349757991116692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH3,Cadherin-3,33191,-0.0135275672746779,0.0144688660759433,-0.0418865447835267,0.0148314102341709,0.349843429356582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN2,Neuroligin-2,31804,-0.0190316708356834,0.0203586601753246,-0.0589346447793197,0.0208713031079529,0.349912073417482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAN,Versican core protein,33191,-0.0116182931812769,0.0124425602721628,-0.036005711314716,0.0127691249521621,0.350456486827501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSCAR,Osteoclast-associated immunoglobulin-like receptor,33136,-0.0127487172921231,0.0136591261397909,-0.0395206045261133,0.0140231699418671,0.350666298365075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPN1,Epsin-1,31908,-0.0165675603672953,0.0177612200633632,-0.0513795516914871,0.0182444309568965,0.350956519192074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,33117,-0.0326043509983449,0.034953979947489,-0.101114151695423,0.0359054496987335,0.350959890592237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2,Brorin,33012,-0.0148522235080313,0.0159545551642324,-0.0461231516299269,0.0164187046138643,0.351927393310451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF8,Immunoglobulin superfamily member 8,33117,-0.0115728257856906,0.0124545295728316,-0.0359837037484406,0.0128380521770595,0.352808132016154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM40,E3 ubiquitin ligase TRIM40,31826,0.0278258605579052,0.0299589421925345,-0.0308936661394625,0.0865453872552729,0.353023231598608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX,Glutaredoxin-1,33062,-0.0219383176564249,0.0236380007367129,-0.0682687991003822,0.0243921637875324,0.353384147783878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3D,Protein FAM3D,31998,-0.0313586585267846,0.0338081442365168,-0.0976226212303575,0.0349053041767883,0.353672024907886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AARSD1,Alanyl-tRNA editing protein Aarsd1,33062,-0.0219581840392802,0.0237126861818539,-0.0684350489557139,0.0245186808771534,0.354466748269316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXOSC10,Exosome component 10,31791,-0.0231937506850233,0.0250674689006584,-0.0723259897303139,0.0259384883602672,0.354864745078521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,31854,-0.0299656630937564,0.0324031783107017,-0.0934758925827318,0.0335445663952189,0.355112881367034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRB,Platelet-derived growth factor receptor beta,33208,0.0132393525853635,0.0143438138547211,-0.0148745225698898,0.0413532277406169,0.356032187664845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LUZP2,Leucine zipper protein 2,31990,0.0165911389444226,0.0179944708734936,-0.0186780239676248,0.05186030185647,0.356551219962609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCG,Pro-glucagon,32951,0.0473253521613676,0.0513540127213891,-0.0533285127725549,0.14797921709529,0.356788879838065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT1,Kunitz-type protease inhibitor 1,33095,-0.00934187428112042,0.010150004787942,-0.0292358836654868,0.0105521351032459,0.357399240931153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],33062,0.0214407378983486,0.0233002192818931,-0.024227691894162,0.0671091676908591,0.357496812324142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB7,Integrin beta-7,33189,-0.0175519386092891,0.0190775859157348,-0.0549440070041293,0.019840129785551,0.357582832228889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE4,Ribonuclease 4,31772,-0.0100656756874875,0.0109605558209547,-0.0315483650965588,0.0114170137215838,0.358463564921642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CANT1,Soluble calcium-activated nucleotidase 1,33090,-0.00754951837868445,0.0082334275465588,-0.0236870363699397,0.00858799961257079,0.359202269770849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLTP,Phospholipid transfer protein,33178,-0.0128709592129467,0.0140546851493418,-0.0404181421056566,0.0146762236797631,0.35980910810994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1D,V-type proton ATPase subunit D,33062,0.00989025242437236,0.0108102923861782,-0.011297920652537,0.0310784255012817,0.360273834373224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB8,DnaJ homolog subfamily B member 8,32973,0.0215585645851693,0.0235730969431942,-0.0246447054234913,0.06776183459383,0.360458501347246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREBZF,CREB/ATF bZIP transcription factor,31793,-0.00988629792049378,0.0108111837649379,-0.0310762180997721,0.0113036222587845,0.360509942413483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGRN,Neugrin,32006,-0.00849548392304815,0.00933052898759495,-0.0267833207387343,0.00979235289263796,0.362585827211264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,31804,-0.0207914264602311,0.0228588983539882,-0.065594867234048,0.0240120143135859,0.363087028987095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHX2,Bifunctional epoxide hydrolase 2,32973,0.0240045274984416,0.0264075972702989,-0.0277543631513442,0.0757634181482274,0.363375403438502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,32044,0.00945557447924126,0.0104044770893726,-0.0109372006159291,0.0298483495744116,0.363485280055163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNLZ,DNL-type zinc finger protein,31804,0.0353242280622138,0.0389022509274668,-0.0409241837556211,0.111572639880049,0.363894617201475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,32020,-0.0141650191276507,0.0156018845126909,-0.0447447127725248,0.0164146745172234,0.36395765726425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXN,"Frataxin, mitochondrial",33189,-0.0278857448420825,0.0307611594370584,-0.0881776173387169,0.032406127654552,0.364683300042135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCP2,Non-specific lipid-transfer protein,32951,-0.0291813561998488,0.032231307667448,-0.0923547192280468,0.0339920068283492,0.365293471182444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BP1,SH3 domain-binding protein 1,31998,-0.0180984588249335,0.0200015378295109,-0.0573014729707748,0.0211045553209079,0.365571963075497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD2,Glutamate decarboxylase 2,31816,-0.0177394548429779,0.0196133406077812,-0.0561816024342291,0.0207026927482732,0.365781858057259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC1,Plexin domain-containing protein 1,32951,0.0132508797362296,0.0146685416320845,-0.015499461862656,0.0420012213351152,0.366363865738858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARFIP1,Arfaptin-1,32020,-0.0256825073034826,0.0284554256393543,-0.081455141556617,0.0300901269496518,0.366792324268513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRD2,Protein ZNRD2,31998,-0.026061087848178,0.0289131717691398,-0.0827309045156919,0.0306087288193359,0.367427338401348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN8,Septin-8,31988,-0.0121551698361619,0.013500163002188,-0.0386154893204503,0.0143051496481265,0.367951044934769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QSOX1,Sulfhydryl oxidase 1,31919,-0.0174660466164812,0.0193992751171544,-0.0554886258461038,0.0205565326131414,0.367965544419197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,31791,0.0248570650579211,0.0276755240473255,-0.0293869620748369,0.0791010921906792,0.369129403935989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP3,Cysteine-rich secretory protein 3,31983,-0.0100468713759985,0.0111877479293525,-0.0319748573175294,0.0118811145655324,0.3692012137831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPKAPK2,MAP kinase-activated protein kinase 2,31908,0.0276473794132502,0.0308046440731095,-0.0327297229700444,0.0880244817965448,0.369477492925467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP45,Rho GTPase-activating protein 45,31907,-0.0305576231300852,0.0340632861891711,-0.0973216640608606,0.0362064178006902,0.369703156216188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMP1,Dentin matrix acidic phosphoprotein 1,31854,0.0231987525826954,0.0258604470438949,-0.0274877236233386,0.0738852287887295,0.369708237057723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",32899,-0.0177625642727815,0.0198211298838515,-0.0566119788451305,0.0210868502995676,0.370201998995097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1B,5-hydroxytryptamine receptor 1B,31804,0.0158380295140739,0.0176778847837877,-0.01881062466215,0.0504866836902978,0.37032304221834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROS1,Vitamin K-dependent protein S,32071,-0.0091297396440062,0.0102004540420647,-0.0291226295664531,0.0108631502784407,0.370797896674214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAPRT,Nicotinate phosphoribosyltransferase,32006,0.0119947150429146,0.0134184242336338,-0.0143053964550077,0.038294826540837,0.371404449245056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP1,Lysosome-associated membrane glycoprotein 1,31826,-0.0101653754643301,0.0113766020301244,-0.032463515443374,0.0121327645147138,0.371600680216828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSTN,Growth/differentiation factor 8,32973,-0.0187387952605384,0.0209787509865371,-0.0598571471941513,0.0223795566730744,0.371760631723067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNST,Consortin,33117,-0.0400587626658415,0.0448525297279521,-0.127969720932628,0.0478521956009446,0.371816865501678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTO1,Protein LTO1 homolog,32981,-0.0163178192681134,0.0182720624555264,-0.0521310616809451,0.0194954231447183,0.371856944972347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GM2A,Ganglioside GM2 activator,31854,-0.0140079773896559,0.0156896646082173,-0.0447597200217618,0.01674376524245,0.371984952903684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAPGEF2,Rap guanine nucleotide exchange factor 2,31908,-0.0195863867512292,0.0219633614078294,-0.0626345751105748,0.0234618016081164,0.372542074564053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PF4,Platelet factor 4,32025,-0.0359308064163263,0.0403224871533992,-0.114962881236989,0.0431012684043361,0.37291130918053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR1,Complement receptor type 1,32022,-0.0128974565718131,0.0144849834480976,-0.0412880241300845,0.0154931109864583,0.373278427033995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABCA2,ATP-binding cassette sub-family A member 2,31791,-0.0137430660918573,0.0154494694016284,-0.0440240261190489,0.0165378939353344,0.373737048219087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP6,Insulin-like growth factor-binding protein 6,33065,0.0102472889804306,0.0115503563414886,-0.0123914094488872,0.0328859874097483,0.375004727099176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",31791,0.0151004300546451,0.0170325255622598,-0.0182833200473841,0.0484841801566743,0.375342541159543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICOSLG,ICOS ligand,33062,0.00691436164539158,0.00780579066847812,-0.00838498806482553,0.0222137113556087,0.375750581726512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC3,PDZ domain-containing protein GIPC3,31998,-0.0357811571969806,0.0403995144550866,-0.11496420552895,0.0434018911349892,0.375816673337697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM1,V-set and transmembrane domain-containing protein 1,32911,-0.0180789772357146,0.0204267099416699,-0.0581153287213875,0.0219573742499584,0.376146436346661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB3,Plexin-B3,33089,-0.017269601458774,0.0195734360226168,-0.0556335360631029,0.0210943331455549,0.377640286997707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11,Coagulation factor XI,31956,0.0108580340048124,0.0123093583517579,-0.0132683083646331,0.0349843763742579,0.377753226681875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIT,Citron Rho-interacting kinase,31826,-0.0173030396977111,0.0196210423041755,-0.0557602826138951,0.021154203218473,0.377880510914679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2B,Alpha-amylase 2B,32501,0.0172973073600337,0.0196314660137456,-0.0211803660269075,0.055774980746975,0.378289381286316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX33,Testis-expressed protein 33,31908,-0.015572773559884,0.0176801346991089,-0.0502258375701375,0.0190802904503694,0.378451074116543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA3,Glutathione S-transferase A3,32951,-0.0280189582458933,0.0318167075710973,-0.0903797050852439,0.0343417885934574,0.378539425223285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",31816,-0.0130056173007342,0.0147850383663488,-0.0419842924987778,0.0159730578973094,0.37907917547713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN2,Matrilin-2,33136,-0.010782806525939,0.0122639156078379,-0.0348200811173013,0.0132544680654233,0.379300732326376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMC1,COX assembly mitochondrial protein homolog,32042,-0.0329255549038273,0.0374552441966487,-0.106337833529259,0.0404867237216041,0.379394431635775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUOM,Fucose mutarotase,31907,-0.0226819220446792,0.0258238181725186,-0.0732966056628156,0.0279327615734572,0.379791121452538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",33121,-0.0169183289349134,0.019273575684175,-0.0546945372758964,0.0208578794060697,0.380077035954903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES1,Liver carboxylesterase 1,33123,-0.0279874876506858,0.0318958126461069,-0.0905032804370554,0.0345283051356837,0.380257948500514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",31826,-0.0287681133001247,0.0327920482530557,-0.0930405278761138,0.0355043012758645,0.380358098762053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IZUMO1,Izumo sperm-egg fusion protein 1,31793,0.0172491325025669,0.0196719170200496,-0.0213078248567303,0.0558060898618641,0.380601999409853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF20,Fibroblast growth factor 20,31816,-0.0159507651861632,0.018225259342641,-0.0516722734977395,0.0197707431254131,0.381493093760629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAP,Prolyl endopeptidase FAP,33208,-0.00970353795369469,0.0110894555669078,-0.0314388708648341,0.0120317949574447,0.381584937216884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB4,Receptor tyrosine-protein kinase erbB-4,33126,0.00868188263740083,0.00993480412474476,-0.0107903334470989,0.0281540987219006,0.382204730144314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBEGF,Proheparin-binding EGF-like growth factor,33161,-0.0261527315959652,0.0299555984869955,-0.0848657046304763,0.032560241438546,0.382659962396172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARMCX2,Armadillo repeat-containing X-linked protein 2,31804,-0.0229581428357379,0.026300596642354,-0.0745073122547517,0.028591026583276,0.382738798494653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L,Seizure 6-like protein,33126,0.00968193492562975,0.0110957494417088,-0.0120657339801196,0.0314296038313791,0.382915910177687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSIP1,PC4 and SFRS1-interacting protein,33109,-0.0234205911607258,0.0268666925170707,-0.0760793084941844,0.0292381261727327,0.38337805135011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP6,Charged multivesicular body protein 6,32042,-0.0200605048990177,0.0230149287548684,-0.0651697652585597,0.0250487554605243,0.383437768249152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP290,Centrosomal protein of 290 kDa,31908,0.018982463539051,0.0217943115799236,-0.0237343871575992,0.0616993142357012,0.383791761648026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1F,Protein phosphatase 1F,32042,-0.0188310918561454,0.0216341550309618,-0.0612340357168305,0.0235718520045398,0.384091109818563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTPBP2,GTP-binding protein 2,31826,-0.0286361440027919,0.0329038402393201,-0.0931276708718594,0.0358553828662756,0.384165939931079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA4,Laminin subunit alpha-4,33167,-0.0118400502145808,0.0136140705343054,-0.0385236284618194,0.0148435280326579,0.384492617544321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TERF1,Telomeric repeat-binding factor 1,31816,-0.011030540928657,0.0126898352748753,-0.0359026180674126,0.0138415362100985,0.384742973987747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2CD2L,Phospholipid transfer protein C2CD2L,32899,-0.0153634698413915,0.0176992298442693,-0.0500539603361593,0.0193270206533764,0.385402341617877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,32898,-0.020848139314312,0.0240886467518113,-0.0680618869478621,0.0263656083192381,0.386802309283175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASN,Vasorin,32989,0.00981122280443322,0.011337421059282,-0.0124101224717595,0.032032568080626,0.386852376264999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD93,Complement component C1q receptor,32778,0.0112480079848914,0.0130079646801691,-0.0142476027882399,0.0367436187580228,0.387227498044533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK1,Docking protein 1,32006,-0.0482498297273884,0.0558515842158603,-0.157718934790475,0.0612192753356978,0.387673736945851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2,Interleukin-2,32981,-0.011057644963721,0.0128059602614496,-0.0361573270761622,0.0140420371487202,0.387899848829534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCC1,GRIP and coiled-coil domain-containing protein 1,32006,-0.038302475963746,0.0443632829578976,-0.125254510561225,0.0486495586337334,0.387954685737832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCYT2,Ethanolamine-phosphate cytidylyltransferase,31998,-0.0275724862194686,0.0319637760813368,-0.0902214873388887,0.0350765148999514,0.388375672802075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN3,Contactin-3,33121,0.0125234421823571,0.0145211698369756,-0.0159380506981151,0.0409849350628293,0.388476700362912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP3,Dual specificity protein phosphatase 3,32911,0.0321806628397181,0.0373398497473823,-0.0410054426651513,0.105366768344587,0.388804617216042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,32020,-0.0355283420239671,0.0412470627575877,-0.116372585028839,0.0453159009809049,0.38907013140651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAGE2A,G antigen 2A,31793,0.0228228479439436,0.0265216672437732,-0.0291596198538519,0.0748053157417391,0.389521782328689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP29,Synaptosomal-associated protein 29,33126,-0.032517890109262,0.0377886682289346,-0.106583679837974,0.0415478996194498,0.389526461689075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD1,Bromodomain-containing protein 1,31908,-0.0109435964255075,0.0127246506764219,-0.0358839117512943,0.0139967189002794,0.38979950318157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAGR1,PAXIP1-associated glutamate-rich protein 1,31854,-0.0163654240856383,0.0190477022715328,-0.0536989205378426,0.0209680723665659,0.390268481371739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR1,Interferon gamma receptor 1,33167,0.00706886401292083,0.00822870100997023,-0.00905938996662081,0.0231971179924625,0.390336664944558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,31791,0.0167816070356765,0.0195389252347015,-0.0215146864243386,0.0550779004956915,0.390434353996341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,33042,-0.0335372688871206,0.0390752925313563,-0.110124842248579,0.0430503044743377,0.390765676961926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPQ,Carboxypeptidase Q,32032,-0.0124372139856442,0.0144963159468679,-0.0408499932415052,0.0159755652702169,0.390943401283927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBXN1,UBX domain-containing protein 1,31907,-0.0247477455670987,0.0288520653545269,-0.0812977936619713,0.031802302527774,0.391060270747007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC6,Sialic acid-binding Ig-like lectin 6,33189,-0.0117352002940704,0.0136818445922082,-0.0385516156947985,0.0150812151066577,0.391070275707652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11R,Junctional adhesion molecule A,33121,-0.0201521040716592,0.0235174702746251,-0.0662463458099243,0.0259421376666059,0.391524220238423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,33042,-0.0336495258581892,0.0392765367116561,-0.110631537813035,0.0433324860966567,0.391616068664428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPR1,Atrial natriuretic peptide receptor 1,31791,-0.0138712427436111,0.016231930155365,-0.0456858258481265,0.0179433403609044,0.39281979056022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOD,Apolipoprotein D,31683,-0.0160777408040313,0.0188314282026811,-0.0529873400812861,0.0208318584732236,0.39325976944225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1A,Meprin A subunit alpha,31998,-0.0241827023719706,0.0283272646586956,-0.079704141103014,0.0313387363590727,0.393303878237336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLASP1,CLIP-associating protein 1,31793,0.0251009808801349,0.0294159015115734,-0.032554186082549,0.0827561478428188,0.393513410784186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOCS2,Molybdopterin synthase catalytic subunit,31907,-0.0238557400900487,0.0279733476391762,-0.0786835014628341,0.0309720212827366,0.393796248437211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABO,Histo-blood group ABO system transferase,32048,0.0509136625065489,0.0598050553628459,-0.0663042460046291,0.168131571017727,0.394614528685095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RB,Cytokine receptor common subunit beta,31816,-0.0154803732527337,0.0181849685341359,-0.05112291157964,0.0201621650741726,0.394645383501771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBD,Thrombomodulin,33117,0.00946284634848926,0.0111165389371675,-0.0123255699683591,0.0312512626653376,0.394659383263077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT14,"Keratin, type I cytoskeletal 14",32619,-0.0100252374284749,0.0117890686782843,-0.0331318120379121,0.0130813371809623,0.395136461601422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFT20,Intraflagellar transport protein 20 homolog,31826,0.0153109874638098,0.0180250966506467,-0.0200182019714576,0.0506401768990773,0.395671813424456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBLD,Phenazine biosynthesis-like domain-containing protein,32911,-0.0176687746678612,0.0208666547165669,-0.0585674179123322,0.0232298685766098,0.397160179258643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLON5,IgLON family member 5,31793,-0.0322114208437506,0.0380426575793441,-0.106775029699265,0.0423521880117638,0.397179661875824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAA4,Serum amyloid A-4 protein,32071,-0.0115047644431551,0.0135879343807882,-0.0381371158295,0.0151275869431897,0.397194679463259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PACS2,Phosphofurin acidic cluster sorting protein 2,31791,-0.0216878845020076,0.025666627622088,-0.0719944746413001,0.028618705637285,0.398147430131111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF9,Fibroblast growth factor 9,31780,-0.0143195312167816,0.0169546193407303,-0.0475505851246129,0.0189115226910498,0.398372990418249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SBSN,Suprabasin,32032,0.0116990538061788,0.0138676293156367,-0.0154814996524691,0.0388796072648268,0.398906617764116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSTB,Cystatin-B,32987,-0.0148337681711007,0.0176086288351288,-0.0493466806879531,0.0196791443457517,0.399579459890992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPAG1,Sperm-associated antigen 1,32020,-0.0197665466013714,0.0235367623770138,-0.0658986008603185,0.0263655076575756,0.401038161992407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,33152,-0.0184242981111921,0.0219427460737249,-0.0614320804156928,0.0245834841933086,0.401125903869478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK3,NT-3 growth factor receptor,33191,0.00745708401310715,0.00888324357925127,-0.00995407340222534,0.0248682414284396,0.401236945324477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,33109,-0.0413756517178996,0.0493261297282585,-0.138054865985286,0.0553035625494871,0.401594538114008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB14,DnaJ homolog subfamily B member 14,31998,-0.0227328813557261,0.027102984752557,-0.0758547314707379,0.0303889687592858,0.401630945312693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YOD1,Ubiquitin thioesterase OTU1,31791,-0.022223432113566,0.0265071113089073,-0.0741773702790244,0.0297305060518924,0.401836147709399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDDM3B,Epididymal secretory protein E3-beta,31990,-0.0147490617471443,0.0176009290911104,-0.0492468827657207,0.0197487592714321,0.402073763969598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCR,Breakpoint cluster region protein,33109,-0.0314783036537316,0.0375796805003024,-0.105134477434324,0.0421778701268611,0.402255146662448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF8,SLAM family member 8,32951,-0.0187566394869692,0.0223994920685053,-0.0626596439412397,0.0251463649673012,0.402408750551348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_A,,32020,-0.0112510826289882,0.0134368478472148,-0.0375873044095292,0.0150851391515527,0.402433256103959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDK,Midkine,33104,-0.0176036572242066,0.0210311372950181,-0.0588246863224422,0.0236173718740289,0.40259977604114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRLB,Fc receptor-like B,32951,-0.0208174702800363,0.0249050235910557,-0.0696313165185054,0.0279963759584328,0.403249094913129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCDC2C,Doublecortin domain-containing protein 2C,31793,-0.0216471592657294,0.0259005676314674,-0.0724122718234054,0.0291179532919466,0.403306253937694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP2,Src kinase-associated phosphoprotein 2,33167,-0.0363481969837783,0.0435467587859029,-0.121699844204148,0.0490034502365913,0.403913175733129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,33191,-0.0199822194819334,0.0239658855729002,-0.0669553552048178,0.026990916240951,0.404429086982171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR1,Folate receptor alpha,33081,0.0094996795436061,0.0114000242127647,-0.0128443679134126,0.0318437270006248,0.404696673552091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF1,Signaling lymphocytic activation molecule,32981,-0.0203328967015122,0.024407888412015,-0.0681723579890616,0.0275065645860373,0.404842046491435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L15,Bcl-2-like protein 15,31816,-0.0205033969190373,0.024614144804278,-0.0687471207354222,0.0277403268973477,0.404875999148978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTPP1,dCTP pyrophosphatase 1,33117,0.0108468407020818,0.0130348585937902,-0.0147014821417469,0.0363951635459105,0.405352275228713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG2,"Arginase-2, mitochondrial",31990,-0.0148656762933709,0.0179255734862763,-0.0499998003264724,0.0202684477397307,0.406960987237053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,33189,-0.0116519071738597,0.014057789478508,-0.0392051745517354,0.0159013602040159,0.407207571156302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFB,Complement factor B,31925,-0.0111845242331188,0.0134951931760374,-0.0376351028581521,0.0152660543919145,0.407256297833672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRDT,Bromodomain testis-specific protein,31791,-0.0125377492478467,0.0151306079726375,-0.0421937408742162,0.0171182423785229,0.407338002077899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA10,N-alpha-acetyltransferase 10,31791,-0.0173813503123577,0.0209826135519063,-0.058507272874094,0.0237445722493786,0.407488394545868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIPF,Gastric triacylglycerol lipase,31854,0.0208174733185859,0.0251665630704343,-0.0285089902994654,0.0701439369366371,0.408157304692651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA5A,von Willebrand factor A domain-containing protein 5A,31793,0.0276699418676306,0.0334512042380983,-0.0378944184390421,0.0932343021743033,0.408165748215185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRO3,Tyrosine-protein kinase receptor TYRO3,33117,-0.00961941497648109,0.011632670158107,-0.0324194484863708,0.0131806185334086,0.408298970937134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RB,Interleukin-10 receptor subunit beta,33167,-0.00949765704272466,0.0114937036735819,-0.0320253162429451,0.0130300021574958,0.40863634009368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDS,Iduronate 2-sulfatase,33208,-0.00299625525206018,0.00363128782611011,-0.010113579391236,0.00412106888711564,0.409324843764125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PQBP1,Polyglutamine-binding protein 1,32951,-0.0195974212598988,0.0237635369517307,-0.066173953685291,0.0269791111654934,0.40957386199414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB103A_DEFB103B,Beta-defensin 103,31759,-0.013887482844375,0.0168399862031939,-0.046893855802635,0.019118890113885,0.409584153266811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB27B,Ras-related protein Rab-27B,32042,-0.0278158752640446,0.0337348975268619,-0.0939362744166939,0.0383045238886048,0.409656976747427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,31908,-0.0176862705488227,0.0214651573577903,-0.0597579789700917,0.0243854378724463,0.409992890581839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBFOX3,RNA binding protein fox-1 homolog 3,32020,-0.0125067622726994,0.0151897024560611,-0.0422785790865793,0.0172650545411804,0.410322927472762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSB,Cathepsin B,33111,0.0182461433774565,0.022184662471853,-0.0252357950673754,0.0617280818222884,0.410834049656027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCAMP3,Secretory carrier-associated membrane protein 3,33062,-0.0292082354591715,0.035520913571199,-0.0988292260587216,0.0404127551403785,0.410938747215809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID3A,AT-rich interactive domain-containing protein 3A,31804,-0.0134583506619716,0.0163791948614384,-0.0455615725903909,0.0186448712664477,0.411289379539416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL1,Angiopoietin-related protein 1,32998,0.00990364044467049,0.0120800947649106,-0.0137733452945543,0.0335806261838953,0.412335118290275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADRA2A,Alpha-2A adrenergic receptor,31791,-0.0252115119473295,0.0307608431682331,-0.0855027645570665,0.0350797406624075,0.412472181567335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOT13,Acyl-coenzyme A thioesterase 13,31998,-0.0381724052995398,0.0466377586457369,-0.129582412245184,0.0532376016461045,0.413104932636657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL1,Interferon lambda-1,32911,-0.0149947324163313,0.018321362991859,-0.0509046038803749,0.0209151390477124,0.413135396427797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP164,Centrosomal protein of 164 kDa,32981,0.0222177564738895,0.0271599678126777,-0.0310157804389588,0.0754512933867379,0.413361059671809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEMIP2,Cell surface hyaluronidase,31816,-0.0120482022203992,0.0147287471143888,-0.0409165465646014,0.0168201421238029,0.413380278069173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL3,Follistatin-related protein 3,33104,-0.010159929768601,0.0124215818673901,-0.0345062302286856,0.0141863706914836,0.413422197348034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGA,Protein O-GlcNAcase,31998,-0.0239179134146924,0.0292656241489898,-0.0812785367467123,0.0334427099173275,0.413800012249808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVALB,Parvalbumin alpha,33142,-0.0388074771198401,0.0474963159354493,-0.131900256353321,0.0542853021136406,0.413914888493664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRAXIN,Draxin,33042,0.0146073303288924,0.0178851938507535,-0.0204476496185844,0.0496623102763693,0.414106799997861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC25A,M-phase inducer phosphatase 1,31793,0.0140806821361901,0.0172600832437492,-0.0197490810215583,0.0479104452939385,0.41464410948918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB2,Lamin-B2,32006,-0.00937426756180555,0.0114935177915783,-0.0319015624332991,0.013153027309688,0.41474697678286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,32899,-0.0155042883510269,0.0190101713579035,-0.0527642242125177,0.021755647510464,0.414764206823348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GORASP2,Golgi reassembly-stacking protein 2,31998,-0.0158541179558167,0.0194430010043973,-0.0539623999244354,0.0222541640128019,0.414860439948207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD14,Monocyte differentiation antigen CD14,32922,-0.0140633888442073,0.0172510287658338,-0.0478754052252416,0.019748627536827,0.414969142118879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEO1,Neogenin,32020,0.00720149935387974,0.00883507373919662,-0.0101152451749456,0.0245182438827051,0.415038729456662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC16A1,Monocarboxylate transporter 1,32911,-0.0198409815904287,0.0243496987544942,-0.0675663911492373,0.02788442796838,0.415189825386048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPP,Lipoma-preferred partner,31791,-0.0225573335457402,0.0277202521323871,-0.0768890277252189,0.0317743606337385,0.415815031402676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS2,Trypsin-2,33138,0.0170068064318637,0.0209169463060015,-0.0239904083278993,0.0580040211916267,0.41620391345035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELL,L-selectin,32071,0.00776320432568706,0.00955167566583658,-0.0109580799793526,0.0264844886307268,0.416382004126445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTRA2,"Serine protease HTRA2, mitochondrial",33126,-0.0208619637706135,0.025686237498212,-0.0712069892671091,0.0294830617258821,0.416708064815679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP4,Peptidoglycan recognition protein 4,31791,0.0212986166971146,0.0262351081902263,-0.030122195355729,0.0727194287499582,0.416911822415349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFA,Protransforming growth factor alpha,33109,-0.0156981252367032,0.0193549696726246,-0.0536338657950474,0.022237615321641,0.417351034125191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARS1,"Methionine--tRNA ligase, cytoplasmic",31892,-0.0286968881140186,0.035430313515184,-0.0981403026037792,0.040746526375742,0.417993102836983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2B,Ubiquitin-conjugating enzyme E2 B,31990,-0.00996234330423716,0.0123038076987459,-0.0340778063937792,0.0141531197853049,0.418140502420902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,31998,-0.0391707137627642,0.048414008296807,-0.134062170024506,0.0557207424989775,0.418495734124407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX2,Transcription factor SOX-2,32009,-0.00781384729626355,0.00965972404508607,-0.0267469064246323,0.0111192118321052,0.418592386943544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB8,Serpin B8,33208,-0.0191468604100821,0.0236706563757604,-0.0655413469065726,0.0272476260864083,0.418602752423844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL5,ADAMTS-like protein 5,32042,-0.0128887120223018,0.015959423663407,-0.0441691824025796,0.0183917583579759,0.419350471544926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MN1,Transcriptional activator MN1,31826,-0.0204230999712039,0.025321147335406,-0.0700525487485996,0.0292063488061918,0.419944322787357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGES2,Prostaglandin E synthase 2,31759,-0.0183419301005611,0.0227551793674602,-0.0629420816607831,0.0262582214596608,0.42023726688835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD69,Early activation antigen CD69,33077,-0.0294930312000423,0.0365951191249879,-0.101219464685019,0.0422334022849341,0.420306583757651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDM1,Nuclear protein MDM1,31826,-0.010388623127023,0.0128912227443427,-0.0356554197059346,0.0148781734518886,0.420344984318677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPBGL,Trophoblast glycoprotein-like,31826,-0.0136730761677271,0.0170033869099911,-0.0469997145113097,0.0196535621758555,0.421342978215235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FYB1,FYN-binding protein 1,33111,-0.0304401247690539,0.0378612747028727,-0.104648223186684,0.0437679736485766,0.421424233837373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TF,Serotransferrin,32071,-0.00728406308890274,0.00907250678429169,-0.0250661763861145,0.010498050208309,0.422073674703545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CWC15,Spliceosome-associated protein CWC15 homolog,31952,-0.0206650135185183,0.0257845828730428,-0.0712027959496822,0.0298727689126455,0.422897476289678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD9,26S proteasome non-ATPase regulatory subunit 9,33062,-0.0188437356022418,0.0235354200947843,-0.064973158988019,0.0272856877835354,0.423353890403283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX2,"Ferredoxin-2, mitochondrial",31791,-0.0187390248899133,0.0234196574667335,-0.064641553524711,0.0271635037448844,0.423655087952042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4D,Semaphorin-4D,33191,-0.00985008714339486,0.012322705176873,-0.034002589290066,0.0143024150032763,0.424112382271732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAP1L4,Nucleosome assembly protein 1-like 4,31986,-0.0137939442392742,0.0172571414791874,-0.0476179415384814,0.020030053059933,0.424131228681047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL1,Fc receptor-like protein 1,33117,-0.0148243960281389,0.0185539949314827,-0.0511902260938449,0.0215414340375672,0.424319996975668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",33109,-0.0273890358285916,0.0342806046953364,-0.0945790210314509,0.0398009493742678,0.42433207620101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI2,Protein-arginine deiminase type-2,32981,0.0188088529256347,0.0235457148402361,-0.0273407481612279,0.0649584540124974,0.424415434403285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31RA,Interleukin-31 receptor subunit alpha,31782,0.0134279385045156,0.0168139274974088,-0.0195273593904058,0.0463832363994369,0.424536670802083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBP,Lipopolysaccharide-binding protein,33138,-0.0191450963588883,0.0239871162226729,-0.0661598441553272,0.0278696514375507,0.424810601689715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN5,CCN family member 5,33121,0.0127677224859887,0.0160065405874552,-0.0186050970654236,0.0441405420374009,0.425091652817585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUCA1,Tissue alpha-L-fucosidase,33167,-0.0266444630181256,0.0334072016894953,-0.0921225783295364,0.0388336522932852,0.425143860655737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,31998,-0.0130502123618283,0.0163643090480352,-0.0451242580959772,0.0190238333723206,0.425197293574254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPH,Hephaestin,32042,-0.00821496617334878,0.0103074793055749,-0.0284176256122755,0.011987693265578,0.425481304465839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSRA,Mitochondrial peptide methionine sulfoxide reductase,33126,-0.0241266820381599,0.0302938247100799,-0.0835025784699164,0.0352492143935967,0.425808331455757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),P4HB,Protein disulfide-isomerase,33070,-0.0127669916604165,0.0160630838368829,-0.044250635980707,0.0187166526598739,0.426749832181072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP1,Dipeptidase 1,33030,0.016969660871307,0.0213561478469957,-0.0248883889088046,0.0588277106514186,0.426866408744293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPMT,Thiopurine S-methyltransferase,32951,0.0243160091066862,0.0306281433272773,-0.0357151518147772,0.0843471700281497,0.427269615806474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,33042,0.0091305403993969,0.0115012391589706,-0.0134118883521854,0.0316729691509792,0.42729042982869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCLS1,Hematopoietic lineage cell-specific protein,33208,-0.0182861900974815,0.02304359036886,-0.0634516272204471,0.026879247025484,0.427480243647062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3,"TNF receptor-associated factor 3, Isoform 2",31816,0.012241491531953,0.0154263185771885,-0.0179940928793363,0.0424770759432424,0.42748541836823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP4,Microfibril-associated glycoprotein 4,31907,0.0102940517410449,0.0129798782903946,-0.0151465097081285,0.0357346131902182,0.427757805846586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLB1,Beta-galactosidase,33042,-0.013370368933778,0.0168612983354859,-0.0464185136713304,0.0196777758037743,0.42782186038371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BANK1,B-cell scaffold protein with ankyrin repeats,33109,-0.034422351337335,0.0434608666404696,-0.119605649952655,0.0507609472779855,0.428364333901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RUVBL1,RuvB-like 1,32951,0.0352205310147334,0.0444695703204105,-0.0519398268132712,0.122380888842738,0.428374503128477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA8,Carbonic anhydrase-related protein,31816,0.00839865326033908,0.0106070847057821,-0.0123912327629939,0.0291885392836721,0.428504807719579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH,Parathyroid hormone,31826,-0.0257128129882861,0.0324886013410809,-0.0893904716168047,0.0379648456402325,0.428712115161568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6B,Ras-related protein Rab-6B,32911,-0.0159223884488166,0.0201186588369798,-0.055354959769297,0.0235101828716638,0.428718828826938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN1,Nectin-1,31816,-0.0102828270646987,0.0130044930475496,-0.0357716334378959,0.0152059793084986,0.429136711599958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2A,Pancreatic alpha-amylase,32766,0.0151284309565329,0.0191365649823882,-0.022379236408948,0.0526360983220137,0.429228587648156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD72,B-cell differentiation antigen CD72,31907,-0.0139494761813857,0.0176638765192348,-0.048570674159086,0.0206717217963146,0.429717760594681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPHN1,Oligophrenin-1,32006,-0.034757116967596,0.0440602981500572,-0.121115301341708,0.0516010674065161,0.430222438181229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP23,Synaptosomal-associated protein 23,33117,-0.0283870355982077,0.0359979308668918,-0.0989429800973156,0.0421689089009003,0.430382552625548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIF1A,Hypoxia-inducible factor 1-alpha,31816,0.0217005986110108,0.0275211549927973,-0.032240865174872,0.0756420623968936,0.430426113811403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORD,Sorbitol dehydrogenase,33149,0.0217290750337179,0.0276062260339483,-0.0323791279928208,0.0758372780602566,0.431240229203441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRV1,Adhesion G-protein coupled receptor V1,31804,0.0225704940466819,0.028756813714268,-0.0337928608332833,0.0789338489266472,0.432552357087405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC15,Thioredoxin domain-containing protein 15,33126,-0.00879585441165929,0.0112075161519577,-0.0307625860694963,0.0131708772461777,0.432582032411591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,31791,0.0172801643672573,0.0220223861342127,-0.0258837124557995,0.0604440411903142,0.432676167612827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NENF,Neudesin,31990,-0.0362290586165869,0.0461718592334907,-0.126725902714229,0.054267785481055,0.432679535331634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAX,Integrin alpha-X,31908,0.0175049787409584,0.0223752633673266,-0.0263505374590018,0.0613604949409186,0.434041856274479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH2,Cadherin-2,33117,-0.0113000008777379,0.0144506466932794,-0.0396232683965655,0.0170232666410897,0.434252404639653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPNMB,Transmembrane glycoprotein NMB,32876,-0.0089148809729212,0.0114187775538046,-0.0312956849783781,0.0134659230325357,0.434988464755968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX9,Transcription factor SOX-9,31826,-0.00861368453033269,0.0110415695286507,-0.0302551608064881,0.0130277917458227,0.435348732334734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGN,Mimecan,33121,0.0128996851215677,0.0165470433346889,-0.0195325198144226,0.0453318900575581,0.435661510213226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FURIN,Furin,33126,-0.0108298041492801,0.013937457469558,-0.0381472207896137,0.0164876124910535,0.437163040612856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2A,DNA-directed RNA polymerase II subunit RPB1,31816,-0.00929801581753851,0.0119797167174274,-0.0327782605836962,0.0141822289486191,0.437687386665179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LG,CMRF35-like molecule 9,33121,0.011821608840154,0.0152386520776366,-0.0180461492320137,0.0416893669123218,0.437909073655777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKZF2,Zinc finger protein Helios,32951,0.0302765966041997,0.0390363001621112,-0.0462345517135382,0.106787744921938,0.43800614214591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC2,"Myosin-binding protein C, fast-type",31854,-0.0266083448924591,0.0343163302401957,-0.0938683521632425,0.0406516623783244,0.438137359431768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDUA,Alpha-L-iduronidase,33189,-0.0146944692327968,0.018956144063681,-0.0518485115976115,0.0224595731320178,0.438252866445787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,33208,-0.0111132660122204,0.0143490894555193,-0.0392374813450383,0.0170109493205974,0.438660355631791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",32042,-0.0235661423199816,0.0304373353216203,-0.0832233195503573,0.0360910349103942,0.438806393174357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA3,Alpha-1-antichymotrypsin,32041,-0.00464855944336553,0.0060049905038112,-0.0164183408308355,0.00712122194410443,0.438886290041481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CABP2,Calcium-binding protein 2,31826,0.0208970544921895,0.0270134323691038,-0.0320492729512539,0.0738433819356329,0.439203924825612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC4A1,Band 3 anion transport protein,32044,0.0149600306020386,0.0193455962084652,-0.0229573379665531,0.0528773991706304,0.439366452811787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP7,Caspase-7,32006,-0.0269074275800404,0.0348078626002856,-0.0951308382766001,0.0413159831165193,0.439530419265141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARAF,Serine/threonine-protein kinase A-Raf,31908,-0.0216149594589571,0.0279714955167202,-0.0764390906717288,0.0332091717538145,0.43969513439065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP4,Metalloproteinase inhibitor 4,33121,-0.0129424424910734,0.0167527303669215,-0.0457777940102394,0.0198929090280927,0.439805543212938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCAT,Phosphatidylcholine-sterol acyltransferase,32048,-0.00693453486296227,0.00898661603646103,-0.0245483022944259,0.0106792325685013,0.440344925591767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18,Interleukin-18,33089,-0.0153604353687359,0.0199096824447832,-0.0543834129605109,0.0236625422230392,0.440428295775691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD9,COMM domain-containing protein 9,31990,0.0128052499657174,0.0166167201329089,-0.019763521494784,0.0453740214262187,0.440953746634794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC2L,C-type lectin domain family 2 member L,31826,0.0159553031261461,0.0207060630286235,-0.0246285804099559,0.0565391866622481,0.440991342359139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTYMK,Thymidylate kinase,32042,-0.0222071918001329,0.0288669942570926,-0.0787865005440345,0.0343721169437687,0.441743018236677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPI,Mannose-6-phosphate isomerase,33062,-0.0273539020326244,0.0355962063747857,-0.0971224665272044,0.0424146624619555,0.442241007087666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR1,Toll-like receptor 1,31816,-0.00836879751051355,0.010893086968284,-0.0297192479683502,0.0129816529473231,0.442353305812176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASEH2A,Ribonuclease H2 subunit A,32020,0.0159944986303587,0.0208522202912915,-0.0248758531405727,0.05686485040129,0.443081330705404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,31826,-0.0168827990835433,0.0220239909658315,-0.0600498213765731,0.0262842232094865,0.443365312859068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEP1,Rab GTPase-binding effector protein 1,31907,-0.0250813852492117,0.0327198344955078,-0.089212260860407,0.0390494903619836,0.443373455734229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,33042,-0.00916935376113927,0.0119646684143679,-0.0326201038533003,0.0142813963310217,0.443477693290369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB11FIP3,Rab11 family-interacting protein 3,32042,-0.0337134487426506,0.0440329540853201,-0.120018038749878,0.0525911412645767,0.443913563787024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1R,Macrophage colony-stimulating factor 1 receptor,32048,-0.0125183916261231,0.0163510443182547,-0.0445664384899024,0.0195296552376562,0.443936963698989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXT,Oxytocin-neurophysin 1,33191,-0.0421159461947064,0.0550429596692486,-0.150000147146434,0.0657682547570208,0.444204777872435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F7,Coagulation factor VII,33124,-0.00928012988268653,0.012136209493563,-0.0330671004900701,0.014506840724697,0.444492092532581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP8,Vesicle-associated membrane protein 8,31816,-0.0280026142596038,0.0366327370521505,-0.0998027788818188,0.0437975503626111,0.444644456545108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3C,Protein FAM3C,33107,0.00907323839955208,0.0119133503400924,-0.0142769282670291,0.0324234050661332,0.446317983614446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3G,Semaphorin-3G,31907,0.013846421204838,0.0181867831393953,-0.0217996737483768,0.0494925161580527,0.446474953714843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR1B,Cornifin-B,31908,0.0263264351759995,0.034673222303802,-0.0416330805394523,0.0942859508914513,0.447713377954853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRP,Gastrin-releasing peptide,31854,-0.0172967968214481,0.0227886679323292,-0.0619625859688133,0.0273689923259171,0.447871531550856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THOP1,Thimet oligopeptidase,33072,-0.00975555203714418,0.0128556798080678,-0.0349526844609571,0.0154415803866688,0.447962136908971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS1BP3,HCLS1-binding protein 3,31854,-0.028094723437914,0.0370337419436563,-0.10068085764748,0.0444914107716523,0.448101052330981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL5A1,Collagen alpha-1(V) chain,31907,-0.0123094577338232,0.0162498268740511,-0.0441591184069634,0.0195402029393171,0.44876642573611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,31908,-0.0350616668399325,0.0463361613820012,-0.125880543148655,0.0557572094687897,0.449265246456319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ODAM,Odontogenic ameloblast-associated protein,32899,0.0172519836279354,0.0228365427227888,-0.0275076401087305,0.0620116073646014,0.449997002086111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BDNF,Brain-derived neurotrophic factor,32044,-0.025611340802977,0.033928162982443,-0.0921105402485653,0.0408878586426112,0.450350607997075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRY2,Protein sprouty homolog 2,32981,-0.0291219492653562,0.0385945738473956,-0.104767314006252,0.0465234154755391,0.450533435317428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_DRA,,33082,0.0111321239548327,0.0147673665242854,-0.0178119144327666,0.0400761623424321,0.450970245186796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLYR1,Putative oxidoreductase GLYR1,31990,-0.0190612222165363,0.0253327306272947,-0.0687133742460339,0.0305909298129613,0.451813260238964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,33030,-0.0347628678170998,0.0462098142045958,-0.125334103658108,0.0558083680239079,0.451901398556626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAMBP,STAM-binding protein,33030,-0.0202117276455614,0.0268794736532302,-0.0728954960058925,0.0324720407147697,0.4521083046301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPB41L5,Band 4.1-like protein 5,31826,0.0199204841592059,0.0265036852550714,-0.032026738940734,0.0718677072591458,0.452308496469905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRTN,Neurturin,32981,-0.0154588371507405,0.0205705518692544,-0.0557771188144792,0.0248594445129983,0.452370564495182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKA,Diacylglycerol kinase alpha,31816,-0.0169803403922019,0.0225994667349338,-0.0612752951926721,0.0273146144082683,0.452459904408198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLMP,CXADR-like membrane protein,33189,0.00617521833903478,0.00822306060863216,-0.00994198045388426,0.0222924171319538,0.452694850312128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTNNA1,Catenin alpha-1,31804,0.0112528076647525,0.0149953767849035,-0.0181381308336584,0.0406437461631634,0.453026726729099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRNN,Cornulin,32865,0.0206774387727576,0.0275562248830893,-0.0333327619980975,0.0746876395436127,0.453051255139381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT1,Angiopoietin-1,33090,-0.0261284147919624,0.0348485161807563,-0.0944315065062447,0.0421746769223199,0.453412919066604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,32951,-0.0203128323238015,0.0271013406539,-0.0734314600054455,0.0328057953578425,0.453568251187676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL24,Interleukin-24,32981,0.0154972036632848,0.0207031153662961,-0.0250809024546556,0.0560753097812251,0.454152419935234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA1,Apolipoprotein A-I,32071,-0.00867865645764206,0.0116021507958771,-0.0314188720175612,0.0140615591022771,0.454470369647298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB1,Heat shock protein beta-1,32976,-0.0211796756271642,0.0283339840799463,-0.0767142844238589,0.0343549331695305,0.454781942842983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGXT,Serine--pyruvate aminotransferase,33117,-0.0237826538181958,0.0318257344010221,-0.0861610932441992,0.0385957856078076,0.454916375383782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL1,Follistatin-related protein 1,31854,-0.00696898063388366,0.00932716247277303,-0.0252502190805188,0.0113122578127515,0.454984382721455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL2,Kin of IRRE-like protein 2,32911,-0.0121458740527094,0.0162828064441461,-0.0440601746832358,0.019768426577817,0.455728936426261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,31816,-0.00963736541429134,0.012920156977507,-0.034960873090205,0.0156861422616223,0.455741332517555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTD,Deoxycytidylate deaminase,31907,-0.0291522382528754,0.0391262351141536,-0.105839659076617,0.0475351825708657,0.456245873749316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAST,Gastrin,32006,-0.0393230601771369,0.0527963497339046,-0.14280390565559,0.0641577853013161,0.45641192424851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS2,Protein MTSS 2,31990,-0.0300668089238918,0.0403906815522434,-0.109232544766289,0.0490989269185053,0.45665793978634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99L2,CD99 antigen-like protein 2,33121,-0.00728625958861314,0.00979799040142634,-0.0264903207754088,0.0119178015981825,0.457109386200888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL3,Insulin-like 3,32006,-0.018157631917059,0.024422507776569,-0.0660257471591343,0.0297104833250162,0.457214599231776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP5,Fatty acid-binding protein 5,33167,-0.0216098861147823,0.0290774710871684,-0.0786017294456323,0.0353819572160678,0.457390845580072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR2,Folate receptor beta,33191,0.00909953707263093,0.0122469520760739,-0.014904488996474,0.0331035631417358,0.457499097992234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGN,Biglycan,32933,0.03698414629947,0.0498590052333947,-0.0607395039579836,0.134707796556924,0.458244420776333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMB1,Laminin subunit beta-1,31854,-0.00903189151206256,0.0121761128780556,-0.0328970727530515,0.0148332897289264,0.458249424986947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP5,Vesicle-associated membrane protein 5,32973,-0.0175438950413213,0.0236715630221262,-0.0639401585646886,0.0288523684820461,0.458630190563668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5F1D,"ATP synthase subunit delta, mitochondrial",31791,0.0161808270410393,0.0218324103367208,-0.0266106972189336,0.0589723513010121,0.458633536628064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPEP,Glutamyl aminopeptidase,31791,-0.0139204676846469,0.0187923848474397,-0.0507535419856287,0.022912606616335,0.458868457495925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1B,C-type lectin domain family 1 member B,33191,-0.0295714745080514,0.0400489850603797,-0.108067485226396,0.0489245362102929,0.460301801439149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO3,Beta-enolase,31854,-0.0171641104343004,0.0232581563315121,-0.0627500968440641,0.0284218759754633,0.460548528774507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF8,Tumor necrosis factor ligand superfamily member 8,32044,-0.0108525217630167,0.0147131155878093,-0.039690228315123,0.0179851847890895,0.460775075617228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD1,Sushi domain-containing protein 1,32973,-0.0146573910429446,0.0198987657144272,-0.053658971843222,0.0243441897573328,0.461387129699358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA11,Serpin A11,33208,-0.012165709974678,0.0165218046961437,-0.0445484471791196,0.0202170272297637,0.461541903931931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO1A,Coronin-1A,32932,-0.0279356628618025,0.0379483501916884,-0.102314429237512,0.0464431035139067,0.461660021836257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MBL2,Mannose-binding protein C,31959,0.0320853813396349,0.0436039015755544,-0.0533782657484518,0.117549028427722,0.461852650768962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNAT1,CDK-activating kinase assembly factor MAT1,31908,0.0132668334444061,0.0180412876671492,-0.0220940903832064,0.0486277572720186,0.462143670767901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX9,Sorting nexin-9,33117,-0.0209718371370768,0.0285511718402452,-0.0769321339439574,0.0349884596698037,0.462642568226657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB2,DnaJ homolog subfamily B member 2,31907,-0.0168476132937253,0.0229389243195253,-0.061807904959995,0.0281126783725443,0.462694426897103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMSB10,Thymosin beta-10,33121,-0.0231125210140587,0.0314956147065774,-0.0848439258389504,0.038618883810833,0.463070378953507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP2,Insulin-like growth factor-binding protein 2,33190,0.019198485616699,0.0261693518971275,-0.032093444101671,0.070490415335069,0.463197122670986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA5,Plasma serine protease inhibitor,31959,-0.0102072586677248,0.0139382460110992,-0.0375262208494792,0.0171117035140296,0.463996034485932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR5,Cadherin-related family member 5,33117,0.0117416100612817,0.0160467356858993,-0.019709991883081,0.0431932120056444,0.464363359693101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC1,Sialoadhesin,33167,-0.0132064469667988,0.0180638607655185,-0.0486116140672151,0.0221987201336174,0.464739137519141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK11,Serine/threonine-protein kinase STK11,32973,-0.0220099517051459,0.0301145413715488,-0.0810344527933816,0.0370145493830898,0.464875881469369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYAR,Cell growth-regulating nucleolar protein,32951,0.0167963784669746,0.0230073738096963,-0.0282980742000302,0.0618908311339794,0.465383855584191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALY,RNA-binding protein Raly,31990,0.0152544419505586,0.0209146616122425,-0.0257382948094367,0.056247178710554,0.465800504614747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP1,Retinol-binding protein 1,31826,0.0207870121686364,0.028509989678269,-0.0350925676007708,0.0766665919380437,0.465955526499994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCS,Copper chaperone for superoxide dismutase,33042,0.0146794211979587,0.0201408089332674,-0.0247965643112455,0.0541554067071628,0.466119591894704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C4BPB,C4b-binding protein beta chain,33126,-0.0124228922102296,0.0170785885619212,-0.0458969257915952,0.021051141371136,0.467003208150501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,32951,-0.0205069442072956,0.0282010631311912,-0.0757810279444303,0.0347671395298391,0.467142347235411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRI1,Methylthioribose-1-phosphate isomerase,31826,-0.0208795901580675,0.0287703396692651,-0.0772694559098271,0.035510275593692,0.468025387338173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMB,RGM domain family member B,33191,0.00756682585858732,0.0104354997200794,-0.0128867535927684,0.028020405309943,0.468407453105102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFR,Epidermal growth factor receptor,33208,0.00480889301233667,0.00663201238531681,-0.00818985126288428,0.0178076372875576,0.46840813445877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB16,Zinc finger and BTB domain-containing protein 16,32951,0.0209271524814529,0.0288841678310286,-0.0356858164673632,0.077540121430269,0.46876659919482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,33109,-0.0185816575168551,0.0256499961399075,-0.0688556499510738,0.0316923349173635,0.468820627666467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGREF1,Cell growth regulator with EF hand domain protein 1,33117,-0.0124158509128114,0.0171786028979335,-0.0460859125927611,0.0212542107671383,0.469852436942019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLNS1A,Methylosome subunit pICln,31826,0.0102452860359674,0.0141830613286765,-0.0175535141682386,0.0380440862401734,0.470095652803797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG3,Desmoglein-3,33163,0.00989329493361166,0.0136990955395397,-0.0169569323238862,0.0367435221911095,0.470199518883275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2R,Cation-independent mannose-6-phosphate receptor,33121,-0.00684017265997812,0.00947572280848853,-0.0254125893646156,0.0117322440446594,0.470398248083946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1B,Lithostathine-1-beta,33208,-0.0165863109001801,0.0230174354328705,-0.0617004843486062,0.0285278625482461,0.471176309749662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB2,Beta-crystallin B2,32006,-0.0199085637960993,0.0276716208407792,-0.0741449406440265,0.0343278130518279,0.471881143660663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK14,Kallikrein-14,33189,-0.0136694037901456,0.019008385889041,-0.050925840132666,0.0235870325523748,0.472083193237861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",31854,-0.0107326205844397,0.0149279327394066,-0.0399913687536767,0.0185261275847973,0.472186855422336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC14A,C-type lectin domain family 14 member A,33121,0.00915147598870886,0.0127339251094064,-0.0158070172257277,0.0341099692031454,0.472364317326524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP6,Platelet glycoprotein VI,33111,-0.0261063637344169,0.036347658653538,-0.0973477746953513,0.0451350472265176,0.472628333904151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNDC1,Fibronectin type III domain-containing protein 1,32006,-0.0135111381177297,0.0188328965095762,-0.050423615276499,0.0234013390410395,0.473135806585309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,31804,-0.010495384728,0.0146307527507012,-0.0391716601193744,0.0181808906633744,0.47318035258681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UXS1,UDP-glucuronic acid decarboxylase 1,32951,0.0164347289019509,0.0229207363553608,-0.0284899143545563,0.0613593721584582,0.473378700425188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILP,Rab-interacting lysosomal protein,33161,-0.0181114677932705,0.0252697283465832,-0.0676401353525735,0.0314171997660325,0.473562485575773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRX,Cone-rod homeobox protein,32973,-0.0317418665907924,0.0442926274672098,-0.118555416426524,0.0550716832449388,0.473615924772032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4C,Semaphorin-4C,33062,-0.00808212411516151,0.0112902190747084,-0.03021095350159,0.0140467052712669,0.474102250768212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCB,Calcitonin gene-related peptide 2,32006,0.0114262938525269,0.0159624724050017,-0.0198601520612764,0.0427127397663301,0.47412320115904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,33062,-0.0279427270010486,0.0390818709318092,-0.104543194027395,0.0486577400252974,0.474641246905383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP5,Rho GTPase-activating protein 5,31793,0.0225202758597304,0.0315392027760278,-0.0392965615812841,0.0843371133007449,0.475224686296476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF3,Trefoil factor 3,33086,0.0153619126285346,0.0215243933764275,-0.0268258983892632,0.0575497236463324,0.475433345975748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX58,Antiviral innate immune response receptor RIG-I,32951,-0.0174386006868334,0.0244417354013526,-0.0653444020734844,0.0304672006998177,0.475570619879356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BB,Platelet glycoprotein Ib beta chain,31791,-0.0197497669420195,0.0276810620005557,-0.0740046484631086,0.0345051145790696,0.475574090181434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FST,Follistatin,33150,0.0154017296480341,0.0215975333710289,-0.0269294357591825,0.0577328950552507,0.475787866939375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLB1,"Phospholipase B1, membrane-associated",32006,0.017624299791414,0.0247147852164841,-0.0308166792328949,0.0660652788157229,0.475801239485626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLNL,Mesothelin-like protein,31826,0.0109036115309262,0.015293870708694,-0.019072375058114,0.0408795981199664,0.475905471702461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,31791,-0.00971591329822642,0.0136438466170049,-0.036457852667556,0.0170260260711032,0.476419585295249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN5,Contactin-5,33135,0.0108985989681363,0.0153069018835597,-0.0191029287236407,0.0409001266599133,0.476480473707788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL15A1,Collagen alpha-1(XV) chain,32044,-0.00749933765602554,0.0105330155527195,-0.0281440481393558,0.0131453728273047,0.476496613656802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPY,Pancreatic prohormone,33097,-0.0297914066092795,0.0419301560325762,-0.111974512433129,0.0523916992145698,0.477412842448296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBAC1,Ubiquitin-associated domain-containing protein 1,33062,0.0105743200168019,0.0148924289365074,-0.0186148406987526,0.0397634807323564,0.477694406883229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COCH,Cochlin,32042,-0.0136383271442886,0.0192390648331614,-0.051346894217285,0.0240702399287078,0.478416240072108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP1,Inactive pancreatic lipase-related protein 1,32006,0.0221307464242901,0.0312788222862383,-0.039175745256737,0.0834372381053171,0.479258183449746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BID,BH3-interacting domain death agonist,33109,-0.0197717302831183,0.0279611288287889,-0.0745755427875446,0.0350320822213081,0.47951412224844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLR,Low-density lipoprotein receptor,33115,-0.0151845299986484,0.0215160543142676,-0.0573559964546129,0.0269869364573161,0.480374893225992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIT1,Signaling threshold-regulating transmembrane adapter 1,32981,0.0162471008232678,0.0230261219710139,-0.0288840982399194,0.061378299886455,0.480459729288784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF3,Wiskott-Aldrich syndrome protein family member 3,32911,-0.0251840523637849,0.0357319525434586,-0.0952186793489636,0.0448505746213939,0.48095111332285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SARG,Specifically androgen-regulated gene protein,32014,-0.0316281988003857,0.0448904989084716,-0.11961357666099,0.0563571790602187,0.481103731374483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP3,Zona pellucida sperm-binding protein 3,31854,-0.0760910188583303,0.108157989557927,-0.288080678391868,0.135898640675207,0.481755545469686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD160,CD160 antigen,33208,-0.0134081537652417,0.019062067617321,-0.0507698062951909,0.0239534987647076,0.48182862766674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT2,Signal transducer and activator of transcription 2,31816,-0.0223460154064948,0.0318405094326069,-0.0847534138944043,0.0400613830814148,0.482819302548759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP1A,Charged multivesicular body protein 1a,33042,-0.0229018747310912,0.032675169887702,-0.0869452077109872,0.0411414582488047,0.483387309621387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT5,"Keratin, type II cytoskeletal 5",32911,-0.0140105279544998,0.0199938720566076,-0.0531985171854507,0.0251774612764511,0.483483873900382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACTB2,Endoribonuclease LACTB2,33117,-0.0193343074568821,0.0276078012046151,-0.0734455978179278,0.0347769829041636,0.483746012801649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,31908,-0.0208266184197075,0.0297677565825056,-0.0791714213214185,0.0375181844820036,0.484175971256954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA4,Annexin A4,33066,-0.0212034386901801,0.0303206346853642,-0.0806318826734941,0.0382250052931338,0.484378939033332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RETN,Resistin,33088,0.0118363923617274,0.0169277398847806,-0.0213419778124427,0.0450147625358974,0.484426811552627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MENT,Protein MENT,31907,-0.00623519677553878,0.00892128395739035,-0.0237209133320239,0.0112505197809463,0.484628525011517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC1,"Myosin-binding protein C, slow-type",32042,-0.0184641238178709,0.0264237749383258,-0.0702547226969895,0.0333264750612478,0.484717601226789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS6,Growth arrest-specific protein 6,33150,-0.00728866880524657,0.0104548910757157,-0.0277802553136493,0.0132029177031561,0.485725074963944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS28,Vacuolar protein sorting-associated protein 28 homolog,31908,-0.0191330164328697,0.0274735185357665,-0.072981112762972,0.0347150798972326,0.486189632264271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GALT1,"Beta-1,4-galactosyltransferase 1",33167,0.0077669143820677,0.0111562757667564,-0.0140993861207749,0.0296332148849103,0.48632691364762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGBL1,Integrin beta-like protein 1,32044,-0.0100357439460236,0.0144319340626738,-0.0383223347088643,0.018250846816817,0.486835624797297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX6,Syntaxin-6,32951,0.0201075357258828,0.0289175787520786,-0.0365709186281912,0.0767859900799568,0.486861555015375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELPLG,P-selectin glycoprotein ligand 1,33109,-0.00790738490224829,0.0114264082405299,-0.0303031450536869,0.0144883752491903,0.488938829401429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT2,Linker for activation of T-cells family member 2,33062,-0.0350898074560077,0.0507399797263327,-0.13454016771962,0.0643605528076043,0.489231504774906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK1,Adenylate kinase isoenzyme 1,33117,-0.0184044879308743,0.0266358375172464,-0.0706107294646772,0.0338017536029285,0.489604713684806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI2,Tissue factor pathway inhibitor 2,33104,-0.0104975530604668,0.0152092737092179,-0.0403077295305338,0.0193126234096003,0.490082292259817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL12,Stromal cell-derived factor 1,32981,-0.0117989894311496,0.0171045004215356,-0.0453238102573594,0.0217258313950602,0.490327520171547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS1,Galectin-1,33117,-0.00960159485370812,0.0139230113407813,-0.0368906970816395,0.0176875073742232,0.49045130288424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC80,Coiled-coil domain-containing protein 80,33117,-0.00979280756045018,0.0142088190589628,-0.0376420929160173,0.0180564777951169,0.490711909400261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A11,Protein S100-A11,33033,-0.0138160792858169,0.0200724886855498,-0.0531581571094946,0.0255259985378607,0.491276675464636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTPN,Myotrophin,32973,-0.00931569299857872,0.0135344222854939,-0.0358431606781469,0.0172117746809894,0.491284938408907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM1,Isthmin-1,33109,-0.010910099186199,0.0158509513356152,-0.0419779638040048,0.0201577654316068,0.491286718281745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOC,Myocilin,33121,0.0128440788915394,0.0186720968630889,-0.0237532309601148,0.0494413887431936,0.491549559151455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC4,MANSC domain-containing protein 4,31791,-0.0184342503164972,0.0268546454408411,-0.0710693553805458,0.0342008547475515,0.492453911939936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG16L1,Autophagy-related protein 16-1,31998,-0.0240441446634376,0.0350909621163757,-0.0928224304115339,0.0447341410846587,0.493242053417994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3,Galectin-3,33124,0.00832574953930283,0.0121526739261746,-0.0154934913559994,0.0321449904346051,0.493301590598216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHP1,Calcineurin B homologous protein 1,31804,0.0208276653236394,0.0304126036309636,-0.0387810377930494,0.0804363684403281,0.49346859967345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD3,Mothers against decapentaplegic homolog 3,31990,-0.0143622860764822,0.0209868221827508,-0.0554964575546737,0.0267718854017094,0.493776593825107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",31907,-0.0292151817381628,0.0427220080355477,-0.112950317487836,0.0545199540115106,0.494095038793404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIB,Peptidyl-prolyl cis-trans isomerase B,33101,-0.0267199093191182,0.03908007528615,-0.103316856879972,0.0498770382417359,0.49416901148797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF2,TNF receptor-associated factor 2,33109,0.0201496985363903,0.0295127089854659,-0.0376952110751228,0.0779946081479034,0.494785315190429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FIS1,Mitochondrial fission 1 protein,33124,-0.022098392258163,0.0323670146381106,-0.0855377409488598,0.0413409564325338,0.494786717721129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHK,Ketohexokinase,31854,-0.0183515056800952,0.0268850327879553,-0.0710461699444876,0.0343431585842971,0.494886113125446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC6,Putative tyrosine-protein phosphatase auxilin,31854,-0.0238666143925435,0.0349710296053634,-0.0924098324190559,0.0446766036339688,0.494964322699945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF10,Rho guanine nucleotide exchange factor 10,32020,-0.0260499312103744,0.0381972428635066,-0.100916527222847,0.0488166648020986,0.495269562376473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",33062,-0.00977759869857855,0.0143510997051953,-0.0379057541207613,0.0183505567236042,0.495691434476969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNH2,Potassium voltage-gated channel subfamily H member 2,31826,-0.0224902550627809,0.0330243112161373,-0.0872179050464099,0.0422373949208482,0.495879479385604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNU13,NHP2-like protein 1,31791,-0.0188499140906105,0.0277032783884053,-0.0731483397318849,0.0354485115506639,0.49625889600244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALCAM,CD166 antigen,33208,-0.00537134117747183,0.00790340017662595,-0.0208620055236587,0.010119323168715,0.496760476196716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR4,Complement factor H-related protein 4,32058,-0.0205428824970894,0.0302561323941223,-0.0798449019895691,0.0387591369953903,0.497180120329387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPCAL1,Hippocalcin-like protein 1,33208,-0.020758161363797,0.0306904058119051,-0.080911356755131,0.0393950340275369,0.498821730714899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POSTN,Periostin,32044,-0.010653474881881,0.0157691031559536,-0.0415609170675501,0.020253967303788,0.499320502468502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP2,Contactin-associated protein-like 2,33109,0.0112556721173459,0.0166780950933772,-0.0214333942656734,0.0439447385003652,0.499771581664301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD2,Bromodomain-containing protein 2,31804,-0.00972411296004893,0.0144554737526803,-0.0380568415153023,0.0186086155952045,0.501163017197256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPGDS,Hematopoietic prostaglandin D synthase,32951,0.0103118518748779,0.0153376082008875,-0.0197498601988617,0.0403735639486175,0.501395325078432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,33117,-0.0182931209523849,0.0272402129105348,-0.0716839382570331,0.0350976963522633,0.501889150025702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAX1BP1,Tax1-binding protein 1,32006,-0.0178377965621507,0.0265847303016286,-0.0699438679533427,0.0342682748290414,0.502254403181892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIP2A,FHF complex subunit HOOK interacting protein 2A,31791,0.0133445642836932,0.0198893436765491,-0.025638549322343,0.0523276778897295,0.502279610194127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD6B,Deubiquitinase OTUD6B,31998,-0.0164755377186402,0.0245851523255135,-0.0646624362766467,0.0317113608393663,0.502787920675293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,31907,0.0186478441963001,0.0278279326273773,-0.0358949037533594,0.0731905921459596,0.502806862925546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRING1,SREBP regulating gene protein,31793,0.0165151936952468,0.0246589749065146,-0.0318163971215219,0.0648467845120154,0.503042237980397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,31854,-0.00553163514420522,0.00826246397691016,-0.0217260645389491,0.0106627942505387,0.50320398328495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",33161,-0.0208231214803637,0.0311125078076808,-0.0818036367834181,0.0401573938226907,0.503331707947598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC1,Stanniocalcin-1,33191,-0.0113081491651048,0.0169172706486474,-0.0444659996364538,0.0218497013062442,0.503871602096081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC7A,C-type lectin domain family 7 member A,33208,-0.0160355929059013,0.0239944690352101,-0.063064752214913,0.0309935664031104,0.503957355697261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,33175,0.00801853266703461,0.0119989274358408,-0.0154993651072134,0.0315364304412826,0.503978439801895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDH1,"Malate dehydrogenase, cytoplasmic",32004,-0.0113588862555856,0.017010875834115,-0.0447002028904509,0.0219824303792798,0.504318324338046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLG,Plasminogen,31874,-0.00622667626609858,0.00932782498138793,-0.0245092132296189,0.0120558606974218,0.504449393456439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS7_LGALS7B,Galectin-7,33093,0.0109166572917651,0.0163717965171648,-0.021172063881878,0.0430053784654082,0.50491990583989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC34A3,Sodium-dependent phosphate transport protein 2C,31793,0.0135532205042274,0.0203260982392137,-0.0262859320446315,0.0533923730530862,0.504927819825228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCA,Calcitonin,33030,-0.0156471126328153,0.0234709058244556,-0.0616500880487484,0.0303558627831177,0.505007303680674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELN,Elastin,32042,-0.0095572329632421,0.0143533070200402,-0.0376897147225208,0.0185752487960366,0.505523499363774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZU1,Azurocidin,32867,-0.0218506567874436,0.0328218842501684,-0.0861815499177736,0.0424802363428865,0.505599141427645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB1,Interleukin-12 receptor subunit beta-1,32981,-0.0103685325654703,0.0155775799477055,-0.040900589262973,0.0201635241320324,0.505680892468756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST6,Cystatin-M,32870,-0.0127954725875748,0.0192814693596359,-0.0505871525324611,0.0249962073573115,0.506954917497825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,31854,0.00980425639154672,0.0147810427519349,-0.0191665874022456,0.0387751001853391,0.507159493910014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHMT1,"Serine hydroxymethyltransferase, cytosolic",33150,-0.0240324275185094,0.0362655880962021,-0.0951129801870656,0.0470481251500467,0.50755400613715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D2,DCN1-like protein 2,31793,0.0229117885890088,0.0345927005419899,-0.0448899044732913,0.090713481651309,0.507780449346407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH9,Protocadherin-9,31998,-0.00928701993901099,0.0140320669485787,-0.0367898711582252,0.0182158312802032,0.508092298915775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYM,Ketimine reductase mu-crystallin,31804,0.0211601506944136,0.0320075268926349,-0.0415746020151509,0.083894903403978,0.508569408500768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBN1,Drebrin,31816,0.0143506956101258,0.0217315187395159,-0.0282430811193254,0.056944472339577,0.509041426268035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDDC2,5'-deoxynucleotidase HDDC2,31998,0.0120583475809494,0.0182745848956578,-0.02375983881454,0.0478765339764388,0.50937505196985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAP3,Cytosol aminopeptidase,32981,0.0133117205227662,0.0202295025511258,-0.0263381044774405,0.0529615455229728,0.510533407354056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEB,Nebulin,31791,-0.0102815679914342,0.0156257219940408,-0.0409079830997542,0.0203448471168858,0.510565228839406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCS1,Neuronal calcium sensor 1,33189,-0.00767796075262635,0.0117136759811356,-0.0306367656756521,0.0152808441703994,0.512182587812634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSR,"Glutathione reductase, mitochondrial",32007,-0.00591480185768008,0.00902467395881502,-0.0236031628169575,0.0117735591015974,0.512228028660838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS5,Transmembrane protease serine 5,32995,0.010327336971523,0.0157577014672613,-0.0205577579043091,0.041212431847355,0.512238542626059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD84,SLAM family member 5,33109,-0.0083711136421626,0.0127792112900592,-0.0334183677706786,0.0166761404863534,0.512448368256754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3RA,Interleukin-3 receptor subunit alpha,32981,0.00876894864135287,0.0133966527147358,-0.0174884906795294,0.0350263879622351,0.512767021763017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRPV3,Transient receptor potential cation channel subfamily V member 3,31791,0.0131981136107907,0.0201702451916811,-0.0263355669649043,0.0527317941864856,0.512915987186103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,32042,-0.0244901799924944,0.0374382906990717,-0.097869229762675,0.0488888697776862,0.513036330048787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",32951,0.0141440931312519,0.0216614563704768,-0.0283123613548825,0.0566005476173864,0.513798877457554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",31990,-0.010065493541422,0.0154314216185326,-0.0403110799137458,0.0201800928309019,0.514245219787408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIF,Macrophage migration inhibitory factor,33107,-0.0185990308835611,0.0285247994790518,-0.0745076378625027,0.0373095760953804,0.51439900106271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN3,Centrin-3,31998,-0.0209773946106449,0.0321868628538857,-0.0840636458042609,0.0421088565829712,0.514590193415701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIT,Bis(5'-adenosyl)-triphosphatase,32911,-0.0201166618522963,0.0308705777255251,-0.0806229941943255,0.0403896704897329,0.514647825970699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM1,U6 snRNA-associated Sm-like protein LSm1,32951,-0.0154415853870021,0.0237239990803966,-0.0619406235845794,0.0310574528105753,0.515138586517393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNMBP,Dynamin-binding protein,33042,-0.016691459754204,0.0256515926992055,-0.0669685814446468,0.0335856619362388,0.51525836280315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZFYVE19,Abscission/NoCut checkpoint regulator,31998,-0.0244012733784004,0.0375113100653134,-0.0979234411064146,0.0491208943496138,0.515386245753942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCB,Tubulin-folding cofactor B,33042,-0.0272075476237326,0.0418306965796696,-0.109195712919885,0.0547806176724197,0.51543795632885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,33109,-0.0224939892876083,0.0346388572531389,-0.0903861495037605,0.0453981709285439,0.516106132967669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN10,Ataxin-10,32911,-0.0193214360793015,0.0298007045525874,-0.0777308170023728,0.0390879448437698,0.516772961240872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART5,Ecto-ADP-ribosyltransferase 5,31804,0.0171903445626295,0.0265454942663288,-0.0348388241993749,0.069219513324634,0.517276530459597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,33062,-0.0123390914532272,0.0190661875386643,-0.0497088190290092,0.0250306361225548,0.517538266494921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGF,Pro-epidermal growth factor,33107,-0.0273900377524982,0.0424411594424715,-0.110574710259742,0.0557946347547459,0.518707803544712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN2,Neutrophil gelatinase-associated lipocalin,32863,0.010119134474873,0.0156857680007855,-0.0206249708066665,0.0408632397564125,0.51886983616255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2A,Sodium channel protein type 2 subunit alpha,31804,0.0132739082517354,0.0205806536600633,-0.0270641729219887,0.0536119894254595,0.518966624057205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR5,Proline-rich protein 5,31816,-0.0125955825888122,0.0195346990328622,-0.0508835926932221,0.0256924275155977,0.519089871272123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,31907,-0.0160520303740038,0.0249267048209052,-0.064908371822978,0.0328043110749705,0.519615211876932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPA,Apolipoprotein(a),31877,0.0471615740981738,0.073367898853653,-0.0966395076549861,0.190962655851334,0.5203676400911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFGE8,Lactadherin,33121,-0.0112482518299057,0.0175021028683079,-0.0455523734517893,0.0230558697919778,0.520448744356897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXL,Tyrosine-protein kinase receptor UFO,33138,0.00729232352119398,0.0113552697329026,-0.014964005155295,0.029548652197683,0.520762036639782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,31990,-0.0251285187834351,0.0391485542837614,-0.101859685179608,0.0516026476127373,0.520973193904456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,33041,-0.00663194029644268,0.0103456852437051,-0.0269094833741047,0.0136456027812193,0.521517426369093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRC1,Macrophage mannose receptor 1,32048,-0.0074783221435518,0.0116916568841241,-0.0303939696364351,0.0154373253493315,0.522433150347305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMIP,C-Maf-inducing protein,31990,-0.0218303608786481,0.0341687192197678,-0.0888010505493931,0.0451403287920968,0.522908044147184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA2,Carbonic anhydrase 2,33097,-0.0190359817027869,0.02981648310488,-0.0774762885883517,0.0394043251827779,0.52320538530484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTF,Ciliary neurotrophic factor,31804,-0.00892003392397102,0.0139747693922812,-0.0363105819328422,0.0184705140849002,0.523301151614422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEFTY2,Left-right determination factor 2,33176,-0.0137608573700457,0.021573693273892,-0.0560452961868739,0.0285235814467826,0.523585741977905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF2,Cyclic AMP-dependent transcription factor ATF-2,32911,-0.0183343698091441,0.0287816030993029,-0.0747463118837777,0.0380775722654895,0.524131023923986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT1,Vascular endothelial growth factor receptor 1,33045,0.00588209677283552,0.00923599464437615,-0.0122204527301417,0.0239846462758128,0.524228686720481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,33117,-0.00609785405566755,0.0095848108861564,-0.0248840833925341,0.012688375281199,0.524663055693657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA4,Apolipoprotein A-IV,32071,0.00969257480801034,0.0152420016433788,-0.0201817484130122,0.0395668980290329,0.524852750442439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFRC,Transferrin receptor protein 1,33139,-0.0103997363340219,0.0163542115810941,-0.0424539910329663,0.0216545183649226,0.524854640509141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD48,CD48 antigen,33150,-0.00777673387886054,0.0122437165344848,-0.0317744182864508,0.0162209505287297,0.525339983413664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP29,Dual specificity phosphatase 29,31826,-0.0179405048032529,0.028250948875904,-0.0733123646000248,0.037431354993519,0.525421517552277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO3,Forkhead box protein O3,32951,0.0257482475351939,0.0405475744420585,-0.0537249983712408,0.105221493441629,0.52543685966516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP44,Endoplasmic reticulum resident protein 44,33044,-0.00672173416532609,0.0105890849923919,-0.0274763407504143,0.0140328724197621,0.525589131895947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D23,TBC1 domain family member 23,33062,-0.0236542250175421,0.0372687338809619,-0.0967009434242275,0.0493924933891433,0.525645165191478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,31793,0.0147924358504084,0.0233249313138804,-0.0309244295247971,0.0605093012256139,0.525976659263211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK12,Kallikrein-12,32951,-0.037558520326483,0.0592250795198213,-0.153639676185333,0.0785226355323668,0.525989687811481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCPKMT,Protein-lysine methyltransferase METTL21D,31793,0.0233212933315623,0.0368052116656046,-0.0488169215330226,0.0954595081961473,0.526334838955008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18RAP,Interleukin-18 receptor accessory protein,32987,-0.046087025095997,0.0727698418363535,-0.18871591509525,0.0965418649032559,0.526537816919455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,31908,0.0163879850470471,0.0258795987676235,-0.034336028537495,0.0671119986315892,0.526596654917582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO1,Alpha-enolase,33095,-0.0207668938528583,0.0328040749582048,-0.0850628807709396,0.043529093065223,0.526712282885928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK2,Serine protease inhibitor Kazal-type 2,31907,-0.00997318496277373,0.015754991061394,-0.040852967443106,0.0209065975175586,0.526741635451835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRA,Platelet-derived growth factor receptor alpha,33117,0.00754147424923938,0.0119243762895053,-0.015830303278191,0.0309132517766698,0.527114901459355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD302,CD302 antigen,33062,-0.00781165659211978,0.0123912775321671,-0.0320985605551674,0.0164752473709278,0.528439335995673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FH,"Fumarate hydratase, mitochondrial",31804,-0.0225169406355664,0.0357290390374529,-0.0925458571489741,0.0475119758778412,0.528574166761123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSP1,Lymphocyte-specific protein 1,33109,-0.0105507031291517,0.0167466227410496,-0.043374083701609,0.0222726774433056,0.528698288347746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3E,T-cell surface glycoprotein CD3 epsilon chain,31908,-0.00927899033867858,0.0147491425942344,-0.0381873098233781,0.0196293291460209,0.529289339162399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",32006,-0.0253727761928025,0.0403587228214505,-0.104475872922845,0.0537303205372405,0.529576701229748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA1,Ephrin-A1,33109,0.00694859632404686,0.0110563429648902,-0.0147218358871379,0.0286190285352316,0.529711698470222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPHA2,Glycoprotein hormone alpha-2,31998,-0.0131834290044354,0.0209928977720632,-0.0543295086376792,0.0279626506288084,0.530026401712764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL5,C-X-C motif chemokine 5,33088,-0.0300554408919867,0.047873571166651,-0.123887640378623,0.0637767585946493,0.53014591515436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",33062,-0.00907535748542519,0.0144593539090011,-0.0374156911470673,0.0192649761762169,0.530252429000716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP1,Insulin-like growth factor-binding protein 1,33191,0.0303822843744309,0.0484529598505572,-0.0645855169326613,0.125350085681523,0.53064479102064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT2,RAC-beta serine/threonine-protein kinase,32020,-0.0325032356547771,0.0518446975238549,-0.134118842801533,0.0691123714919785,0.530721005347302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT2,Thialysine N-epsilon-acetyltransferase,31908,-0.0178609715195292,0.0286074569483856,-0.073931587138365,0.0382096440993065,0.532419019527419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,32042,-0.0104735067627724,0.0167885288196693,-0.0433790232493242,0.0224320097237794,0.532745510359128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL1A1,Collagen alpha-1(I) chain,33208,-0.00669899150608546,0.0107497701205437,-0.027768540942351,0.0143705579301801,0.533185544728388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA4,Carboxypeptidase A4,31764,0.0111397009476819,0.0178800357973876,-0.0239051692151979,0.0461845711105617,0.533287831275579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED8,Protein TMED8,31998,-0.0262219417685768,0.0422997100080794,-0.109129373384412,0.0566854898472588,0.535336872055713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXN,Thioredoxin,31914,-0.0113649362338446,0.0183415487852575,-0.0473143718529494,0.0245844993852602,0.53552168110071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGA4,Pepsin A-4,32048,0.0172492740501711,0.0278469976754861,-0.0373308413937817,0.0718293894941238,0.535651505147932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,32836,0.0166798523078997,0.026945394083869,-0.0361331200964835,0.0694928247122829,0.535917204076826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGR,Tyrosine-protein kinase Fgr,32911,-0.0149555577116793,0.0241836886050035,-0.0623555873774861,0.0324444719541276,0.536318410848719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYGD,Gamma-crystallin D,32006,-0.0245061775071528,0.0397568070752808,-0.102429519374703,0.0534171643603977,0.537647773063022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADD1,Alpha-adducin,31907,-0.017972655161711,0.029209657313924,-0.075223583497002,0.0392782731735799,0.538376461278373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINH1,Serpin H1,31908,-0.032987632093168,0.0536232685526539,-0.13808923845637,0.0721139742700337,0.538458695857146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVPL,Envoplakin,31908,-0.00834746280958722,0.0135773832288417,-0.0349591339381169,0.0182642083189425,0.538701309453004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP3,Syntaxin-binding protein 3,32951,0.0111762525163751,0.0181890360470966,-0.0244742581359343,0.0468267631686844,0.53893447672259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITM2A,Integral membrane protein 2A,33109,-0.0149460223829659,0.0243679740600772,-0.0627072515407172,0.0328152067747853,0.539663074383989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMPD3,AMP deaminase 3,32006,0.0187455189481294,0.0305788860426939,-0.0411890976955506,0.0786801355918094,0.539880484704658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF16,Fibroblast growth factor 16,31816,-0.0124524769324802,0.0203200178665925,-0.0522797119510015,0.0273747580860411,0.540015474211618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK8,Serine protease inhibitor Kazal-type 8,31791,-0.00855567388221578,0.013963037025561,-0.0359232264523153,0.0188118786878837,0.540069027489597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNLR1,Interferon lambda receptor 1,33109,0.00954435595578262,0.0156342109288037,-0.0210986974646726,0.0401874093762378,0.541560639447316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH1B,All-trans-retinol dehydrogenase,31907,-0.0186203954515778,0.0305491882312034,-0.0784968043847364,0.0412560134815808,0.542197219127825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEP,Leptin,33117,-0.0159079743860062,0.0261271699455833,-0.0671172274793495,0.0353012787073371,0.542628489660652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFAT5,Nuclear factor of activated T-cells 5,31816,0.0222051858197623,0.0364923731768855,-0.0493198656069333,0.0937302372464578,0.542882363899635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,31791,-0.00522544328054872,0.0085938064256575,-0.0220693038748374,0.01161841731374,0.543174726977251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDHD2,Phospholipase DDHD2,32020,-0.0164968157302533,0.0271347220053062,-0.0696808708606536,0.0366872394001469,0.543232487913127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD1,26S proteasome non-ATPase regulatory subunit 1,32020,-0.0124108421242276,0.0204173676452615,-0.0524288827089401,0.027607198460485,0.543300486429896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,32973,-0.00661324308667604,0.0109028899240595,-0.0279829073378327,0.0147564211644807,0.544159953614901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",32020,-0.0174680026540776,0.0288174573608738,-0.0739502190813902,0.0390142137732349,0.544426399031584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG4,Chondroitin sulfate proteoglycan 4,32044,-0.00820709850710478,0.0135591512526437,-0.0347830349622864,0.0183688379480769,0.545010303495052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROC,Vitamin K-dependent protein C,33127,-0.0062510012840797,0.0103308636227876,-0.0264994939847435,0.0139974914165841,0.545141520134775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YTHDF3,YTH domain-containing family protein 3,32981,-0.0211038262534962,0.0349136662459327,-0.0895346120955242,0.0473269595885318,0.545555617788354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTN,Titin,31791,-0.0169886719413516,0.0281092121031686,-0.0720827276635621,0.0381053837808589,0.545609089890145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,31896,-0.0115667133912683,0.0191382263438435,-0.0490776370252015,0.025944210242665,0.545611110641085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1R,Complement C1r subcomponent,32071,-0.00499335410674441,0.00826932854665098,-0.0212012380581803,0.0112145298446915,0.545967778571665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN3,Ataxin-3,32006,-0.0158319403409451,0.0262523961595284,-0.0672866368136208,0.0356227561317306,0.546482564479141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAM,Integrin alpha-M,33121,-0.00778814812656688,0.0129505852763869,-0.0331712952682852,0.0175949990151514,0.547606489719791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCA,Alpha-synuclein,31907,-0.0284136728740679,0.0472588505377181,-0.121041019927995,0.0642136741798596,0.547701786136791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLI1,Friend leukemia integration 1 transcription factor,32951,-0.0272442023712229,0.0453404665703898,-0.116111516849187,0.0616231121067411,0.54793560364918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP2,Cysteine-rich secretory protein 2,33189,-0.0151192101173913,0.0251819745966892,-0.064475880326902,0.0342374600921195,0.548256515451262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GL3,Endophilin-A3,31868,-0.0208198354780816,0.0347575209293816,-0.0889445764996695,0.0473049055435062,0.549189637925996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRN1,Secernin-1,33109,0.0138803670483967,0.0231908651562022,-0.0315737286577596,0.059334462754553,0.549503775138359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,31816,0.0113845589335908,0.0190611840814822,-0.0259753618661144,0.048744479733296,0.550349503144566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP15,Matrix metalloproteinase-15,32042,-0.0123051855865023,0.0206203598266787,-0.0527210908467926,0.028110719673788,0.550692561331612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3L,Microfibrillar-associated protein 3-like,31826,-0.0167081829827547,0.0280071366267013,-0.0716021707710892,0.0381858048055798,0.550813642120018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7,Interleukin-7,33109,-0.0159476017898642,0.0267416002318024,-0.0683611382441968,0.0364659346644684,0.550950821923253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,33042,-0.0182978110354407,0.0307018576047163,-0.0784734519406848,0.0418778298698033,0.551201724493171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNT,Aryl hydrocarbon receptor nuclear translocator,32981,0.00916106119535391,0.015374384820506,-0.0209727330528379,0.0392948554435458,0.551281081110715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCG22,Protein PBMUCL2,31791,0.013745989049161,0.0230840717193998,-0.0314987915208627,0.0589907696191846,0.551544325020632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHD,SH2 domain-containing adapter protein D,31773,0.0211432276252328,0.0355496786300112,-0.0485341424895891,0.0908205977400547,0.552027916625681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",31908,-0.0181686595295628,0.0305612069388985,-0.0780686251298039,0.0417313060706782,0.552195299603612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC37,Hsp90 co-chaperone Cdc37,33126,-0.020686737488006,0.0348677946378498,-0.0890276149781916,0.0476541400021795,0.553002105874399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",32951,-0.0201819882053506,0.0340464131805455,-0.0869129580392198,0.0465489816285187,0.553345042472651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RWDD1,RWD domain-containing protein 1,33191,-0.0157988129513187,0.0266541638907205,-0.0680409741771308,0.0364433482744934,0.553374928080737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,32044,-0.00953707375774358,0.0160917732453164,-0.0410769493185637,0.0220028018030766,0.553421233652424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5,T-cell surface glycoprotein CD5,33174,-0.00809498892808513,0.013664082275789,-0.0348765901886317,0.0186866123324614,0.553579183170486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,33152,-0.0155986332903536,0.0263415901384313,-0.067228149961679,0.0360308833809717,0.553753826082355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,31990,-0.0156758304624415,0.0265015642456996,-0.0676188963840126,0.0362672354591297,0.554199269680905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPPED1,Serine/threonine-protein phosphatase CPPED1,33191,-0.0162896897858402,0.0276392219340835,-0.0704625647766438,0.0378831852049634,0.555629264839319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,32951,0.0311303995442667,0.0529371189775605,-0.0726263536517519,0.134887152740285,0.556505143258193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,33042,-0.0132734640745859,0.022579569239632,-0.0575294197842646,0.0309824916350927,0.55664652128715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG5,Chondroitin sulfate proteoglycan 5,31804,-0.0117445399639274,0.0199851732300618,-0.0509154794948486,0.0274263995669938,0.556776795038435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT19,"Keratin, type I cytoskeletal 19",33097,-0.0160993631161852,0.0274027799554371,-0.0698088118288419,0.0376100855964715,0.556877661946911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2,Granulocyte-macrophage colony-stimulating factor,31791,-0.00860106427275814,0.0146401247830773,-0.0372957088475896,0.0200935803020734,0.556886439311135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1RL,Complement C1r subcomponent-like protein,32062,-0.00469435968307848,0.00801181495858348,-0.0203975170019021,0.0110087976357451,0.557940188839368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,31804,0.0136987225948321,0.0233824388175799,-0.0321308574876245,0.0595283026772886,0.557990831055465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRB1,Chymotrypsinogen B,33121,0.0131596287494614,0.0224733793824372,-0.0308881948401156,0.0572074523390384,0.558182986808237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL24,C-C motif chemokine 24,33150,-0.0202184884755292,0.0345601489778944,-0.0879563804722023,0.0475194035211438,0.558547301810836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAN,Aggrecan core protein,33040,0.00679566918059626,0.0116194783725369,-0.015978508429576,0.0295698467907686,0.558662946931298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3A,Uroplakin-3a,31804,0.0121043711460556,0.0206990076633885,-0.0284656838741858,0.052674426166297,0.558713422043797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP2B4,Plasma membrane calcium-transporting ATPase 4,31791,-0.0154943934871645,0.02653242475595,-0.0674979460088265,0.0365091590344976,0.559252018255322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH3,Neurogenic locus notch homolog protein 3,33208,-0.00825573523450406,0.0141392754968806,-0.0359687152083901,0.019457244739382,0.559311567141504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN2,Prefoldin subunit 2,32911,0.0133339196062095,0.0228542993770717,-0.0314605071728511,0.0581283463852701,0.559618369883735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF1R,Insulin-like growth factor 1 receptor,33062,-0.00501108093012068,0.00862507843280929,-0.0219162346584269,0.0118940727981855,0.561262665219243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLPBP,Pyridoxal phosphate homeostasis protein,33117,-0.0165464907197182,0.0284996517269249,-0.072405808104491,0.0393128266650546,0.561534799543647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS2,Podocin,31816,-0.0254045376014242,0.0439380484388753,-0.11152311254162,0.0607140373387715,0.563153570032548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB2,Calretinin,32911,0.00724487296173769,0.0125322874634096,-0.017318410466545,0.0318081563900204,0.563214280961482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC11A,C-type lectin domain family 11 member A,33109,-0.0115333251952316,0.019974394467633,-0.0506831383517923,0.0276164879613292,0.563680576447299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRN,"Attractin, Isoform 2",32071,-0.00393903261855445,0.00682260407845727,-0.0173113366123307,0.00943327137522179,0.56371988982165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA7,Thyroxine-binding globulin,32071,0.00454296309703983,0.0078802774056471,-0.0109023806180285,0.0199883068121081,0.564295742988906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,33124,0.00723273115483011,0.0125609793301028,-0.0173867883321714,0.0318522506418316,0.564758896990624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRAS,GTPase Hras,31897,-0.0235412296591578,0.0408915348557544,-0.103688637976436,0.0566061786581208,0.564835821078713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIM1,Cysteine-rich motor neuron 1 protein,33167,0.00479239011281087,0.00832998218853614,-0.01153437497672,0.0211191552023417,0.565090987819691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR2,Hepatitis A virus cellular receptor 2,33121,-0.00806678568020371,0.014035359287837,-0.0355760898843642,0.0194425185239568,0.565477087688954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",32973,0.0213043565231925,0.0370716446184579,-0.051356066928985,0.0939647799753701,0.565522473428242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLN,Mesothelin,33051,-0.0127266363252375,0.0221712497273724,-0.0561822857908875,0.0307290131404125,0.565972468706274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDA,Cytidine deaminase,32028,0.0112666183653114,0.0196704449525435,-0.0272874537416739,0.0498206904722966,0.566818202726275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRSK2,Serine/threonine-protein kinase BRSK2,32020,-0.0093415388704139,0.0163278300445728,-0.0413440857577766,0.0226610080169488,0.567255153582707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILPL2,RILP-like protein 2,32042,-0.0228900259351799,0.0400582139653275,-0.101404125307222,0.0556240734368621,0.567732549333311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,31998,-0.00723699417780986,0.0127042567315387,-0.0321373373716256,0.0176633490160059,0.568931300619915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCARE,Photoreceptor cilium actin regulator,31804,0.0209531843219533,0.0367948723550308,-0.0511647654939071,0.0930711341378136,0.569061843189104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",32020,-0.0176733121118814,0.0310438318041915,-0.0785192224480967,0.043172598224334,0.56916818026799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1A,Lithostathine-1-alpha,33061,-0.0114249924594366,0.0200698521923079,-0.0507619027563601,0.0279119178374869,0.569193599189946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTR,Methionine synthase,31791,0.0150352568121754,0.0264660802312409,-0.0368382604410567,0.0669087740654076,0.569987612597136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD1,Superoxide dismutase [Cu-Zn],32911,-0.0117464860103742,0.0206848842122338,-0.0522888590663525,0.0287958870456041,0.570133036570871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,33126,-0.00782097028990279,0.0137886058231987,-0.0348466377033722,0.0192046971235666,0.570589386393307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GYS1,"Glycogen [starch] synthase, muscle",32973,-0.0216231565369819,0.0381484995945605,-0.0963942157423206,0.0531479026683568,0.570854545606333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLEKHO1,Pleckstrin homology domain-containing family O member 1,32006,-0.0161417564290593,0.0285408690468477,-0.0720818597608808,0.0397983469027623,0.571705374992516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,31907,-0.00666123977091928,0.0118481834360424,-0.0298836793055625,0.0165611997637239,0.573985680196468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANF,Mesencephalic astrocyte-derived neurotrophic factor,33167,-0.0277054677085927,0.0493172411123786,-0.124367260288855,0.0689563248716693,0.574279979940614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH1,Neurogenic locus notch homolog protein 1,33208,-0.00360352263302358,0.00641640626166486,-0.0161796789058867,0.00897263363983954,0.574395638951497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA2,Annexin A2,31753,-0.0170350349938707,0.0304059088861763,-0.0766306164107763,0.0425605464230348,0.575323323148174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STIP1,Stress-induced-phosphoprotein 1,33107,-0.0153957721965956,0.027483629962821,-0.0692636869237247,0.0384721425305336,0.575371355316837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR3,Folate receptor gamma,33101,-0.0424555177851656,0.0758068578724146,-0.191036959215098,0.106125923644767,0.575460854537001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MESD,LRP chaperone MESD,33121,-0.0280641241733367,0.0501952357890743,-0.126446786319922,0.0703185379732489,0.576108354469575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRG,Histidine-rich glycoprotein,32025,0.00723978266721727,0.0129583599067276,-0.0181586027499687,0.0326381680844033,0.576385790601637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK4,Serine protease inhibitor Kazal-type 4,33109,0.0148986902974763,0.0266717474914559,-0.0373779347857773,0.0671753153807298,0.576452971422262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFP,Properdin,32071,-0.00538025837472526,0.00963375972505458,-0.0242624274358322,0.0135019106863817,0.576533335732044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAMR1,Inactive serine protease PAMR1,33121,-0.00645375256258239,0.0115767315889844,-0.0291441464769919,0.0162366413518271,0.577216495962587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HARS1,"Histidine--tRNA ligase, cytoplasmic",33121,-0.0178125724321829,0.0319913230149135,-0.0805155655414133,0.0448904206770474,0.577682648312192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WNT9A,Protein Wnt-9a,32981,0.00643187021854159,0.0115543492528736,-0.0162146543170906,0.0290783947541737,0.577772808983525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC42BPB,Serine/threonine-protein kinase MRCK beta,31998,-0.0235918871453956,0.0424055830164399,-0.106706829857618,0.0595230555668266,0.577995506641247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,31998,0.0110046422627268,0.019797148240271,-0.0277977682882044,0.0498070528136579,0.578316157632459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRV1,Acrosomal protein SP-10,31816,0.00811652280611156,0.0146130189543802,-0.0205249943444736,0.0367580399566967,0.578616809068108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS10,Regulator of G-protein signaling 10,32020,-0.0137592489374229,0.02478028228236,-0.0623286022108485,0.0348101043360027,0.57874016184801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC1,SPARC-related modular calcium-binding protein 1,33189,-0.00760469628300066,0.01370074798688,-0.0344581623372855,0.0192487697712842,0.57886987261085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,31791,-0.0115439084279648,0.0208570161819102,-0.0524236601445087,0.0293358432885792,0.579952711880298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,31908,0.00881375305483023,0.0159398127011773,-0.0224282798394774,0.0400557859491378,0.580321373055297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,31793,-0.0137551985294845,0.0248910291215559,-0.062541615607734,0.035031218548765,0.580542725177654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,31804,-0.0135532841588636,0.0245581705341338,-0.0616872984057658,0.0345807300880387,0.581043970152097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES2,Cocaine esterase,33062,-0.0122926327275338,0.0222888475307461,-0.0559787738877961,0.0313935084327286,0.581295030540662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCC,Tubulin-specific chaperone C,33042,-0.0186486295457721,0.0338328268040638,-0.0849609700817372,0.047663710990193,0.58151141433771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA1,Paraneoplastic antigen Ma1,31854,-0.0128716740671991,0.0233545314286738,-0.0586465556673997,0.0329032075330015,0.581552650786987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNDP1,Beta-Ala-His dipeptidase,33138,-0.0106714329494336,0.0193749191117893,-0.0486462744085407,0.0273034085096735,0.581794591894065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC1,WAP four-disulfide core domain protein 1,31837,-0.0127154990188202,0.0230965710817799,-0.0579847783391087,0.0325537803014683,0.581968290679135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT5B,Signal transducer and activator of transcription 5B,33062,-0.0314121865241817,0.0570758179046791,-0.143280789617353,0.0804564165689893,0.582087484231736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB2,Transforming growth factor beta-2 proprotein,31990,0.0121244983600664,0.0220341217637997,-0.0310623802969811,0.0553113770171138,0.582157281610237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACHE,Acetylcholinesterase,31907,0.00733395148160317,0.0133390460108076,-0.0188105786995797,0.033478481662786,0.582465624580184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD2,"Superoxide dismutase [Mn], mitochondrial",33121,-0.00852801678616177,0.0155861487183782,-0.039076868274183,0.0220208347018594,0.584287321342979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),M6PR,Cation-dependent mannose-6-phosphate receptor,31854,-0.00943898949671818,0.0173068994459526,-0.0433605124107852,0.0244825334173489,0.585502560256645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR3,Small proline-rich protein 3,32006,-0.0161675326066855,0.0296533550007121,-0.0742881084080813,0.0419530431947102,0.585619928869204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP1,Caspase-1,32911,-0.0155072909140404,0.0284670408912042,-0.0713026910608005,0.0402881092327198,0.58594296347371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSC,Dipeptidyl peptidase 1,33104,0.00952947412051531,0.0175126312704085,-0.0247952831694854,0.0438542314105161,0.586353228074758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLIF,Cobalamin binding intrinsic factor,33107,0.0159811761270095,0.0293721951389053,-0.041588326345245,0.073550678599264,0.586392187234868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTK7,Inactive tyrosine-protein kinase 7,32911,-0.00853248407533598,0.0156881305092264,-0.0392812198734196,0.0222162517227477,0.586537348897507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBP1,Z-DNA-binding protein 1,31816,-0.00947370611426479,0.0174290447043121,-0.0436346337347166,0.024687221506187,0.586761749745308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM4,Intercellular adhesion molecule 4,33109,0.0120170831839466,0.0221113225385276,-0.0313211089915676,0.0553552753594608,0.58681267886517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,31804,-0.0165247671197484,0.0304137662918297,-0.0761357490517345,0.0430862148122378,0.586917829314707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP25,Ubiquitin carboxyl-terminal hydrolase 25,31990,-0.0161712777772522,0.0297835057279066,-0.0745469490039492,0.0422043934494448,0.587172807293459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRADD,Death domain-containing protein CRADD,33030,-0.0172467202611621,0.0317688830694091,-0.079513731077204,0.0450202905548798,0.587225902980604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPPK1,Epiplakin,31854,-0.0170842983131915,0.0315840504637328,-0.0789890372221078,0.0448204405957247,0.588582194128189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,33126,-0.00999974859965936,0.018499926405565,-0.0462596043545667,0.026260107155248,0.588846075721189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL3,Fc receptor-like protein 3,32981,-0.0121618235894243,0.0225241869645324,-0.0563092300399078,0.0319855828610592,0.589249015225179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK4,Serine/threonine-protein kinase 4,33117,-0.0193372197544844,0.0358364704239063,-0.0895767017853408,0.050902262276372,0.589489470587098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,33208,-0.00831634085189983,0.0154242140480508,-0.0385478003860794,0.0219151186822797,0.589780254015754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IQGAP2,Ras GTPase-activating-like protein IQGAP2,33062,0.0122973771072764,0.0228239276509595,-0.0324375210886042,0.0570322753031571,0.590043483181135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMP,Olfactory marker protein,31804,0.011155516210988,0.0207228851600805,-0.0294613387027698,0.0517723711247458,0.590373352916152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QDPR,Dihydropteridine reductase,33072,-0.00991060540764201,0.0184158531815371,-0.0460056776434546,0.0261844668281706,0.590483116327025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RHOC,Rho-related GTP-binding protein RhoC,32980,-0.0259054256138302,0.0482256488666091,-0.120427697392384,0.0686168461647235,0.591163435658928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT5,Glutathione hydrolase 5 proenzyme,33042,-0.00509959616229462,0.00950191775110122,-0.023723354954453,0.0135241626298638,0.591494796739533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL1,Chordin-like protein 1,33150,-0.00666764784170523,0.0124380335069858,-0.0310461935153974,0.0177108978319869,0.591924368744878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,33121,-0.0084395053293256,0.0157668397766492,-0.0393425112915581,0.0224635006329069,0.59247738034254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEBP1,Phosphatidylethanolamine-binding protein 1,33121,-0.0133087581005481,0.0248701799032146,-0.0620543107108488,0.0354367945097525,0.592574283791817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHCY,Adenosylhomocysteinase,33117,-0.0151482321855634,0.0283756662691957,-0.0707645380731868,0.0404680737020601,0.593461870697614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",31791,-0.0192296773132726,0.0360237493332245,-0.0898362260063926,0.0513768713798475,0.593492240681673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,33138,0.00837899743410762,0.0156991599179769,-0.0223913560051272,0.0391493508733424,0.593547084650396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKB,Creatine kinase B-type,32044,0.0132538760939779,0.0248349757855494,-0.0354226764456989,0.0619304286336547,0.593580071086469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE2,Adhesion G protein-coupled receptor E2,33167,-0.00615654795366237,0.0115453246061717,-0.0287853841817589,0.0164722882744341,0.593873915846057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100G,Protein S100-G,32020,0.00986466949686167,0.0185101438962328,-0.0264152125397547,0.046144551533478,0.594095497195664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARCL1,SPARC-like protein 1,33108,0.00600354963412176,0.0112668290479462,-0.0160794352998527,0.0280865345680962,0.594149882756008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCOR1,REST corepressor 1,32973,-0.0103403933529488,0.0194378434083542,-0.048438566433323,0.0277577797274254,0.594759082102565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPT,Microtubule-associated protein tau,32911,-0.0116400960475156,0.0218874330675087,-0.0545394648598326,0.0312592727648014,0.594867122888036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,32071,0.00432571571810723,0.00813987142533511,-0.0116284322755496,0.0202798637117641,0.59514110876737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STEAP4,Metalloreductase STEAP4,31804,-0.0162912615742847,0.0306696579002718,-0.0764037910588174,0.043821267910248,0.595306647870158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRP15,RRP15-like protein,31804,0.0199955465541971,0.0376498162343448,-0.0537980932651188,0.093789186373513,0.595370512455562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLUL1,Clusterin-like protein 1,33111,0.00992216035099521,0.0186881579665533,-0.0267066292634492,0.0465509499654397,0.595478804473915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENND2B,DENN domain-containing protein 2B,31791,-0.0107069031391011,0.0202020522015711,-0.0503029254541804,0.0288891191759782,0.596134296981252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO1,Forkhead box protein O1,33109,0.018541763715805,0.0349991316992921,-0.0500565344148075,0.0871400618464176,0.596279570582709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD1,COMM domain-containing protein 1,31854,-0.0136240837472749,0.0257243735330644,-0.0640438558720812,0.0367956883775313,0.596392898072393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA3,Annexin A3,33180,-0.0152836625081633,0.0289012704159015,-0.0719301525233303,0.0413628275070038,0.596941544659654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YY1,Transcriptional repressor protein YY1,31816,-0.0062413744128676,0.0118024933652851,-0.0293742614088265,0.0168915125830913,0.596947443325913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK1,Serine protease inhibitor Kazal-type 1,33121,-0.00934508391512696,0.0176971763560034,-0.0440315495728937,0.0253413817426398,0.597474621682956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIK2,"Glutamate receptor ionotropic, kainate 2",32020,-0.00912373511991039,0.0172849016313162,-0.0430021423172902,0.0247546720774695,0.597622949715865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADM,Pro-adrenomedullin,33189,-0.00579450078420071,0.0109809636299813,-0.0273171894989642,0.0157281879305627,0.597730691153145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB1,Scavenger receptor class B member 1,32911,-0.0130837045046747,0.0247985250904588,-0.0616888136819739,0.0355214046726244,0.597790756118802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA2,Pulmonary surfactant-associated protein A2,32951,-0.0108523345705208,0.0205781434574287,-0.0511854957470811,0.0294808266060395,0.597949120394177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLI2,Zinc finger protein GLI2,31816,0.00752480664397372,0.0142719547262021,-0.0204482246193825,0.0354978379073299,0.598039838309676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLHL41,Kelch-like protein 41,32020,-0.00995066544760684,0.0188771052820662,-0.0469497918004565,0.0270484609052428,0.598119614089441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,32042,0.0158107477950753,0.0301032884612922,-0.0431916975890574,0.0748131931792079,0.599447945277657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS1,Protein MTSS 1,31998,0.0239882197368437,0.0458958334680347,-0.0659676138605043,0.113944053334192,0.60122162172133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVR,Poliovirus receptor,33191,0.00793962796864871,0.0152087143450172,-0.0218694521475851,0.0377487080848825,0.601652473891503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBL1X,F-box-like/WD repeat-containing protein TBL1X,32951,0.0182489181939369,0.0349597353511752,-0.0502721630943664,0.0867699994822402,0.601685202097924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTHRC1,Collagen triple helix repeat-containing protein 1,32044,-0.00611103284311632,0.0117100997992822,-0.0290628284497094,0.0168407627634768,0.601783024981434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,33062,0.00430509226539393,0.00826344899789614,-0.0118912677704825,0.0205014523012704,0.602394050794524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MITD1,MIT domain-containing protein 1,33042,-0.0208419595740289,0.0400492162885608,-0.099338423499608,0.0576545043515502,0.602792177385067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYT1,Synaptotagmin-1,32006,0.00818501689479249,0.0157670476987158,-0.0227183965946905,0.0390884303842755,0.603691072012936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDF1,Endothelial differentiation-related factor 1,32020,-0.0156333660707552,0.0301304045916558,-0.0746889590704006,0.0434222269288903,0.603875758410943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPCDC,Phosphopantothenoylcysteine decarboxylase,33191,-0.0102943491957026,0.0198517143443053,-0.0492037093105411,0.0286150109191358,0.604079185374318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,31826,-0.0109862525474474,0.0212464333884711,-0.0526292619888507,0.0306567568939559,0.605111001058688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTLA,B- and T-lymphocyte attenuator,31793,-0.0186165765245032,0.0360224870449431,-0.0892206511325917,0.0519874980835852,0.605308340426134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C1A,Cytosolic 5'-nucleotidase 1A,32006,-0.00662717012211025,0.0128523950124692,-0.0318178643465498,0.0185635241023294,0.606123069006993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSLP,Thymic stromal lymphopoietin,32973,-0.0131727725945166,0.0255701694375997,-0.0632903046922119,0.0369447595031787,0.606453376332043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBL1,Neuroblastoma suppressor of tumorigenicity 1,33126,0.0055283990463131,0.0107356469884539,-0.0155134690510566,0.0265702671436828,0.606596028704404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP112,Centrosomal protein of 112 kDa,31791,-0.00931089950275199,0.0180821865684585,-0.0447519851769306,0.0261301861714266,0.60662365908878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINC1,Antithrombin-III,32051,0.00311986511014593,0.00607018001348226,-0.00877768771627929,0.0150174179365712,0.607290825478419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,32020,0.0142092234324459,0.0276666636947044,-0.0400174374091748,0.0684358842740666,0.607556152255392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM25,RNA-binding protein 25,31793,0.00994193751032828,0.0194051917583419,-0.0280922383360219,0.0479761133566785,0.608432759219911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GET3,ATPase GET3,32042,0.0123303540301099,0.0241008096700977,-0.0349072329232815,0.0595679409835014,0.608934837707267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKZ,Diacylglycerol kinase zeta,32981,0.00761978272291483,0.014897479845826,-0.021579277774904,0.0368188432207337,0.609027303240006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYOU1,Hypoxia up-regulated protein 1,33208,0.00445373224839783,0.00870889015180977,-0.0126156924491493,0.021523156945945,0.609083422093031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3B,Sodium channel subunit beta-3,31804,-0.00968981214585065,0.0189687030005487,-0.046868470026926,0.0274888457352248,0.609484346180663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFE2,Transcription factor NF-E2 45 kDa subunit,31854,0.0158573561942772,0.0310592078942313,-0.0450186912784163,0.0767334036669706,0.609679669875703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC2,Plexin domain-containing protein 2,32006,-0.00587204078389053,0.0115029498235732,-0.0284178224380939,0.0166737408703129,0.609729228290767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3G,T-cell surface glycoprotein CD3 gamma chain,31816,-0.0186920149170367,0.0366254166779963,-0.0904778316059095,0.0530938017718362,0.609817110257658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLP1R,Glucagon-like peptide 1 receptor,31804,0.00796561154589592,0.0156120949763524,-0.0226340946077547,0.0385653176995466,0.609912280116862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTP1,Glutathione S-transferase P,32858,0.0146567047961445,0.0287579142940253,-0.0417088072201451,0.0710222168124341,0.610304371434313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPS16,"28S ribosomal protein S16, mitochondrial",31816,-0.0064927424741558,0.012758286918679,-0.0314989848347666,0.018513499886455,0.610834805168112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX101,Testis-expressed protein 101,31826,-0.00818003504091745,0.0160756366150842,-0.0396882828064825,0.0233282127246476,0.610874889168594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL11,Interleukin-11,32981,-0.0133965959421884,0.0263318247330583,-0.0650069724189827,0.0382137805346058,0.610933173018349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA3,Carbonic anhydrase 3,33191,0.0131069567669303,0.0257854945434063,-0.0374326125381461,0.0636465260720067,0.6112506367774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKL5,Cyclin-dependent kinase-like 5,31804,-0.0115492661156624,0.022754381778392,-0.0561478544013107,0.033049322169986,0.611775567592821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO2,Amphoterin-induced protein 2,33062,-0.00473218570703455,0.00932549054696307,-0.0230101471790822,0.0135457757650131,0.611854700893124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR2,Fibroblast growth factor receptor 2,33126,-0.0044932610279756,0.00889471467168161,-0.0219269017844716,0.0129403797285204,0.613458746889827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RN,Interleukin-1 receptor antagonist protein,33101,-0.01177295106977,0.0233105723513604,-0.0574616728784364,0.0339157707388963,0.613538198321117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,31990,-0.0100766774610572,0.0199962141736011,-0.0492692572413153,0.0291159023192009,0.614325813583622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,31791,-0.0101651675129126,0.0201769600882072,-0.0497120092857987,0.0293816742599736,0.614416526583034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNIP4,Kv channel-interacting protein 4,32911,0.0105182438049127,0.0208915944647672,-0.0304292813460309,0.0514657689558563,0.614648567345656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD86,T-lymphocyte activation antigen CD86,31998,-0.0060891538473511,0.0121161619264562,-0.0298368312232053,0.0176585235285031,0.615285102026661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS37A,Vacuolar protein sorting-associated protein 37A,33062,0.0165835846340731,0.0330139102364085,-0.0481236794292875,0.0812908486974337,0.615454495723752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIFR,Leukemia inhibitory factor receptor,33109,-0.00492840235754663,0.0098200090210529,-0.0241756200388103,0.0143188153237171,0.615769266220238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZN,Kazrin,31998,-0.0213715967933932,0.0426179958961363,-0.10490286874982,0.0621596751630339,0.616055834026266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM132A,Transmembrane protein 132A,31854,0.0129547687850667,0.0258983039294951,-0.0378059069167437,0.063715444486877,0.616937244691374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCLM,Glutamate--cysteine ligase regulatory subunit,31791,-0.00994075899041513,0.0199056664028588,-0.0489558651400183,0.029074347159188,0.617517217798283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP4,Guanylate-binding protein 4,32911,-0.0101202116011511,0.0202809342181407,-0.0498708426687069,0.0296304194664047,0.617791477046069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME1,Nucleoside diphosphate kinase A,31816,-0.00439491161459644,0.00880759972706744,-0.0216578070796486,0.0128679838504557,0.617800740177746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSRP3,Cysteine and glycine-rich protein 3,31791,-0.0201500192521477,0.0404666392546314,-0.0994646321912253,0.0591645936869298,0.61854019199374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL2,Interleukin-1 receptor-like 2,32981,-0.00828051178868027,0.0166410627589655,-0.0408969947962526,0.0243359712188921,0.618782264934769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,31854,0.00767437487601749,0.0154277843355075,-0.0225640824215773,0.0379128321736123,0.618894592747257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL3A1,Collagen alpha-1(III) chain,32044,-0.00465338920757696,0.00935870733131561,-0.0229964555769556,0.0136896771618016,0.619044343979161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC21,DnaJ homolog subfamily C member 21,32006,0.00776074385131091,0.0156189308602103,-0.0228523606347014,0.0383738483373232,0.619287707520068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAG,S-arrestin,31804,-0.0107647344524406,0.0216801594352378,-0.0532578469455066,0.0317283780406254,0.619539116698797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3R,Granulocyte colony-stimulating factor receptor,31816,0.00644296421690337,0.0129931574531541,-0.0190236243912786,0.0319095528250853,0.619998366965658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKKL1,Dickkopf-like protein 1,33062,-0.0180881816285349,0.0364885598010168,-0.0896057588385278,0.053429395581458,0.620103219631948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,31801,0.00817696777320682,0.0165096466860744,-0.0241819397314991,0.0405358752779127,0.620414304018264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,31804,0.00662915557799039,0.013416708613056,-0.0196675933035993,0.0329259044595801,0.621252432622726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG2,Bone marrow proteoglycan,32044,0.0104880012487591,0.02124296431721,-0.0311482088129726,0.0521242113104908,0.621520717685025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,32943,-0.0161297166848765,0.0326825174341365,-0.080187450855784,0.0479280174860311,0.621652774187696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT5,ADP-sugar pyrophosphatase,33121,-0.0107995360789694,0.0218966540429924,-0.0537169780032345,0.0321179058452958,0.621880340920716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRK5,G protein-coupled receptor kinase 5,32973,-0.0107620214135819,0.0218436458897805,-0.0535755673575516,0.0320515245303879,0.622248366366235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBA,Lysosomal acid glucosylceramidase,31826,-0.0110447917444856,0.0224311247514473,-0.0550097962573223,0.0329202127683511,0.622460524734315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO3,R-spondin-3,33189,-0.00562337561909249,0.0114495600997985,-0.0280645134146975,0.0168177621765125,0.623337379722048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15,Interleukin-15,33109,0.0064934131284893,0.0132240805853008,-0.0194257848187003,0.0324126110756789,0.62341805943504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP13,Dual specificity protein phosphatase 13 isoform A,31990,-0.00816521853126028,0.0166384466440397,-0.0407765739535781,0.0244461368910575,0.623621778702821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPA1,Inositol monophosphatase 1,33042,-0.0124273535490558,0.0253671663125153,-0.0621469995215857,0.0372922924234741,0.624217766227238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",32006,0.00540896375219699,0.0110478431720184,-0.0162448088649591,0.0270627363693531,0.624435053906185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,31804,-0.00665488443247354,0.013601588865053,-0.0333139986079775,0.0200042297430304,0.624663329442624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA2_BOLA2B,BolA-like protein 2,31854,-0.0114609334345331,0.0234351121322577,-0.0573937532137582,0.0344718863446921,0.624821035120657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM3,Paralemmin-3,31791,0.0153706577612593,0.0314694213320871,-0.0463094080496315,0.07705072357215,0.625258803033157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE10,Inactive ribonuclease-like protein 10,31854,-0.00981050328077481,0.0200881723336639,-0.0491833210547561,0.0295623144932065,0.625300754107343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBB,Inhibin beta B chain,31907,-0.0104477940675783,0.021396159116289,-0.0523842659355048,0.0314886778003482,0.625350082539662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,32973,0.0113287726249116,0.0232765970427394,-0.0342933575788577,0.0569509028286809,0.62648185413462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD8,Ly6/PLAUR domain-containing protein 8,32951,0.0101443454543774,0.0209605882991902,-0.0309384076120353,0.0512270985207901,0.628417952699178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",32981,-0.0241897848457954,0.0500308061748461,-0.122250164948494,0.0738705952569029,0.628754731621872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP2,Integrin beta-1-binding protein 2,32973,-0.0223732942464899,0.0462981898027622,-0.113117746259904,0.068371157766924,0.628935345349666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA1,Laminin subunit alpha-1,31791,0.0109653300371116,0.0227093091302835,-0.0335449158582441,0.0554755759324674,0.629212266976886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSBPL2,Oxysterol-binding protein-related protein 2,32006,-0.0084128298144381,0.017440615080041,-0.0425964353713186,0.0257707757424424,0.629557092181607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD22,B-cell receptor CD22,33208,-0.00810983399226704,0.0168321194822239,-0.0411007881774258,0.0248811201928917,0.629955055792621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G15,Phospholipase A2 group XV,33126,-0.00508163139876206,0.0105556218300265,-0.025770650185614,0.0156073873880899,0.630233943332704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPB,CCAAT/enhancer-binding protein beta,32973,-0.00772539413665834,0.0160536074808224,-0.0391904647990703,0.0237396765257536,0.630369089627525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL24,"39S ribosomal protein L24, mitochondrial",31791,-0.00795427032954922,0.0165461939596055,-0.040384810490376,0.0244762698312775,0.630721941491254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF149,E3 ubiquitin-protein ligase RNF149,31854,-0.0060062468766201,0.0125034795875489,-0.030513066868216,0.0185005731149758,0.630981339010471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC123,Cell division cycle protein 123 homolog,31793,0.0127533992392921,0.0265668572879636,-0.0393176410451166,0.0648244395237008,0.631206694487497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIAPIN1,Anamorsin,33126,-0.0126880106328599,0.0264801500449631,-0.0645891047209875,0.0392130834552677,0.631842745000714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSBP1,Heat shock factor-binding protein 1,31854,-0.0190218075854245,0.0397674825909996,-0.0969660734637837,0.0589224582929347,0.632432558376342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPACAM2,HEPACAM family member 2,32006,0.00801401657929033,0.0167567321692402,-0.0248291784724204,0.040857211631001,0.632481472210894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC26,Anaphase-promoting complex subunit CDC26,31986,-0.0139082669534634,0.0290982229996217,-0.070940784032722,0.0431242501257951,0.632680794757786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLGN,Calmegin,31826,0.00851216857314644,0.0178246724041008,-0.0264241893388912,0.0434485264851841,0.632984828667072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGT,Angiotensinogen,32048,0.00438326204323278,0.0091845873161482,-0.0136185290964177,0.0223850531828833,0.633204217334339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIP2,CAP-Gly domain-containing linker protein 2,33109,-0.0220233701340368,0.0461578243667918,-0.112492705892949,0.0684459656248752,0.633280249500025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK7,Proprotein convertase subtilisin/kexin type 7,31990,0.0088268144623275,0.0184999842424027,-0.0274331546527818,0.0450867835774368,0.633286580693592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDA1,DET1- and DDB1-associated protein 1,31791,-0.00799770684365533,0.0167819202478877,-0.0408902705295152,0.0248948568422045,0.633684783027711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRCAM,Neuronal cell adhesion molecule,33117,0.00538168310275405,0.0113000983710685,-0.0167665097045401,0.0275298759100482,0.633907580506021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",32042,-0.0174550395537741,0.0367025624401411,-0.0893920619364506,0.0544819828289025,0.634386635490034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK2,BDNF/NT-3 growth factors receptor,33117,0.0049915982598462,0.0104995052998079,-0.0155874321277773,0.0255706286474697,0.634504821288006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",32020,-0.0152086196637629,0.0320146892988774,-0.0779574106895626,0.0475401713620367,0.634764120129363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TK1,"Thymidine kinase, cytosolic",31908,-0.00879050756639059,0.0185090088189626,-0.0450681648515572,0.027487149718776,0.634849853851613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAL,Galanin peptides,33167,-0.0122115710536189,0.0257398509242809,-0.0626616788652095,0.0382385367579717,0.635210354407655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK1D,Casein kinase I isoform delta,31816,0.0126146936976359,0.0266609066070002,-0.0396406832520845,0.0648700706473563,0.636117897064815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN2,Ficolin-2,33067,-0.00799201132015927,0.0169362482625878,-0.0411870579148314,0.0252030352745128,0.637018727255498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",31793,0.00995972017961918,0.0211556719077585,-0.0315053967595874,0.0514248371188258,0.637810048259201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME2,Proteasome activator complex subunit 2,33000,-0.00728637413860449,0.0154883346560983,-0.0376435100645572,0.0230707617873482,0.638050758444648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NARS1,"Asparagine--tRNA ligase, cytoplasmic",32020,-0.00913645854207563,0.0194714516534851,-0.0473005037829064,0.0290275866987551,0.638923559138273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM2,Paralemmin-2,32006,-0.00699429197369406,0.0149170499541258,-0.0362317098837807,0.0222431259363926,0.639169633981919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB2B,Ras-related protein Rab-2B,31990,-0.0116560134564972,0.0249018055446838,-0.0604635523240774,0.0371515254110831,0.639741594256227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7B,B-cell CLL/lymphoma 7 protein family member B,31990,0.0087342796403717,0.0186681657390348,-0.0278553252081366,0.04532388448888,0.639890895377885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA2,Paraneoplastic antigen Ma2,31804,0.00834536148951812,0.0178564882670409,-0.026653355513882,0.0433440784929183,0.640258064300837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20,Interleukin-20,32981,0.0101515390219278,0.0217404971730571,-0.032459835437264,0.0527629134811197,0.640553704385693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX2,Heme oxygenase 2,32911,-0.00885612611906126,0.019007555602204,-0.046110935099381,0.0283986828612585,0.64128002316964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB9,Serpin B9,33042,-0.00647333222220653,0.0138937793911936,-0.033705139828946,0.020758475384533,0.641287538944318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2B,V-set and transmembrane domain-containing protein 2B,31908,0.00830875901849269,0.017906966320431,-0.0267888949695521,0.0434064130065374,0.642664226498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC25,Leucine-rich repeat-containing protein 25,33062,0.00734205216504807,0.015826553008925,-0.023677991732445,0.0383620960625412,0.642725949639927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,31974,-0.00601716331500404,0.0130055488372892,-0.0315080390360909,0.0194737124060828,0.643620590257955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPA,CCAAT/enhancer-binding protein alpha,31816,0.00723326224194861,0.015651008227609,-0.0234427138841649,0.0379092383680622,0.643980592765962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL4,Angiopoietin-related protein 4,33150,-0.00860395991622827,0.0186255045081518,-0.0451099487522057,0.0279020289197492,0.644132268236585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAFA5,Chemokine-like protein TAFA-5,33062,0.00662496661245024,0.0143530901557939,-0.0215070900929058,0.0347570233178062,0.64440083376521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,32951,0.0119681612538288,0.0259894847659268,-0.0389712288873876,0.0629075513950453,0.645169056088099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSDE1,Cold shock domain-containing protein E1,31791,0.0226185761245451,0.0493355697806061,-0.0740791406454429,0.119316292894533,0.646632791175906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM8,U6 snRNA-associated Sm-like protein LSm8,31908,0.017516552419642,0.0382126435876924,-0.057380229012235,0.092413333851519,0.64668077142082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF10,Multiple epidermal growth factor-like domains protein 10,33121,-0.00719079492977531,0.0156909345706673,-0.0379450266882832,0.0235634368287326,0.646764910150029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DFFA,DNA fragmentation factor subunit alpha,33208,-0.0129712799378176,0.0283446026052659,-0.0685267010441388,0.0425841411685036,0.647231176440988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,33105,-0.0117858338578768,0.0257677578334568,-0.0622906392114521,0.0387189714956986,0.647404490058479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIGYF2,GRB10-interacting GYF protein 2,32020,0.0144446111462876,0.0315823312959083,-0.0474567581936927,0.0763459804862679,0.647422796825913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171B,Protein FAM171B,31990,0.00511274678960997,0.0111864136649852,-0.016812623993761,0.0270381175729809,0.64764850787146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID4B,AT-rich interactive domain-containing protein 4B,32911,-0.00819775680059955,0.0179400728355183,-0.0433602995582154,0.0269647859570163,0.647717094747907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP6,Guanylate-binding protein 6,31791,-0.00888676373321477,0.0194502409406537,-0.0470092359768959,0.0292357085104664,0.647758344401649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,33062,-0.00526365605118411,0.0115225884110057,-0.0278479293367553,0.0173206172343871,0.647817741611395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTN3,Myeloblastin,32910,0.00914141883160472,0.0200266656071741,-0.0301108457584565,0.048393683421666,0.648069260291334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT4,Vascular endothelial growth factor receptor 3,33126,0.00634936533228824,0.0139129448780284,-0.0209200066286475,0.0336187372932239,0.648139770244065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX2,Sorting nexin-2,31990,0.0147644715927001,0.0323790681218879,-0.0486985019262001,0.0782274451116004,0.648411630487362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB6,Heat shock protein beta-6,33189,-0.00680275803503854,0.0149290719186476,-0.0360637389955879,0.0224582229255109,0.64863728140166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE1,Adhesion G protein-coupled receptor E1,31998,-0.0104047043042388,0.022845854116522,-0.055182578372622,0.0343731697641444,0.648812486235729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI16,Peptidase inhibitor 16,32048,-0.00464329347788331,0.010197519536063,-0.0246304317685668,0.0153438448128002,0.648880846826343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A5,Zinc transporter ZIP5,33109,-0.00992196827557076,0.0217938870681337,-0.0526379869291129,0.0327940503779714,0.648930869124427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_E,,33109,-0.00538684522158024,0.0118371149621592,-0.0285875905474122,0.0178139001042517,0.649062432880026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOST,Sclerostin,33107,0.00732142915962837,0.0160936427410943,-0.0242221106129165,0.0388649689321732,0.649173322338405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG4,V-set and immunoglobulin domain-containing protein 4,33105,-0.00726686231582851,0.0159831068934531,-0.0385937518269965,0.0240600271953395,0.6493660356073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL2,Protein kinase C-binding protein NELL2,33167,-0.00533045964932222,0.0117328714627896,-0.0283268877163898,0.0176659684177453,0.64961097320263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRUNE2,Protein prune homolog 2,31908,-0.00533788522311584,0.0117547220656988,-0.0283771404718855,0.0177013700256538,0.649766034393092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POF1B,Protein POF1B,31816,-0.00873446683762124,0.019318987066432,-0.046599681487828,0.0291307478125856,0.651197105720458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB6,Ephrin type-B receptor 6,33030,0.00572244857420497,0.0126572284823447,-0.0190857192511907,0.0305306163996006,0.651201797588672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSR1,Macrophage scavenger receptor types I and II,33191,-0.00815232915960608,0.0180543565548383,-0.0435388680070891,0.027234209687877,0.651609013747951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNNI3,"Troponin I, cardiac muscle",32973,-0.01595554807507,0.0353503157955431,-0.0852421670343344,0.0533310708841945,0.651745068942429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA1,Interleukin-13 receptor subunit alpha-1,33017,-0.00387606941021706,0.00860235474045216,-0.0207366847015033,0.0129845458810692,0.652301978783824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LELP1,Late cornified envelope-like proline-rich protein 1,31804,-0.0139290051774364,0.0309172319078867,-0.0745267797168942,0.0466687693620214,0.652344767778322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC59,Leucine-rich repeat-containing protein 59,32042,-0.00894090408815721,0.0198516292115829,-0.0478500973428596,0.0299682891665452,0.652444703695096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,33042,0.0131382580154606,0.0291723427986638,-0.0440395338699204,0.0703160499008416,0.652457263232059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDR1,Epithelial discoidin domain-containing receptor 1,33191,-0.00415666135698036,0.00923616845885781,-0.0222595515363417,0.0139462288223809,0.652691504531559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM13A,Protein FAM13A,31998,-0.0125005863015874,0.0277831538282705,-0.0669555678049976,0.0419543952018229,0.652770935257556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17F,Interleukin-17F,32981,0.0148576456327849,0.0330853831317378,-0.0499897053054211,0.0797049965709909,0.653392731522773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APCS,Serum amyloid P-component,32003,-0.00671120644833971,0.0149455914425171,-0.0360045656756732,0.0225821527789937,0.653413851179255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN4,Contactin-4,33121,-0.00446338629327479,0.00995405427953687,-0.023973332681167,0.0150465600946175,0.653876592576704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM5,Tripartite motif-containing protein 5,33109,0.015862323336998,0.0353797538550473,-0.0534819942188946,0.0852066408928907,0.653915702353407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSH,Pro-cathepsin H,32949,-0.013381754147943,0.0299439678197502,-0.0720719310746535,0.0453084227787674,0.654963598911043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17D,Interleukin-17D,32981,0.00586006482606341,0.0131779372836599,-0.0199686922499101,0.0316888219020369,0.656556841603016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,32006,-0.00740353440999056,0.0166571291873381,-0.0400515076171732,0.0252444387971921,0.656718141899454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G1,V-type proton ATPase subunit G 1,31854,-0.0133837341074592,0.0301201130226401,-0.0724191556318338,0.0456516874169153,0.656805862097664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAC1,Zinc phosphodiesterase ELAC protein 1,32020,-0.0156053088376178,0.0351648705086271,-0.0845284550345269,0.0533178373592913,0.657217573015793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CX3CL1,Fractalkine,33042,-0.00611514826033443,0.0138113603648602,-0.0331854145754603,0.0209551180547915,0.657948897973351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPG1,Interphotoreceptor matrix proteoglycan 1,31804,0.00535258097571991,0.0121350120098328,-0.0184320425635524,0.0291372045149922,0.659163883541674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRAP2,GRB2-related adapter protein 2,33117,-0.0232718949325334,0.0527902728826227,-0.126740829782474,0.0801970399174072,0.659342148393795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1A,T-cell leukemia/lymphoma protein 1A,33025,-0.0173364133273277,0.0394034700604271,-0.0945672146457648,0.0598943879911093,0.659968665763667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FES,Tyrosine-protein kinase Fes/Fps,32951,0.0084992932201445,0.0193198675823957,-0.0293676472413511,0.0463662336816401,0.660002597145161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELENOP,Selenoprotein P,32071,-0.00412584428549703,0.00938896660318227,-0.0225282188277343,0.0142765302567402,0.660358544309799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRAS,Ras-related protein R-Ras,31826,-0.0236841005686092,0.053911354239471,-0.129350354877972,0.0819821537407539,0.660445723072103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD36,Platelet glycoprotein 4,31816,-0.00803570193388176,0.0183148173177264,-0.0439327438766255,0.027861340008862,0.660852564430654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSTN,Osteocrin,31826,-0.0078297710953835,0.0178567961077134,-0.0428290914665018,0.0271695492757348,0.661054329817894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD276,CD276 antigen,33121,-0.00640943704075678,0.0146260146238343,-0.035076425703472,0.0222575516219585,0.661236496309981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRK1,NKG2-D type II integral membrane protein,32006,-0.00821247531583947,0.0188261952143523,-0.0451118179359699,0.028686867304291,0.662685251933135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD1,Mothers against decapentaplegic homolog 1,32951,-0.014530349991685,0.0333708083138199,-0.079937134286772,0.050876434303402,0.663267943242487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA6C,Semaphorin-6C,31816,0.00488840070683062,0.0112275892100641,-0.0171176741448951,0.0268944755585563,0.663290793856829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH2,Neurogenic locus notch homolog protein 2,32044,-0.00373940309021267,0.00861132055996939,-0.0206175913877527,0.0131387852073273,0.664124548865325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID2,Nidogen-2,33121,-0.0132901156047681,0.0306222232857994,-0.0733096732449348,0.0467294420353986,0.664297564958414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF19,Fibroblast growth factor 19,33167,0.0136289923262193,0.0314040891628747,-0.0479230224330151,0.0751810070854537,0.664308025839273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGFL2,Hepatoma-derived growth factor-related protein 2,32006,-0.0114353506684813,0.0264186131840153,-0.0632158325091513,0.0403451311721887,0.665134620109535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENDOU,Poly(U)-specific endoribonuclease,31477,-0.00885902274822217,0.0204787139032523,-0.0489973019985966,0.0312792565021523,0.665321112854927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSP,Alpha-hemoglobin-stabilizing protein,33111,0.0159016462071418,0.0368086707600917,-0.0562433484826379,0.0880466408969215,0.665746237783753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3A,Sodium channel protein type 3 subunit alpha,31826,-0.00678982643846771,0.0157646120797287,-0.037688466114736,0.0241088132378005,0.666698737297129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPT,Dermatopontin,33208,0.00460500860161493,0.0107652930733791,-0.0164949658222081,0.025704983025438,0.668833213892724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHH,Sonic hedgehog protein,31816,0.00744980501890873,0.0174156096081871,-0.026684789813138,0.0415843998509555,0.668834028370109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMRK2,Nicotinamide riboside kinase 2,31793,-0.00793126958883048,0.0185756837019343,-0.0443396096446218,0.0284770704669608,0.669413311304778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENR,Density-regulated protein,31816,-0.0100442240926297,0.0235291224974233,-0.0561613041875794,0.0360728560023199,0.669475737133242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGOLN2,Trans-Golgi network integral membrane protein 2,32048,0.00445659245371103,0.0104452993167413,-0.016016194207102,0.0249293791145241,0.669639007274407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRME1,Break repair meiotic recombinase recruitment factor 1,31804,0.0070099539197306,0.0164352050501254,-0.0252030479785152,0.0392229558179764,0.669741010777877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN1A,Cyclin-dependent kinase inhibitor 1,33062,-0.0185800723021354,0.0436328922555228,-0.10410054112296,0.0669403965186893,0.670244409878652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDAR,Tumor necrosis factor receptor superfamily member EDAR,33109,-0.0162298580743825,0.0381287008687167,-0.0909621117770672,0.0585023956283022,0.67036628491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",31908,-0.00878482980746354,0.0206450460621595,-0.0492491200892962,0.0316794604743691,0.670471698191893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LARP1,La-related protein 1,31990,0.011473505333432,0.0269778303785014,-0.0414030422084308,0.0643500528752947,0.670634616969471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),A1BG,Alpha-1B-glycoprotein,32071,-0.00303977287443852,0.00717525773937609,-0.0171032780436157,0.0110237322947386,0.671835592013125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAG1,Dystroglycan,33167,-0.00836544700525928,0.0197491178262121,-0.047073717944635,0.0303428239341164,0.671878324634138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFC,Platelet-derived growth factor C,32951,0.00509126173754867,0.0120602642775283,-0.0185468562464067,0.028729379721504,0.672924931217427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANG,Angiogenin,33083,0.0059835248871821,0.0141738987766314,-0.0217973167150155,0.0337643664893797,0.672925353102891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEXIM1,Protein HEXIM1,33109,-0.0142547040844241,0.0338350190840074,-0.0805713414890787,0.0520619333202304,0.673546262258002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBQ1,Hemoglobin subunit theta-1,33189,-0.0105240506916375,0.0250228843279116,-0.0595689039743443,0.0385208025910693,0.674074304244429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAX,Protein max,32911,0.0181560072475635,0.0431713112508731,-0.0664597628041479,0.102771777299275,0.67408911096333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN6,Prefoldin subunit 6,31826,0.0116723674194437,0.0278918023823344,-0.0429955652499317,0.066340300088819,0.675602995850091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIP,Gastric inhibitory polypeptide,31854,-0.00896687523261473,0.0214487504072248,-0.0510064260307753,0.0330726755655459,0.675915014221651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ID4,DNA-binding protein inhibitor ID-4,31908,-0.00778732260641019,0.018693314408618,-0.0444262188473015,0.0288515736344811,0.676995218178529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKBIE,NF-kappa-B inhibitor epsilon,32951,-0.00851413683365859,0.0204415788015597,-0.0485796312847155,0.0315513576173984,0.677046838144329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC38,Leucine-rich repeat-containing protein 38,31826,-0.0085730486508339,0.0205905537690128,-0.048930534038099,0.0317844367364312,0.67715993082754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX39A,ATP-dependent RNA helicase DDX39A,31816,0.00393727127944164,0.00948603564044762,-0.0146553585758357,0.022529901134719,0.678110278606858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",31816,0.00474524361427001,0.0114329713083403,-0.0176633801500769,0.027153867378617,0.678118104760273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRN1,Neuritin,32020,-0.00629292173957508,0.0151882354227416,-0.0360618631681486,0.0234760196889984,0.678645145306012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARK7,Parkinson disease protein 7,33121,-0.00926232046338305,0.0223700405959452,-0.0531076000314357,0.0345829591046696,0.678847564202774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT1S1,Proline-rich AKT1 substrate 1,32911,-0.0114730367346838,0.0278203536951716,-0.0660009299772201,0.0430548565078525,0.68005874572987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",33092,-0.0121490370168191,0.0294634982315602,-0.0698974935506771,0.0455994195170389,0.680099017924571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP6,Gastrotropin,32956,-0.0094953277655692,0.02304634422866,-0.0546661624537428,0.0356755069226044,0.680342367572134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGLAP,Osteocalcin,32044,-0.0156605204640769,0.0380273615208977,-0.0901941490450363,0.0588731081168825,0.680481205217528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAT,Catalase,31941,0.00944043628563685,0.022933843237509,-0.0355098964598808,0.0543907690311545,0.680616717113142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC2,MAM domain-containing protein 2,32042,-0.00582236554026111,0.0141477839509592,-0.0335520220841412,0.021907291003619,0.680688935066751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",31793,0.00986761350367399,0.0240306846744776,-0.0372325284583022,0.0569677554656502,0.681359098385596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME1,Proteasome activator complex subunit 1,33029,-0.00650161630654788,0.015860078492453,-0.0375873701517557,0.0245841375386599,0.681863172801153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A13,Protein S100-A13,31816,0.00595797596255817,0.0145529053618057,-0.022565718546581,0.0344816704716974,0.682257214534519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",32006,0.00905554775200259,0.022120402683372,-0.0343004415074065,0.0524115370114116,0.682275828039557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,33208,0.0118596367729538,0.0290294921934052,-0.0450381679261204,0.068757441472028,0.682889080511768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAU,Urokinase-type plasminogen activator,33121,0.00520340047305974,0.0127386678878849,-0.0197643885871947,0.0301711895333142,0.682936619637002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXLNA,Alpha-taxilin,33042,-0.0150437471496585,0.0368913208913048,-0.0873507360966159,0.057263241797299,0.683441294425929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPM,Carboxypeptidase M,33150,-0.00582076649707901,0.0142957192616453,-0.0338403762499037,0.0221988432557457,0.683894258612136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGA,Chromogranin-A,32044,0.0150035445469241,0.0368499652914164,-0.0572223874242521,0.0872294765181004,0.683907682855749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAP18,Histone deacetylase complex subunit SAP18,31908,-0.0125158695333129,0.0307791133371441,-0.0728429316741154,0.0478111926074897,0.684287644309906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMS,Spermine synthase,31804,-0.010390261610261,0.0255631561312067,-0.0604940476274261,0.0397135244069042,0.684420461974934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2,T-cell surface antigen CD2,31791,-0.00656340045565548,0.0161490592429323,-0.0382155565718027,0.0250887556604918,0.684441337632671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLB,Beta-klotho,32911,-0.0124086472982924,0.0305346433907115,-0.0722565483440871,0.0474392537475022,0.684474200103729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX1,Neuronal pentraxin-1,33121,-0.006617400015781,0.0162970151018874,-0.0385595496154803,0.0253247495839183,0.684716018592608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT2A1,Bile salt sulfotransferase,33109,-0.00925486593671553,0.0228247611665291,-0.0539913978231126,0.0354816659496816,0.685138543358004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS53,Serine protease 53,32006,0.00616549634179689,0.0152056683776117,-0.023637613678322,0.0359686063619157,0.685140939868834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG3,Proteoglycan 3,32044,-0.00825802721807892,0.0204584704730237,-0.0483566293452054,0.0318405749090476,0.68648271673293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPME1,Protein phosphatase methylesterase 1,33062,0.0103829751382421,0.0257992361171647,-0.0401835276514007,0.060949477927885,0.687360800245918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIRC2,Baculoviral IAP repeat-containing protein 2,32951,-0.0104195335176444,0.0259698494120797,-0.0613204383653207,0.0404813713300318,0.688270779897282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,31816,-0.0131071421677176,0.0326824113863006,-0.0771646684848669,0.0509503841494316,0.688398077253413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEPD,Xaa-Pro dipeptidase,32048,0.00421635880424439,0.0105316819768678,-0.0164257378704165,0.0248584554789053,0.68891000961126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTD,Biotinidase,32071,0.00340856918235912,0.00853571012158942,-0.0133214226559561,0.0201385610206744,0.689660907223811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM20A,Pseudokinase FAM20A,32042,0.00466430862125143,0.0116834968039711,-0.018235345114532,0.0275639623570348,0.689740887767196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOPH1,Enolase-phosphatase E1,31990,-0.00934458333299465,0.0234366741556819,-0.0552804646781313,0.036591298012142,0.690113570762278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B10,Aldo-keto reductase family 1 member B10,31826,0.0096564087525368,0.0242198182257483,-0.0378144349699299,0.0571272524750035,0.69012680927419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREH,Trehalase,32044,-0.012268461459122,0.0307920366006477,-0.0726208531963914,0.0480839302781474,0.69032468378996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36A,Interleukin-36 alpha,31816,0.00944260515010474,0.0237186801457976,-0.0370460079356585,0.055931218235868,0.690561843853507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSG,Basigin,33197,-0.00315022718977583,0.00792141796542088,-0.0186762064020008,0.0123757520224491,0.690872280606585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBP1,"Fructose-1,6-bisphosphatase 1",33117,0.0119330983239805,0.0300233349510632,-0.0469126381801033,0.0707788348280644,0.69103748812909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT7,N-acetylgalactosaminyltransferase 7,33062,-0.00340607340748993,0.00857129678297933,-0.0202058151021294,0.0133936682871496,0.691096123698103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPR,Gastric inhibitory polypeptide receptor,31816,-0.00809528668366456,0.0203803763822548,-0.0480408243928839,0.0318502510255548,0.6912242151033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GID8,Glucose-induced degradation protein 8 homolog,32020,-0.00541662275781189,0.0136446565603206,-0.0321601496160402,0.0213269041004164,0.691395186931022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2orf69,UPF0565 protein C2orf69,31826,-0.00992360418342722,0.0250225689766562,-0.0589678393776734,0.039120631010819,0.691684146769325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC1,MANSC domain-containing protein 1,33126,-0.00449797222594965,0.0113787533119802,-0.0268003287174309,0.0178043842655316,0.692634395126773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG1,Arginase-1,33070,-0.00879780671711233,0.0223239957628068,-0.0525528384122137,0.0349572249779891,0.693519607941096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YES1,Tyrosine-protein kinase Yes,33062,-0.0185889641014636,0.047179796099901,-0.111061364457269,0.0738834362543423,0.693588849283495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL2,Chordin-like protein 2,33117,-0.00931437771275324,0.0236665732885425,-0.0557008613582965,0.03707210593279,0.693910574019097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,31908,0.00722138493244668,0.0183763020991671,-0.0287961671819208,0.0432389370468141,0.694350884431433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICA1,Islet cell autoantigen 1,32981,-0.0129394906337453,0.0329519031958523,-0.0775252208976158,0.0516462396301252,0.694567063180527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5E,5'-nucleotidase,33126,-0.00931059815319805,0.0237294426787571,-0.055820305803562,0.0371991094971659,0.694798327341737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC37A2,Leucine-rich repeat-containing protein 37A2,31998,-0.00682458611622021,0.0174312672837415,-0.0409898699923535,0.0273406977599131,0.695428357527307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME3,Nucleoside diphosphate kinase 3,33136,0.00386631746480053,0.00988535267359909,-0.0155089737754537,0.0232416087050547,0.695721249168286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF41,E3 ubiquitin-protein ligase NRDP1,32951,-0.0109151809116127,0.02794361754974,-0.0656846713091032,0.0438543094858777,0.696092030304137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI,Tissue factor pathway inhibitor,33083,0.00506813667093194,0.0130029692860881,-0.0204176831298007,0.0305539564716646,0.696717990709823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYZL2,Lysozyme-like protein 2,31793,-0.00584897214557426,0.0150100566777567,-0.0352686832339775,0.023570738942829,0.696791721418346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM2,Neural cell adhesion molecule 2,33121,-0.00427984618514487,0.0109883347493858,-0.0258169822939411,0.0172572899236514,0.696923295459404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK11,Kallikrein-11,33050,0.00478347956526824,0.012295925510418,-0.019316534435151,0.0288834935656875,0.697263848911355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP2,Tubulin polymerization-promoting protein family member 2,31908,-0.013391894713703,0.034476157509785,-0.0809651634328815,0.0541813740054755,0.697702051587998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22RA1,Interleukin-22 receptor subunit alpha-1,32981,-0.00672999173032641,0.0173341094939952,-0.040704846338557,0.0272448628779042,0.69783971251081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA6,Corticosteroid-binding globulin,32071,0.00291619778092433,0.00752325803781843,-0.0118293879731998,0.0176617835350485,0.698304896758021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB17,Zinc finger and BTB domain-containing protein 17,32973,-0.00691694531891695,0.0178749657560112,-0.0419518782006989,0.028117987562865,0.698793472786687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164,Sialomucin core protein 24,33121,0.00443167340765848,0.0114632456040676,-0.018036287976314,0.0268996347916309,0.69906296677436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUCB2,Nucleobindin-2,33174,-0.00597163209325296,0.0154500518018501,-0.0362537336248791,0.0243104694383732,0.699126865620414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGACT,Gamma-glutamylaminecyclotransferase,32042,-0.0113176844845453,0.029285659714433,-0.0687175775248339,0.0460822085557433,0.699168158291623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,33109,-0.0159976941057322,0.0414569582405028,-0.0972533322571176,0.0652579440456532,0.699589968755233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APPL2,DCC-interacting protein 13-beta,31907,-0.0177333668596616,0.0459699813869883,-0.107834530378159,0.0723677966588354,0.69968564117983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WAS,Wiskott-Aldrich syndrome protein,32981,0.0108606554217381,0.0281707342988884,-0.0443539838040831,0.0660752946475593,0.699854603339986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK2,Protein AHNAK2,31854,0.00456365937133117,0.0118389061620225,-0.018640596706233,0.0277679154488953,0.699893034669445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPLAH,5-oxoprolinase,31854,0.0109622656279752,0.0284604594778617,-0.0448202349486337,0.0667447662045841,0.700118619472319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTLA4,Cytotoxic T-lymphocyte protein 4,32044,0.00456911549044803,0.0118730905790205,-0.0187021420444322,0.0278403730253283,0.700374522226636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSC2,Desmocollin-2,33027,0.00528432674041475,0.01374293284783,-0.021651821641332,0.0322204751221615,0.700608315201898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MILR1,Allergin-1,32981,-0.00782630706606342,0.0204754468150052,-0.0479581828234737,0.0323055686913469,0.702301126905445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN3,Matrilin-3,33024,0.00499054924299281,0.0130749720833951,-0.0206363960404616,0.0306174945264472,0.702702870016963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD3,Bromodomain-containing protein 3,31791,-0.0074547628837237,0.0195341487526754,-0.0457416944389675,0.0308321686715201,0.702748939355436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,31826,0.00501816017202045,0.0131686971279215,-0.0207924861987056,0.0308288065427465,0.703164271253581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,33162,-0.00938726188089913,0.0246578368052302,-0.0577166220191503,0.038942098257352,0.703434448594023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC4,Syndecan-4,33117,0.00710687929183496,0.0186707237988695,-0.0294877393539493,0.0437014979376192,0.703477541326791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12A_IL12B,Interleukin-12,33062,-0.0122926583888764,0.032335010909122,-0.0756692797707556,0.0510839629930028,0.70383188027881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC44A4,Choline transporter-like protein 4,31826,-0.0112170908608166,0.0295108184317624,-0.069058294987071,0.0466241132654378,0.703881409187913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUB1,NEDD8 ultimate buster 1,33109,0.0131881670313099,0.0347270508633018,-0.0548768526607616,0.0812531867233814,0.704128142863499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,31578,-0.00761692947398475,0.0200685728380664,-0.0469513322365948,0.0317174732886253,0.704294393324721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTH3,Cytohesin-3,31793,0.011388858154766,0.03002490632802,-0.0474599582481532,0.0702376745576851,0.704465902387972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC12,WAP four-disulfide core domain protein 12,33177,-0.00999314686471313,0.0264313479734992,-0.0617985888927715,0.0418122951633452,0.705380845606724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR1,TGF-beta receptor type-1,31816,-0.0033683374730089,0.0089097296006884,-0.0208314074903582,0.0140947325443404,0.705403163661323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRND,Prion-like protein doppel,32006,-0.00838526235645415,0.0221884131955614,-0.0518745522197544,0.0351040275068461,0.705506761667262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPL14,60S ribosomal protein L14,31854,0.00664661703259412,0.0176168447081609,-0.0278823985954013,0.0411756326605895,0.705970703777935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED10,Transmembrane emp24 domain-containing protein 10,31791,0.00826540925088685,0.0219826532916477,-0.0348205912007427,0.0513514097025164,0.706930076752806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZHX2,Zinc fingers and homeoboxes protein 2,32006,-0.00523982587002632,0.0139384584817145,-0.0325592044941868,0.0220795527541342,0.706982631030656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",33062,-0.0150298631654546,0.0400311084768349,-0.0934908357800511,0.0634311094491419,0.707331665892932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD8A,T-cell surface glycoprotein CD8 alpha chain,33191,-0.00764995046589668,0.0203932955204614,-0.0476208096860011,0.0323209087542077,0.707579690493584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSZ,Cathepsin Z,33106,0.00483618055378886,0.0129047497885382,-0.020457129031746,0.0301294901393237,0.70784834856128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36G,Interleukin-36 gamma,31786,-0.0104327118640005,0.0278920075843225,-0.0651010467292725,0.0442356230012716,0.708385760469023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK8,Kallikrein-8,32814,0.00551085818911151,0.0147449630728014,-0.0233892694335792,0.0344109858118022,0.708603418432922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA4,DnaJ homolog subfamily A member 4,32006,0.0112475004772808,0.0301138051415438,-0.0477755576001451,0.0702705585547067,0.708786968372852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD226,CD226 antigen,31816,-0.0064648874130952,0.0173101980701473,-0.0403928756305838,0.0274631008043934,0.708807367723404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKD2,Serine/threonine-protein kinase D2,31791,-0.00773904999267107,0.0207342517762268,-0.0483781834740757,0.0329000834887336,0.7089735065067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1A,C-type lectin domain family 1 member A,32973,-0.00501766078648597,0.0134479771785268,-0.0313756960563984,0.0213403744834265,0.709071096887025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NADK,NAD kinase,33117,-0.00873897440901409,0.0234384805540521,-0.0546783962949563,0.0372004474769281,0.709271209438114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,32973,-0.00322002152554691,0.00863734971096174,-0.0201492269590319,0.0137091839079381,0.709305062718775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A16,Protein S100-A16,32899,0.009542914192947,0.0257639624016217,-0.0409544521142316,0.0600402805001256,0.711095423047787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP4,Caspase-4,31908,0.0261055911922681,0.0706411220517039,-0.112351008029072,0.164562190413608,0.711726571008685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELT,Tumor necrosis factor receptor superfamily member 19L,33121,-0.00407345143074115,0.0110228547909789,-0.0256782468210598,0.0175313439595775,0.711729850514719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYAT1,Kynurenine--oxoglutarate transaminase 1,33103,-0.00888734339541969,0.0240619895399993,-0.0560488428938182,0.0382741561029789,0.711874428263419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5,Interleukin-5,32981,-0.0220351231714213,0.0598938361443751,-0.139427042014396,0.0953567956715539,0.712954678127826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKLR,Pyruvate kinase PKLR,33135,0.0103490009637989,0.0281382858676838,-0.0448020393368613,0.065500041264459,0.713038239277806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3,Interleukin-3,31793,0.00922006238780381,0.0251117529273219,-0.0399989733497472,0.0584390981253548,0.713509331308749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL6B,Myosin light chain 6B,31826,-0.0137739814948179,0.0375409939556069,-0.0873543296478073,0.0598063666581715,0.713700347835902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK3,Dickkopf-related protein 3,33208,0.00449131028800017,0.012244724398577,-0.0195083495332108,0.0284909701092112,0.713780398610003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADIPOQ,Adiponectin,32071,-0.010151370925837,0.0276923901857211,-0.0644284556898503,0.0441257138381762,0.713945349473823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAND5,DAN domain family member 5,31816,0.0084470340594309,0.0230580366563835,-0.0367467177870808,0.0536407859059426,0.714123433216475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BABAM1,BRISC and BRCA1-A complex member 1,31816,0.00429927988202036,0.0117412793466179,-0.0187136276373506,0.0273121874013913,0.714250294408721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRZB,Secreted frizzled-related protein 3,33010,-0.00406070276593233,0.0111015289963218,-0.0258196995987231,0.0176982940668584,0.714539260971147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,33062,-0.00672086319639266,0.0183863905863827,-0.0427581887457028,0.0293164623529175,0.714721311920371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWF,von Willebrand factor,33208,-0.0108311653723819,0.0296471574552587,-0.0689395939846889,0.0472772632399251,0.714869648239721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1B,Interleukin-1 beta,32936,-0.00863520607620317,0.0236415740450223,-0.0549726912044469,0.0377022790520406,0.714930078065367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA5,Annexin A5,32880,-0.00461774138194053,0.0126503845085222,-0.0294124950186441,0.020177012254763,0.715099851933065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COLEC12,Collectin-12,33121,-0.00373986854254971,0.0102520731947845,-0.0238339320043274,0.016354194919228,0.71527599377922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G4A,Cytosolic phospholipase A2,33167,-0.0131337581359094,0.0362318366687081,-0.0841481580065773,0.0578806417347586,0.71699304224443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS53,Vacuolar protein sorting-associated protein 53 homolog,33062,-0.0114998028565879,0.0317955255701413,-0.0738190329740649,0.050819427260889,0.717600116143384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMBS,Porphobilinogen deaminase,33189,-0.00686937696972164,0.0190264526668758,-0.0441612241967981,0.0304224702573548,0.718075661791832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2,Microtubule-associated protein 2,32006,-0.00672804570486558,0.018638816541359,-0.0432601261259293,0.0298040347161981,0.718132284714094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL19,C-C motif chemokine 19,33191,-0.0194173292281505,0.0538675999102558,-0.124997825052252,0.0861631665959508,0.718508903514498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP3,Stromelysin-1,33121,-0.00706291333650014,0.0196144230264875,-0.0455071824684156,0.0313813557954153,0.718790289950609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD2,Sushi domain-containing protein 2,33121,-0.00418468210776017,0.0116928659063473,-0.0271026992842009,0.0187333350686806,0.720439318974796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN6,Dynactin subunit 6,32911,-0.0105178781793296,0.0295308507748635,-0.0683983456980621,0.0473625893394028,0.721725307874016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOCK9,Dedicator of cytokinesis protein 9,31804,-0.0174070339511219,0.0488802256986149,-0.113212276320407,0.0783982084181633,0.721763860022885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPTC,Opticin,33062,0.00680474735205913,0.0191139849575159,-0.0306586631646721,0.0442681578687903,0.721842677533747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESAM,Endothelial cell-selective adhesion molecule,33208,0.00449380724749086,0.0126372502529312,-0.0202752032482543,0.029262817743236,0.722148647066717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE3,Eosinophil cationic protein,33077,0.0164840415171208,0.0463931037352291,-0.0744464418039283,0.10741452483817,0.722364312123348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,32981,-0.00633750679788056,0.0178558786636775,-0.0413350289786884,0.0286600153829273,0.722654174422934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAX,Apoptosis regulator BAX,32899,-0.012998937677822,0.036624663131894,-0.0847832774163343,0.0587854020606903,0.722656089789686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17A,Interleukin-17A,32973,-0.00618711044623013,0.0174411019912397,-0.0403716703490599,0.0279974494565996,0.72279084412408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF12,Rho guanine nucleotide exchange factor 12,33109,-0.0149875075190563,0.0422810665032172,-0.097858397865362,0.0678833828272493,0.722992873421542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARBP2,RISC-loading complex subunit TARBP2,32911,-0.0115216176139407,0.032532393165995,-0.0752851082192909,0.0522418729914095,0.723229067228021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAM1,Vascular cell adhesion protein 1,33127,-0.0039755207537382,0.0112320991715268,-0.0259904351299307,0.0180393936224543,0.723390344413771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBIN,Erbin,33062,-0.0150079668071787,0.0424766162623437,-0.0982621346813723,0.068246201067015,0.72385493142263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB1,Lamin-B1,31982,-0.00904839677509851,0.0256198419011821,-0.0592632869014155,0.0411664933512185,0.723963942619969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLINT1,Clathrin interactor 1,31793,-0.0067875367521804,0.0192272521030228,-0.0444729508741052,0.0308978773697444,0.724086225558482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,31907,0.00555842281227135,0.0158697775670104,-0.0255463412190691,0.0366631868436118,0.726159409995467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB1,Beta-crystallin B1,32042,-0.00931784783813554,0.0267918881760465,-0.0618299486631866,0.0431942529869156,0.728010430464748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3,Receptor-type tyrosine-protein kinase FLT3,32951,0.00451246883592742,0.0129823502640362,-0.0209329376815836,0.0299578753534384,0.728160560094268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL13,C-C motif chemokine 13,33189,-0.00996854527009312,0.0286966695159654,-0.0662140175213853,0.046276926981199,0.728316940653548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLC,Galectin-10,33105,-0.0095721635894959,0.0276149229693239,-0.0636974126093708,0.044553085430379,0.728877656311885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,32951,0.0140840095282522,0.0406332457232373,-0.065557152089293,0.0937251711457974,0.728890689964874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXDNL,Peroxidasin-like protein,31990,-0.00765929837885032,0.0221772302728028,-0.0511266697135439,0.0358080729558432,0.729827614932533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLFM4,Olfactomedin-4,31658,-0.0172676732991895,0.0501683500138996,-0.115597639326433,0.0810622927280537,0.73071001443878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,31793,-0.0117261533319488,0.0340779108517587,-0.0785188586013959,0.0550665519374983,0.730782169790771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),H2AP,Huntingtin-interacting protein M,31793,-0.00687611220202455,0.0200071486593662,-0.0460901235743823,0.0323378991703332,0.731094715553329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLG4,Disks large homolog 4,32006,-0.0100072319542004,0.0291289290474279,-0.067099932887159,0.0470854689787581,0.731194593589771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS4,Thrombospondin-4,33111,-0.00642637524820121,0.0187146898154973,-0.0431071672865759,0.0302544167901734,0.731315913706913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PZP,Pregnancy zone protein,32071,-0.0091468392296631,0.0267208149650249,-0.061519636561112,0.0432259581017858,0.7321260093316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",31791,-0.0091402937708859,0.026707199691246,-0.0614864051657281,0.0432058176239563,0.732179472493392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD209,CD209 antigen,33117,-0.00545955925362666,0.0160140837349707,-0.0368471633741693,0.025928044866916,0.733170295325078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C3A,Cytosolic 5'-nucleotidase 3A,33099,-0.0125040647191145,0.0366989068293934,-0.0844339221047255,0.0594257926664965,0.733322387793297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD4,Sushi domain-containing protein 4,31990,-0.00624460942336315,0.0183453897691965,-0.0422015733709882,0.0297123545242619,0.733571422443085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX1,"Adrenodoxin, mitochondrial",31791,-0.00905837309308151,0.0266156144465342,-0.0612249774082885,0.0431082312221255,0.733609817512493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4R,Interleukin-4 receptor subunit alpha,33109,-0.00496748743410433,0.0146085766512362,-0.0336002976705273,0.0236653228023186,0.733835323615837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSNAX,Translin-associated protein X,31791,-0.00569012085871608,0.0167593137590543,-0.0385383758264625,0.0271581341090304,0.734227808874269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL25,Interleukin-25,31767,-0.00492386657508906,0.0145252683493574,-0.0333933925398296,0.0235456593896515,0.734629801837946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",32981,-0.0100475317680427,0.0298416883306079,-0.0685372408960342,0.0484421773599488,0.736355507981224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER2,Low affinity immunoglobulin epsilon Fc receptor,33121,0.00665535483811578,0.0197801486691685,-0.0321137365534545,0.045424446229686,0.736527350982484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,33162,0.00483861739019579,0.0144029740562514,-0.023391211760057,0.0330684465404486,0.736919896249614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",33109,0.0131529561336771,0.0392393678444021,-0.063756204841351,0.0900621171087053,0.737483881068052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMFR,E3 ubiquitin-protein ligase AMFR,32911,0.00898009156074975,0.026809655470539,-0.0435668331615067,0.0615270162830062,0.737665553205061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP3,Caspase-3,33208,-0.012178081854326,0.0364153805675653,-0.083552227766754,0.0591960640581021,0.738069617373226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,33208,-0.00399081737806713,0.0119733901517026,-0.0274586620754043,0.01947702731927,0.738910371050466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPT1,Palmitoyl-protein thioesterase 1,31826,-0.0104623911805273,0.0313977113357122,-0.0720019053985232,0.0510771230374685,0.738976594617003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,31908,-0.00863995054925003,0.0259376476765391,-0.0594777399952667,0.0421978388967666,0.739064669974471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DARS1,"Aspartate--tRNA ligase, cytoplasmic",33030,-0.0101369285668249,0.0304340474480285,-0.0697876615649607,0.049513804431311,0.739083126355637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,31826,0.0066692602030322,0.0200293024446456,-0.0325881725884732,0.0459266929945377,0.739162499139787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4D,C-type lectin domain family 4 member D,33109,-0.00840552650827273,0.0252473549342751,-0.0578903421794519,0.0410792891629065,0.739197438678528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK13,Mitogen-activated protein kinase 13,31793,-0.00594253002951682,0.0181461040575984,-0.0415088939824098,0.0296238339233761,0.743312377237292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI4,Protein-arginine deiminase type-4,32899,-0.00990971322907642,0.0302979662171887,-0.0692937270147663,0.0494743005566135,0.743619116455404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST3,Cystatin-C,33124,-0.00372185663301494,0.0113852476576119,-0.0260369420419343,0.0185932287759044,0.743750136989428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK4,Dickkopf-related protein 4,33032,-0.00626153300528066,0.0191853316217062,-0.0438647829838248,0.0313417169732635,0.744151749035537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG6,Large proline-rich protein BAG6,32973,-0.00490719805741583,0.0150578122860795,-0.0344205101381316,0.0246061140233,0.744515201966509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L2,Mortality factor 4-like protein 2,31793,0.0050167984179911,0.0154154039790741,-0.0251973933809941,0.0352309902169763,0.744856902149542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1LG2,Programmed cell death 1 ligand 2,33062,0.00414919966302921,0.0128109316646412,-0.0209602263996675,0.0292586257257259,0.74603704169338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AAMDC,Mth938 domain-containing protein,31854,0.00721932291674476,0.0223126229266949,-0.0365134180195773,0.0509520638530669,0.746285384660598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIE,Peptidyl-prolyl cis-trans isomerase E,31908,0.00836812907251378,0.0258847372068017,-0.0423659558528176,0.0591022139978452,0.746489011420976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMD,Dystrophin,31854,-0.00679123547532427,0.0210094524904525,-0.0479697623566112,0.0343872914059627,0.746517572985289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD4B,FERM domain-containing protein 4B,31791,0.00940454529824195,0.0291257197484627,-0.047681865408745,0.0664909560052289,0.746784065313212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9,Complement component C9,32048,-0.00649154659773315,0.0201217872124658,-0.0459302495341661,0.0329471563386998,0.746997359540448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,33121,-0.00494310164372504,0.015369545210155,-0.0350674102556289,0.0251812069681788,0.747750882633271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200R1,Cell surface glycoprotein CD200 receptor 1,33076,0.00459728565409256,0.0142953176963984,-0.0234215370308483,0.0326161083390334,0.747768229293371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRG1,Leucine-rich alpha-2-glycoprotein,32071,-0.0034603276805318,0.010761364347542,-0.0245526018017142,0.0176319464406506,0.747801675752928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORC3,MORC family CW-type zinc finger protein 3,32006,-0.00374796303402604,0.011668381625543,-0.0266179910200902,0.0191220649520382,0.748062597359907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC50,Coiled-coil domain-containing protein 50,32020,0.0104067435480588,0.0324297877284406,-0.0531556403996849,0.0739691274958024,0.748294458205111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH7B,Myosin-7B,31793,-0.00599577513891877,0.0186993880253849,-0.0426465756686733,0.0306550253908357,0.748492211538887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2,Apoptosis regulator Bcl-2,31998,-0.00727242168662164,0.0227869272837296,-0.0519347991627316,0.0373899557894883,0.749622474355853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,32020,-0.0140334997377935,0.0440272561294088,-0.100326921751435,0.0722599222758478,0.74992813332426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTTG1,Securin,31908,-0.00557190897063737,0.0174848454117052,-0.0398422059775796,0.0286983880363049,0.749985115986717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NSFL1C,NSFL1 cofactor p47,33191,-0.00883914269467113,0.0277977075376337,-0.0633226494684331,0.0456443640790909,0.750506951088643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR2,TGF-beta receptor type-2,33126,0.0040019845065046,0.0125967117868221,-0.0206875705956667,0.0286915396086759,0.750719606291799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,32911,-0.00819194807250618,0.0258971848738006,-0.0589504304251554,0.042566534280143,0.751763025064828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMOD4,Tropomodulin-4,31793,-0.00538997693168493,0.0170500933176889,-0.0388081598343552,0.0280282059709854,0.751915899027434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFER,FAD-linked sulfhydryl oxidase ALR,32951,-0.0084151083939886,0.0266484774753382,-0.0606461242456514,0.0438159074576742,0.752175767294892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR101,Probable G-protein coupled receptor 101,31804,-0.00814512939070552,0.0258869657155786,-0.0588835821932396,0.0425933234118285,0.753042334907987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGFR,Opioid growth factor receptor,33062,0.00437987470087862,0.013931161832823,-0.0229252024914545,0.0316849518932117,0.753229375254363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3F,Semaphorin-3F,33117,0.00336025739888875,0.0106960446634937,-0.0176039901415588,0.0243245049393363,0.753407935767411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANK2,Ankyrin-2,31791,-0.00930799931815894,0.0296561714783131,-0.0674340954156526,0.0488180967793348,0.753633389453415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11B,Transmembrane protease serine 11B,31804,-0.0101264446786195,0.0324291435027806,-0.0736875659440694,0.0534346765868304,0.754848972599177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIN2,Bridging integrator 2,33121,-0.0117598642091543,0.0376648024296518,-0.0855828769712718,0.0620631485529632,0.754877622838128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROCR,Endothelial protein C receptor,31791,-0.00457614053101818,0.0147531048899029,-0.0334922261152278,0.0243399450531914,0.756431728758108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHODH,Dihydroorotate dehydrogenase,31791,0.00641207887103245,0.0206935691540342,-0.0341473166708746,0.0469714744129395,0.756677339326547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN4,Nectin-4,33126,-0.00373797408492572,0.0120750603487769,-0.0274050923685285,0.0199291441986771,0.756901855126908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH1,Somatotropin,33107,0.0224112883653914,0.0725390745494791,-0.119765297751588,0.16458787448237,0.757363419047057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASRGL1,Isoaspartyl peptidase/L-asparaginase,31854,0.0130437341009581,0.0422651407415548,-0.0697959417524893,0.0958834099544056,0.757621695744175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF5,Fibroblast growth factor 5,32981,0.00408351611238615,0.0132779169437618,-0.0219412010973869,0.0301082333221592,0.758438427166356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP1,Inositol polyphosphate 1-phosphatase,33062,0.00695908329957625,0.022634115717528,-0.0374037835067786,0.0513219501059311,0.758500765680335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAB2,Disabled homolog 2,33189,-0.0142126592443963,0.0462283167033632,-0.104820159982988,0.0763948414941956,0.758512100381501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNER,Delta and Notch-like epidermal growth factor-related receptor,33101,-0.00312523386295152,0.0101712843021479,-0.0230609510951614,0.0168104833692583,0.758652499231363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF2,Growth/differentiation factor 2,33117,-0.00449383798552683,0.014633951163112,-0.0331763822652263,0.0241887062941727,0.758787557639597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB4,Ephrin type-B receptor 4,33208,-0.00307265817300699,0.0100061152679956,-0.0226846440982784,0.0165393277522645,0.758791281775226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,31907,0.00268385177701523,0.00874408819318761,-0.0144545610816325,0.0198222646356629,0.758902720365201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUOX,"Sulfite oxidase, mitochondrial",32020,-0.00798381737706491,0.0260124328324386,-0.0589681857286445,0.0430005509745147,0.758910325174064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBR1,T-box brain protein 1,31826,0.00623018847254134,0.0203454169013652,-0.0336468286541344,0.0461072055992171,0.759445232734269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH1,Cadherin-1,32814,-0.00502139158603894,0.0164094770579424,-0.037183966619606,0.0271411834475281,0.759608013160062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA11,Carbonic anhydrase-related protein 11,32951,-0.00400823429748537,0.0131197925206207,-0.029723027637902,0.0217065590429313,0.759984860536476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM7,PDZ and LIM domain protein 7,33167,0.015915298855738,0.0521955003591536,-0.0863878818482031,0.118218479559679,0.760436598432332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM1,Myomesin-1,31804,0.00614907480477474,0.0202398948291756,-0.0335211190604095,0.045819268669959,0.761281532865351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP152,Centrosomal protein of 152 kDa,31793,-0.00540162145549928,0.0177949342195964,-0.0402796925259083,0.0294764496149097,0.761480671521518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFD,Vascular endothelial growth factor D,33189,-0.00414969500802708,0.0137073014800087,-0.0310160059088441,0.0227166158927899,0.762098190261737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECM1,Extracellular matrix protein 1,31861,0.00451236766224146,0.0149163152108298,-0.0247236101509849,0.0337483454754678,0.7622701097077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRM,Receptor-type tyrosine-protein phosphatase mu,33097,-0.00307692514068456,0.0101792693661923,-0.0230282930984215,0.0168744428170523,0.762450717806047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,33136,-0.00364318248534717,0.0120528744826067,-0.0272668164712563,0.0199804515005619,0.762456007194904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAPIN,SNARE-associated protein Snapin,32020,-0.00719265953168398,0.0238298740320048,-0.0538992126344133,0.0395138935710454,0.76278711753955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARA5,Scavenger receptor class A member 5,33191,-0.00358768398448206,0.0119131906126307,-0.0269375375852383,0.0197621696162741,0.763305575411681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN2,Centrin-2,32911,0.00829951277608718,0.0275828262528918,-0.0457628266795807,0.062361852231755,0.76350255908323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH1A1,Retinal dehydrogenase 1,33121,-0.00672768677057645,0.0224251542264165,-0.0506809890543528,0.0372256155131999,0.764179569670644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS15,Enteropeptidase,33062,-0.0113971798177771,0.0380103822626974,-0.0858975290526639,0.0631031694171098,0.764303494808377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTC,Probetacellulin,32951,-0.00932494234515965,0.0311544374180263,-0.0703876396844912,0.0517377549941719,0.764708207063354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATOX1,Copper transport protein ATOX1,33126,-0.00885468872084957,0.0296247097156401,-0.0669191197635041,0.049209742321805,0.765027036463856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USO1,General vesicular transport factor p115,33062,-0.0112026084306679,0.037566979525993,-0.0848338883016141,0.0624286714402783,0.765554972127926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREB3,Cyclic AMP-responsive element-binding protein 3,31793,0.00693918558222563,0.0233067722769049,-0.038742088080508,0.0526204592449593,0.765915695826436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM21,E3 ubiquitin-protein ligase TRIM21,33109,-0.0097582566966658,0.0328176912735109,-0.0740809315927472,0.0545644181994156,0.766208396286671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPS,Colipase,33111,-0.00850727527643381,0.0286256111858745,-0.0646134732007478,0.0475989226478802,0.766327787792056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPJ,Centromere protein J,31908,0.00912970200354222,0.0307377366564963,-0.0511162618431906,0.069375665850275,0.766460024039211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREM2,Triggering receptor expressed on myeloid cells 2,33121,-0.00607526713624594,0.020529045250663,-0.0463121958275454,0.0341616615550535,0.767286656116757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXTL1,Exostosin-like 1,31791,0.00582893794576229,0.0197383964715013,-0.0328583191383802,0.0445161950299048,0.767765738325282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCC,Netrin receptor DCC,31826,-0.00269714257862074,0.009149167659209,-0.0206295111906704,0.0152352260334289,0.768157641121324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPN3,Calpain-3,31990,-0.00442167330280342,0.0150061092553257,-0.0338336474432417,0.0249903008376349,0.768263103602993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR2,Complement receptor type 2,33138,-0.00565408429935688,0.0192071151058044,-0.0433000299067336,0.0319918613080198,0.768478808706805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,31998,-0.0210078872933897,0.0713869357917689,-0.160926281445257,0.118910506858477,0.768550551841883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTB,Lymphotoxin-beta,31990,-0.00421401024582397,0.01437525832754,-0.0323895165678024,0.0239614960761545,0.769420712764583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC28A1,Sodium/nucleoside cotransporter 1,31793,0.00742821302587372,0.0253498251129176,-0.0422574441954447,0.0571138702471922,0.769508897240383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D17,TBC1 domain family member 17,32911,-0.00555429010013445,0.0189565466798788,-0.0427091215926969,0.031600541392428,0.769528454781315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC22D1,TSC22 domain family protein 1,32020,-0.00817303554408933,0.027956284141414,-0.0629673524612608,0.0466212813730821,0.770026613179334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNDA,Myeloid cell nuclear differentiation antigen,33105,0.0122762865511453,0.0421433153196839,-0.0703246114754352,0.0948771845777258,0.770829980191973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO2,Roundabout homolog 2,33191,-0.00280109003872033,0.00961900884481684,-0.0216543473745613,0.0160521672971207,0.77090251772088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAK4,Serine/threonine-protein kinase PAK 4,32911,-0.00741855382290222,0.0255261330832257,-0.0574497746660246,0.0426126670202201,0.771344621260696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP13,Collagenase 3,32911,-0.00393049349451248,0.0135255726678485,-0.0304406159234956,0.0225796289344707,0.771366528557729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7A,B-cell CLL/lymphoma 7 protein family member A,31793,-0.00735056929526243,0.0254201309369521,-0.0571740259316886,0.0424728873411638,0.77246457004455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ING1,Inhibitor of growth protein 1,32899,0.00554496552179828,0.0192976880520122,-0.0322785030601456,0.0433684341037421,0.773860322226423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEF,Thyrotroph embryonic factor,31791,0.00503913705832887,0.0175575214443904,-0.0293736049726762,0.039451879089334,0.774114822975785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN1A1,Butyrophilin subfamily 1 member A1,31976,-0.00484311440809401,0.0168836799525832,-0.0379351271151571,0.0282488982989691,0.774233677631984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBZ,Hemoglobin subunit zeta,32042,-0.0122897913774111,0.0429890932432294,-0.0965484141341407,0.0719688313793185,0.774976597605859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYDC1,Pyrin domain-containing protein 1,31854,-0.00498353319237632,0.0174368628039292,-0.0391597842880775,0.0291927179033248,0.775035887967728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF75D,Zinc finger protein 75D,31908,-0.00730766590997417,0.025723419780744,-0.0577255686802323,0.043110236860284,0.776352290299809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA2,Protein disulfide-isomerase A2,31793,0.0048715073806424,0.0171631202877328,-0.0287682083833138,0.0385112231445986,0.776544249115537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN7,Septin-7,31908,-0.0061977766521504,0.0218495242261628,-0.0490228441354296,0.0366272908311288,0.776680910509289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINK1,Misshapen-like kinase 1,32006,-0.0107835120455347,0.0380858064917319,-0.0854316927693292,0.0638646686782599,0.777079355641765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKBKG,NF-kappa-B essential modulator,33109,0.0106300109888918,0.0375485286884208,-0.062965105240413,0.0842251272181966,0.777106490929705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB2,Dynein regulatory complex protein 8,31908,0.00415136654348653,0.0146801433234265,-0.0246217143704293,0.0329244474574024,0.777347299104134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP1,Rho GTPase-activating protein 1,32951,-0.00544718945668059,0.0193011628802653,-0.0432774687020006,0.0323830897886394,0.777781089028819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZT1,Mitotic-spindle organizing protein 1,32951,0.00609082993292775,0.0215869686993489,-0.036219628717796,0.0484012885836515,0.777832996083657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL4,Early placenta insulin-like peptide,31990,-0.00608991590846948,0.0216289033577221,-0.0484825664896048,0.0363027346726658,0.778285740774202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX25,ATP-dependent RNA helicase DDX25,31826,0.00466735486200637,0.0165935027835579,-0.027855910593767,0.0371906203177798,0.778506573084545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAV3,Guanine nucleotide exchange factor VAV3,31804,-0.0114863013088265,0.0408447051076449,-0.0915419233198105,0.0685693207021575,0.77855045574704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R9B,Neurabin-2,33208,0.0109926551197453,0.0392054275122804,-0.0658499828043243,0.087835293043815,0.779187959326482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLSCR3,Phospholipid scramblase 3,31988,-0.00690367463888983,0.024626342723619,-0.0551713063771832,0.0413639570994035,0.779226673840415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSNL1,Visinin-like protein 1,32006,-0.00431325230222808,0.0154211139037442,-0.0345386355535668,0.0259121309491106,0.779716990894344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP10,Bone morphogenetic protein 10,31907,0.00325784045389062,0.0116818316959011,-0.0196385496700756,0.0261542305778568,0.780343915151111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL6,C-X-C motif chemokine 6,33208,-0.00897829764901007,0.0322130980164803,-0.0721159697613116,0.0541593744632914,0.780469559420317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGT1,Protein SGT1 homolog,32951,-0.00940644200363556,0.0337549762453972,-0.0755661954446142,0.056753311437343,0.780506168225646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RA,Interleukin-10 receptor subunit alpha,32981,-0.00704573743266557,0.0253571414817629,-0.0567457347369209,0.0426542598715898,0.781126501925839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,33191,0.00533498014954059,0.0192075435906794,-0.0323118052881911,0.0429817655872723,0.781207452077603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP4,Bone morphogenetic protein 4,33024,-0.00520384865231359,0.0187410333617878,-0.0419362740414177,0.0315285767367906,0.781271326420532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCT5,T-complex protein 1 subunit epsilon,32951,0.00526105539601331,0.0189514623259799,-0.0318838107629073,0.0424059215549339,0.781320940102315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,31998,-0.0124178814050696,0.0447797261373987,-0.100186144634371,0.0753503818242318,0.781549411295632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZCCHC8,Zinc finger CCHC domain-containing protein 8,31791,-0.00733516991132477,0.0265132458537893,-0.0593011317847518,0.0446307919621023,0.782048536198705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGA,Fibrinogen alpha chain,31878,0.00354804502053504,0.0128374858899394,-0.0216134273237462,0.0287095173648163,0.782262671258637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB1,Pleckstrin homology-like domain family B member 1,31998,0.00602194267038377,0.0218011788217951,-0.0367083678203347,0.0487522531611022,0.782385919467039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF1C,Kinesin-like protein KIF1C,31791,-0.00430788009674989,0.0156081303351536,-0.0348998155536509,0.0262840553601511,0.782554059820238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB39B,Ras-related protein Rab-39B,31791,0.0102239390349973,0.0370856794041716,-0.0624639925971791,0.0829118706671737,0.782798328001166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA1,von Willebrand factor A domain-containing protein 1,33176,-0.00475083360608273,0.0172378699207202,-0.0385370586506944,0.029035391438529,0.782858421213623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDI2,Protein DDI1 homolog 2,31907,0.00913697336377225,0.0332204226003967,-0.0559750549330053,0.0742490016605498,0.783292474085923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMT,Catechol O-methyltransferase,32874,-0.00973175239890753,0.0354139883290843,-0.0791431695239128,0.0596796647260977,0.783476890143085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB33A,Ras-related protein Rab-33A,31791,-0.00756283466617152,0.0275323843274782,-0.0615263079480289,0.0464006386156859,0.783563150653798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,33129,-0.00675549156417419,0.024697327130888,-0.0551622527407147,0.0416512696123663,0.78445135918804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBN2,Fibrillin-2,31826,-0.00674285384667569,0.024658964806829,-0.0550744248680604,0.0415887171747091,0.78451934654425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGK,N-acetyl-D-glucosamine kinase,31843,-0.00647862119072222,0.0237929782960143,-0.0531128586509102,0.0401556162694657,0.785405644886942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM5,PDZ and LIM domain protein 5,32020,-0.0132020592207168,0.0485271229035018,-0.10831522011158,0.0819111016701467,0.785586948308101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDC,Nuclear migration protein nudC,33208,-0.00713646597587097,0.0262547212314831,-0.0585957195895778,0.0443227876378358,0.785769539487235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,32790,0.00416138988379851,0.0153462585320961,-0.0259172768391099,0.0342400566067069,0.786269756464429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SV2A,Synaptic vesicle glycoprotein 2A,31826,0.00700387459213784,0.0258571284044491,-0.0436760970805824,0.057683846264858,0.78649996230934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFX1,Transcriptional repressor NF-X1,31791,0.00749479519171515,0.0279094240227302,-0.0472076758928361,0.0621972662762664,0.788291279823677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSR,Insulin receptor,31816,-0.00185549548668626,0.00691299866480482,-0.0154049728697037,0.0116939818963312,0.788393764609627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP10,Inactive dipeptidyl peptidase 10,33109,-0.00373902964462097,0.0139311724534297,-0.0310441276533431,0.0235660683641012,0.788403195849267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BA,Platelet glycoprotein Ib alpha chain,33080,0.00357510898211338,0.0133396788037656,-0.0225706614732673,0.029720879437494,0.788701394101348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM3,Dynamin-3,32020,-0.00612020505603617,0.022893759076787,-0.0509919728465387,0.0387515627344663,0.789221821937158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIFBP,KIF-binding protein,33062,-0.00914281736793626,0.0342045621897837,-0.0761837592599124,0.0578981245240399,0.789245986750617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TST,Thiosulfate sulfurtransferase,32901,-0.0083058869990134,0.0311090106812673,-0.0692795479342973,0.0526677739362705,0.789481093871802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFA1_DEFA1B,Neutrophil defensin 1,32920,0.00591480937364633,0.0222050661404411,-0.0376071202616182,0.0494367390089109,0.789959160869352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4M,C-type lectin domain family 4 member M,32028,0.00526935974176282,0.0197907587768287,-0.0335205274608214,0.0440592469443471,0.790051191186719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAME,Melanoma antigen preferentially expressed in tumors,31793,0.0028476941040484,0.010701237910284,-0.0181267322001083,0.0238221204082051,0.790162853379781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDR,Vascular endothelial growth factor receptor 2,33126,0.00282038059555311,0.0106036139054275,-0.0179627026590847,0.023603463850191,0.790258655378378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA10,Annexin A10,32911,0.00911527253840085,0.034325529213667,-0.0581627647203865,0.0763933097971882,0.790589390744793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP43,Centrosomal protein 43,32894,-0.00760455265860092,0.0286955230954119,-0.0638477779256082,0.0486386726084063,0.791009514789407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXN,Paxillin,32911,0.00579402235173393,0.0219712915101351,-0.0372697090081309,0.0488577537115988,0.792010757530615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSND,Barttin,31793,0.00373595201579886,0.0142229843674664,-0.0241410973444353,0.031613001376033,0.792812273881125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,31816,-0.00474926400332487,0.0181248932028577,-0.040274054680926,0.0307755266742762,0.793305717241409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS2,RNA-binding protein with multiple splicing 2,31854,0.0111985497816186,0.0428194146366367,-0.0727275029061894,0.0951246024694266,0.79369130539013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THRAP3,Thyroid hormone receptor-associated protein 3,31791,-0.0128223356873517,0.049115223647962,-0.109088174037357,0.0834435026626539,0.79404861080495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABL1,Tyrosine-protein kinase ABL1,33062,-0.00740957383045756,0.0283963803634756,-0.0630664793428697,0.0482473316819546,0.794149842975406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300E,CMRF35-like molecule 2,33158,-0.00435937543220455,0.0167189435603699,-0.0371285048105296,0.0284097539461205,0.794295582075228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSG1,Tryptase gamma,31816,-0.00292537571268629,0.0112197675716578,-0.0249161201531356,0.019065368727763,0.79430487762567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTCN1,V-set domain-containing T-cell activation inhibitor 1,32951,0.00352608304491777,0.013536080952938,-0.0230046356228408,0.0300568017126763,0.794488189152369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFH,Complement factor H,31598,-0.00252154485790708,0.00971206724236129,-0.0215571966529352,0.0165141069371211,0.795156605540016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,32973,-0.00322998601619729,0.0124590749997885,-0.0276497730157827,0.0211898009833881,0.795450424371638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB2,Lysosome membrane protein 2,32879,-0.00319822786576534,0.0123481705162685,-0.0274006420776515,0.0210041863461209,0.795638336061929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC2,PDZ domain-containing protein GIPC2,32006,0.00313173508401262,0.0121107084977331,-0.0206052535715443,0.0268687237395695,0.795956926407056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9orf40,Uncharacterized protein C9orf40,31998,-0.0089367897577579,0.0345882585292152,-0.0767297764750197,0.0588561969595039,0.796123474217526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RAP,Interleukin-1 receptor accessory protein,33121,0.0046492522956325,0.0179966594879229,-0.0306242003006963,0.0399227048919613,0.796150853243709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPC,C-type natriuretic peptide,33109,-0.00453921417304539,0.0175822641171363,-0.0390004518426325,0.0299220234965417,0.796281800978143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSMR,Oncostatin-M-specific receptor subunit beta,33148,0.00221626399146875,0.00859836861289999,-0.0146365384898152,0.0190690664727527,0.796602859015512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC13,Mucin-13,32911,-0.00522649294644139,0.0203156398960634,-0.0450451471427257,0.0345921612498429,0.796980852398297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGF,Hepatoma-derived growth factor,33181,0.010049365337833,0.0393188148408312,-0.0670155117501963,0.0871142424258622,0.798276026906108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD55,Complement decay-accelerating factor,32806,0.00266754335664007,0.010437423644688,-0.0177898069869485,0.0231248937002286,0.798285404721612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLR1,Oxidized low-density lipoprotein receptor 1,33034,0.00629204624345838,0.0246296305967598,-0.0419820297261907,0.0545661222131075,0.798368914114721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDK2,Protein sidekick-2,31907,-0.00398059548475924,0.0156323986427785,-0.0346200968246051,0.0266589058550866,0.799010087892798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",33126,-0.00366163047950806,0.0144835944447319,-0.0320494755911827,0.0247262146321665,0.800419271479272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM2,Intercellular adhesion molecule 2,33208,-0.00320737633859511,0.0127051553309005,-0.02810948078716,0.0216947281099698,0.80070162325771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD7,T-cell antigen CD7,31798,-0.00451318037643585,0.0179269391648691,-0.0396499811395793,0.0306236203867076,0.801238182612675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD28,T-cell-specific surface glycoprotein CD28,32951,-0.00372243332528733,0.0148613712928764,-0.0328507210593251,0.0254058544087504,0.80222445903087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERCC1,DNA excision repair protein ERCC-1,31793,0.00334592034970516,0.0133596834207716,-0.0228390591550071,0.0295308998544174,0.80224709116799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGF,Beta-nerve growth factor,33042,0.00124218060292376,0.0049600651038911,-0.00847954700070279,0.0109639082065503,0.802255910696711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1C4,Aldo-keto reductase family 1 member C4,32973,0.00562435818634888,0.0224693983290739,-0.0384156625386359,0.0496643789113336,0.802352175389628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",31816,0.00633206932541886,0.0253136288327622,-0.043282643186795,0.0559467818376327,0.802482450109996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX3,Syntaxin-3,32006,-0.00400701052795304,0.0160396187116131,-0.0354446632027148,0.0274306421468087,0.802733683702955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,33150,-0.00915758985548651,0.036659254717758,-0.0810097291022921,0.0626945493913191,0.802745639935175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP7,GTPase IMAP family member 7,31907,-0.00358066089975258,0.014335679716662,-0.0316785931444101,0.024517271344905,0.802770043363081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ORM1,Alpha-1-acid glycoprotein 1,32047,-0.00204125072054388,0.00817553980669775,-0.0180653087416715,0.0139828073005837,0.802843286720598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R1,Interleukin-1 receptor type 1,33109,0.00228022982046786,0.00915610217630209,-0.0156657304450842,0.02022619008602,0.803336243913237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED21,Mediator of RNA polymerase II transcription subunit 21,31791,-0.00524608206336051,0.0210772924849458,-0.0465575753338543,0.0360654112071333,0.803447156636986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",33062,0.00427610988283873,0.0171867737716707,-0.0294099667096358,0.0379621864753133,0.803519599415053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DXO,Decapping and exoribonuclease protein,32006,-0.00469888464304602,0.0189028012507089,-0.0417483750944354,0.0323506058083434,0.80369136147668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REPS1,RalBP1-associated Eps domain-containing protein 1,31816,-0.00407174638848643,0.0163874748285227,-0.0361911970523909,0.0280477042754181,0.803780043395021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM25,Transmembrane protein 25,32020,-0.00455453116974278,0.0183726849594489,-0.0405649936902626,0.0314559313507771,0.804220923977662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1,Macrophage colony-stimulating factor 1,33167,-0.00275649487926756,0.0111311879358416,-0.024573623233517,0.0190606334749819,0.804421052116219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP5,Microfibrillar-associated protein 5,33208,-0.0040792480408998,0.0164777136536921,-0.0363755668021364,0.0282170707203368,0.804479481745297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNIP1,TNFAIP3-interacting protein 1,32006,-0.00909197762132324,0.0367626140244944,-0.0811467011093322,0.0629627458666857,0.804670504206964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,31990,-0.00843133792810522,0.0341153134330222,-0.0752973522568287,0.0584346764006183,0.80480480826724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A14,Zinc transporter ZIP14,32911,-0.00337168983953082,0.0136737137703627,-0.0301721688294417,0.02342878915038,0.805237824455042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R2,Protein phosphatase inhibitor 2,33117,-0.00814914288493955,0.0331699231849873,-0.0731621923275147,0.0568639065576356,0.805936797321245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",32981,0.00588617714249728,0.0239627922344295,-0.0410808956369846,0.0528532499219791,0.805968226341756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL1,Growth-regulated alpha protein,33106,0.00991355484376953,0.0405033339088173,-0.0694729796175124,0.0893000893050514,0.806648857329165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHR1,Corticotropin-releasing factor receptor 1,32973,0.00631895522096104,0.0258738924802432,-0.0443938740403156,0.0570317844822377,0.807065324456665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6,Seizure protein 6 homolog,31826,0.00301239055189021,0.0123686199250395,-0.0212301045011872,0.0272548856049676,0.807585306694743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL4,ADAMTS-like protein 4,31854,0.00231210176052783,0.00952441727122785,-0.0163557560910788,0.0209799596121344,0.808201773632245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A4,Collagen alpha-4(IV) chain,31893,0.00523155121518389,0.0215618553811913,-0.0370296853319511,0.0474927877623189,0.808298789185043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C5,Complement C5,32071,0.00151908090795593,0.0062680457653644,-0.0107662887921583,0.0138044506080701,0.808513022709054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMR1,Synaptic functional regulator FMR1,32951,-0.00354952871036199,0.0146526504481392,-0.0322687235887148,0.0251696661679908,0.808596310573401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,32071,0.00191750750302893,0.00793971933283586,-0.0136443423893293,0.0174793573953872,0.809167743667095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESYT2,Extended synaptotagmin-2,32006,-0.008139538462737,0.0339534228872287,-0.0746882473217053,0.0584091703962313,0.810548720368457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KEL,Kell blood group glycoprotein,32911,-0.0034884295850271,0.0145527764634024,-0.0320118714532957,0.0250350122832415,0.810561766989955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT3,Dynein light chain Tctex-type 3,31990,-0.00436588880732172,0.0182178105673532,-0.0400727975193341,0.0313410199046906,0.81060851960799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2B3,SH2B adapter protein 3,32951,0.00968302898477262,0.0404653808018762,-0.0696291173869048,0.08899517535645,0.810885185917281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMTN,Smoothelin,31995,0.00955882688569437,0.0400035055048949,-0.0688480439038997,0.0879656976752884,0.81115105398217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL14,C-C motif chemokine 14,33083,0.00386642827100216,0.0162020605578408,-0.0278896104223659,0.0356224669643702,0.811391916881632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTBS,Di-N-acetylchitobiase,31930,-0.00262110187571464,0.0109893104184473,-0.0241601502958713,0.018917946544442,0.811489170763801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRS,Receptor-type tyrosine-protein phosphatase S,33208,-0.00237457916366968,0.00996992547394222,-0.0219156330925964,0.0171664747652571,0.811751549162479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD46,Membrane cofactor protein,33052,-0.00271971771701802,0.0114512173339265,-0.0251641036915139,0.0197246682574779,0.812270945941851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A1,Collagen alpha-1(IX) chain,33109,-0.00458527467818623,0.0193372161957379,-0.0424862184218325,0.0333156690654601,0.812567944858863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCTN3,Tectonic-3,32042,-0.00284300860988067,0.0120141572286363,-0.0263907567780079,0.0207047395582465,0.812943863834377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD34,Hematopoietic progenitor cell antigen CD34,33160,0.00233091684808821,0.00991396252778215,-0.0171004497063648,0.0217622834025412,0.814125353563894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGN,Secretagogin,32981,0.0042363630492701,0.0180770036285977,-0.0311945640627814,0.0396672901613216,0.81471815651801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGED1,Melanoma-associated antigen D1,32951,0.00466739776268746,0.0199684450405785,-0.0344707545168464,0.0438055500422213,0.815193495308815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB6,Serpin B6,33153,-0.00582279225591369,0.0249650454571766,-0.0547542813519799,0.0431086968401525,0.815582242213388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK2,Docking protein 2,33117,-0.0116991558117122,0.0505235315586496,-0.110725277666665,0.0873269660432411,0.816886370927763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBP,Protein AMBP,33174,0.00183154919176579,0.00792396048144881,-0.0136994133518739,0.0173625117354054,0.817210975703235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC134,Coiled-coil domain-containing protein 134,31990,-0.0046878949980313,0.0203035708862482,-0.0444828939350778,0.0351071039390152,0.817406391331329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSPN,Claspin,32899,0.00323884874426293,0.0140787795800516,-0.0243555592326382,0.030833256721164,0.81805708015031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS9,Galectin-9,33122,-0.00309335815558006,0.013475043330923,-0.0295044430841891,0.023317726773029,0.818437538193586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,32006,0.00813180596409162,0.0356301596741432,-0.061703306997229,0.0779669189254122,0.819475044008021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRM1,Muscarinic acetylcholine receptor M1,31826,-0.00335985566878921,0.0147257009479472,-0.0322222295267657,0.0255025181891873,0.81952608504149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP1,Src kinase-associated phosphoprotein 1,33030,0.00698058141611806,0.0305969405855573,-0.0529894221315743,0.0669505849638104,0.819537877997884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UGDH,UDP-glucose 6-dehydrogenase,31791,-0.00946494038311168,0.0416999457099297,-0.091196833974574,0.0722669532083506,0.820447728542265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED1,Transmembrane emp24 domain-containing protein 1,31908,-0.00503151381240147,0.0222693679128276,-0.0486794749215436,0.0386164472967407,0.821255228598011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTproBNP,N-terminal prohormone of brain natriuretic peptide,33117,0.00909504634230642,0.0403206450238783,-0.069933417904495,0.0881235105891079,0.821542769048193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,32020,-0.00615441619906856,0.0272928681791881,-0.0596484378302772,0.0473396054321401,0.821599993044385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF23,Fibroblast growth factor 23,33173,-0.00571172319753978,0.0254459898727562,-0.0555858633481419,0.0441624169530624,0.822401090411255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10,Interleukin-10,32981,0.00785796841665315,0.035111197886267,-0.0609599794404301,0.0766759162737364,0.822916465638087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASH1,Tubulinyl-Tyr carboxypeptidase 1,33109,-0.00759728837189205,0.0339686392128552,-0.0741758212290883,0.0589812444853042,0.823030299615769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHBP,Corticotropin-releasing factor-binding protein,33121,-0.00261916706020191,0.0117338465876082,-0.0256175063719139,0.0203791722515101,0.823373669919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF1,Trefoil factor 1,33073,-0.0071154686192219,0.0318844108512214,-0.0696089138876159,0.0553779766491721,0.823412767083572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,32973,0.00533624985046411,0.0240851244522815,-0.0418705940760077,0.0525430937769359,0.824663359722427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD4,T-cell surface glycoprotein CD4,33091,0.00283361229462993,0.0127934593068228,-0.0222415679467427,0.0279087925360026,0.824716826862868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7orf50,Uncharacterized protein C7orf50,32006,-0.00212508132358141,0.0096154933070295,-0.0209714482053592,0.0167212855581964,0.825093765925828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TINAGL1,Tubulointerstitial nephritis antigen-like,33090,0.00199863458350741,0.00909725316436034,-0.0158319816186389,0.0198292507856537,0.826112730196634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL1,Delta-like protein 1,33126,-0.00265141039406472,0.012070279671455,-0.0263091585501165,0.0210063377619871,0.826137723536526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRBP,Acrosin-binding protein,31990,-0.00343947755943159,0.0157012945037045,-0.0342140147866925,0.0273350596678293,0.826611622190577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP3,Metalloproteinase inhibitor 3,33167,-0.0120600295296288,0.0551181226417713,-0.120091549907501,0.095971490848243,0.82680836571366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK4,Interleukin-1 receptor-associated kinase 4,33109,-0.00939260064116389,0.043000446909915,-0.0936734765845973,0.0748882753022695,0.827099005984509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN1,Dynactin subunit 1,33189,0.00591373817062741,0.0271402343711054,-0.0472811211967392,0.059108597537994,0.827515529162028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOC1,Apolipoprotein C-I,32051,0.00328675145378153,0.0150858123574332,-0.0262814407667876,0.0328549436743506,0.827535967210783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC2,Stanniocalcin-2,33105,0.0023969298334332,0.0110153532450794,-0.0191931625269224,0.0239870221937888,0.827746695597351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK9,Proprotein convertase subtilisin/kexin type 9,33208,0.00343957180144555,0.015814383761003,-0.0275566203701202,0.0344357639730113,0.827826566988675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMC3,Structural maintenance of chromosomes protein 3,31793,-0.00493853689167895,0.022813224290127,-0.0496524565003278,0.0397753827169699,0.828622016540495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP2,Guanylate-binding protein 2,32981,0.00534279820844041,0.0246855561637288,-0.043040891872468,0.0537264882893488,0.828654498778473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,31780,0.00474920443172842,0.021944183900144,-0.0382613960125538,0.0477598048760106,0.828664833883983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIF,Leukemia inhibitory factor,32911,0.0045763305666318,0.0211492620722757,-0.0368762230950285,0.0460288842282921,0.828694810372814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN4,Prefoldin subunit 4,31793,0.00483324526245675,0.0224153428761487,-0.0391008267747946,0.0487673172997081,0.82928824988911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,31791,0.00518047427875207,0.0241003208969314,-0.0420561546792335,0.0524171032367376,0.829808705800023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEMP1,Mast cell-expressed membrane protein 1,31816,-0.00824903387066846,0.0384217265561524,-0.0835556179207272,0.0670575501793903,0.830009416434235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLLT1,Protein ENL,31793,0.00629252602048604,0.029331949880716,-0.0511980957457172,0.0637831477866893,0.830141253757195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF20B,Kinesin-like protein KIF20B,31804,0.00698701503766602,0.0326852974956929,-0.057076168053892,0.0710501981292241,0.830735235643756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR5,Complement factor H-related protein 5,31930,-0.0036179709679412,0.0169402005415753,-0.0368207640294287,0.0295848220935463,0.830885808958757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6AP2,Renin receptor,32951,-0.00350331407563774,0.016420271758228,-0.0356870467217645,0.028680418570489,0.831056762289028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CILP,Cartilage intermediate layer protein 1,32044,0.00460567315734677,0.0216570056189407,-0.0378420578557771,0.0470534041704706,0.831594479934077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAM,Cytotoxic and regulatory T-cell molecule,33042,-0.00445486672460896,0.0209859889151417,-0.0455874049982867,0.0366776715490688,0.831895084044646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB1,Transforming growth factor beta-1 proprotein,33197,0.00332435487893328,0.0157258961814192,-0.0274984016366483,0.0341471113945149,0.832585023116577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",31816,0.00406890743018848,0.0192609197242409,-0.0336824952293237,0.0418203100897006,0.832696497221957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCIN,Adseverin,31804,0.00635474923988197,0.0301522306273653,-0.052743622789754,0.0654531212695179,0.83308388457333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR7L,Aflatoxin B1 aldehyde reductase member 4,31816,0.00623384353094994,0.0295888597154546,-0.0517603215113411,0.064228008573241,0.833141161110609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST5,Cystatin-D,32967,0.00482094789191001,0.0228976649355327,-0.0400584753817341,0.0497003711655541,0.833248767954471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD82,CD82 antigen,31908,0.00357976017651025,0.017134978978684,-0.0300047986217105,0.037164318974731,0.834520025962261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EP300,Histone acetyltransferase p300,31816,-0.00265190305872736,0.0127222561121628,-0.0275875250385664,0.0222837189211117,0.834886527880888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNF1A,Hepatocyte nuclear factor 1-alpha,31826,-0.00618589946411998,0.0297168178491681,-0.0644308624484894,0.0520590635202494,0.835108562728812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TET2,Methylcytosine dioxygenase TET2,31897,0.00842436459862565,0.0405881785146224,-0.0711284652900342,0.0879771944872855,0.835580481453453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA1,Pulmonary surfactant-associated protein A1,32951,0.00503670135077424,0.0242765441524104,-0.0425453251879502,0.0526187278894986,0.835646286892586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIL1,Nucleotide exchange factor SIL1,31854,0.00293797184514707,0.0141631264043909,-0.0248217559074591,0.0306976995977533,0.835673446851002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNPO1,Transportin-1,31908,0.00294937264588924,0.0142439009795238,-0.0249686732739775,0.0308674185657559,0.8359669821547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THAP12,52 kDa repressor of the inhibitor of the protein kinase,31780,-0.0078199727999232,0.037896665128694,-0.0820974364521634,0.066457490852317,0.836523340579599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA2,Carboxypeptidase A2,33164,0.00545461125284245,0.0265847713905507,-0.046651540672637,0.0575607631783219,0.837437820530976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK13,Kallikrein-13,32910,0.00368541720830652,0.0179710083897638,-0.0315377592356306,0.0389085936522436,0.837517912826344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BACH1,Transcription regulator protein BACH1,33109,-0.0061612084807931,0.0301016899427856,-0.0651605207686528,0.0528381038070666,0.837827099678403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD248,Endosialin,32044,0.0033612195843931,0.0164361329644345,-0.0288536010258985,0.0355760401946847,0.837966828932271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL26,C-C motif chemokine 26,33109,0.00774017036228148,0.037915149584335,-0.0665735228230151,0.082053863547578,0.838245356410295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBS,Cystathionine beta-synthase,31854,-0.00427142741851122,0.0210592313822013,-0.0455475209276258,0.0370046660906034,0.83927409525451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMVK,Phosphomevalonate kinase,32895,-0.00926758905475279,0.0457071784069122,-0.0988536587323006,0.080318480622795,0.839327482872824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCNA,Proliferating cell nuclear antigen,31793,0.00536598910829345,0.0264708634815877,-0.0465169033156185,0.0572488815322054,0.839364951062058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA10,Ephrin type-A receptor 10,32911,-0.00542359831811112,0.0268035224214185,-0.0579585022640913,0.0471113056278691,0.839650734576991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPSCR1,Tether containing UBX domain for GLUT4,32020,-0.00571238554724324,0.0284182985558873,-0.0614122507167823,0.0499874796222958,0.840695514006241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP7,Dipeptidyl peptidase 2,33037,-0.00492933015266954,0.0245757408148903,-0.0530977821498546,0.0432391218445155,0.841034038300046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEBP1,Heme-binding protein 1,32973,0.00482518391883521,0.0240606300689095,-0.0423336510162274,0.0519840188538978,0.841060945989207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,33042,0.00880105385650527,0.0440656190222443,-0.0775675594270936,0.0951696671401041,0.841699534428134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRKL,Crk-like protein,33135,0.00878145487738143,0.0440669829163501,-0.0775898316386648,0.0951527413934276,0.842052178398395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,32044,-0.0116078360918688,0.05839210778573,-0.1260563673519,0.102840695168162,0.842431417633909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,31854,-0.0034276258265169,0.0175214017756748,-0.0377695733068394,0.0309143216538056,0.844908989177808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC9,Thioredoxin domain-containing protein 9,32006,-0.00435049606176578,0.0222980156880287,-0.048054606810302,0.0393536146867704,0.845314531168565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF2,Alpha-2-antiplasmin,31935,-0.00111492299126515,0.00572971500144189,-0.0123451643940912,0.0101153184115609,0.845722255011708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLMAP,Sarcolemmal membrane-associated protein,31998,-0.0067169128213073,0.0345300440513439,-0.0743957991619414,0.0609619735193268,0.845771056527574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFAP1,Actin filament-associated protein 1,31907,-0.00694746262511865,0.0357293888570499,-0.0769770647849364,0.0630821395346991,0.84583140555977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG3,BAG family molecular chaperone regulator 3,33024,0.00309593087664594,0.0159545938478918,-0.028175073065222,0.0343669348185139,0.846144179003699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLOD4,Glyoxalase domain-containing protein 4,33107,-0.00293219698385234,0.0151761675671138,-0.0326774854153954,0.0268130914476907,0.846798543209046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJAP1,Tight junction-associated protein 1,33126,-0.00654618369469672,0.0341120552661557,-0.0734058120163618,0.0603134446269684,0.847823185776975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAP,Cartilage-associated protein,31826,0.00385763666379972,0.020106720503001,-0.0355515355220823,0.0432668088496817,0.847858662312492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUOX2,Dual oxidase 2,32973,0.0057953638771694,0.0303448531794057,-0.0536805483544657,0.0652712761088046,0.848543132077055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL3,Angiopoietin-related protein 3,33111,-0.0028573892160884,0.0149993217727701,-0.0322560598907178,0.026541281458541,0.848920846900693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOB,Elongin-B,31791,0.00311184663555633,0.0163707221168797,-0.028974768713528,0.0351984619846406,0.849246923410786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR3,Anterior gradient protein 3,32932,-0.00466682452530371,0.0246250776240853,-0.0529319766685109,0.0435983276179035,0.849693642002299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL4,Delta-like protein 4,31854,0.00694497136841139,0.0368772402575098,-0.0653344195363079,0.0792243622731307,0.850625667726567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRH,Receptor-type tyrosine-protein phosphatase H,31998,-0.00366224695099019,0.0196959569397122,-0.0422663225528261,0.0349418286508457,0.852497579236205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM58,E3 ubiquitin-protein ligase TRIM58,31990,-0.0066822865466874,0.0359386077094554,-0.07712195765722,0.0637573845638452,0.852499831719869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMP,Cartilage oligomeric matrix protein,33016,0.00256374029049846,0.013805454742463,-0.0244949510047291,0.029622431585726,0.852680600683225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,31816,-0.00273749059354177,0.0147440956147711,-0.0316359179984932,0.0261609368114097,0.852711096925453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDHB,Succinate dehydrogenase,31998,-0.00531154660848056,0.0287485380972158,-0.0616586812790235,0.0510355880620624,0.853423156393567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TADA3,Transcriptional adapter 3,31990,0.00303487701581959,0.0164430116484219,-0.0291934258150874,0.0352631798467265,0.853571743316183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF830,Zinc finger protein 830,31990,-0.00609741909797268,0.0332461987891743,-0.0712599687247543,0.0590651305288089,0.85448754536146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA1,Glucosamine-6-phosphate isomerase 1,31854,0.00258851867527343,0.0141561774993306,-0.0251575892234145,0.0303346265739613,0.854917307947409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP170,Centrosomal protein of 170 kDa,31854,0.0058933465278998,0.0322690769300205,-0.0573540442549404,0.06914073731074,0.855092250710289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX3,Probable E3 ubiquitin-protein ligase DTX3,33062,-0.00184429968902052,0.0101132769869951,-0.021666322583531,0.0179777232054899,0.855301210585474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESM1,Endothelial cell-specific molecule 1,33121,-0.00256442388357944,0.0140624579414664,-0.0301268414488537,0.0249979936816948,0.85530481064766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRXN3,Neurexin-3,31826,0.00263429274954479,0.0144904175392659,-0.0257669256274164,0.031035511126506,0.855748210426907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,33109,0.0110391121108775,0.0608155849573228,-0.108159434405475,0.13023765862723,0.855965400534849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAMPT,Nicotinamide phosphoribosyltransferase,32951,-0.00408366638696616,0.022556751172427,-0.0482948986849231,0.0401275659109908,0.856340769134641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RA,Interleukin-17 receptor A,33121,0.00326077483444628,0.0181211660342022,-0.03225671059259,0.0387782602614826,0.857201615746097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REXO2,"Oligoribonuclease, mitochondrial",31791,-0.00377158228568181,0.0209835709544164,-0.044899381356338,0.0373562167849743,0.857361829538952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNL1,Thioredoxin-like protein 1,31786,0.00711307455496533,0.0396041460268036,-0.0705110516575698,0.0847372007675005,0.857468197704201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPCAT2,Lysophosphatidylcholine acyltransferase 2,33062,0.00304218472557501,0.0169592706249802,-0.0301979856993862,0.0362823551505362,0.857642131262041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA2,GDNF family receptor alpha-2,33062,0.00152528180218648,0.00852447510567543,-0.0151826894049374,0.0182332530093103,0.85799710926413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,32911,0.00345392912382409,0.0193170500766328,-0.0344074890263762,0.0413153472740244,0.858097378173391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP4,Insulin-like growth factor-binding protein 4,33002,0.00299105544762221,0.0167734762399194,-0.0298849579826199,0.0358670688778643,0.858475468463561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK2,SLIT and NTRK-like protein 2,33189,0.00277827167393927,0.0156739364130952,-0.0279426436957273,0.0334991870436058,0.85931280224666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,33150,-0.00555118029852559,0.0313315311615655,-0.0669609813751939,0.0558586207781427,0.859374649736402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIT1,ARF GTPase-activating protein GIT1,31816,-0.00713006686813454,0.0402453114290685,-0.0860108772691087,0.0717507435328396,0.859383536753138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB5,Serpin B5,32973,0.00364289381557143,0.0206028215043494,-0.0367386363329534,0.0440244239640962,0.859657682530175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,33042,0.00452736581556671,0.025654551737929,-0.0457555555907741,0.0548102872219075,0.859925597011079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,31799,-0.00210027177207399,0.0119367591691192,-0.0254963197435477,0.0212957761993997,0.86033813898816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12B,Interleukin-12 subunit beta,33208,-0.00392683322399435,0.0224687711419064,-0.0479656246621308,0.0401119582141421,0.861265588671872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLURP1,Secreted Ly-6/uPAR-related protein 1,31997,-0.0027852475282517,0.0160528377284819,-0.0342488094760763,0.0286783144195729,0.862259156524363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F10,Coagulation factor X,32048,0.00179608432815808,0.010383180497186,-0.0185549494463265,0.0221471181026427,0.862671623480826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,32911,-0.00790255224097257,0.0457144236459616,-0.0975028225870573,0.0816977181051122,0.862759471490314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD2,Leiomodin-2,31804,-0.00460936816477024,0.0266954655492701,-0.0569324806413396,0.0477137443117992,0.862919638734902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX8,Syntaxin-8,33109,0.00352715101399701,0.0204505139101901,-0.0365558562499755,0.0436101582779695,0.863070120453145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB116,Beta-defensin 116,31804,0.00540107796345674,0.0314706198662658,-0.0562813369744242,0.0670834929013377,0.863738753414785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAMD9L,Sterile alpha motif domain-containing protein 9-like,33109,-0.00510050458474976,0.0298257140896858,-0.063558904200534,0.0533578950310345,0.864219656194511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT3,RAC-gamma serine/threonine-protein kinase,32912,-0.00407667574066251,0.0238457714968268,-0.0508143878744431,0.0426610363931181,0.864259219110957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEXN,Nexilin,32048,-0.00480471922059536,0.0281531534822161,-0.059984900045739,0.0503754616045482,0.864492811815303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",32020,0.00308269826544574,0.0181191518010281,-0.0324308392645693,0.0385962357954607,0.864908673822173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC10,Sialic acid-binding Ig-like lectin 10,33109,-0.00231984934633824,0.0136365336094856,-0.0290474552209299,0.0244077565282535,0.864919610649469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2,Prothrombin,32071,-0.0010396693711535,0.00614215251054395,-0.0130782882918196,0.0109989495495126,0.865590402701866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,31793,0.00470136100964869,0.0279926720810652,-0.0501642762692391,0.0595669982885365,0.866627473252318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,31990,-0.00250630129395469,0.0149647611878552,-0.0318372332221509,0.0268246306342416,0.86699671314169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPING1,Plasma protease C1 inhibitor,32051,-0.00127987107077872,0.00765055404116534,-0.0162749569914628,0.0137152148499053,0.867145306925104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM3,Myomesin-3,31907,-0.00629227159649448,0.0377030118849523,-0.080190174891001,0.067605631698012,0.867460795173801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,33117,-0.00346763066291089,0.0207894696719121,-0.0442149912198587,0.0372797298940369,0.867533312065799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICALL2,MICAL-like protein 2,31826,0.00474349503720049,0.0286749536975105,-0.0514594142099202,0.0609464042843211,0.868615636547853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIT,Mast/stem cell growth factor receptor Kit,33127,0.00204259704242968,0.0123493194306805,-0.022162069041704,0.0262472631265634,0.868631758100484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARC,SPARC,33126,0.00482149493834572,0.0292077888580328,-0.0524257712233985,0.0620687611000899,0.868888279720639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENSA,Alpha-endosulfine,31990,-0.00365482342158494,0.0221472930530217,-0.0470635178055075,0.0397538709623377,0.868929924345053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RA,Interleukin-20 receptor subunit alpha,32981,-0.00301900273409704,0.0183542916550692,-0.0389934143780327,0.0329554089098386,0.869353377601984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP2,E3 SUMO-protein ligase RanBP2,31804,-0.00224211417565514,0.0136383916270925,-0.0289733617647564,0.0244891334134461,0.869422941998212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RFC4,Replication factor C subunit 4,31990,-0.00147988936375492,0.00903456585009035,-0.019187638429932,0.0162278597024222,0.869890588834136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,32042,-0.00218579040875998,0.0133563106615641,-0.0283641593054256,0.0239925784879057,0.870009259972529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGM2,Phosphoglucomutase-2,31826,0.00399387554203764,0.0244222322075916,-0.0438736995848419,0.0518614506689171,0.870102157473677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YAP1,Transcriptional coactivator YAP1,32006,-0.00177975707609074,0.0108864806825328,-0.023117259213855,0.0195577450616736,0.870142345775269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC5D,Netrin receptor UNC5D,31816,0.00183611426855726,0.0113165987434413,-0.0203444192685877,0.0240166478057022,0.871113708443808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1A,Protein phosphatase 1A,32951,0.00209909584289296,0.0129589751551245,-0.023300495461151,0.0274986871469369,0.871325390423999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP2B1,AP-2 complex subunit beta,31826,-0.00336074355078305,0.020813124516978,-0.04415446760406,0.0374329805024938,0.871725832547592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHBP1,EH domain-binding protein 1,32042,0.00493940161643621,0.0307020301907485,-0.0552365775574308,0.0651153807903032,0.872190682923526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX4,Probable ATP-dependent RNA helicase DDX4,31816,-0.00363359838719302,0.0226664592311965,-0.0480598584803382,0.0407926617059521,0.872643422748184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GKN1,Gastrokine-1,32738,0.00181839256711817,0.0115578454541442,-0.0208349845230045,0.0244717696572409,0.874988833639396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B3,Testosterone 17-beta-dehydrogenase 3,31791,-0.00323771572875769,0.0205950089846403,-0.0436039333386527,0.0371285018811373,0.875084652963508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK1,Interleukin-1 receptor-associated kinase 1,32981,0.00448753218518978,0.0285862491725991,-0.0515415161931045,0.060516580563484,0.875262595009466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1F,V-type proton ATPase subunit F,32899,-0.00436916233365308,0.0279039528662347,-0.0590609099514732,0.050322585284167,0.875580698195728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100P,Protein S100-P,32973,0.00354742283937234,0.0226886228175981,-0.04092227788312,0.0480171235618646,0.87575888217796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSD1,Tryptase delta,32020,-0.00238081910953848,0.0152748349577251,-0.0323194956266797,0.0275578574076028,0.876143232024446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGMT,Methylated-DNA--protein-cysteine methyltransferase,33109,-0.00789885902890584,0.0508122992746227,-0.107490965607166,0.0916932475493546,0.876468841829105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PITHD1,PITH domain-containing protein 1,31780,-0.00535851729879285,0.0344704880974739,-0.0729206739698417,0.062203639372256,0.876469022733413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CUZD1,CUB and zona pellucida-like domain-containing protein 1,31826,-0.0023975059506724,0.0155607691715362,-0.0328966135268833,0.0281016016255385,0.877555807385285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RICTOR,Rapamycin-insensitive companion of mTOR,31816,0.00315466772553165,0.0205194467105431,-0.0370634478271328,0.0433727832781961,0.877818649983375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK10,Kallikrein-10,33104,0.00247380870213781,0.0162485463454873,-0.0293733421350173,0.0343209595392929,0.878994885783857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA6,Integrin alpha-6,33109,-0.00337873881651155,0.0221935753000154,-0.0468781464045418,0.0401206687715187,0.87900158794412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXADR,Coxsackievirus and adenovirus receptor,33109,-0.0033140596087523,0.0218431314297021,-0.0461265972109684,0.0394984779934638,0.879410605792952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP2,Retinol-binding protein 2,33062,-0.00476023560447364,0.031424240450985,-0.0663517468884043,0.056831275679457,0.879598334664628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15RA,Interleukin-15 receptor subunit alpha,32981,0.00221932846643468,0.0146838757574179,-0.0265610680181044,0.0309997249509737,0.879868451823804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPRKB,EKC/KEOPS complex subunit TPRKB,31793,0.00388412456500399,0.0259070272886599,-0.0468936489207693,0.0546618980507773,0.880827495156786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,33062,0.00283256648314406,0.0189253778106867,-0.0342611740258018,0.03992630699209,0.881028267449656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,33191,0.0016623434509263,0.01111421591199,-0.0201215197365741,0.0234462066384268,0.881108027236054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB5,Integrin beta-5,33126,-0.00234994170452405,0.0157428030115391,-0.0332058356071407,0.0285059521980926,0.881343380238613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5,Eukaryotic translation initiation factor 5,31791,0.00280683637747305,0.0188387309272146,-0.0341170762398675,0.0397307489948136,0.881563361603009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP73,Tumor protein p73,31826,0.00215677034173127,0.014483090426609,-0.0262300868944224,0.0305436275778849,0.881623636656995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF10,Tumor necrosis factor ligand superfamily member 10,33208,-0.00164399682534527,0.0110481657409638,-0.0232984016776343,0.0200104080269438,0.881712751598416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PER3,Period circadian protein homolog 3,31816,-0.00724896410839605,0.0487218491065197,-0.102743788357175,0.0882458601403825,0.881729243237477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEPK,Rab9 effector protein with kelch motifs,32951,-0.0036861061309252,0.0248359238692002,-0.0523645169145576,0.0449923046527072,0.882016162872814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAGLN3,Transgelin-3,31793,-0.003803785511145,0.0256503940724723,-0.0540785578931907,0.0464709868709008,0.882115254850991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TANK,TRAF family member-associated NF-kappa-B activator,32981,0.00427570614228973,0.0288536748768074,-0.0522774966162527,0.0608289089008322,0.882199606981624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDCCAG8,Serologically defined colon cancer antigen 8,31990,0.00693868695454138,0.0469121375149911,-0.0850091025748412,0.098886476483924,0.882419220901982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JCHAIN,Immunoglobulin J chain,32981,-0.00372886641126447,0.0252132066845523,-0.053146751512987,0.045689018690458,0.882430407057522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR2,Interferon gamma receptor 2,33042,-0.00316807359844729,0.0215068136941666,-0.0453214284390137,0.0389852812421192,0.882894287863283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTR,Transthyretin,31984,-0.00153499736036099,0.0104437874982275,-0.0220048208568869,0.0189348261361649,0.883154047345008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK15,Kallikrein-15,31983,-0.00305737820095809,0.0208249889670502,-0.0438743565763765,0.0377596001744604,0.883283587388627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PREB,Prolactin regulatory element-binding protein,32981,-0.00179167686629686,0.0122059360363776,-0.025715311497597,0.0221319577650033,0.883303348046923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL3,C-X-C motif chemokine 3,33122,-0.00574079815323252,0.0391474939256477,-0.0824698862475021,0.070988289941037,0.883415361873484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF5,E3 ubiquitin-protein ligase RNF5,31854,-0.00442564192284474,0.0303488271376694,-0.0639093431126767,0.0550580592669872,0.884062880881167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBLN2,Fibulin-2,32044,-0.00185190100069945,0.0127435602863988,-0.026829279162041,0.0231254771606421,0.884461659855783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK24,Serine/threonine-protein kinase 24,32911,-0.00370107957135081,0.0255720802338782,-0.053822356829752,0.0464201976870504,0.884926499627776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD1C,T-cell surface glycoprotein CD1c,33126,-0.00140340215540119,0.0099468545080762,-0.0208992369912305,0.0180924326804282,0.887802083840417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RG,Cytokine receptor common subunit gamma,31990,-0.00225952757257778,0.0160401991721066,-0.0336983179499067,0.0291792628047511,0.887979129171939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNXB,Tenascin-X,33121,0.00147320944868124,0.0105270762544573,-0.0191598600100551,0.0221062789074176,0.888706865313377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP1,Secreted frizzled-related protein 1,33014,0.00252353564564166,0.0180637534272685,-0.0328814210718047,0.037928492363088,0.888899031049788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IPCEF1,Interactor protein for cytohesin exchange factors 1,33024,-0.00516854888155897,0.0370799201404087,-0.0778451923567601,0.0675080945936421,0.889145700161146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD59,CD59 glycoprotein,32767,-0.00122894518761184,0.0088915984066449,-0.0186564780646358,0.0161985876894122,0.890074477250874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA9,Carbonic anhydrase 9,33189,-0.00253879384572129,0.0183936284694617,-0.0385903056458662,0.0335127179544236,0.890223269819328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLVRB,Flavin reductase,33121,0.0038867991052901,0.0281767763790015,-0.0513396825975528,0.059113280808133,0.890288388257282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN1,Cerebellin-1,31804,-0.00562201207242942,0.0408613472306358,-0.0857102526444755,0.0744662284996167,0.890570174606504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF4,Neurotrophin-4,32951,-0.00229636314678088,0.0168186616801159,-0.035260940039808,0.0306682137462462,0.891400314325186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRAP,BRCA1-associated protein,31933,0.00612027716440552,0.0448690213921613,-0.0818230047642306,0.0940635590930416,0.891506230867309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD3,Extracellular superoxide dismutase,32048,0.00331972226702761,0.0243497780497045,-0.0444058427103933,0.0510452872444485,0.89156022243801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA11,Integrin alpha-11,33109,0.00190499124374164,0.01401368792114,-0.0255618370816928,0.0293718195691761,0.891873537994574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",32911,-0.00169979749262173,0.0125511588188755,-0.0263000687776177,0.0229004737923742,0.892275503004277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMMR,Hyaluronan mediated motility receptor,31781,-0.00275663730505969,0.020363875546514,-0.0426698333762272,0.0371565587661078,0.892323856798032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPRE3,Microtubule-associated protein RP/EB family member 3,31793,0.00783497715708981,0.0583566566788139,-0.106544069933385,0.122214024247565,0.893200494259754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH15,Cadherin-15,33179,-0.00239683487343966,0.017887291715895,-0.0374559266365939,0.0326622568897146,0.893408414685747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",31843,-0.00444104685219627,0.0331641710022487,-0.0694428220166036,0.0605607283122111,0.893476608590254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PENK,Proenkephalin-A,31907,0.00165374610275461,0.0123955015808545,-0.0226414369957202,0.0259489292012295,0.893868767656062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK,Neuroblast differentiation-associated protein AHNAK,31854,0.0017422015021894,0.0132589242143533,-0.024245289957943,0.0277296929623218,0.895463720922353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3A,Regenerating islet-derived protein 3-alpha,33208,-0.00332028144759879,0.0253238729960205,-0.0529550725197989,0.0463145096246013,0.895689164290109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJP3,Tight junction protein ZO-3,31804,-0.00235894624092449,0.0183528910629173,-0.0383306127242423,0.0336127202423933,0.897730954912351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA2,Glucosamine-6-phosphate isomerase 2,31907,0.00193739590130702,0.0151715001624944,-0.0277987444171819,0.031673536219796,0.898390077952995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS2,Growth arrest-specific protein 2,31908,0.00274774554251615,0.021535633215294,-0.03946209555946,0.0449575866444923,0.898476367942285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6ST,Interleukin-6 receptor subunit beta,33117,-0.000900255722810448,0.00708982988581161,-0.0147963222990012,0.0129958108533803,0.898960388571915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1,Huntingtin-interacting protein 1,31791,-0.00179862972050856,0.0142030889747553,-0.029636684111029,0.0260394246700119,0.899231562239198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN9,Septin-9,33062,0.0014788147303027,0.011696126252345,-0.0214455927242936,0.024403222184899,0.89938953510487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD6,T-cell differentiation antigen CD6,33197,-0.00277490782455207,0.0220901572068967,-0.0460716159500696,0.0405218003009654,0.900037686823175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACC3,Transforming acidic coiled-coil-containing protein 3,33062,-0.00606822012979666,0.048399935468871,-0.100932093648784,0.0887956533891905,0.900228326818905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,32951,-0.0023073791695464,0.0184286670471645,-0.0384275665819889,0.0338128082428961,0.900363450810634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH22,Cadherin-22,31908,-0.00156248065211713,0.0125011040571505,-0.0260646446041322,0.0229396832998979,0.900536884953006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QA,Complement C1q subcomponent subunit A,33169,-0.00117837233553231,0.00945711336410191,-0.019714314529172,0.0173575698581074,0.900841761165203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO2,Gamma-enolase,33191,-0.00337308233436606,0.0272503947993203,-0.0567838561410339,0.0500376914723018,0.901491487293363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP1,Integrin beta-1-binding protein 1,32951,-0.00206336303411608,0.0167182912531904,-0.0348312138903693,0.0307044878221371,0.901777840133436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,31908,0.00338949921336879,0.0274921599512583,-0.0504951342910975,0.0572741327178351,0.90188104698114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRH,Corticoliberin,32937,0.00441454717152767,0.0359397208726147,-0.0660273057387971,0.0748564000818524,0.902243056625272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPK1,Thiamin pyrophosphokinase 1,32042,-0.0013748203535589,0.0111985486026647,-0.0233239756147816,0.0205743349076638,0.902294281723676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX16,Syntaxin-16,32951,0.00302043642787703,0.0246284194957294,-0.0452512657837526,0.0512921386395066,0.902394850780439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAL,Integrin alpha-L,31816,-0.00222543718942515,0.0181886584544716,-0.0378752077601896,0.0334243333813393,0.902622786632145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,32981,0.001840202797213,0.0150404222275806,-0.0276390247688451,0.0313194303632711,0.902624341903954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGDS,Prostaglandin-H2 D-isomerase,33042,0.00144685004614531,0.0119657555842809,-0.0220060308990453,0.0248997309913359,0.903760480224382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPL,Periplakin,31816,-0.00158309263631248,0.0131323318964368,-0.0273224631533287,0.0241562778807037,0.904051364489123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNGB3,Cyclic nucleotide-gated cation channel beta-3,31804,-0.00259646455227293,0.0217249452802135,-0.0451773573014913,0.0399844281969454,0.904870341015169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX2,Peroxiredoxin-2,31923,-0.00317675061864089,0.026588776558275,-0.0552907526728599,0.0489372514355782,0.904900573115654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP2,Caspase-2,33109,-0.00333946910265588,0.028024816865171,-0.0582681101583911,0.0515891719530793,0.905150458588932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP1,Ran-specific GTPase-activating protein,31854,-0.00263379873181718,0.022140761068837,-0.0460296904267378,0.0407620929631034,0.905312643133564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ULBP2,UL16-binding protein 2,33042,-0.00179073448804596,0.015260641942634,-0.0317015926956086,0.0281201237195167,0.90659073608235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKAP4,Cytoskeleton-associated protein 4,33170,0.00124221273535019,0.010617290302189,-0.0195676762569403,0.0220521017276407,0.906863512096429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC16,Mucin-16,33062,-0.00908662246447606,0.0782778421177697,-0.162511193015305,0.144337948086352,0.907590524769554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC3B,Tetranectin,31885,-0.00106005703313913,0.00913436494468221,-0.0189634123247163,0.016843298258438,0.907614837176115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REEP4,Receptor expression-enhancing protein 4,32020,0.00295222169283287,0.0255698797948322,-0.0471647427050383,0.0530691860907041,0.908085962142986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENAH,Protein enabled homolog,32981,0.00226979878620197,0.019785722905585,-0.0365102181087447,0.0410498156811486,0.908670536319189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGLL,Monoglyceride lipase,33150,0.00408676128892208,0.0357908134078108,-0.0660632329903871,0.0742367555682313,0.909094060029361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMS1,PMS1 protein homolog 1,31826,0.00233078400712204,0.0204465399602232,-0.0377444343149153,0.0424060023291594,0.909245609296756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTX3,Pentraxin-related protein PTX3,33109,-0.00233579607287612,0.0205490955288724,-0.042612023309466,0.0379404311637138,0.909502787457181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPRIP,Myosin phosphatase Rho-interacting protein,31978,0.00203556253745557,0.0180976679583988,-0.0334358666610061,0.0375069917359172,0.910448593305033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP8,Caspase-8,33161,-0.00287329483437635,0.0256571016514017,-0.0531612140711236,0.0474146244023709,0.910835275540143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCN,Decorin,32973,-0.00103581961702706,0.00927839060409669,-0.0192214652010566,0.0171498259670025,0.911113185807926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM2,Myomesin-2,31791,0.00209688807512789,0.0188189295641145,-0.0347882138705365,0.0389819900207922,0.91128285328577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASHC3,WASH complex subunit 3,32006,-0.00348987490376124,0.0315776873149392,-0.065382142041042,0.0584023922335195,0.912002213049997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",33109,0.0020556650334331,0.0187030730000148,-0.0346023580465959,0.0387136881134621,0.912482863468849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB1,Leukocyte elastase inhibitor,33093,-0.00408032845634021,0.0372013235612938,-0.0769949226364761,0.0688342657237956,0.912663848481324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4C,C-type lectin domain family 4 member C,33109,-0.00205595872735362,0.0187600099298494,-0.0388255781898583,0.0347136607351511,0.912735000253266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPVL,Probable serine carboxypeptidase CPVL,33177,-0.00186632128731229,0.017043781199928,-0.0352721324391712,0.0315394898645466,0.912807172173898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4,Interleukin-4,32981,-0.00398290365366507,0.0369672685741023,-0.0764387500589056,0.0684729427515754,0.914203397131511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3BL1,Uroplakin-3b-like protein 1,31896,0.00233628288367022,0.022024383095676,-0.0408315079838547,0.0455040737511951,0.915524031400499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF22,Kinesin-like protein KIF22,31791,0.00526226697195055,0.0506376139665614,-0.0939874564025098,0.104511990346411,0.91723557887687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLK1,Protein delta homolog 1,33208,-0.00223805719384287,0.0216161142330588,-0.0446056410906381,0.0401295267029523,0.917539539467364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF6,Fibroblast growth factor 6,31816,0.00181795573477961,0.0175919581430252,-0.0326622822255498,0.036298193695109,0.917695818693214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPE,Coatomer subunit epsilon,32911,-0.00192550611320408,0.0187848157314158,-0.038743744946779,0.0348927327203709,0.91835960172946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,31908,-0.00449095974162393,0.0438887791014046,-0.0905129667803769,0.081531047297129,0.918500733045373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF2,Fibroblast growth factor 2,33109,0.00278669380485782,0.0275692525968824,-0.0512490412850316,0.0568224288947473,0.919489475113937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G7,Platelet-activating factor acetylhydrolase,33121,-0.00130258624118393,0.0129708439111013,-0.0267254403069425,0.0241202678245746,0.920009903693279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP8,Ubiquitin carboxyl-terminal hydrolase 8,32973,0.00402460035343199,0.0402145464791903,-0.0747959107457811,0.0828451114526451,0.920284578367027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4R,Reticulon-4 receptor,33189,-0.0013897808322871,0.0138933140038528,-0.0286206762798386,0.0258411146152644,0.920320938726526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FADD,FAS-associated death domain protein,33117,-0.00318475561427914,0.0318841878875111,-0.0656777638738009,0.0593082526452426,0.920437848468544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC9,Sialic acid-binding Ig-like lectin 9,33174,0.00121179070198849,0.0121767349011063,-0.0226546097041798,0.0250781911081568,0.920730170868861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOTL2,Angiomotin-like protein 2,31960,0.00199561263137597,0.0201274331179927,-0.0374541562798898,0.0414453815426417,0.92102270248387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SATB1,DNA-binding protein SATB1,32020,-0.00132112106821283,0.0133760957968105,-0.0275382688299614,0.0248960266935358,0.921325636138973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4G,C-type lectin domain family 4 member G,33109,0.00132280559370585,0.0134587559971946,-0.0250563561607956,0.0277019673482073,0.92170757041827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,33139,0.00442377183436677,0.0459066300220895,-0.0855532230089287,0.0944007666776622,0.923233267394006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORN4,MORN repeat-containing protein 4,31793,0.00312480432722551,0.0324736977777202,-0.0605236433171061,0.0667732519715571,0.923343945853924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1,Integrin beta-1,33096,-0.00084069802409032,0.0089200846520805,-0.0183240639421681,0.0166426678939874,0.924914528671408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3LG,Fms-related tyrosine kinase 3 ligand,33208,0.00126712361848495,0.0135558721636922,-0.0253023858223518,0.0278366330593217,0.925529024289207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF4,Cyclic AMP-dependent transcription factor ATF-4,31793,0.00132354664871451,0.0143018469814005,-0.0267080734348305,0.0293551667322595,0.92626855274025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDC,Aromatic-L-amino-acid decarboxylase,33107,0.00184615426156938,0.020005997507729,-0.0373656008535794,0.0410579093767182,0.926477681756294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH5,Cadherin-5,33208,-0.00115343694245011,0.0125124359322418,-0.0256778113696441,0.0233709374847439,0.926554559075123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCK2,Cytoplasmic protein NCK2,33167,0.00398517975277418,0.0434532149478046,-0.0811831215449229,0.0891534810504712,0.926928998187545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99,CD99 antigen,33121,-0.00071920436258165,0.00790429205840572,-0.0162116167970569,0.0147732080718936,0.927503360108478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC12A2,Solute carrier family 12 member 2,31791,0.00104533506234091,0.011551672483609,-0.0215959430055327,0.0236866131302145,0.927898643688168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SETMAR,Histone-lysine N-methyltransferase SETMAR,33011,-0.00113606561831232,0.0126428723579949,-0.0259160954399823,0.0236439642033576,0.928402009305423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP25,Rho GTPase-activating protein 25,32951,0.00220468241947272,0.0247596445937685,-0.0463242209843136,0.050733585823259,0.929049533545203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC9,Histone deacetylase 9,31804,0.00234715042329008,0.0268141294588672,-0.0502085433160896,0.0549028441626698,0.930249373396612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSCAM,Down syndrome cell adhesion molecule,32020,0.00128233894554964,0.0147269514072251,-0.0275824858126116,0.0301471637037109,0.930614759179058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT17,"Keratin, type I cytoskeletal 17",31791,-0.00136664217590294,0.0159534726475651,-0.0326354485651306,0.0299021642133247,0.931735663418191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRC,Proto-oncogene tyrosine-protein kinase Src,33110,-0.00424237776737637,0.0498258943726055,-0.101901130737683,0.0934163752029305,0.932148850027533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAM,Signal transducing adapter molecule 1,31990,0.00135964415804707,0.0160756895702708,-0.0301487073996838,0.0328679957157779,0.932599408587462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKAP12,A-kinase anchor protein 12,31907,-0.00075400927452826,0.00895839646631291,-0.0183124663485016,0.016804447799445,0.932925212367631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMD,Osteomodulin,33167,0.00155260745602518,0.0184881356168312,-0.0346841383529639,0.0377893532650143,0.933075387676522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRG2,Developmentally-regulated GTP-binding protein 2,33062,-0.00193324771400221,0.0233551208598601,-0.0477092845993281,0.0438427891713236,0.934031433057389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA9,Serpin A9,33013,-0.00248823201849839,0.0300991938876926,-0.0614826520383759,0.0565061880013791,0.934117677818466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON1,Serum paraoxonase/arylesterase 1,32048,-0.0008777593019176,0.0106235133990581,-0.0216998455640715,0.0199443269602363,0.934152534833663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTLC1,Serine palmitoyltransferase 1,32006,-0.00125597145205693,0.0152340922093354,-0.0311147921823544,0.0286028492782405,0.93429520857679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT1,Deaminated glutathione amidase,31854,0.00166177849681524,0.0202852390469676,-0.0380972900352412,0.0414208470288717,0.934712085933341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTN,Neuroplastin,32951,0.00296847587927366,0.0369169357063974,-0.0693887181052653,0.0753256698638126,0.9359133885071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLU,Clusterin,32071,0.00114018922809372,0.0142271601236179,-0.0267450446141973,0.0290254230703848,0.936126638408655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP10,Stromelysin-2,33106,0.00198583614477379,0.0249417226742523,-0.0468999402967607,0.0508716125863083,0.936542088379045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKCQ,Protein kinase C theta type,32981,0.00144533180198492,0.0183425218467523,-0.0345060110176496,0.0373966746216194,0.93719610757502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH23,Cadherin-23,32006,-0.000850639546102593,0.010874429332684,-0.0221645210381632,0.020463241945958,0.937652075798714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSO,Cathepsin O,33208,-0.000992360431257806,0.0127154990762302,-0.025914738620669,0.0239300177581534,0.937795335172442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,31816,0.00196430749043355,0.025197340704131,-0.0474224802896632,0.0513510952705303,0.937864426349149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP1,Prolow-density lipoprotein receptor-related protein 1,33062,-0.000848112634764699,0.0109013392578506,-0.0222147375801518,0.0205185123106224,0.937989797751156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,31804,-0.00201498195446555,0.026019601293035,-0.0530134004888141,0.048983436579883,0.938274893556811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C3,Complement C3,31664,-0.00146268946474109,0.0190275878334743,-0.0387567616183507,0.0358313826888685,0.938727474103999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF11,Tumor necrosis factor ligand superfamily member 11,33109,0.0019228553545183,0.0252228839948582,-0.0475139972754039,0.0513597079844405,0.939234252829889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPB,Natriuretic peptides B,32973,-0.0039305630773691,0.052759886977823,-0.107339941553902,0.099478815399164,0.94061502140524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB2,Pleckstrin homology-like domain family B member 2,31793,0.00295080802545214,0.0397210576791568,-0.0749024650256953,0.0808040810765996,0.940783047175185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGA1,ADP-ribosylation factor-binding protein GGA1,32911,-0.00212104680821442,0.0285930587717838,-0.0581634420009107,0.0539213483844819,0.940868532216593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX2,Neuronal pentraxin-2,32044,-0.000997957356744481,0.0135032161023629,-0.0274642609173757,0.0254683462038868,0.941087796416529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMCN2,Hemicentin-2,31890,0.00173384158384433,0.0236894504660611,-0.0446974813296354,0.048165164497324,0.941656532338668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,33189,0.000916898942745053,0.0125284272040012,-0.0236388183770974,0.0254726162625875,0.941660196990515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18BP,Interleukin-18-binding protein,33138,-0.000919310380237186,0.0125941171372623,-0.0256037799692713,0.0237651592087969,0.941811600149149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN4,Alpha-actinin-4,32981,0.000962756089557529,0.0133174078955272,-0.0251393633856758,0.0270648755647908,0.942370387376853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,31854,-0.00126400500766623,0.0177928131246955,-0.0361379187320694,0.0336099087167369,0.943367680301243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPD1,Glycerol-3-phosphate dehydrogenase,31990,0.00149472565509724,0.0210707596525273,-0.0398039632638563,0.0427934145740508,0.943448675554973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,31908,-0.00245024733957196,0.0352203325147275,-0.0714820990684379,0.066581604389294,0.944538486195724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN2,Nectin-2,33107,0.000807734762385853,0.0116333632535809,-0.0219936572146326,0.0236091267394044,0.944646877325325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIDA,"Axin interactor, dorsalization-associated protein",31826,0.00244225165557065,0.0353105808281253,-0.066766486767555,0.0716509900786963,0.944860262911106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,33138,0.00124279874381775,0.0179934644584563,-0.0340243915947566,0.0365099890823921,0.944935925993604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC27,Cell division cycle protein 27 homolog,32951,-0.00177044115315283,0.0256526874484815,-0.0520497085521765,0.0485088262458708,0.944978653902894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP2,"Fatty acid-binding protein, intestinal",33117,0.00220099346809628,0.0320053605376858,-0.0605295131857679,0.0649315001219604,0.945174662312814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRN,Progranulin,33078,0.000684821828738901,0.0100989123355334,-0.0191090463489065,0.0204786900063843,0.945937305374526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY6D,Lymphocyte antigen 6D,33073,-0.00102974519785462,0.0152311765849667,-0.0308828513043894,0.0288233609086802,0.946099473653528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS1,"Nitric oxide synthase, brain",32911,-0.00139375294035662,0.0206749368453743,-0.0419166291572903,0.0391291232765771,0.946254766709608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLK,STE20-like serine/threonine-protein kinase,31908,0.00220829650221123,0.0328198645097182,-0.0621186379368364,0.0665352309412588,0.946356333114599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZD2,PDZ domain-containing protein 2,31791,-0.00164997440737112,0.0249835254970336,-0.0506176843815571,0.0473177355668148,0.947345790464308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC10A,C-type lectin domain family 10 member A,33042,0.000981183962728095,0.014885895570301,-0.0281951713550618,0.030157539280518,0.947448093495758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MELTF,Melanotransferrin,32042,-0.000776481638673202,0.0117890663523916,-0.0238830516893608,0.0223300884120144,0.947487392986094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIC5,Chloride intracellular channel protein 5,31826,0.000893467450081565,0.0137432651596201,-0.0260433322627737,0.0278302671629369,0.948166770337109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED18,Mediator of RNA polymerase II transcription subunit 18,32951,-0.00206922059914573,0.0318621977803222,-0.0645191282485773,0.0603806870502858,0.948221063887847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APRT,Adenine phosphoribosyltransferase,33029,0.00128215813348314,0.0200095104439779,-0.0379364823367135,0.0405007986036798,0.948910061282692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA2013,Uncharacterized protein KIAA2013,31990,0.00141233160330779,0.0220429710458433,-0.0417918916465451,0.0446165548531606,0.94891479934066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,32973,0.00131191463317817,0.0206467974466626,-0.0391558083622806,0.0417796376286369,0.949337338215013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPE,Ribulose-phosphate 3-epimerase,31908,0.00185113482453965,0.0295326090130055,-0.0560327788409511,0.0597350484900304,0.950022170966209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFA,Vascular endothelial growth factor A,33175,-0.00152121813868199,0.0243573192424842,-0.0492615638539509,0.046219127576587,0.950202523809499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF2,Scavenger receptor class F member 2,33191,-0.000745689397817867,0.0120597494053617,-0.0243827982323268,0.0228914194366911,0.950697309379406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHR,Growth hormone receptor,31907,-0.000717535081813982,0.011873810601259,-0.0239902038602817,0.0225551336966537,0.951814738158053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX15,Sorting nexin-15,31907,0.0013653276663873,0.0228444192705253,-0.0434097341038424,0.046140389436617,0.952343324638711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP4,"Fatty acid-binding protein, adipocyte",33208,0.00118051347934664,0.0199646172516324,-0.0379501363338529,0.0403111632925462,0.952849687418795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYZL1,Quinone oxidoreductase-like protein 1,31854,-0.00225982791732256,0.0384269461763059,-0.0775766424228821,0.0730569865882369,0.953106290879313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY4,Protein canopy homolog 4,33062,-0.00179110447832066,0.0311835443296898,-0.0629108513645127,0.0593286424078713,0.954198033379417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBPL1,Insulin-like growth factor-binding protein-like 1,33117,0.000792460496448741,0.0138217041697098,-0.0262980796761825,0.02788300066908,0.954280060594096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGM2,Protein-glutamine gamma-glutamyltransferase 2,33105,-0.00181739032188407,0.0317221128101503,-0.0639927314297786,0.0603579507860105,0.954314743583448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNN,Tenascin-N,32044,-0.00103487142161378,0.0181655111232426,-0.0366392732231693,0.0345695303799417,0.954571370282786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF2,Trefoil factor 2,33150,0.00131735464866105,0.0231613372189073,-0.0440788663003973,0.0467135755977194,0.954644232344527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN2,Contactin-2,33189,-0.00105471655318259,0.0185829284957446,-0.0374772564048421,0.0353678232984769,0.95473983922222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF12,Tumor necrosis factor ligand superfamily member 12,33208,-0.000680446168822967,0.0119927571269583,-0.0241862501376613,0.0228253578000154,0.954755123687448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP85,Centrosomal protein of 85 kDa,32951,-0.00147147320410493,0.0260588954935784,-0.0525469083715186,0.0496039619633087,0.954970941388722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP4,Dipeptidyl peptidase 4,32952,0.000687769673056137,0.0122677940095398,-0.0233571065856419,0.0247326459317542,0.955292915049534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRF,Receptor-type tyrosine-protein phosphatase F,33208,-0.000660315268282367,0.0117930627585395,-0.0237747182750198,0.0224540877384551,0.955349586232566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPOCK1,Testican-1,33042,0.000553114545653076,0.0102114376602044,-0.0194613032683475,0.0205675323596536,0.956804027121217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS1,Nephrin,31816,0.000769138373307414,0.0143600650348887,-0.0273765890950744,0.0289148658416893,0.957286441619452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD2,Protein disulfide isomerase CRELD2,33150,-0.00111454227073423,0.0212268792330617,-0.0427192255675351,0.0404901410260666,0.958126579633352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",32911,0.00121019621827759,0.0230607223562708,-0.0439888196000131,0.0464092120365683,0.958148523752348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA4,Kallistatin,31932,0.000508061259076092,0.00990832117999692,-0.0189122482537179,0.01992837077187,0.959106785835634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX5,Sorting nexin-5,31854,-0.000648667505515047,0.0127582936044539,-0.0256549229702446,0.0243575879592145,0.959452148902847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,31998,-0.000674074562187368,0.0135649464804206,-0.0272613696638118,0.0259132205394371,0.960368838893896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,33077,0.0035922383338322,0.073992274915185,-0.14143262049993,0.148617097167595,0.961279974135684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,32951,-0.000699662440249242,0.0146607007731326,-0.0294346359555891,0.0280353110750906,0.961937591284411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",33044,-0.00150392146036534,0.031516213180202,-0.0632756992935612,0.0602678563728305,0.961941318739774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX4,Syntaxin-4,33062,0.00115135958892119,0.0252739083855355,-0.0483855008467283,0.0506882200245707,0.963665782122705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDP1,Tyrosyl-DNA phosphodiesterase 1,31990,-0.00132231026715123,0.0291199460222901,-0.0583974044708398,0.0557527839365373,0.963782438049378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHBG,Sex hormone-binding globulin,32048,0.000979011325465826,0.0221774119424848,-0.0424887160818044,0.0444467387327361,0.964790361541953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP5,Platelet glycoprotein V,31907,-0.000650975865281599,0.0147944748504728,-0.0296481465722083,0.0283461948416451,0.964904560129713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARTN,Artemin,32981,-0.00085151964323877,0.0193997037646319,-0.0388749390219172,0.0371718997354397,0.96499037560724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA1,Carbonic anhydrase 1,32908,0.00115981914162256,0.026460652768284,-0.0507030602842141,0.0530226985674593,0.965039480454033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMC3,26S proteasome regulatory subunit 6A,31793,0.000536701071780651,0.0123603625638578,-0.0236896095533806,0.0247630116969419,0.965367004767943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,33107,0.00180830652679938,0.042405898199483,-0.0813072539441873,0.084923866997786,0.965987255228369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53,Cellular tumor antigen p53,32951,0.000743298979432724,0.0177090059470434,-0.0339663526767723,0.0354529506356377,0.966521258717164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1B,T-cell leukemia/lymphoma protein 1B,32973,0.00139515941705104,0.0334133535152282,-0.0640950134727963,0.0668853323068984,0.966695348452647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAM,Peptidyl-glycine alpha-amidating monooxygenase,33166,0.00045304389979961,0.0109274394854404,-0.0209647374916635,0.0218708252912627,0.966930695389236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH6,Cadherin-6,33117,0.000639561288562011,0.0155293142558013,-0.0297978946528085,0.0310770172299325,0.967150054664877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL4,Myosin light chain 4,31854,0.000916316774345839,0.0222882416405708,-0.0427686368411729,0.0446012703898645,0.967207624467284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,31990,-0.00183096543212942,0.0446236507307608,-0.0892933208644206,0.0856313900001618,0.967272047037436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR,GMP reductase 1,33208,-0.000875519617188527,0.021404111417059,-0.0428275779946241,0.0410765387602471,0.967373143530406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN3,Perilipin-3,33117,0.000737314226469676,0.0180253577471255,-0.0345923869578963,0.0360670154108356,0.967373150146047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A2,Collagen alpha-2(IX) chain,31908,-0.000772356804157568,0.0189219350395608,-0.0378593494816967,0.0363146358733816,0.967442029218094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164L2,CD164 sialomucin-like 2 protein,31826,-0.000604973753335536,0.0150729481771267,-0.0301479521805039,0.0289380046738328,0.967985475288494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL5,Insulin-like peptide INSL5,31998,-0.0015476545935666,0.038758636735549,-0.0775145825952427,0.0744192734081095,0.968149532741421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HK2,Hexokinase-2,32973,0.000461116558584786,0.0117135291004458,-0.022497400478289,0.0234196335954585,0.968599388581954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK3,Prostate-specific antigen,32044,0.000915729063401979,0.0235121637339499,-0.0451681118551398,0.0469995699819438,0.968933640551079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM172A,Cotranscriptional regulator FAM172A,31854,-0.000995968940367069,0.0255955585117227,-0.0511632636233435,0.0491713257426093,0.968961767796263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT1A1,Sulfotransferase 1A1,33191,0.00205992094628221,0.053276523419915,-0.102362064956751,0.106481906849316,0.969158598592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD1,Glutamate decarboxylase 1,31793,0.000421221745619156,0.0110232146089807,-0.021184278887983,0.0220267223792213,0.969519499272655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",31804,-0.00084391477811363,0.0227747669768033,-0.0454824580526481,0.0437946284964208,0.970442305658618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A12,Protein S100-A12,32986,-0.00116898238390641,0.0315824239133738,-0.0630705332541191,0.0607325684863063,0.970474947429653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MERTK,Tyrosine-protein kinase Mer,33208,-0.000391841226893848,0.0106155769080729,-0.0211983719667166,0.0204146895129289,0.97055608430577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QL2,Complement C1q-like protein 2,31816,-0.000673097695441572,0.018344795252571,-0.0366288963904808,0.0352827009995976,0.970731996252827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL52,"39S ribosomal protein L52, mitochondrial",31781,0.00038448700776964,0.0105314784480197,-0.020257210750349,0.0210261847658883,0.970878007024766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAVS,Mitochondrial antiviral-signaling protein,32951,-0.00135279879970186,0.0385468707127006,-0.076904665396595,0.0741990677971913,0.972004887599614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERMAP,Erythroid membrane-associated protein,31816,0.000649867386018999,0.018739451398119,-0.0360794573542942,0.0373791921263322,0.972336563320209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIPR1,Vasoactive intestinal polypeptide receptor 1,31854,-0.000355311346953149,0.0102566438856639,-0.0204583333628544,0.0197477106689481,0.972366090912164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,31990,-0.000655303874781935,0.0189787903425419,-0.037853732946164,0.0365431251966001,0.972456852558256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBNL,Drebrin-like protein,33167,0.00131795391120676,0.0382683275628567,-0.0736879681119925,0.076323875934406,0.972527227619276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D1,DCN1-like protein 1,31804,0.00105264390230596,0.0308056482241854,-0.0593264266170974,0.0614317144217093,0.972742130962055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML2,Trem-like transcript 2 protein,33121,0.000466306721805986,0.013647040682853,-0.0262818930165858,0.0272145064601978,0.972743115411166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDRKH,Tudor and KH domain-containing protein,32911,-0.00118377934754904,0.0349850249989959,-0.069754428345581,0.0673868696504829,0.973008133291073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,33121,-0.00035311990320804,0.0105869497856205,-0.0211035414830243,0.0203973016766082,0.973392850400478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHM,Rab proteins geranylgeranyltransferase component A 1,31826,0.000829944309473505,0.0251327078260893,-0.0484301630296614,0.0500900516486084,0.973657555734659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MKI67,Proliferation marker protein Ki-67,31816,0.000555077407178426,0.0168667121091535,-0.0325036783267625,0.0336138331411193,0.973747538025858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSAB1,Tryptase alpha/beta-1,33190,0.000707125338884788,0.0216479146151096,-0.0417227873067301,0.0431370379844997,0.973942620690425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TG,Thyroglobulin,31990,0.0015319777144231,0.0482274293306101,-0.0929937837735726,0.0960577392024188,0.974659746835275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMARCA2,Probable global transcription activator SNF2L2,32911,0.000938722930834631,0.0300599699543183,-0.0579788181796293,0.0598562640412986,0.975088176451647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A3,Protein S100-A3,31990,0.000594818561680999,0.0192596216526048,-0.0371540398774244,0.0383436770007864,0.975362685156769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,31816,-0.000379128835252962,0.0124530108754613,-0.0247870301511571,0.0240287724806512,0.975713179002061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABGAP1L,Rab GTPase-activating protein 1-like,32981,-0.000754841641163286,0.0253714337760242,-0.0504828518421707,0.0489731685598441,0.976265827335905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDGF1,Teratocarcinoma-derived growth factor 1,32911,-0.00170723360109802,0.0586566672713257,-0.116674301452896,0.1132598342507,0.976781109097366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBR,Tumor necrosis factor receptor superfamily member 3,33078,-0.0003197057069091,0.0110915211972961,-0.0220590872536095,0.0214196758397913,0.977005360362437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",32020,0.000560727932873737,0.0194872708304341,-0.0376343228947772,0.0387557787605246,0.977045546796052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN1,Tetraspanin-1,32973,-0.000368662313587185,0.0128200236106397,-0.025495908590441,0.0247585839632666,0.977059262349276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM,Paralemmin-1,31957,-0.000342241156044213,0.0120180641853478,-0.0238976469593258,0.0232131646472374,0.977282287119421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",33030,-0.00111967418596148,0.0396793811649705,-0.0788912612693036,0.0766519128973806,0.977488909138352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAFB2,Scaffold attachment factor B2,32020,-0.00029583308613911,0.0111727365331365,-0.0221943966910867,0.0216027305188085,0.978876681350041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDI2,Isopentenyl-diphosphate delta-isomerase 2,32911,0.000484919893772527,0.0187724923966064,-0.0363091652035761,0.0372790049911212,0.979392420264886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC27A4,Long-chain fatty acid transport protein 4,32911,-0.000693472554574646,0.0272054817000267,-0.054016216686627,0.0526292715774777,0.979664584517245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,33062,0.000414703038371744,0.0170183751060538,-0.0329413121694938,0.0337707182462373,0.980559671781755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF31,E3 ubiquitin-protein ligase RNF31,31816,0.000350348212324985,0.014752655553354,-0.0285648566722489,0.0292655530968989,0.981054145615288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASA1,Ras GTPase-activating protein 1,32911,0.000327220063296926,0.0141243895437222,-0.0273565834423985,0.0280110235689924,0.98151758948423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAV,Integrin alpha-V,33189,-0.000150428299923205,0.00665151710426533,-0.0131874018242833,0.0128865452244368,0.981957386518421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA1A,Heat shock 70 kDa protein 1A,33152,-0.000665019143238231,0.0300766066878435,-0.0596151682514115,0.0582851299649351,0.982360043803642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPG,Macrophage-capping protein,33047,0.000527023960212126,0.0241345258601672,-0.0467766467257156,0.0478306946461398,0.982578541946166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM2,Isthmin-2,32044,-0.000362398315715213,0.0172327628710373,-0.0341386135429482,0.0334138169115178,0.983222586630766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,31990,0.000408209725886016,0.0194775528996822,-0.0377677939574912,0.0385842134092632,0.983279748060292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG2,V-set and immunoglobulin domain-containing protein 2,31990,0.00049617609071741,0.0237019840495532,-0.0459597126464068,0.0469520648278417,0.983298900398353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPDC1,Neural proliferation differentiation and control protein 1,33117,-0.000253208458027755,0.0122771462654074,-0.0243164151382262,0.0238099982221707,0.983545771716529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPK2,SRSF protein kinase 2,33109,-0.000683023320831734,0.0344318306640918,-0.0681694114224516,0.0668033647807882,0.984173880056839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASQ2,Calsequestrin-2,31791,-0.000406083668465269,0.020722841717612,-0.0410228534349848,0.0402106860980543,0.984366231263829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3,Granulocyte colony-stimulating factor,32981,0.000397370707759058,0.0204449925818742,-0.0396748147527143,0.0404695561682324,0.984493675139034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A4,Protein S100-A4,33126,-0.000447968548624363,0.0238022513251671,-0.0471003811459518,0.0462044440487031,0.984984790685199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,33194,-0.000208089652428419,0.011218421035015,-0.0221961948810577,0.0217800155762009,0.985201370924874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCP11,T-complex protein 11 homolog,31908,-0.000445684071543416,0.0252152994015752,-0.0498676708986308,0.048976302755544,0.985898481948756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",31854,-0.000307561626508988,0.0188374266980629,-0.0372289179547123,0.0366137947016943,0.986973832172839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,32951,0.00050916408446712,0.0358510916645376,-0.0697589755780266,0.0707773037469608,0.988669004615658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCT,Secretin,31826,-0.000257322998576666,0.0186361115850506,-0.0367841017052758,0.0362694557081225,0.988983723258739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASL,Neural Wiskott-Aldrich syndrome protein,31816,-0.000351344034453487,0.0254788629873731,-0.0502899154897049,0.0495872274207979,0.988998191209344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1,DNA topoisomerase 1,31998,0.000575921908336543,0.0441001263436892,-0.0858603257252942,0.0870121695419673,0.989580734781644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABHD14B,Protein ABHD14B,33019,-0.000279411985308394,0.0240417374784805,-0.0474012174431301,0.0468423934725134,0.990727501092962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF12,Fibroblast growth factor 12,31816,0.000234183076010531,0.0201577278633833,-0.0392749635362207,0.0397433296882418,0.990731072705125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEK,Angiopoietin-1 receptor,33126,0.000102423543179595,0.00897029936959612,-0.0174793632212288,0.017684210307588,0.990890155476703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF1,Formylglycine-generating enzyme,31816,-0.000333230872673742,0.0292635831845659,-0.0576898539144229,0.0570233921690754,0.990914817433515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF1,Wiskott-Aldrich syndrome protein family member 1,32973,-0.000435988047150747,0.0385063647216422,-0.0759084629015694,0.0750364868072679,0.990966415688593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,33109,0.000462258081552529,0.0413264949910244,-0.0805376721008554,0.0814621882639604,0.991075695050342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCFD2,Multiple coagulation factor deficiency protein 2,33084,-0.000201410532862317,0.0180959734314591,-0.0356695184585221,0.0352666973927974,0.991119881846688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MB,Myoglobin,33208,0.000221921447259889,0.0202053786455011,-0.0393806206979222,0.039824463592442,0.991237032287998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4A,C-type lectin domain family 4 member A,33109,-0.000150669343549437,0.0142606612575982,-0.0281015654084419,0.027800226721343,0.991570444561773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI1,Neuroserpin,31892,-0.000136537183245845,0.0132729136312499,-0.0261514479004957,0.025878373534004,0.991792658989445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,33164,-0.000416891994451221,0.0426383928406493,-0.0839881419621239,0.0831543579732214,0.992199123407417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP2,Dipeptidase 2,33062,0.000112383143378039,0.0115754967382824,-0.0225755904636555,0.0228003567504116,0.992253916643677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK9,Mitogen-activated protein kinase 9,33109,-0.000167658292599843,0.0176523835537285,-0.0347663300579077,0.034431013472708,0.9924222081209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13,Interleukin-13,32981,0.000176383804460155,0.0197260135273233,-0.0384866027090935,0.0388393703180138,0.992865871578571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,31791,-9.79377733740664e-05,0.011862543776536,-0.0233485235753846,0.0231526480286364,0.993412923139926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,31894,0.0001667534061181,0.0203755962563575,-0.0397694152563426,0.0401029220685788,0.993470423555678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOC,Brother of CDO,32973,-7.87733204848887e-05,0.00971796868943729,-0.019125991951782,0.0189684453108122,0.993532652154897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D5,TBC1 domain family member 5,33109,-0.000262693274628803,0.032703436158701,-0.0643614281456828,0.0638360415964252,0.993591174942525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB2,Nuclear factor NF-kappa-B p100 subunit,31908,0.000182545317223854,0.0236710759227851,-0.046212763491435,0.0465778541258827,0.993847184497624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTN,Pleiotrophin,32973,0.000148417245939317,0.0205460499408667,-0.0401218406381595,0.0404186751300381,0.994236589263051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",31854,-9.78967995863231e-05,0.0137685980865325,-0.0270843490491901,0.0268885554500175,0.994327160387053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL46,"39S ribosomal protein L46, mitochondrial",32911,-7.63879875964124e-05,0.0116051332433221,-0.0228224491445077,0.0226696731693149,0.994748310662724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF9,Protein turtle homolog A,32042,-0.00018029598498737,0.0330229952459292,-0.0649053666670085,0.0645447746970338,0.995643946627738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL,Podocalyxin,33062,-3.4854332977534e-05,0.0063953762493401,-0.0125697917816841,0.0125000831157291,0.995651735265236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL4,C-C motif chemokine 4,33139,-0.000145676508273398,0.0282032981378479,-0.0554241408584552,0.0551327878419084,0.995878880037694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERI1,3'-5' exoribonuclease 1,31908,6.83231509865194e-05,0.0147550327155173,-0.0288515409714274,0.0289881872734005,0.996305534137842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX2,Probable E3 ubiquitin-protein ligase DTX2,31826,0.000114351444094889,0.0276727324110505,-0.0541242040815641,0.0543529069697539,0.996703039747499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA12,Serpin A12,32894,-0.000140544851365906,0.0477367337127454,-0.0937045429283469,0.0934234532256151,0.997650968646977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP30,Rho GTPase-activating protein 30,31908,4.28865235611938e-05,0.0156058052739727,-0.0305444918134252,0.0306302648605476,0.997807398976713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13,Tumor necrosis factor ligand superfamily member 13,33167,2.95178163463601e-05,0.0109148131393663,-0.0213635159368116,0.0214225515695043,0.997842280457006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA13,Carbonic anhydrase 13,33007,-3.20788132961957e-05,0.0432072415877058,-0.0847182723251995,0.0846541146986071,0.999407635419047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXIN1,Axin-1,33109,1.707930029462e-05,0.0388270418280932,-0.0760839226827681,0.0761180812833574,0.999649035429831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA4,Carbonic anhydrase 4,33208,3.54679566421921e-06,0.00956008643835398,-0.0187342226235096,0.018741316214838,0.999703992986314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD10,Frizzled-10,31826,2.06811872983088e-06,0.0253975907489781,-0.0497772097492671,0.0497813459867268,0.999935030685547
